text,title,id,project_number,terms,administration,organization,mechanism,year,award_amount,cong_dist,score
"Integrated Cardio-Renal Risk Prediction Models in Type 1 Diabetes    DESCRIPTION (provided by applicant):  This application addresses broad Challenge Area (03) Biomarker Discovery and Validation, and the specific Challenge Topic that this application addresses is: 03-DK-101 Discovery of biomarkers for disease risk, progression or response to therapy in diseases of interest to NIDDK. The Challenge: Despite tremendous progress in treatment, patients with type 1 diabetes continue to die 15 years earlier, experience excess morbidity and have medical costs over 10 times higher than the general population. The risk of coronary artery disease and diabetic nephropathy is still greatly increased and responsible for 80% of deaths in these patients. Diabetic nephropathy and coronary artery disease are intertwined, suggesting common pathways, and yet current risk prediction is inadequate. Study Rationale: Nearly 25% of T1D patients develop end-stage renal disease. The conventional theory is that the sequence of events leading to diabetic nephropathy begins from microalbuminuria, progressing to overt proteinuria and eventual end-stage renal disease. Primary prevention with ACE/ARB treatment usually begins when persistent microalbuminuria is found. However, recent prospective studies using serial measurements of kidney function estimated from serum cystatin C have changed this paradigm by demonstrating that decline in glomerular filtration may begin in the absence of microalbuminuria or continue despite remission of microalbuminuria. By their mid 40's, over 70% of men and 50% of women with type 1 diabetes develop coronary artery calcification (CAC) - a marker of significant atherosclerotic plaque burden. Cardiovascular disease is particularly prevalent among patients with renal disease, but most cardiac events occur in patients with normal albumin excretion rates. Evidence has accumulated that diabetic nephropathy and CAC are parallel, rather than sequential, complications of type 1 diabetes, sharing a number of important predictors. Accurate prediction of the individual's global cardio-renal risk is needed to guide treatment choices. As a result, there is a recognized need for better risk partitioning, either from the discovery of additional biomarkers or the application of superior methods for discrimination of disease states. Our Approach: We are proposing to use the biobank of 652 adults with type 1 diabetes who have been thoroughly genotyped and prospectively followed for development of diabetic nephropathy and coronary artery disease by the Coronary Artery Calcification in Type 1 Diabetes study (CACTI, R01 HL61753, 1999- 2009) to develop and validate integrated biomarker prediction models for cardio-renal complications in type 1 diabetes. Our study aims are the investigation of biomarkers within the well-characterized CACTI cohort for 1) early progressive renal function decline, 2) the presence and progression of coronary artery calcium, and the 3) development of combined renal and cardiovascular disease burden. Renal disease and coronary artery disease (CAD) are the leading causes of death among adults with type 1 diabetes, but traditional screening tests (urinary albumin and serum creatinine) for renal disease are inadequate, and traditional CAD risk factors (dyslipidemia, hypertension, smoking, obesity) do not fully explain the increased burden of disease associated with type 1 diabetes. Renal and cardiovascular complications are intertwined, suggesting shared pathways. Increased systemic inflammation is present in type 1 diabetes and inflammatory mediators such as uric acid, vitamin D and bone metabolism markers have been suggested to play a role in both renal and cardiovascular diseases. As a result, it is of critical public health importance to discover and validate new biomarkers for cardio-renal disease among adults with type 1 diabetes.       PUBLIC HEALTH RELEVANCE:  Renal disease and coronary artery disease (CAD) are the leading causes of death among adults with type 1 diabetes, but traditional screening tests (urinary albumin and serum creatinine) for renal disease are inadequate, and traditional CAD risk factors (dyslipidemia, hypertension, smoking, obesity) do not fully explain the increased burden of disease associated with type 1 diabetes. Renal and cardiovascular complications are intertwined, suggesting shared pathways. Increased systemic inflammation is present in type 1 diabetes and inflammatory mediators such as uric acid, vitamin D and bone metabolism markers have been suggested to play a role in both renal and cardiovascular diseases. As a result, it is of critical public health importance to discover and validate new biomarkers for cardio-renal disease among adults with type 1 diabetes.          Project Narrative  Renal disease and coronary artery disease (CAD) are the leading causes of death among adults with type 1 diabetes, but traditional screening tests (urinary albumin and serum creatinine) for renal disease are inadequate, and traditional CAD risk factors (dyslipidemia, hypertension, smoking, obesity) do not fully explain the increased burden of disease associated with type 1 diabetes. Renal and cardiovascular complications are intertwined, suggesting shared pathways. Increased systemic inflammation is present in type 1 diabetes, and inflammatory mediators such as uric acid, vitamin D and bone metabolism markers have been suggested to play a role in both renal and cardiovascular diseases. As a result, it is of critical public health importance to discover and validate new biomarkers for cardio-renal disease among adults with type 1 diabetes.",Integrated Cardio-Renal Risk Prediction Models in Type 1 Diabetes,7829755,RC1DK086958,"['Disease ', ' disease/disorder ', ' Disorder ', ' Candidate Disease Gene ', ' Candidate Gene ', ' IL6 gene ', ' Interleukin-6 Gene ', ' Interleukin 6 (Interferon, Beta 2) Gene ', ' IL6 ', ' IL-6 Gene ', ' IFNB2 Gene ', ' Hybridoma Growth Factor Gene ', ' Hepatocyte Stimulatory Factor Gene ', ' HSF Gene ', ' Beta-2 Gene Interferon ', ' BSF2 Gene ', ' BSF-2 Gene ', ' B-Cell Stimulatory Factor 2 Gene ', ' B-Cell Differentiation Factor Gene ', ' Address ', ' Estradiol ', ' Therapeutic Estradiol ', ' Progynon ', ' Ovocylin ', ' Ovocyclin ', ' Estraldine ', ' Estradiol-17beta ', ' Estradiol-17 beta ', ' Estrace ', ' Estra-1,3,5(10)-triene-3,17-diol (17beta)- ', ' Diogynets ', ' Diogyn ', ' Dimenformon ', ' Aquadiol ', ' Data ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Validation ', ' Coronary ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Cardiac ', ' urinary ', ' Development ', ' developmental ', ' Arterial Fatty Streak ', ' vulnerable plaque ', ' atherosclerotic plaque ', ' atherosclerotic lesions ', ' atherosclerosis plaque ', ' Atheromatous plaque ', ' Atheromatous degeneration ', ' Atheromatous ', ' Atheroma ', ' Arterial Fatty Streaks ', ' coronary artery calcification ', ' coronary calcification ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Genotype ', ' calcification ', ' Glomerular Filtration Rate ', ' Age ', ' base ', ' Goals ', ' Glycosylated hemoglobin A ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Albumins ', ' Albuminuria ', ' Homocysteine ', ' L-Isomer Homocysteine ', ' 2-amino-4-mercaptobutyric acid ', ' Homocystine ', "" Butanoic acid, 4,4'-dithiobis(2-amino)- "", ' Coronary artery ', ' Heart artery ', ' Cardiac artery ', ' Area ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Medical ', ' Inflammation ', ' Screening procedure ', ' screenings ', ' screening ', ' Excretory function ', ' excretion ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Serum ', ' Blood Serum ', ' Renal function ', ' kidney function ', ' glomerular filtration ', ' Individual ', ' High Density Lipoprotein Cholesterol ', ' alpha-Lipoprotein Cholesterol ', ' HDL Cholesterol Lipoproteins ', ' HDL Cholesterol ', ' Dyslipidemias ', ' Measurement ', ' Inflammation Mediators ', ' inflammatory mediator ', ' men ', "" men's "", ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' chemokine ', ' chemoattractant cytokine ', ' SIS cytokines ', ' Intercrines ', ' Homologous Chemotactic Cytokines ', ' Chemotactic Cytokines ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Patients ', ' Phenotype ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Primary Prevention ', ' Staging ', ' Inflammatory ', ' Prospective Studies ', ' Proteinuria ', ' public health medicine (field) ', ' Public Health ', ' Interleukin 2 Receptor ', ' TCGF Receptors ', ' T-Cell Growth Factor Receptors ', ' IL2 Receptors ', ' IL-2 Receptors ', ' High Affinity Interleukin-2 Receptor ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Serum Albumin ', ' Sex Hormone-Binding Globulin ', ' Testosterone-Estradiol Binding Globulin ', ' Sex Steroid-Binding Protein ', ' Smoke ', ' Smoking ', ' statistics ', ' Interleukin-18 ', ' MGC12320 ', ' Interleukin-18 Precursor ', ' Interleukin-1 Gamma ', ' Interleukin 18 Proprotein ', ' Interleukin 18 (Interferon-Gamma-Inducing Factor) ', ' Interferon-gamma-Inducing Factor ', ' IL1F4 ', ' IL18 Protein ', ' IL-1g ', ' IL-18 ', ' IL-1 Gamma ', ' IGIF ', ' IFN-gamma-Inducing Factor ', ' adiponectin ', ' apM1 (adipose-specific) protein ', ' apM-1 protein ', ' adipocyte, C1q and collagen domain containing protein ', ' adipocyte complement-related protein 30-kDa ', ' ACRP30 protein ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Testing ', ' Testosterone ', ' Trans-Testosterone ', ' Therapeutic Testosterone ', ' Time ', ' Uric Acid ', ' Trioxopurine ', ' 2,6,8-Trihydroxypurine ', ' 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro- ', ' Vitamin D ', ' VIT D ', ' Vitamin D Deficiency ', ' Investigation ', ' Woman ', ' Event ', ' Techniques ', ' Tumor necrosis factor receptor 11b ', ' osteoprotegerin ', ' osteoclastogenesis inhibitory factor ', ' opg gene product ', ' Tumor Necrosis Factor Receptor Superfamily Member 11B ', ' TNFRSF11B gene product ', ' OPG protein ', ' OCIF protein ', ' interest ', ' Disease remission ', ' Remission ', ' Blood ', ' Blood Reticuloendothelial System ', ' bone metabolism ', ' early experience ', ' Biological Neural Networks ', ' neural network ', ' cohort ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Calcium ', ' Factor IV ', ' Coagulation Factor IV ', ' Ca++ element ', ' Blood Coagulation Factor IV ', ' novel ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' post gamma-globulins ', ' post-gamma-protein ', ' cystatin C ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Microalbuminuria ', ' Hyperuricemia ', ' uricacidemia ', ' Cause of Death ', ' cytokine ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' response ', ' theories ', ' lipoprotein-associated phospholipase A(2) ', ' lipoprotein-associated phospholipase A2 ', ' Lp-PLA2 ', ' Lp-PLA(2) ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' predictive modeling ', ' computer based prediction ', ' public health relevance ', ' inflammatory marker ', ' inflammation marker ', ' biomarker ', ' biobank ', ' biorepository ', ' adaptive immunity ', ' Coronary Arteriosclerosis ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Creatinine ', ' 2-amino-1,5-dihydro-1-methyl-4H-imidazol-4-one ', ' Cessation of life ', ' Death ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Diabetic Nephropathy ', ' Diabetic Kidney Disease ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' ']",NIDDK,UNIVERSITY OF COLORADO DENVER,RC1,2010,496938,CO-06,0.09430903316154575
"Digital image analysis for quantitative and qualitative assessment of pig islets    DESCRIPTION (provided by applicant): The demonstration by the Edmonton group that human islet transplantation can be successfully used to manage adult type 1 diabetes patients with refractory hypoglycemia has led to increased funding of clinical trials and further research to extend the scope of this therapy by using porcine islets in place of human islets. Significant advances have been made in improving immunosuppression treatment regimens so that results obtained from treating adult diabetic patients with human islet transplants are similar to those obtained after pancreas transplantation. The major hurdle to move this therapy from clinical research to routine clinical practice is to improve the yield and quality of islets recovered from human or porcine pancreas. Presently, there are no standardized methods that can accurately assess the number or quality of islets that are used in the islet transplantation procedures so that results between laboratories can be objectively evaluated. This grant is focused on developing a robust, islet image analysis software to objectively analyze the number and quality of porcine islets recovered from the pancreas. The two major aims of the project are first to develop an improved image analysis software program that will provide a standardized measurement of the number and mass of porcine islets in a cell preparation. And second, enhance the capabilities of the software program by correlating the image signatures of each porcine islet to an artificial category. Porcine islets of similar size will be handpicked and sorted into three categories based on the shape, border, integrity, or uniformity of dithizone staining. The first software enhancement will find those features in the images that can be used to distinguish the different categories of islets. The second enhancement will assess the feasibility of using machine learning methods to correlate these features with data recovered from the images but also other discrete or continuous variables that are used to characterize the porcine islet preparations. If successful, the ability to use a rapid and objective image analysis methodology will improve the assessment of the number and quality of islets within and between laboratories; correlate image features with success of transplantation as measured by graft survival and insulin independence; and improve the islet isolation methods to achieve favorable islet image scores that are determined by retrospective analysis. The ability of a commercial firm focused on improving islet yields by focusing on tissue dissociation with a leading academic laboratory that has sophisticated expertise in developing software algorithms from microscopic images provides a fresh approach to a difficult medical that needs to be resolved to realize the full potential of islet transplantation to treat adult type 1 diabetic patients.      PUBLIC HEALTH RELEVANCE: An objective, reliable and accurate method for the assessment of islet quantity and quality is paramount to the standardization and subsequent success of islet transplantation as a treatment for type 1 diabetes. Conventional manual methods for determining islet yields using an optical microscope with a calibrated eyepiece reticule are subjective, time consuming and often overestimate islet mass due to sampling errors and erroneous assumptions in the conversion of islet numbers to islet equivalents. The research proposed will utilize recent advances in digital image analysis, including machine learning and pattern recognition, to develop a software algorithm for the rapid characterization of islets destined for transplantation procedures.           An objective, reliable and accurate method for the assessment of islet quantity and quality is paramount to the standardization and subsequent success of islet transplantation as a treatment for type 1 diabetes. Conventional manual methods for determining islet yields using an optical microscope with a calibrated eyepiece reticule are subjective, time consuming and often overestimate islet mass due to sampling errors and erroneous assumptions in the conversion of islet numbers to islet equivalents. The research proposed will utilize recent advances in digital image analysis, including machine learning and pattern recognition, to develop a software algorithm for the rapid characterization of islets destined for transplantation procedures.         ",Digital image analysis for quantitative and qualitative assessment of pig islets,8058009,R43DK091103,"['Standardization ', ' Islet Cell ', ' Pattern Recognition Systems ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Sampling Errors ', ' Dithizon ', ' Diphenylthiocarbazone ', ' Diazenecarbothioic acid, phenyl-, 2-phenylhydrazide ', ' Dithizone ', ' standardize measure ', ' computer imaging ', ' digital imaging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Refractory ', ' Pancreas Grafting ', ' Pancreas Transplantation ', ' Portal Vein ', ' Portal vein structure ', ' Pattern Recognition ', ' Graft Survival ', ' islet transplantation ', ' islet cell transplantation ', ' islet cell transplant ', ' islet beta cell transplantation ', ' Pancreatic Islets Transplantation ', ' Islets of Langerhans Grafting ', ' Islands of Pancreas Transplantation ', ' Islands of Langerhans Transplantation ', ' Islets of Langerhans Transplantation ', ' type 1 diabetic ', ' type I diabetic ', ' islet ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' developing computer software ', ' develop software ', ' software development ', ' Clinical ', ' Grant ', ' Screening procedure ', ' Sampling ', ' Performance ', ' indexing ', ' Diameter ', ' Caliber ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Measurement ', ' LOINC Axis 4 System ', ' System ', ' Biological ', ' Methods ', ' Data Collection ', ' Body Tissues ', ' Tissues ', ' Techniques ', ' Address ', ' Patients ', ' Protocol ', ' Protocols documentation ', ' Recovery ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Proteomics ', ' Adoption ', ' Funding ', ' Data ', ' Structure ', ' Reporting ', ' Research ', ' clinical investigation ', ' Clinical Trials ', ' programs ', ' Stainings ', ' Staining method ', ' Pancreatic ', ' Pancreas ', ' Modification ', ' Shapes ', ' Scientist ', ' Population ', ' Procedures ', ' developmental ', ' Development ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Microscope ', ' Laboratories ', ' Phenotype ', ' Categories ', ' Survival Rate ', ' tool ', ' Algorithms ', ' innovative ', ' innovate ', ' innovation ', ' Outcome ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Predictive Value ', ' Probabilistic Models ', ' Statistical Models ', ' Organ ', ' Method LOINC Axis 6 ', ' Methodology ', ' improved ', ' Medical ', ' Manuals ', ' cell preparation ', ' Feasibility Studies ', ' Drops ', ' clinical practice ', ' Clinical Study ', ' Clinical Research ', ' Biochemical ', ' Preparation ', ' In Vitro ', ' transplant ', ' Transplantation ', ' imaging ', ' Image ', ' base ', ' Genetic ', ' Enzymes ', ' pathway ', ' Pathway interactions ', ' Measures ', ' success ', ' diabetic patient ', ' Time ', ' optical ', ' Optics ', ' computer program/software ', ' Software ', ' Computer software ', ' sorting ', ' Sorting - Cell Movement ', ' Stress ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Stains ', ' suid ', ' porcine ', ' Swine ', ' Suidae ', ' Pigs ', ' Family suidae ', ' Dissociation ', ' Microscopic ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' Clinical Management ', ' immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppressions (Physiology) ', ' Immunosuppression Effect ', ' Natural immunosuppression ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' computer aided ', ' Computer Assisted ', ' digital ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' ']",NIDDK,"VITACYTE, LLC",R43,2011,232329,IN-07,0.006850953964469037
"Exploring Clinically-relevant Image Retrieval for Diabetic Retinopathy Diagnosis    DESCRIPTION (provided by applicant): All people with diabetes have the risk of developing diabetic retinopathy, a vision-threatening complication. Despite advances in diabetes care over the years, diabetic retinopathy remains a potentially devastating complication. Early detection and timely intervention or treatment can reduce the incidence of blindness due to diabetic retinopathy. Recent years, diagnosis based on digital retinal imaging has become an alternative to traditional face-to-face evaluation. The potential benefits of automated analysis of digital images of diabetic retinopathy have been shown in existing studies. However, no current computer-based systems can achieve the same level of performance of human experts. This application takes a new perspective in developing a computer-aided system for improved diagnosis of diabetic retinopathy, by exploring novel computational methods for retrieving clinically-relevant images from archived database with prior diagnosis information, for a given novel image. Images are considered as being clinically relevant if they contain the same types of lesions with similar severity levels. Research and development on content-based retinal image search/retrieval is still in its infancy, with only limited success, largely due to the challenge of explicitly coding expert-knowledge into a computational algorithm. To deal with the challenge, this research project takes a distinctly different approach engaging a machine-learning approach, where a labeled image set is used to train a computer algorithm for analyzing other new images, with the focus of training on similarity in clinical relevance instead of image features. The training is enabled in part by the investigators' existing research on computer-based lesion simulation. One specific aim of the research is to build a content-based image retrieval system that can provide a clinician with instant reference to archival images that are clinically relevant to the image under diagnosis. This is an innovative way of exploiting vast expert knowledge hidden in libraries of previously-diagnosed digital images of diabetic retinopathy for a clinician's improved performance in diagnosis. Another specific aim is to build an image information management system for diabetic retinopathy that supports the deployment of the retrieval system in a realistic clinical setting. In addition to the retrieval system, the direct outcome of the research also includes automated evaluation algorithms for diabetic retinopathy images with potentially improved performance compared with existing methods. In particular, the design of the proposed work allows different configurations of the resultant system according to the specific needs of a physician.      PUBLIC HEALTH RELEVANCE: This project develops a computer-based system for improved diagnosis of diabetic retinopathy, a vision- threatening complication in people with diabetes. Early detection and timely intervention or treatment can reduce the incidence of blindness, and the computer-based system can potentially improve not only the speed but also the accuracy in diagnosing or screening patients with diabetic retinopathy.           This project develops a computer-based system for improved diagnosis of diabetic retinopathy, a vision- threatening complication in people with diabetes. Early detection and timely intervention or treatment can reduce the incidence of blindness, and the computer-based system can potentially improve not only the speed but also the accuracy in diagnosing or screening patients with diabetic retinopathy.         ",Exploring Clinically-relevant Image Retrieval for Diabetic Retinopathy Diagnosis,8192056,R21HS019792,[''],AHRQ,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R21,2011,148255,AZ-09,0.0056277825377048975
"Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study    DESCRIPTION (provided by applicant): Preservation of brain health is a critical goal in the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment. Weight loss and increased physical activity hold promise as potentially effective strategies for this purpose, but are currently unproven in any population. Because unintended weight loss often precedes declines in later life brain health, a randomized controlled clinical trial is necessary, which must feature an effective behavioral intervention that is sustained over a long period of time in a large well characterized cohort. Mounting such a program de novo would be very expensive. Instead, we propose to make use of the ongoing and very successful Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, adding cross-sectional magnetic resonance imaging (MRI) to its extensive data collection protocol. This is feasible: participants in clinical trials have been repeatedly shown to be willing to join brain imaging studies and we have developed successful protocols for maintaining safety, confidentiality, and quality. This is novel: Look AHEAD and the state-of-the-art MRI protocols that we propose provide an unprecedented opportunity to assess the long-term effectiveness of mid-life behavioral changes on brain structure and function and to advance understanding of brain health in diabetes. We address an important public health priority for a rapidly growing and under-studied segment of the US population in a cost-effective manner, leveraging the extensive research resources available from Look AHEAD. We respond to PAR-09-247, which targets ancillary study applications to major NIDDK clinical trials, including Look AHEAD.  We will enroll 496 participants, ages 55-85 years with type 2 diabetes, from 3 Look AHEAD clinics. They will have been randomly assigned 10 years ago when they were obese or overweight, with equal probability, to either an ongoing intensive lifestyle intervention that has induced sustained weight loss and increased physical activity or control condition (diabetes support and education) that has fostered excellent retention. A proven protocol for standardized structural MRI will provide regional brain and ischemic lesion volumes; functional MRI will provide assessments of functional activation, resting state connectivity, and cerebral blood flow. A tested cognitive battery and physical activity assessment will be administered. A comprehensive analysis of these data will make use of established statistical approaches and novel machine-learning methods. Look AHEAD provides extensive 10-year characterizations of participant's health and behavior, their medical care and its cost, and the trial's interventions; state-of-the art data management systems; and provisions for developing public access databases. Our research team includes established and productive experts in brain imaging, diabetes research, behavioral medicine, data and image analysis, neuroepidemiology, and collaboration.   The goal of this project is the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment.",Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study,8162264,R01DK092237,"['Dyslipidemias ', ' Intervention Trial ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Atrophy ', ' Atrophic ', ' preservation ', ' Biologic Preservation ', ' Biological Preservation ', ' Ancillary Study ', ' Clinic ', ' Physical activity ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Cognitive deficits ', ' Reporting ', ' Age ', ' Position ', ' Positioning Attribute ', ' Probability ', ' brain volume ', ' enroll ', ' Enrollment ', ' Public Health ', ' public health medicine (field) ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' aged ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' meetings ', ' primary outcome ', ' clinical care ', ' Over weight ', ' Overweight ', ' co-morbidity ', ' Comorbidity ', ' Data Analysis ', ' Data Analyses ', ' cost-effective ', ' cost effective ', ' Behavioral ', ' Research Resources ', ' Resources ', ' facial ', ' faces ', ' Face ', ' Preventive strategy ', ' Prevention strategy ', ' Amentia ', ' Dementia ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Safety ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Life ', ' intervention effect ', ' insulin resistant ', ' Insulin Resistance ', ' Intracranial Vascular Disorders ', ' Intracranial Vascular Diseases ', ' Cerebrovascular Disease ', ' Brain Vascular Disorders ', ' Cerebrovascular Disorders ', ' cognitive function ', ' Education ', ' Educational aspects ', ' Cognition ', ' Health behavior ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' Event ', ' Area ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Rest ', ' cohort ', ' QOL ', ' Quality of life ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Body Weight decreased ', ' Clinical Study ', ' Clinical Research ', ' Motivation ', ' Fostering ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' public health priorities ', ' secondary outcome ', ' Critiques ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' data management ', ' life style intervention ', ' lifestyle intervention ', ' Cost Savings ', ' brain visualization ', ' Brain imaging ', ' Effectiveness ', ' Goals ', ' Weight ', ' clinical investigation ', ' Clinical Trials ', ' diabetes ', ' Diabetes Mellitus ', ' programs ', ' Collaborations ', ' Measures ', ' Risk Factors ', ' Participant ', ' interest ', ' Caring ', ' Population ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Mediating ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Individual ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Mission ', ' Medical ', ' Methods ', ' Risk ', ' cost ', ' Measurement ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' multidisciplinary ', ' Protocol ', ' Protocols documentation ', ' Outcome ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' Research ', ' LOINC Axis 4 System ', ' System ', ' Testing ', ' Link ', ' Cognitive ', ' Memory ', ' Address ', ' novel ', ' Lifestyle ', ' Life Style ', ' Data ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' preventing ', ' prevent ', ' Time ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Clinical ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Affect ', ' Health ', ' Structure ', ' Data Collection ', ' imaging ', ' Image ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' Behavioral Medicine ', ' ischemic lesion ', ' Randomized Controlled Clinical Trials ', ' cortical atrophy ', ' brain atrophy ', ' cerebral atrophy ', ' information privacy ', ' Confidentiality ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Conduct Clinical Trials ', ' Medical Care Costs ', ' cerebrocirculation ', ' cerebral circulation ', ' cerebral blood flow ', ' Cerebrovascular Circulation ', ' ']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2011,790366,NC-06,0.1268675121939964
"Exploring Clinically-relevant Image Retrieval for Diabetic Retinopathy Diagnosis  Project Summary All people with diabetes have the risk of developing diabetic retinopathy, a vision-threatening complication. Despite advances in diabetes care over the years, diabetic retinopathy remains a potentially devastating complication. Early detection and timely intervention or treatment can reduce the incidence of blindness due to diabetic retinopathy. Recent years, diagnosis based on digital retinal imaging has become an alternative to traditional face-to-face evaluation. The potential benefits of automated analysis of digital images of diabetic retinopathy have been shown in existing studies. However, no current computer-based systems can achieve the same level of performance of human experts. This proposal takes a new perspective in developing a computer-aided system for improved diagnosis of diabetic retinopathy, by exploring novel computational methods for retrieving clinically-relevant images from archived database with prior diagnosis information, for a given novel image. Images are considered as being clinically relevant if they contain the same types of lesions with similar severity levels. Research and development on content-based retinal image search/retrieval is still in its infancy, with only limited success, largely due to the challenge of explicitly coding expert-knowledge into a computational algorithm. To deal with the challenge, this research project takes a distinctly different approach engaging a machine-learning approach, where a labeled image set is used to train a computer algorithm for analyzing other new images, with the focus of training on similarity in clinical relevance instead of image features. The training is enabled in part by the investigators' existing research on computer-based lesion simulation. One specific aim of the research is to build a content-based image retrieval system that can provide a clinician with instant reference to archival images that are clinically relevant to the image under diagnosis. This is an innovative way of exploiting vast expert knowledge hidden in libraries of previously-diagnosed digital images of diabetic retinopathy for a clinician's improved performance in diagnosis. Another specific aim is to build an image information management system for diabetic retinopathy that supports the deployment of the retrieval system in a realistic clinical setting. In addition to the retrieval system, the direct outcome of the research also includes automated evaluation algorithms for diabetic retinopathy images with potentially improved performance compared with existing methods. In particular, the design of the proposed work allows different configurations of the resultant system according to the specific needs of a physician.  Project Narrative This project develops a computer-based system for improved diagnosis of diabetic retinopathy, a vision- threatening complication in people with diabetes. Early detection and timely intervention or treatment can reduce the incidence of blindness, and the computer-based system can potentially improve not only the speed but also the accuracy in diagnosing or screening patients with diabetic retinopathy.",Exploring Clinically-relevant Image Retrieval for Diabetic Retinopathy Diagnosis,8300746,R21HS019792,[''],AHRQ,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R21,2012,151744,AZ-09,0.008745180638455951
"Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study DESCRIPTION (provided by applicant): Preservation of brain health is a critical goal in the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment. Weight loss and increased physical activity hold promise as potentially effective strategies for this purpose, but are currently unproven in any population. Because unintended weight loss often precedes declines in later life brain health, a randomized controlled clinical trial is necessary, which must feature an effective behavioral intervention that is sustained over a long period of time in a large well characterized cohort. Mounting such a program de novo would be very expensive. Instead, we propose to make use of the ongoing and very successful Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, adding cross-sectional magnetic resonance imaging (MRI) to its extensive data collection protocol. This is feasible: participants in clinical trials have been repeatedly shown to be willing to join brain imaging studies and we have developed successful protocols for maintaining safety, confidentiality, and quality. This is novel: Look AHEAD and the state-of-the-art MRI protocols that we propose provide an unprecedented opportunity to assess the long-term effectiveness of mid-life behavioral changes on brain structure and function and to advance understanding of brain health in diabetes. We address an important public health priority for a rapidly growing and under-studied segment of the US population in a cost-effective manner, leveraging the extensive research resources available from Look AHEAD. We respond to PAR-09-247, which targets ancillary study applications to major NIDDK clinical trials, including Look AHEAD. We will enroll 496 participants, ages 55-85 years with type 2 diabetes, from 3 Look AHEAD clinics. They will have been randomly assigned 10 years ago when they were obese or overweight, with equal probability, to either an ongoing intensive lifestyle intervention that has induced sustained weight loss and increased physical activity or control condition (diabetes support and education) that has fostered excellent retention. A proven protocol for standardized structural MRI will provide regional brain and ischemic lesion volumes; functional MRI will provide assessments of functional activation, resting state connectivity, and cerebral blood flow. A tested cognitive battery and physical activity assessment will be administered. A comprehensive analysis of these data will make use of established statistical approaches and novel machine-learning methods. Look AHEAD provides extensive 10-year characterizations of participant's health and behavior, their medical care and its cost, and the trial's interventions; state-of-the art data management systems; and provisions for developing public access databases. Our research team includes established and productive experts in brain imaging, diabetes research, behavioral medicine, data and image analysis, neuroepidemiology, and collaboration. The goal of this project is the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment.",Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study,8333347,R01DK092237,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Behavioral Medicine ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cerebrocirculation ', ' cerebral circulation ', ' cerebral blood flow ', ' Cerebrovascular Circulation ', ' Intracranial Vascular Disorders ', ' Intracranial Vascular Diseases ', ' Cerebrovascular Disease ', ' Brain Vascular Disorders ', ' Cerebrovascular Disorders ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Cognition ', ' co-morbidity ', ' Comorbidity ', ' information privacy ', ' Confidentiality ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Education ', ' Educational aspects ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' Health ', ' Health behavior ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' insulin resistant ', ' Insulin Resistance ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Memory ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Mission ', ' Motivation ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' preservation ', ' Biologic Preservation ', ' Biological Preservation ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' Research ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' Risk Factors ', ' Safety ', ' Testing ', ' Time ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Body Weight decreased ', ' Weight ', ' Measures ', ' Cost Savings ', ' Mediating ', ' Medical Care Costs ', ' Caring ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' brain visualization ', ' Brain imaging ', ' Area ', ' Clinical ', ' Medical ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Physical activity ', ' cortical atrophy ', ' brain atrophy ', ' cerebral atrophy ', ' Individual ', ' Fostering ', ' Dyslipidemias ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Atrophy ', ' Atrophic ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Life ', ' programs ', ' cognitive function ', ' Event ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' LOINC Axis 4 System ', ' System ', ' Amentia ', ' Dementia ', ' Over weight ', ' Overweight ', ' interest ', ' data management ', ' cohort ', ' Structure ', ' Cognitive deficits ', ' novel ', ' Participant ', ' Preventive strategy ', ' Prevention strategy ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Reporting ', ' Intervention Trial ', ' brain volume ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Ancillary Study ', ' Cognitive ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' Behavioral ', ' imaging ', ' Image ', ' cost ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' cost-effective ', ' cost effective ', ' Population ', ' aged ', ' life style intervention ', ' lifestyle intervention ', ' multidisciplinary ', ' ischemic lesion ', ' clinical care ', ' primary outcome ', ' secondary outcome ', ' intervention effect ', ' public health priorities ', ' ']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2012,635910,NC-06,0.1268675121939964
"Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study DESCRIPTION (provided by applicant): Preservation of brain health is a critical goal in the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment. Weight loss and increased physical activity hold promise as potentially effective strategies for this purpose, but are currently unproven in any population. Because unintended weight loss often precedes declines in later life brain health, a randomized controlled clinical trial is necessary, which must feature an effective behavioral intervention that is sustained over a long period of time in a large well characterized cohort. Mounting such a program de novo would be very expensive. Instead, we propose to make use of the ongoing and very successful Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, adding cross-sectional magnetic resonance imaging (MRI) to its extensive data collection protocol. This is feasible: participants in clinical trials have been repeatedly shown to be willing to join brain imaging studies and we have developed successful protocols for maintaining safety, confidentiality, and quality. This is novel: Look AHEAD and the state-of-the-art MRI protocols that we propose provide an unprecedented opportunity to assess the long-term effectiveness of mid-life behavioral changes on brain structure and function and to advance understanding of brain health in diabetes. We address an important public health priority for a rapidly growing and under-studied segment of the US population in a cost-effective manner, leveraging the extensive research resources available from Look AHEAD. We respond to PAR-09-247, which targets ancillary study applications to major NIDDK clinical trials, including Look AHEAD. We will enroll 496 participants, ages 55-85 years with type 2 diabetes, from 3 Look AHEAD clinics. They will have been randomly assigned 10 years ago when they were obese or overweight, with equal probability, to either an ongoing intensive lifestyle intervention that has induced sustained weight loss and increased physical activity or control condition (diabetes support and education) that has fostered excellent retention. A proven protocol for standardized structural MRI will provide regional brain and ischemic lesion volumes; functional MRI will provide assessments of functional activation, resting state connectivity, and cerebral blood flow. A tested cognitive battery and physical activity assessment will be administered. A comprehensive analysis of these data will make use of established statistical approaches and novel machine-learning methods. Look AHEAD provides extensive 10-year characterizations of participant's health and behavior, their medical care and its cost, and the trial's interventions; state-of-the art data management systems; and provisions for developing public access databases. Our research team includes established and productive experts in brain imaging, diabetes research, behavioral medicine, data and image analysis, neuroepidemiology, and collaboration. The goal of this project is the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment.",Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study,8541137,R01DK092237,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Behavioral Medicine ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cerebrocirculation ', ' cerebral circulation ', ' cerebral blood flow ', ' Cerebrovascular Circulation ', ' Intracranial Vascular Disorders ', ' Intracranial Vascular Diseases ', ' Cerebrovascular Disease ', ' Brain Vascular Disorders ', ' Cerebrovascular Disorders ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Cognition ', ' co-morbidity ', ' Comorbidity ', ' information privacy ', ' Confidentiality ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Education ', ' Educational aspects ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' Health ', ' Health behavior ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' insulin resistant ', ' Insulin Resistance ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Memory ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Mission ', ' Motivation ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' preservation ', ' Biologic Preservation ', ' Biological Preservation ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' Research ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' Risk Factors ', ' Safety ', ' Testing ', ' Time ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Body Weight decreased ', ' Weight ', ' Measures ', ' Cost Savings ', ' Mediating ', ' Medical Care Costs ', ' Caring ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' brain visualization ', ' Brain imaging ', ' Area ', ' Clinical ', ' Medical ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Physical activity ', ' cortical atrophy ', ' brain atrophy ', ' cerebral atrophy ', ' Individual ', ' Fostering ', ' Dyslipidemias ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Atrophy ', ' Atrophic ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Life ', ' programs ', ' cognitive function ', ' Event ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' LOINC Axis 4 System ', ' System ', ' Amentia ', ' Dementia ', ' Over weight ', ' Overweight ', ' interest ', ' data management ', ' cohort ', ' Structure ', ' Cognitive deficits ', ' novel ', ' Participant ', ' Preventive strategy ', ' Prevention strategy ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Reporting ', ' Intervention Trial ', ' brain volume ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Ancillary Study ', ' Cognitive ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' Behavioral ', ' imaging ', ' Image ', ' cost ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' cost-effective ', ' cost effective ', ' Population ', ' aged ', ' life style intervention ', ' lifestyle intervention ', ' multidisciplinary ', ' ischemic lesion ', ' clinical care ', ' primary outcome ', ' secondary outcome ', ' intervention effect ', ' public health priorities ', ' ']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2012,326943,NC-06,0.1268675121939964
"Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study DESCRIPTION (provided by applicant): Preservation of brain health is a critical goal in the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment. Weight loss and increased physical activity hold promise as potentially effective strategies for this purpose, but are currently unproven in any population. Because unintended weight loss often precedes declines in later life brain health, a randomized controlled clinical trial is necessary, which must feature an effective behavioral intervention that is sustained over a long period of time in a large well characterized cohort. Mounting such a program de novo would be very expensive. Instead, we propose to make use of the ongoing and very successful Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, adding cross-sectional magnetic resonance imaging (MRI) to its extensive data collection protocol. This is feasible: participants in clinical trials have been repeatedly shown to be willing to join brain imaging studies and we have developed successful protocols for maintaining safety, confidentiality, and quality. This is novel: Look AHEAD and the state-of-the-art MRI protocols that we propose provide an unprecedented opportunity to assess the long-term effectiveness of mid-life behavioral changes on brain structure and function and to advance understanding of brain health in diabetes. We address an important public health priority for a rapidly growing and under-studied segment of the US population in a cost-effective manner, leveraging the extensive research resources available from Look AHEAD. We respond to PAR-09-247, which targets ancillary study applications to major NIDDK clinical trials, including Look AHEAD. We will enroll 496 participants, ages 55-85 years with type 2 diabetes, from 3 Look AHEAD clinics. They will have been randomly assigned 10 years ago when they were obese or overweight, with equal probability, to either an ongoing intensive lifestyle intervention that has induced sustained weight loss and increased physical activity or control condition (diabetes support and education) that has fostered excellent retention. A proven protocol for standardized structural MRI will provide regional brain and ischemic lesion volumes; functional MRI will provide assessments of functional activation, resting state connectivity, and cerebral blood flow. A tested cognitive battery and physical activity assessment will be administered. A comprehensive analysis of these data will make use of established statistical approaches and novel machine-learning methods. Look AHEAD provides extensive 10-year characterizations of participant's health and behavior, their medical care and its cost, and the trial's interventions; state-of-the art data management systems; and provisions for developing public access databases. Our research team includes established and productive experts in brain imaging, diabetes research, behavioral medicine, data and image analysis, neuroepidemiology, and collaboration. The goal of this project is the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment.",Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study,8581053,R01DK092237,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Behavioral Medicine ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cerebrocirculation ', ' cerebral circulation ', ' cerebral blood flow ', ' Cerebrovascular Circulation ', ' Intracranial Vascular Disorders ', ' Intracranial Vascular Diseases ', ' Cerebrovascular Disease ', ' Brain Vascular Disorders ', ' Cerebrovascular Disorders ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Cognition ', ' co-morbidity ', ' Comorbidity ', ' information privacy ', ' Confidentiality ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Education ', ' Educational aspects ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' Health ', ' Health behavior ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' insulin resistant ', ' Insulin Resistance ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Memory ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Mission ', ' Motivation ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' preservation ', ' Biologic Preservation ', ' Biological Preservation ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' Research ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' Risk Factors ', ' Safety ', ' Testing ', ' Time ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Body Weight decreased ', ' Weight ', ' Measures ', ' Cost Savings ', ' Mediating ', ' Medical Care Costs ', ' Caring ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' brain visualization ', ' Brain imaging ', ' Area ', ' Clinical ', ' Medical ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Physical activity ', ' cortical atrophy ', ' brain atrophy ', ' cerebral atrophy ', ' Individual ', ' Fostering ', ' Dyslipidemias ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Atrophy ', ' Atrophic ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Life ', ' programs ', ' cognitive function ', ' Event ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' LOINC Axis 4 System ', ' System ', ' Amentia ', ' Dementia ', ' Over weight ', ' Overweight ', ' interest ', ' data management ', ' cohort ', ' Structure ', ' Cognitive deficits ', ' novel ', ' Participant ', ' Preventive strategy ', ' Prevention strategy ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Reporting ', ' Intervention Trial ', ' brain volume ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Ancillary Study ', ' Cognitive ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' Behavioral ', ' imaging ', ' Image ', ' cost ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' cost-effective ', ' cost effective ', ' Population ', ' aged ', ' life style intervention ', ' lifestyle intervention ', ' multidisciplinary ', ' ischemic lesion ', ' clinical care ', ' primary outcome ', ' secondary outcome ', ' intervention effect ', ' public health priorities ', ' ']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2013,649018,NC-06,0.1268675121939964
"Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study DESCRIPTION (provided by applicant): Preservation of brain health is a critical goal in the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment. Weight loss and increased physical activity hold promise as potentially effective strategies for this purpose, but are currently unproven in any population. Because unintended weight loss often precedes declines in later life brain health, a randomized controlled clinical trial is necessary, which must feature an effective behavioral intervention that is sustained over a long period of time in a large well characterized cohort. Mounting such a program de novo would be very expensive. Instead, we propose to make use of the ongoing and very successful Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, adding cross-sectional magnetic resonance imaging (MRI) to its extensive data collection protocol. This is feasible: participants in clinical trials have been repeatedly shown to be willing to join brain imaging studies and we have developed successful protocols for maintaining safety, confidentiality, and quality. This is novel: Look AHEAD and the state-of-the-art MRI protocols that we propose provide an unprecedented opportunity to assess the long-term effectiveness of mid-life behavioral changes on brain structure and function and to advance understanding of brain health in diabetes. We address an important public health priority for a rapidly growing and under-studied segment of the US population in a cost-effective manner, leveraging the extensive research resources available from Look AHEAD. We respond to PAR-09-247, which targets ancillary study applications to major NIDDK clinical trials, including Look AHEAD. We will enroll 496 participants, ages 55-85 years with type 2 diabetes, from 3 Look AHEAD clinics. They will have been randomly assigned 10 years ago when they were obese or overweight, with equal probability, to either an ongoing intensive lifestyle intervention that has induced sustained weight loss and increased physical activity or control condition (diabetes support and education) that has fostered excellent retention. A proven protocol for standardized structural MRI will provide regional brain and ischemic lesion volumes; functional MRI will provide assessments of functional activation, resting state connectivity, and cerebral blood flow. A tested cognitive battery and physical activity assessment will be administered. A comprehensive analysis of these data will make use of established statistical approaches and novel machine-learning methods. Look AHEAD provides extensive 10-year characterizations of participant's health and behavior, their medical care and its cost, and the trial's interventions; state-of-the art data management systems; and provisions for developing public access databases. Our research team includes established and productive experts in brain imaging, diabetes research, behavioral medicine, data and image analysis, neuroepidemiology, and collaboration. The goal of this project is the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment.",Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study,8538960,R01DK092237,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Behavioral Medicine ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cerebrocirculation ', ' cerebral circulation ', ' cerebral blood flow ', ' Cerebrovascular Circulation ', ' Intracranial Vascular Disorders ', ' Intracranial Vascular Diseases ', ' Cerebrovascular Disease ', ' Brain Vascular Disorders ', ' Cerebrovascular Disorders ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Cognition ', ' co-morbidity ', ' Comorbidity ', ' information privacy ', ' Confidentiality ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Education ', ' Educational aspects ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' Health ', ' Health behavior ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' insulin resistant ', ' Insulin Resistance ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Memory ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Mission ', ' Motivation ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' preservation ', ' Biologic Preservation ', ' Biological Preservation ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' Research ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' Risk Factors ', ' Safety ', ' Testing ', ' Time ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Body Weight decreased ', ' Weight ', ' Measures ', ' Cost Savings ', ' Mediating ', ' Medical Care Costs ', ' Caring ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' brain visualization ', ' Brain imaging ', ' Area ', ' Clinical ', ' Medical ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Physical activity ', ' cortical atrophy ', ' brain atrophy ', ' cerebral atrophy ', ' Individual ', ' Fostering ', ' Dyslipidemias ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Atrophy ', ' Atrophic ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Life ', ' programs ', ' cognitive function ', ' Event ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' LOINC Axis 4 System ', ' System ', ' Amentia ', ' Dementia ', ' Over weight ', ' Overweight ', ' interest ', ' data management ', ' cohort ', ' Structure ', ' Cognitive deficits ', ' novel ', ' Participant ', ' Preventive strategy ', ' Prevention strategy ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Reporting ', ' Intervention Trial ', ' brain volume ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Ancillary Study ', ' Cognitive ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' Behavioral ', ' imaging ', ' Image ', ' cost ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' cost-effective ', ' cost effective ', ' Population ', ' aged ', ' life style intervention ', ' lifestyle intervention ', ' multidisciplinary ', ' ischemic lesion ', ' clinical care ', ' primary outcome ', ' secondary outcome ', ' intervention effect ', ' public health priorities ', ' ']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2013,581285,NC-06,0.1268675121939964
"Optical Tomographic Imaging of Peripheral Arterial Disease     DESCRIPTION (provided by applicant): We propose to build and test a dynamic vascular optical tomographic imaging (DVOTI) system that can be used to detect and monitor peripheral arterial disease (PAD). PAD is estimated to affect approximately 8 to 12 million individuals in the United States. However, the disease is considerably under-diagnosed, since most patients are asymptomatic and no single reliable screening modality has been established. Most of the undiagnosed and untreated patients are diabetics. They commonly suffer from peripheral neuropathy and hence do not sense and report symptoms (such as pain) that are early signs of the disease. Consequently more than 60% (~65,000 per year) of all lower extremity amputations in the United States are performed in diabetic patients with PAD. With the number of diabetic patients expected to triple and reach almost 100 million by 2050, the problems related to undiagnosed PAD will only rise in the years to come  The most widely used diagnostic test for PAD, determination of the ankle-brachial index (ABI) in conjunction with pulse-volume recordings (PVR), is known to be unreliable for diabetics. And even in non- diabetics, ABI with PVR and all other existing diagnostic tests (such as Duplex Ultrasound or Magnetic resonance angiography), only provides accurate information about proximal occlusions in major arteries of the leg. However, none of these tests assess the distal perfusion of the foot where most complications, such as ulcers and gangrene, typically occur. Monitoring the success of surgical interventions, such as angioplasty or bypass surgery, suffers from the same shortcomings, as physicians are limited to the same suite of tests that are inadequate to assess the perfusion of the foot.  Dynamic VOTI promises to overcome the limitations of current diagnostic and monitoring techniques and has the potential to initiate a paradigm shift concerning how vascular diseases are assessed. In preliminary studies we have shown that DVOTI can provide three-dimensional time-series images that provide valuable information about the perfusion of the vascular bed in feet of PAD patients. The near-infrared light used in the instrument has no adverse health effects and measurements can be repeated frequently to monitor post interventional progress. Therefore, we believe that DVOTI will prove to be a safe and accurate method to diagnose and monitor PAD in non-diabetic and diabetic patients.         PUBLIC HEALTH RELEVANCE: We propose to build and test a novel optical imaging system that will allow for the diagnosis and monitoring of peripheral artery disease (PAD), which affects approximately 8 to 12 million individuals in the United States. The disease is considerably under-diagnosed, especially in diabetic patients, the elderly, and patients with kidney disease. The system will address an unmet need to directly assess the degree of blood perfusion in the feet, where most PAD-related complications occur, which lead to over 65,000 amputations each year.            ",Optical Tomographic Imaging of Peripheral Arterial Disease,8580503,R01HL115336,"['Accounting ', ' Affect ', ' Air ', ' Algorithms ', ' Amputation ', ' Tarsus ', ' Tarsal Bone ', ' Regio tarsalis ', ' Ankle ', ' Arteries ', ' vascular ', ' Blood Vessels ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Diffusion ', ' disease/disorder ', ' Disorder ', ' Disease ', ' foot ', ' Gangrene ', ' Head ', ' Health ', ' Image Reconstructions ', ' indexing ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' Photoradiation ', ' Light ', ' Maps ', ' Methods ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' optical ', ' Optics ', ' Painful ', ' Pain ', ' Patients ', ' Perfusion ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Peripheral Nervous System Diseases ', ' Physicians ', ' Risk ', ' Sensitivity and Specificity ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Ulceration ', ' Ulcer ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' United States ', ' vasculopathy ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Measures ', ' Treatment outcome ', ' Diagnostic tests ', ' intraluminal angioplasty ', ' Angioplasty ', ' evaluation/testing ', ' Procedures ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Distal ', ' Medical ', ' Series ', ' Ensure ', ' Individual ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' MRI Angiography ', ' Magnetic Resonance Angiography ', ' tool ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Diagnostic Procedure ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' early detection ', ' Early Diagnosis ', ' experience ', ' light emission ', ' success ', ' vascular bed ', ' perfusion (blood) ', ' novel ', ' Modality ', ' Devices ', ' Reporting ', ' Bypass ', ' Coding System ', ' Code ', ' Statistical Methods ', ' LOINC Axis 2 Property ', ' Property ', ' theories ', ' Leg ', ' Address ', ' Preventive ', ' Symptoms ', ' Data ', ' Detection ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' post intervention ', ' optical imaging ', ' optic imaging ', ' designing ', ' design ', ' elderly patient ', ' older patient ', ' data acquisition ', ' healthy volunteer ', ' nondiabetic ', ' non-diabetic ', ' prototype ', ' tissue phantom ', ' public health relevance ', ' treatment response ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' diabetic patient ', ' screening ', ' ']",NHLBI,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2013,469362,NY-13,0.010743813042986048
"Optical Tomographic Imaging of Peripheral Arterial Disease     DESCRIPTION (provided by applicant): We propose to build and test a dynamic vascular optical tomographic imaging (DVOTI) system that can be used to detect and monitor peripheral arterial disease (PAD). PAD is estimated to affect approximately 8 to 12 million individuals in the United States. However, the disease is considerably under-diagnosed, since most patients are asymptomatic and no single reliable screening modality has been established. Most of the undiagnosed and untreated patients are diabetics. They commonly suffer from peripheral neuropathy and hence do not sense and report symptoms (such as pain) that are early signs of the disease. Consequently more than 60% (~65,000 per year) of all lower extremity amputations in the United States are performed in diabetic patients with PAD. With the number of diabetic patients expected to triple and reach almost 100 million by 2050, the problems related to undiagnosed PAD will only rise in the years to come  The most widely used diagnostic test for PAD, determination of the ankle-brachial index (ABI) in conjunction with pulse-volume recordings (PVR), is known to be unreliable for diabetics. And even in non- diabetics, ABI with PVR and all other existing diagnostic tests (such as Duplex Ultrasound or Magnetic resonance angiography), only provides accurate information about proximal occlusions in major arteries of the leg. However, none of these tests assess the distal perfusion of the foot where most complications, such as ulcers and gangrene, typically occur. Monitoring the success of surgical interventions, such as angioplasty or bypass surgery, suffers from the same shortcomings, as physicians are limited to the same suite of tests that are inadequate to assess the perfusion of the foot.  Dynamic VOTI promises to overcome the limitations of current diagnostic and monitoring techniques and has the potential to initiate a paradigm shift concerning how vascular diseases are assessed. In preliminary studies we have shown that DVOTI can provide three-dimensional time-series images that provide valuable information about the perfusion of the vascular bed in feet of PAD patients. The near-infrared light used in the instrument has no adverse health effects and measurements can be repeated frequently to monitor post interventional progress. Therefore, we believe that DVOTI will prove to be a safe and accurate method to diagnose and monitor PAD in non-diabetic and diabetic patients.         PUBLIC HEALTH RELEVANCE: We propose to build and test a novel optical imaging system that will allow for the diagnosis and monitoring of peripheral artery disease (PAD), which affects approximately 8 to 12 million individuals in the United States. The disease is considerably under-diagnosed, especially in diabetic patients, the elderly, and patients with kidney disease. The system will address an unmet need to directly assess the degree of blood perfusion in the feet, where most PAD-related complications occur, which lead to over 65,000 amputations each year.",Optical Tomographic Imaging of Peripheral Arterial Disease,8724239,R01HL115336,"['Accounting ', ' Affect ', ' Air ', ' Algorithms ', ' Amputation ', ' Variance Analyses ', ' ANOVA ', ' Analysis of Variance ', ' Tarsus ', ' Tarsal Bone ', ' Regio tarsalis ', ' Ankle ', ' Arteries ', ' vascular ', ' Blood Vessels ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Diffusion ', ' disease/disorder ', ' Disorder ', ' Disease ', ' foot ', ' Gangrene ', ' Head ', ' Health ', ' Image Reconstructions ', ' indexing ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' Photoradiation ', ' Light ', ' Maps ', ' Methods ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' optical ', ' Optics ', ' Painful ', ' Pain ', ' Patients ', ' Perfusion ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Peripheral Nervous System Diseases ', ' Physicians ', ' Risk ', ' Sensitivity and Specificity ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Ulceration ', ' Ulcer ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' United States ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Measures ', ' Treatment outcome ', ' Diagnostic tests ', ' intraluminal angioplasty ', ' Angioplasty ', ' evaluation/testing ', ' Procedures ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Distal ', ' Medical ', ' Series ', ' Ensure ', ' Individual ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' MRI Angiography ', ' Magnetic Resonance Angiography ', ' tool ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Diagnostic Procedure ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' early detection ', ' Early Diagnosis ', ' experience ', ' light emission ', ' success ', ' vascular bed ', ' perfusion (blood) ', ' novel ', ' Modality ', ' Devices ', ' Reporting ', ' Bypass ', ' Coding System ', ' Code ', ' Statistical Methods ', ' LOINC Axis 2 Property ', ' Property ', ' theories ', ' Leg ', ' Address ', ' Preventive ', ' Symptoms ', ' Data ', ' Detection ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' post intervention ', ' optical imaging ', ' optic imaging ', ' designing ', ' design ', ' elderly patient ', ' older patient ', ' data acquisition ', ' healthy volunteer ', ' nondiabetic ', ' non-diabetic ', ' prototype ', ' tissue phantom ', ' public health relevance ', ' treatment response ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' diabetic patient ', ' screening ', ' Geometry ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2014,341074,NY-13,0.010743813042986048
"Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy     DESCRIPTION (provided by applicant): Our understanding of cervical remodeling during pregnancy and labor is incomplete, partly due to the lack of in vivo studies on the biochemical changes that occur in the cervix over the course of pregnancy. Elucidation of the mechanisms for cervical ripening could be used to predict the onset of preterm labor. Until recently, in vivo research methods were too invasive to be used as discovery tools, particularly in women who present with preterm labor. This proposal will use in vivo Raman spectroscopy, an optical technique that is sensitive to collagen content, collagen structure, hydration, lipids, proteins, ad other biomolecules to non-invasively investigate the biochemistry of the cervix throughout pregnancy. Using fiber optic in vivo Raman spectroscopy, we recently found significant differences in Raman spectra in at least four important peaks during the course of pregnancy in mice, including discrete signatures for lipids, collagen, amide bonds, and enriched amino acids (proline, tyrosine). Computational analysis of these spectra yielded predictive algorithms with 94% classification accuracy for stage of pregnancy. Studies performed in 2-hour windows at the end of pregnancy identified spectra predictive for the timing of parturition. This approach provides a detailed real-time biomolecular map of cervical ripening that is currently unavailable by other means. In this proposal, we hypothesize that the different mechanisms of premature cervical ripening have unique Raman spectral signatures that correspond to underlying biochemical and mechanical changes that precede preterm birth, which can be detected in vivo. Two Specific Aims are proposed: 1) Determine spectral changes in the cervix of mice with normal and abnormal pregnancy and parturition; 2) Identify specific mediators of cervical remodeling by comparing Raman spectra to mechanical and biochemical changes in the ex vivo cervix during normal and abnormal parturition. Raman spectroscopy has primarily been used for detection of disease. Collaboration between our reproductive biology and bioengineering groups will capitalize on our expertise in Raman analysis of cervical tissues to study dynamic changes in cervix composition during pregnancy. Key elements in cervical biochemistry will be identified. In vivo Raman spectroscopy will be combined with biomechanical studies and imaging mass spectrometry, a powerful tool for in situ proteomic analysis, to examine mice with premature or delayed cervical remodeling. Together, these highly innovative approaches will generate in-depth profiles of cervical biology that will translate into novel non-invasive methods to detect impending premature birth in women.         PUBLIC HEALTH RELEVANCE: This proposal will use Raman Spectroscopy, a non-invasive, optical scattering technique, to investigate the composition of the cervix throughout pregnancy and provide detailed real-time information on cervical ripening. These studies will identify spectral differences in the cervix during normal and abnormal cervical maturation; optical and biochemical markers will be identified to help monitor pregnancy non-invasively, as the fiber optic probe only requires brief contact with the external surface of the cervix to obtain measurements. Elucidating the mechanisms that initiate cervical ripening will provide a critical step for early detection and treatment of preterm birth, which is the leading cause of infant morbidity and mortality.            ",Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy,8766404,R01HD081121,"['Algorithms ', ' Prostaglandin E1alpha ', ' Prostaglandin E1 ', ' Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)- ', ' PGE1alpha ', ' PGE1 ', ' Muse ', ' Lipo-PGE1 ', ' Caverject ', ' Alprostadil ', ' Amides ', ' aminoacid ', ' Amino Acids ', ' Biological Chemistry ', ' Biochemistry ', ' Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Biology ', ' biomechanical ', ' Biomechanics ', ' bioengineering ', ' Biomedical Engineering ', ' Parturition ', ' Birth ', ' Uterine Cervix ', ' Cervix ', ' Cervix Uteri ', ' Systematics ', ' Classification ', ' Collagen ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Elasticity ', ' Fetal Development ', ' Fetal development of the mammalian embryo or fetus ', ' Fiber Optics ', ' Foundations ', ' Goals ', ' Health ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' In element ', ' Indium ', ' Preterm Labor ', ' Premature Obstetric Labor ', ' Premature Labor ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lipids ', ' Maintenance ', ' Maps ', ' Methods ', ' Mifeprex ', ' Mifegyne ', ' Mifepristone ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' optical ', ' Optics ', ' Phenotype ', ' physical science ', ' Gestation ', ' Pregnancy ', ' L-Proline ', ' Proline ', ' gene product ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Spectrum Analyses ', ' Spectroscopy ', ' Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Raman spectrometry ', ' Raman Spectroscopy ', ' IR/UV/Raman Spectroscopy ', ' Raman Spectrum Analysis ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Translating ', ' Translations ', ' para-Tyrosine ', ' L-isomer Tyrosine ', ' L-Tyrosine ', ' Tyrosine ', ' Woman ', ' Generations ', ' Measures ', ' Research Methods ', ' Research Methodology ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Premature Birth ', ' in situ Hybridization Staining Method ', ' in situ Hybridization Genetics ', ' In Situ Hybridization ', ' base ', ' Cervical ', ' Surface ', ' Clinical ', ' prematurity ', ' premature ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Medical ', ' Biochemical Markers ', ' Link ', ' insight ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' High-Risk Pregnancy ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' mechanical ', ' Mechanics ', ' Hour ', ' In Situ ', ' Techniques ', ' Hormonal ', ' early detection ', ' Early Diagnosis ', ' Cervical Ripenings ', ' Cervical Ripening ', ' Structure ', ' novel ', ' Prevention ', ' Modality ', ' RU486 ', ' RU38486 ', ' RU-38486 ', ' R38486 ', ' R 38486 ', ' RU-486 ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' Proteomics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Hydration ', ' Hydration status ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Data ', ' Detection ', ' Grant Proposals ', ' Applications Grants ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Reproductive Biology ', ' in vivo ', ' computational analysis ', ' Computer Analysis ', ' Emergent Technologies ', ' Emerging Technologies ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' computer based prediction ', ' predictive modeling ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' early therapy ', ' Early treatment ', ' computer algorithm ', ' Computational algorithm ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' mouse model ', ' pregnant ', ' public health relevance ', ' novel therapeutic approach ', ' new therapeutic intervention ', ' new therapeutic approach ', ' novel therapeutic intervention ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' infant morbidity/mortality ', ' ']",NICHD,VANDERBILT UNIVERSITY,R01,2014,387356,TN-05,0.06547748270019423
"A Novel Pregnancy Prevention Intervention for Latino Middle School Girls     DESCRIPTION (provided by applicant): This new investigator-initiated R01 proposal will test the efficacy of a promising and innovative intervention (Mighty Girls) to reduce teen Latina sexual behavior and pregnancy that was developed in a successful R15 feasibility trial. US teen pregnancy rates have declined but are still high among Latinas (49.4%), and the socioeconomic costs associated with these pregnancies are considerable; e.g., $3.2 billion lost tax revenue (2008 dollars) for decreased maternal educational attainment and productivity. Mighty Girls is designed to empower middle school Latinas with the skills they need to resist peer pressure that would otherwise accelerate their involvement in sexual behavior, allowing them to delay their initiation of intercourse and ultimately reduce their risk for teen pregnancy and sexually transmitted infections.  Mighty Girls uses cutting-edge technology to create a novel, highly interactive, video game that provides a live, realistic simulation of peer pressure. Players talk directly with avatars as they would with peers in their everyday life. This intervention focuses on building communication skills for resistance that are derived from evidence-based programs that do not jeopardize friendships and incorporate Latino cultural values (Marianismo, Personalismo, Simpata) - skills valued by middle school Latinas.  In addition to efficacy testing, the proposed interdisciplinary study evaluates (1) the intervention's cost- effectiveness and (2) influence of participant characteristics and how well the intervention was delivered (implementation quality) on study outcomes. The study will be conducted with seventh grade Latinas enrolled in 20 middle schools in Florida's Miami-Dade County, and followed into ninth grade, a period in which risky behaviors typically increase. Half of these schools will be randomly assigned to receive the Mighty Girls intervention and booster in addition to standard in-school sex education, while the other half will receive only standard in-school sex education. Data will be collected before and after the intervention, and at 2 (pre-booster), 12, and 24 months post-intervention using computerized surveys. Growth curve analysis will compare changes in peer resistance and sexual behavior observed in the two study conditions over the course of the study. Cost-effectiveness analyses will weigh the benefit of the intervention when added to current in-school sex education against its cost of delivery. This proposal addresses Healthy People 2020 objectives to reduce pre-term birth, increase the proportion of women who use contraception to plan pregnancy, and eliminate health disparities. It lays the foundation for a dissemination study of the Mighty Girls intervention that would have a major impact on the lives of vulnerable adolescents and reduce the personal and public burden of early sexual initiation. Study results would also advance the science of communications, health games, and computer engineering by generating data on human-avatar interactions and the use of highly interactive game technology to build health-related interpersonal skills.         PUBLIC HEALTH RELEVANCE: The teen pregnancy rate continues to be high among U.S. Latinas and results in significant personal, health care related and other societal costs. This study will test the efficacy of a promising and innovative intervention (Mighty Girls) that uses classroom activities in combination with a highly interactive video game to empower middle school Latinas to resist peer pressure to engage in intercourse. Girls play the game by talking directly with avatars that represent typical middle school children (no keyboard input required); thereby developing the skills needed to decrease their risk for teen pregnancy and sexually transmitted infections. Study results will be helpful for developing similar interventions for othe at risk youth, including boys, and guiding development of other technology based games designed to promote health.            ",A Novel Pregnancy Prevention Intervention for Latino Middle School Girls,8815713,R01NR014851,"['Taxes ', ' Teaching ', ' Educational process of instructing ', ' Technology ', ' Testing ', ' Video Games ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Work ', ' County ', ' Relative ', ' Relative (related person) ', ' health care ', ' Healthcare ', ' Latino ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' base ', ' Friendships ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Evaluation ', ' full-term birth ', ' Fullterm Birth ', ' Term Birth ', ' Individual ', ' European ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Life ', ' programs ', ' Country ', ' Outcome Study ', ' empowered ', ' Peer Pressure ', ' experience ', ' Self Efficacy ', ' condoms ', ' skills ', ' simulation ', ' novel ', ' Participant ', ' peer ', ' intimacy ', ' intimate behavior ', ' public education ', ' 7th grade ', ' seventh grade ', ' high school freshman ', ' 9th grade ', ' ninth grade ', ' cultural values ', ' Prevention ', ' Reporting ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Contraceptive methods ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' positive youth development ', ' boys ', ' girls ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' health disparities ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' Data ', ' Health Communication ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' developmental ', ' Development ', ' post intervention ', ' pregnancy prevention ', ' effectiveness trial ', ' initiation of intercourse ', ' early sexual initiation ', ' early sex initiation ', ' cost ', ' computerized ', ' designing ', ' design ', ' efficacy trial ', ' developing resistance ', ' Resistant development ', ' Resistance development ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' fourteen year old ', ' age 14 years ', ' 14 year old ', ' resistant ', ' Resistance ', ' Evidence based program ', ' social learning theory ', ' social cognitive theory ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' multimodal intervention ', ' multifaceted intervention ', ' multicomponent intervention ', ' multi-modal intervention ', ' multi-faceted intervention ', ' multi-component intervention ', ' young woman ', ' Healthy People 2020 ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Attitude ', ' Awareness ', ' Behavior ', ' sibling order ', ' Birth Order ', ' Canada ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Coitus ', ' Communication ', ' Computers ', ' cost effectiveness ', ' Curriculum ', ' Educational Curriculum ', ' depression ', ' Mental Depression ', ' Engineering ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Learning ', ' Theoretic Models ', ' Theoretical model ', ' Names ', ' well-being ', ' Personal Satisfaction ', ' Play ', ' Gestation ', ' Pregnancy ', ' Underage Pregnancy ', ' Teenage Pregnancy ', ' Teen Pregnancy ', ' Pregnancy in Minors ', ' Adolescent Pregnancy ', ' Pregnancy in Adolescence ', ' Pregnancy Rate ', ' Planned Pregnancy ', ' pressure ', ' Productivity ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Schools ', ' Science ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sex Education ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Societies ', ' Survey Instrument ', ' Surveys ', ' ']",NINR,UNIVERSITY OF MIAMI CORAL GABLES,R01,2014,709980,FL-27,0.06008087110215526
"Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study DESCRIPTION (provided by applicant): Preservation of brain health is a critical goal in the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment. Weight loss and increased physical activity hold promise as potentially effective strategies for this purpose, but are currently unproven in any population. Because unintended weight loss often precedes declines in later life brain health, a randomized controlled clinical trial is necessary, which must feature an effective behavioral intervention that is sustained over a long period of time in a large well characterized cohort. Mounting such a program de novo would be very expensive. Instead, we propose to make use of the ongoing and very successful Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, adding cross-sectional magnetic resonance imaging (MRI) to its extensive data collection protocol. This is feasible: participants in clinical trials have been repeatedly shown to be willing to join brain imaging studies and we have developed successful protocols for maintaining safety, confidentiality, and quality. This is novel: Look AHEAD and the state-of-the-art MRI protocols that we propose provide an unprecedented opportunity to assess the long-term effectiveness of mid-life behavioral changes on brain structure and function and to advance understanding of brain health in diabetes. We address an important public health priority for a rapidly growing and under-studied segment of the US population in a cost-effective manner, leveraging the extensive research resources available from Look AHEAD. We respond to PAR-09-247, which targets ancillary study applications to major NIDDK clinical trials, including Look AHEAD. We will enroll 496 participants, ages 55-85 years with type 2 diabetes, from 3 Look AHEAD clinics. They will have been randomly assigned 10 years ago when they were obese or overweight, with equal probability, to either an ongoing intensive lifestyle intervention that has induced sustained weight loss and increased physical activity or control condition (diabetes support and education) that has fostered excellent retention. A proven protocol for standardized structural MRI will provide regional brain and ischemic lesion volumes; functional MRI will provide assessments of functional activation, resting state connectivity, and cerebral blood flow. A tested cognitive battery and physical activity assessment will be administered. A comprehensive analysis of these data will make use of established statistical approaches and novel machine-learning methods. Look AHEAD provides extensive 10-year characterizations of participant's health and behavior, their medical care and its cost, and the trial's interventions; state-of-the art data management systems; and provisions for developing public access databases. Our research team includes established and productive experts in brain imaging, diabetes research, behavioral medicine, data and image analysis, neuroepidemiology, and collaboration. The goal of this project is the care of adults with type 2 diabetes mellitus, who are at increased risk for atrophy, cerebrovascular disease, and cognitive impairment.",Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study,8723169,R01DK092237,"['Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Ancillary Study ', ' Cognitive ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' Behavioral ', ' imaging ', ' Image ', ' cost ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' cost-effective ', ' cost effective ', ' Population ', ' aged ', ' life style intervention ', ' lifestyle intervention ', ' multidisciplinary ', ' ischemic lesion ', ' clinical care ', ' primary outcome ', ' secondary outcome ', ' intervention effect ', ' public health priorities ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Behavioral Medicine ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cerebrocirculation ', ' cerebral vasculature ', ' cerebral circulation ', ' cerebral blood flow ', ' Cerebrovascular Circulation ', ' Intracranial Vascular Disorders ', ' Intracranial Vascular Diseases ', ' Cerebrovascular Disease ', ' Brain Vascular Disorders ', ' Cerebrovascular Disorders ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Cognition ', ' co-morbidity ', ' Comorbidity ', ' information privacy ', ' Confidentiality ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Education ', ' Educational aspects ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' Health ', ' Health behavior ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Insulin (ox), 8A-L-threonine-10A-L-isoleucine-30B-L-threonine- ', ' Humulin R ', ' Insulin ', ' insulin resistant ', ' Insulin Resistance ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Memory ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Mission ', ' Motivation ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' preservation ', ' Biologic Preservation ', ' Biological Preservation ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' Research ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' Risk Factors ', ' Safety ', ' Testing ', ' Time ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Body Weight decreased ', ' Weight ', ' Measures ', ' Cost Savings ', ' Mediating ', ' Medical Care Costs ', ' Caring ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' brain visualization ', ' Brain imaging ', ' Area ', ' Clinical ', ' Medical ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Physical activity ', ' cortical atrophy ', ' brain atrophy ', ' cerebral atrophy ', ' Individual ', ' Fostering ', ' Dyslipidemias ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Atrophy ', ' Atrophic ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Life ', ' programs ', ' cognitive function ', ' Event ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' LOINC Axis 4 System ', ' System ', ' Amentia ', ' Dementia ', ' Over weight ', ' Overweight ', ' interest ', ' data management ', ' cohort ', ' Structure ', ' Cognitive deficits ', ' novel ', ' Participant ', ' Preventive strategy ', ' Prevention strategy ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Reporting ', ' Intervention Trial ', ' brain volume ', ' ']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2014,654364,NC-06,0.1268675121939964
"Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury     DESCRIPTION (provided by applicant): Throughout human pregnancy, the placenta is indispensable for embryonic development, fetal growth and tissue differentiation. The placenta also protects the fetus against diverse insults, while preserving maternal health. Placental dysfunction is commonly implicated in complications of pregnancy that challenge maternal physiology (e.g., preeclampsia) and fetal development (e.g., fetal death or fetal growth restriction) or that leads to preterm birth. Within the placenta, the trophoblast constitutes the outermost layer, which is directly bathed in maternal blood and therefore positioned to regulate maternal-fetal gas exchange, nutrient delivery, waste removal and the production of hormones, faithfully balancing fetal needs and maternal supply. Trophoblast damage, which is common in dysfunctional placentas, may interrupt the delicate maternal-fetal balance, cause clinical disease, and leave a lifelong mark on health. A fundamental challenge in perinatal medicine arises from our limited ability to diagnose placental disorders in real time and throughout pregnancy. However, the recent discovery, by ourselves and others, that (a) placental trophoblasts release distinctive micro- and nanovesicles into the maternal circulation and (b) these vesicles contain trophoblast-specific non-coding RNA cargo, created a new opportunity for assessing trophoblast health. These vesicles are actively released by trophoblasts throughout pregnancy, and thus serve as a venipuncture-accessible ""natural biopsy"" of trophoblasts, which can furnish information on trophoblast health in real time. Our established perinatal biology group at Magee- Womens Research Institute includes expertise in perinatal medicine and placental pathology, developmental and molecular biology, and bioinformatics. Inspired by these recent advances, we have partnered with an experienced group of bioengineers that includes experts from Carnegie Mellon University, MIT, and Penn State University, with unique skills in biophysics-based vesicle analytics, including microfluidics, nanomechanics, micro/nano fabrication and vesicle sorting using acoustic tweezers. Together, our new transdisciplinary group will use integrated molecular and biophysical methodologies to directly assess the use of trophoblast-derived extracellular vesicles from maternal plasma as revelatory of trophoblast health in real time and as a technique that may be employed throughout pregnancy. Our approach is comprehensive, centering on miRNAs as well as lncRNAs and circRNAs, analyzed in exosome nanovesicles, as well as microvesicles and apoptotic bodies. As each vesicle features a unique bimolecular and biophysical signature, we will deploy our machine learning- based training and testing pipeline to informatively integrate these distinct signals into an innovative diagnostic tool. Lastly, our deployment of affordable acoustic tweezers technology to sort trophoblastic vesicles will facilitate the translation of our advances into a new ""lab on a chip"" placental diagnostic technology, suitable for small blood volumes. This technology may not only denote trophoblast pathology, but has potential to identify those who may benefit from intervention and to monitor therapeutic success.         PUBLIC HEALTH RELEVANCE: Although the placenta is critical for fetal development and pregnancy outcome, it is not currently accessible for real-time diagnostics throughout pregnancy. Having developed tools for isolation and analysis of placenta- specific extracellular from the maternal plasma, we will study molecular and biophysical properties of these vesicles as indicators of placental health and disease.            ",Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury,9019135,R01HD086325,"['placental abruption ', ' Premature Separation of Placenta ', ' Abruptio Placentae ', ' Acoustic ', ' Acoustics ', ' Arteries ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' bioengineering ', ' Biomedical Engineering ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Biophysics ', ' Biopsy ', ' needle biopsy ', ' Needle biopsy procedure ', ' Blood Reticuloendothelial System ', ' Blood ', ' Circulation ', ' Bloodstream ', ' Blood Circulation ', ' Blood Volume ', ' Communication ', ' Developmental Biology ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' balance function ', ' balance ', ' Equilibrium ', ' fetus death ', ' Fetal Death ', ' Fetal Development ', ' Fetal development of the mammalian embryo or fetus ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Fetus ', ' Future ', ' Gases ', ' Au element ', ' Gold ', ' Health ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Chemotherapy-Hormones/Steroids ', ' Hormones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Maternal Health ', ' Medicine ', ' Methods ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Pathology ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Placental Diseases ', ' Placenta Disorders ', ' Placenta Diseases ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Plasma Proteins ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' Pregnancy Complications ', ' Pregnancy Outcome ', ' Pregnancy-Associated alpha-Plasma Protein ', ' PAPP-alpha ', ' PAPP-A ', ' Insulin-Like-Growth Factor Binding Protein-4 Protease ', ' Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease ', ' IGFBP-4-Specific Proteinase ', ' IGFBP-4 Protease ', ' IGFBP-4 Metalloproteinase ', ' Pregnancy-Associated Plasma Protein-A ', ' Production ', ' Research Institute ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Technology ', ' Testing ', ' Time ', ' tomography ', ' Translations ', ' trophoblast ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Universities ', ' Viscosity ', ' Woman ', ' closed circular RNA ', ' circular RNA ', ' Transforming Growth Factor P Receptor III ', ' Endoglin (Osler-Rendu-Weber Syndrome 1) ', ' CD105 Antigen ', ' Endoglin ', ' Glean ', ' Baths ', ' Bathing ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Premature Birth ', ' pregnancy disorder ', ' Injury ', ' base ', ' Perinatal ', ' improved ', ' Left ', ' Clinical ', ' Diffuse ', ' Histologically ', ' Histologic ', ' Evaluation ', ' Training ', ' peripheral blood ', ' Blood flow ', ' wasting ', ' fetus tissue ', ' Fetal Tissues ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Therapeutic ', ' Shapes ', ' Vesicle ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' mechanical ', ' Mechanics ', ' Investigation ', ' Dimensions ', ' Techniques ', ' Location ', ' extracellular ', ' fetal ', ' experience ', ' success ', ' viscoelasticity ', ' Venipunctures ', ' Nutrient ', ' skills ', ' novel ', ' sorting ', ' Sorting - Cell Movement ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' Position ', ' Positioning Attribute ', ' intrauterine growth ', ' Fetal Growth ', ' LOINC Axis 2 Property ', ' Property ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Untranslated RNA ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' MicroRNAs ', ' Provider ', ' Bio-Informatics ', ' Bioinformatics ', ' Microfluidic ', ' Microfluidics ', ' Placental Growth Factor Gene ', ' PlGF ', ' PLGF-2 ', ' PGF gene ', ' fitness ', ' Data ', ' Maternal Physiology ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Predictive Value ', ' in vivo ', ' Apoptotic ', ' Tissue Differentiation ', ' Monitor ', ' Characteristics ', ' Molecular ', ' injured ', ' designing ', ' design ', ' nanofabricate ', ' nano fabrication ', ' nano fabricate ', ' nanofabrication ', ' nano mechanics ', ' nanomechanics ', ' cost-effective ', ' cost effective ', ' innovative ', ' innovate ', ' innovation ', ' mu-TAS ', ' Lab On a Chip ', ' micro-total analysis system ', ' stem ', ' public health relevance ', ' clinical care ', ' nano vesicle ', ' nanovesicle ', ' RNAseq ', ' RNA-seq ', ' transcriptome sequencing ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' biophysical properties ', ' biophysical methods ', ' biophysical methodology ', ' biophysical approaches ', ' biophysical techniques ', ' ']",NICHD,MAGEE-WOMEN'S RES INST AND FOUNDATION,R01,2015,804679,PA-18,0.07382966896677148
"Optical Tomographic Imaging of Peripheral Arterial Disease DESCRIPTION (provided by applicant): We propose to build and test a dynamic vascular optical tomographic imaging (DVOTI) system that can be used to detect and monitor peripheral arterial disease (PAD). PAD is estimated to affect approximately 8 to 12 million individuals in the United States. However, the disease is considerably under-diagnosed, since most patients are asymptomatic and no single reliable screening modality has been established. Most of the undiagnosed and untreated patients are diabetics. They commonly suffer from peripheral neuropathy and hence do not sense and report symptoms (such as pain) that are early signs of the disease. Consequently more than 60% (~65,000 per year) of all lower extremity amputations in the United States are performed in diabetic patients with PAD. With the number of diabetic patients expected to triple and reach almost 100 million by 2050, the problems related to undiagnosed PAD will only rise in the years to come  The most widely used diagnostic test for PAD, determination of the ankle-brachial index (ABI) in conjunction with pulse-volume recordings (PVR), is known to be unreliable for diabetics. And even in non- diabetics, ABI with PVR and all other existing diagnostic tests (such as Duplex Ultrasound or Magnetic resonance angiography), only provides accurate information about proximal occlusions in major arteries of the leg. However, none of these tests assess the distal perfusion of the foot where most complications, such as ulcers and gangrene, typically occur. Monitoring the success of surgical interventions, such as angioplasty or bypass surgery, suffers from the same shortcomings, as physicians are limited to the same suite of tests that are inadequate to assess the perfusion of the foot.  Dynamic VOTI promises to overcome the limitations of current diagnostic and monitoring techniques and has the potential to initiate a paradigm shift concerning how vascular diseases are assessed. In preliminary studies we have shown that DVOTI can provide three-dimensional time-series images that provide valuable information about the perfusion of the vascular bed in feet of PAD patients. The near-infrared light used in the instrument has no adverse health effects and measurements can be repeated frequently to monitor post interventional progress. Therefore, we believe that DVOTI will prove to be a safe and accurate method to diagnose and monitor PAD in non-diabetic and diabetic patients. PUBLIC HEALTH RELEVANCE: We propose to build and test a novel optical imaging system that will allow for the diagnosis and monitoring of peripheral artery disease (PAD), which affects approximately 8 to 12 million individuals in the United States. The disease is considerably under-diagnosed, especially in diabetic patients, the elderly, and patients with kidney disease. The system will address an unmet need to directly assess the degree of blood perfusion in the feet, where most PAD-related complications occur, which lead to over 65,000 amputations each year.",Optical Tomographic Imaging of Peripheral Arterial Disease,8896855,R01HL115336,"['Accounting ', ' Affect ', ' Air ', ' Algorithms ', ' Amputation ', ' Variance Analyses ', ' ANOVA ', ' Analysis of Variance ', ' Tarsus ', ' Tarsal Bone ', ' Regio tarsalis ', ' Ankle ', ' Arteries ', ' vascular ', ' Blood Vessels ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Diffusion ', ' disease/disorder ', ' Disorder ', ' Disease ', ' foot ', ' Gangrene ', ' Head ', ' Health ', ' Image Reconstructions ', ' indexing ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' Photoradiation ', ' Light ', ' Maps ', ' Methods ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' optical ', ' Optics ', ' Painful ', ' Pain ', ' Patients ', ' Perfusion ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Peripheral Nervous System Diseases ', ' Physicians ', ' Risk ', ' Sensitivity and Specificity ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Ulceration ', ' Ulcer ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' United States ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Measures ', ' Treatment outcome ', ' Diagnostic tests ', ' intraluminal angioplasty ', ' Angioplasty ', ' evaluation/testing ', ' Procedures ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Distal ', ' Medical ', ' Series ', ' Ensure ', ' Individual ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' MRI Angiography ', ' Magnetic Resonance Angiography ', ' tool ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Diagnostic Procedure ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' early detection ', ' Early Diagnosis ', ' experience ', ' light emission ', ' success ', ' vascular bed ', ' perfusion (blood) ', ' novel ', ' Modality ', ' Devices ', ' Reporting ', ' Bypass ', ' Coding System ', ' Code ', ' Statistical Methods ', ' LOINC Axis 2 Property ', ' Property ', ' theories ', ' Leg ', ' Address ', ' Preventive ', ' Symptoms ', ' Data ', ' Detection ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' post intervention ', ' optical imaging ', ' optic imaging ', ' designing ', ' design ', ' elderly patient ', ' older patient ', ' data acquisition ', ' healthy volunteer ', ' nondiabetic ', ' non-diabetic ', ' prototype ', ' tissue phantom ', ' treatment response ', ' diabetic patient ', ' screening ', ' Geometry ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2015,542263,NY-13,0.010743813042986048
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,8934878,P50GM115318,"['Affect ', ' autophagy ', ' Autophagocytosis ', ' California ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' coronary disorder ', ' Coronary Disease ', ' Coronary heart disease ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Deoxyribonucleic Acid ', ' DNA ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Hybrids ', ' hyperglycemic ', ' Hyperglycemia ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Leadership ', ' Lipids ', ' Control Locus ', ' Inbred Strains Mice ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' muscular disorder ', ' Myopathic disease or syndrome ', ' Myopathic Diseases and Syndromes ', ' Myopathic Conditions ', ' Muscular Diseases ', ' Muscle disease or syndrome ', ' Muscle Disorders ', ' Muscle Disease ', ' Myopathy ', ' Patients ', ' Pharmacies ', ' Pharmacy facility ', ' Clinical Pharmacology ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' statistics ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Testing ', ' United States ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Synvinolin ', ' Simvastatin ', ' Treatment outcome ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Custom ', ' base ', ' improved ', ' Clinical ', ' Residual ', ' Residual state ', ' Variation ', ' Variant ', ' Biological ', ' Susceptibility ', ' Predisposition ', ' Training ', ' lymphoblast ', ' disability ', ' Muscle function ', ' Fostering ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Collaborations ', ' Metabolic ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Event ', ' LOINC Axis 4 System ', ' System ', ' cardiovascular disease prevention ', ' cardiac disease prevention ', ' cardiovascular disorder prevention ', ' cohort ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' Informatics ', ' Disease Outcome ', ' novel ', ' lymphoblastoid cell line ', ' disease risk ', ' disorder risk ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' drug action ', ' Drug effect disorder ', ' Genetic analyses ', ' genetic analysis ', ' Modeling ', ' Sampling ', ' response ', ' Adverse Experience ', ' Adverse event ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Genomics ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Pharmacogenomics ', ' preventing ', ' prevent ', ' metabolism measurement ', ' metabolomics ', ' genetic association ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Symptoms ', ' Data ', ' Recombinants ', ' in vivo ', ' Transcript ', ' Molecular ', ' Coronary ', ' Electronic Health Record ', ' pathway ', ' Pathway interactions ', ' clinical phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' data integration ', ' designing ', ' design ', ' clinical efficacy ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' innovative ', ' innovate ', ' innovation ', ' Heritability ', ' resistant ', ' Resistance ', ' transcriptomics ', ' Cellular model ', ' Cell model ', ' clinical relevance ', ' clinically relevant ', ' mouse model ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' novel therapeutic target ', ' new therapeutic target ', ' public health relevance ', ' alternative treatment ', ' population based ', ' treatment strategy ', ' new marker ', ' novel marker ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' clinical practice ', ' candidate validation ', ' exomes ', ' exome ', ' adverse consequence ', ' adverse outcome ', ' ']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2015,2836708,CA-13,0.046688146864863535
"Identification of patients with diabetes at high risk for treatment failure     DESCRIPTION (provided by applicant):  The overall goal of this project is to improve quality of care of patients with diabetes by identifying patients who may have particular difficulty reaching treatment targets and who could therefore potentially benefit from additional resources. Investigators propose to achieve this goal by developing a technology to accurately identify patients at high risk for not reaching blood glucose target to enable cost-effective implementation of resource-intensive interventions that improve glycemic control in high-risk individuals.  Improving blood glucose control in patients with diabetes could both improve their quality of life by reducing diabetes complications and decrease costs. Some patients that face particularly high barriers to glucose control may benefit from additional resources that are too expensive to apply to broad patient populations. However, it is not currently possible to identify patients at high risk not being able to reach blood glucose targets with sufficient accuracy to make these interventions cost-effective.  One reason for this is that a large fraction of critical information about the patients' functional status, social circumstances and other important factors that may present barriers to glucose control is only found in narrative documents, from which it is difficult to extract. Furthermore, the amount of information about any single patient i the medical record is enormous, and is impossible to process efficiently using standard analytical algorithms such as regression analysis.  In the proposed project investigators will combine two novel technologies - natural language processing of electronic provider notes and artificial intelligence technology Dynamic Logic - to help circumvent these challenges to build a high-accuracy model of risk of not being able to reach blood glucose targets in patients with diabetes. Natural language processing will identify key concepts documented in the provider notes and will help translate their text into a compendium of facts about the patient. Dynamic Logic makes use of a limited number of iterative approximations to reduce the complexity of a problem with multiple predictor variables from exponential to approximately linear. Utilization of Dynamic Logic will therefore allow to greatly increasing the number of factors / variables that can be considered for the models for prediction of failure to reach glucose control, and ultimately improve their accuracy. Consequently this translational multidisciplinary project will both advance our understanding of the risk factors for not being able to reach glucose control for patients with diabetes and assist in real-life implementation of interventions that can help lower their blood glucose, decrease the rate of diabetes complications, improve the patients' quality of life and help control the rising costs of healthcare.         PUBLIC HEALTH RELEVANCE:  Lowering blood glucose of patients with diabetes could both improve their quality of life and reduce healthcare costs, but may be more difficult for some patients than others. Patients who have particularly high barriers to blood glucose control could benefit from extra resources, but it can be challenging to identify them in advance. In this projec the investigators will combine advanced computational technologies including artificial intelligence and natural language processing to identify patients with diabetes at high risk for difficulty lowering blood glucose to help make commitment of additional resources cost-effective.                ",Identification of patients with diabetes at high risk for treatment failure,8902473,R41DK105612,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Blood Sugar ', ' Blood Glucose ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Counseling ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Diabetic Retinopathy ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Epidemic ', ' facial ', ' faces ', ' Face ', ' Patient Care ', ' Patient Care Delivery ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' inducement ', ' Incentives ', ' Language ', ' Lifestyle ', ' Life Style ', ' Logic ', ' Medical Records ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' natural language understanding ', ' Natural Language Processing ', ' Patients ', ' well-being ', ' Personal Satisfaction ', ' QOL ', ' Quality of life ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Technology ', ' Testing ', ' Translating ', ' Transportation ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' Caring ', ' Treatment Failure ', ' Guidelines ', ' analytical method ', ' base ', ' improved ', ' Phase ', ' Medical ', ' Logistic Regressions ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Fees for Service ', ' Fee-for-Service Plans ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Complications of Diabetes Mellitus ', ' Life ', ' neuropathic ', ' Neuropathy ', ' Source ', ' Techniques ', ' functional status ', ' Structure ', ' novel technologies ', ' new technology ', ' social ', ' Modeling ', ' QOC ', ' Quality of Care ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Provider ', ' Data ', ' Process ', ' Text ', ' cost ', ' glycemic control ', ' Outcome ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' cost-effective ', ' cost effective ', ' Prevalence ', ' combinatorial ', ' multidisciplinary ', ' commercial application ', ' high risk ', ' public health relevance ', ' patient population ', ' ']",NIDDK,LP INFORMATION TECHNOLOGY,R41,2015,223336,MA-04,0.0572460972864876
"Development of real-time, automated 3D ultrasound tools for the study of placental invasion and morphology     DESCRIPTION (provided by applicant) Among the most intractable pregnancy pathologies are those related to aberrant trophoblast invasion and the subsequent remodeling of maternal vasculature at the utero-placental interface (UPI). These include preeclampsia (PE), intrauterine growth restriction (IUGR) and abnormally invasive placenta (AIP, aka placenta accreta). Despite this, tools to measure placental structure and function in the crucial late first to early second trimester period have yet to be developed that can be translated from the research environment to routine clinical use. We are now constructing 3D power Doppler ultrasound technologies that provide real-time, quantitative assessment of placental structural and vascular development. We have developed novel semi- automated methods for calculation of placental volume (PlaV) and new methods to measure gross placental morphology (GPM; dimensions, surface area etc.) and to assess the vasculature at the UPI (Fractional Moving Blood Volume, FMBV). We propose four Aims intended to move the field towards routine imaging of placental structure and function in real time and to generate clinically useful tests for monitoring significant placental pathologies. In Aim 1, using machine learning techniques and an extant database of ~2800 1st trimester placental scans, we will fully automate the novel tools developed for measurement of PlaV into a real-time analytical package. Aim 2 will focus on 3D ultrasound techniques to interrogate the vasculature at the UPI through refinement of our new method for determining FMBV, a quantitative measure of vascularity. This will lead to a tool that can assess the entire UPI, a major site of pathology in PE, IUGR and AIP. We also aim to develop 3D power Doppler ultrasound tools for the examination of the size and distribution of the spiral artery jets feeding the intervillous space, enabling us to explore normal and pathological development of the intervillous supply in real-time. Aims 3 and 4 are prospective validation studies designed to test the utility of the tools described above. Aim 3 extends our recently published study of over-invasion of the maternal vasculature to the 1 /2 trimester. The presence and severity of AIP is assessed using Acon, the largest area of standard 3D power Doppler signal at the UPI. Under-invasion will be addressed via analysis of prospectively collected 11-13 week 3D-PD scans in women who develop PE. We will compare PlaV, GPM, FMBV and spiral artery jets in normotensive and preeclamptic pregnancies. The prospective study in Aim 4 will address the environmental impact of smoking by comparing structural and vascular parameters between smokers and non-smokers at weekly intervals from 8-18 wks. These powerful longitudinal studies will map the development of morphologic and vascular features in smokers and non-smokers and provide new insights into the factors responsible for smoking-induced growth restriction. The strong investigative team, composed of bioengineers, maternal-fetal medicine specialists and placental biologists, is delivering these new tools in the research setting and is poised to generate new methods for clinical measurement of placental structure and vascular function in real-time.          PUBLIC HEALTH RELEVANCE: If the placenta does not develop normally, complications like poor fetal growth and preeclampsia in the mother occur. We are developing new ultrasound techniques to measure the placenta early in pregnancy. This could permit early detection of problems that occur months later in the pregnancy. This would allow doctors to monitor the pregnancy and to prevent or treat problems quickly, before they have serious effects on the fetus.        ","Development of real-time, automated 3D ultrasound tools for the study of placental invasion and morphology",9076751,U01HD087209,"['bioengineering ', ' Biomedical Engineering ', ' vascular ', ' Blood Vessels ', ' Blood Volume ', ' Decidua Graviditas ', ' Decidua ', ' Environment ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Fetus ', ' Goals ', ' Au element ', ' Gold ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Growth and Development ', ' Growth and Development function ', ' Hand ', ' indexing ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' long-term study ', ' Longitudinal Studies ', ' Manuals ', ' Maps ', ' Methods ', ' Mothers ', ' Uterine Muscle ', ' myometrium ', ' Pathology ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Placenta Accreta ', ' Placental Development ', ' Placentation ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' Second Trimester ', ' Midtrimester ', ' Second Pregnancy Trimester ', ' Prospective Studies ', ' Publishing ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Research Resources ', ' Resources ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Translating ', ' trophoblast ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Vascularization ', ' Woman ', ' Generations ', ' Measures ', ' Specialist ', ' Doppler Ultrasound ', ' Site ', ' Area ', ' Surface ', ' Clinical ', ' normotensive ', ' insight ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' root ', ' Plant Roots ', ' Ecological impact ', ' Environmental Impact ', ' Morphology ', ' Shapes ', ' tool ', ' Smoker ', ' nonsmoker ', ' Non-smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Dimensions ', ' Severities ', ' Dependence ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Techniques ', ' fetal ', ' early detection ', ' Early Diagnosis ', ' Structure ', ' novel ', ' validation studies ', ' intrauterine growth ', ' Fetal Growth ', ' Modeling ', ' model development ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' in vivo ', ' Spiral Artery ', ' Spiral Artery of the Endometrium ', ' Validation ', ' Monitor ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' feeding ', ' prospective ', ' implantation ', ' public health relevance ', ' fetal medicine ', ' screening ', ' ']",NICHD,HACKENSACK UNIVERSITY MEDICAL CENTER,U01,2015,3316475,NJ-05,0.025778783573049205
"Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy DESCRIPTION (provided by applicant): Our understanding of cervical remodeling during pregnancy and labor is incomplete, partly due to the lack of in vivo studies on the biochemical changes that occur in the cervix over the course of pregnancy. Elucidation of the mechanisms for cervical ripening could be used to predict the onset of preterm labor. Until recently, in vivo research methods were too invasive to be used as discovery tools, particularly in women who present with preterm labor. This proposal will use in vivo Raman spectroscopy, an optical technique that is sensitive to collagen content, collagen structure, hydration, lipids, proteins, ad other biomolecules to non-invasively investigate the biochemistry of the cervix throughout pregnancy. Using fiber optic in vivo Raman spectroscopy, we recently found significant differences in Raman spectra in at least four important peaks during the course of pregnancy in mice, including discrete signatures for lipids, collagen, amide bonds, and enriched amino acids (proline, tyrosine). Computational analysis of these spectra yielded predictive algorithms with 94% classification accuracy for stage of pregnancy. Studies performed in 2-hour windows at the end of pregnancy identified spectra predictive for the timing of parturition. This approach provides a detailed real-time biomolecular map of cervical ripening that is currently unavailable by other means. In this proposal, we hypothesize that the different mechanisms of premature cervical ripening have unique Raman spectral signatures that correspond to underlying biochemical and mechanical changes that precede preterm birth, which can be detected in vivo. Two Specific Aims are proposed: 1) Determine spectral changes in the cervix of mice with normal and abnormal pregnancy and parturition; 2) Identify specific mediators of cervical remodeling by comparing Raman spectra to mechanical and biochemical changes in the ex vivo cervix during normal and abnormal parturition. Raman spectroscopy has primarily been used for detection of disease. Collaboration between our reproductive biology and bioengineering groups will capitalize on our expertise in Raman analysis of cervical tissues to study dynamic changes in cervix composition during pregnancy. Key elements in cervical biochemistry will be identified. In vivo Raman spectroscopy will be combined with biomechanical studies and imaging mass spectrometry, a powerful tool for in situ proteomic analysis, to examine mice with premature or delayed cervical remodeling. Together, these highly innovative approaches will generate in-depth profiles of cervical biology that will translate into novel non-invasive methods to detect impending premature birth in women. PUBLIC HEALTH RELEVANCE: This proposal will use Raman Spectroscopy, a non-invasive, optical scattering technique, to investigate the composition of the cervix throughout pregnancy and provide detailed real-time information on cervical ripening. These studies will identify spectral differences in the cervix during normal and abnormal cervical maturation; optical and biochemical markers will be identified to help monitor pregnancy non-invasively, as the fiber optic probe only requires brief contact with the external surface of the cervix to obtain measurements. Elucidating the mechanisms that initiate cervical ripening will provide a critical step for early detection and treatment of preterm birth, which is the leading cause of infant morbidity and mortality.",Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy,8925122,R01HD081121,"['Algorithms ', ' Prostaglandin E1alpha ', ' Prostaglandin E1 ', ' Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)- ', ' PGE1alpha ', ' PGE1 ', ' Muse ', ' Lipo-PGE1 ', ' Caverject ', ' Alprostadil ', ' Amides ', ' aminoacid ', ' Amino Acids ', ' Biological Chemistry ', ' Biochemistry ', ' Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Biology ', ' biomechanical ', ' Biomechanics ', ' bioengineering ', ' Biomedical Engineering ', ' Parturition ', ' Birth ', ' Uterine Cervix ', ' Cervix ', ' Cervix Uteri ', ' Systematics ', ' Classification ', ' Collagen ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Elasticity ', ' Fetal Development ', ' Fetal development of the mammalian embryo or fetus ', ' Fiber Optics ', ' Foundations ', ' Goals ', ' Health ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' In element ', ' Indium ', ' Preterm Labor ', ' Premature Obstetric Labor ', ' Premature Labor ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lipids ', ' Maintenance ', ' Maps ', ' Methods ', ' Mifeprex ', ' Mifegyne ', ' Mifepristone ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' optical ', ' Optics ', ' Phenotype ', ' physical science ', ' Gestation ', ' Pregnancy ', ' L-Proline ', ' Proline ', ' gene product ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Spectrum Analyses ', ' Spectroscopy ', ' Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Raman spectrometry ', ' Raman Spectroscopy ', ' IR/UV/Raman Spectroscopy ', ' Raman Spectrum Analysis ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Translating ', ' Translations ', ' para-Tyrosine ', ' L-isomer Tyrosine ', ' L-Tyrosine ', ' Tyrosine ', ' Woman ', ' Generations ', ' Measures ', ' Research Methods ', ' Research Methodology ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Premature Birth ', ' in situ Hybridization Staining Method ', ' in situ Hybridization Genetics ', ' In Situ Hybridization ', ' base ', ' Cervical ', ' Surface ', ' Clinical ', ' prematurity ', ' premature ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Medical ', ' Biochemical Markers ', ' Link ', ' insight ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' High-Risk Pregnancy ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' mechanical ', ' Mechanics ', ' Hour ', ' In Situ ', ' Techniques ', ' Hormonal ', ' early detection ', ' Early Diagnosis ', ' Cervical Ripenings ', ' Cervical Ripening ', ' Structure ', ' novel ', ' Prevention ', ' Modality ', ' RU486 ', ' RU38486 ', ' RU-38486 ', ' R38486 ', ' R 38486 ', ' RU-486 ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' Proteomics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Hydration ', ' Hydration status ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Data ', ' Detection ', ' Grant Proposals ', ' Applications Grants ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Reproductive Biology ', ' in vivo ', ' computational analysis ', ' Computer Analysis ', ' Emergent Technologies ', ' Emerging Technologies ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' early therapy ', ' Early treatment ', ' computer algorithm ', ' Computational algorithm ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' mouse model ', ' pregnant ', ' novel therapeutic approach ', ' new therapeutic intervention ', ' new therapeutic approach ', ' novel therapeutic intervention ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' infant morbidity/mortality ', ' ']",NICHD,VANDERBILT UNIVERSITY,R01,2015,362979,TN-05,0.06547748270019423
"QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES     DESCRIPTION (provided by applicant): Tissue identification and quantification plays a significant role in the study of aging and age-related diseases. For example, the accumulation of fat in the human body and its regional distribution with aging is associated with type 2 diabetes and cardiovascular diseases. Changes in muscle composition are strongly linked to decline of muscle strength, decreased mobility caused by aging, or musculoskeletal disorders. Especially interesting is analysis of longitudinal changes of morphometric descriptors that is significant for studying the aging process and for the diagnosis and prevention of age-related diseases.  Medical imaging has emerged as a major tool for estimation of body composition mainly due to being non- invasive and producing multi-dimensional information. Nowadays MRI and CT acquisition is a central component of clinical trials. An abundance of imaging data is collected, but this wealth of information has not been utilized to full extent. Therefore research on image analysis techniques for tissue quantification that are reproducible and can be used on large-scale clinical trials is of particular importance.  The technical hypothesis of this work is that quantitative image processing can robustly and accurately segment, register, and fuse body composition data from modern MRI and CT imaging. The central hypothesis of this proposal is that qualitative body composition phenotypes on clinical imaging will differentiate individuals who are healthy versus those who are not. The goal of our work is to provide a foundation for image analysis of the abdomen and lower extremities and to study the relationship between body morphological changes and age-related pathologies.  We will build upon recent advances in medical image computing to segment muscle, regional adipose tissue, and bone in clinical CT and MRI scans. We will also develop image registration procedures to achieve intra- and inter-subject correspondence and make efficient use of information provided by multi-modal and multi-temporal imaging data collected in clinical trials (aim 1). After these methods have been developed, we will address the hypothesis that quantitative use of clinical imaging can increase the prognostic accuracy of age-related pathologies (aim2).          PUBLIC HEALTH RELEVANCE: Age-related diseases such as type-2 diabetes, cardiovascular diseases, and sarcopenia have become a worldwide epidemic and affect the quality of life of millions. To give a global perspective, roughly 343.8 million people in the world have type-2 diabetes today, and 175 million don't know they have diabetes at all. Metabolic diseases are strongly linked to longitudinal changes in body composition, morphology and function. This project will contribute novel and non-invasive medical image analysis techniques for studying the human body composition and its changes with increasing age to achieve timely prognosis of these pathologies.                 ",QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES,8854343,SC3GM113754,"['Abdominal ', ' Abdomen ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Adipose tissue ', ' Affect ', ' Age ', ' Aging ', ' Algorithms ', ' Anatomical Sciences ', ' Anatomic ', ' Anatomy ', ' Body Composition ', ' bone ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' clinical investigation ', ' Clinical Trials ', ' Data Analysis ', ' Data Analyses ', ' Delaware ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fats ', ' Fatty acid glycerol esters ', ' Foundations ', ' Goals ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' long-term study ', ' Longitudinal Studies ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Medical Imaging ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Metabolic Diseases ', ' Methods ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' musculoskeletal disorder ', ' Musculoskeletal Diseases ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Noise ', ' Pathology ', ' Pennsylvania ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' QOL ', ' Quality of life ', ' Research ', ' social role ', ' Role ', ' statistics ', ' Thigh ', ' Thigh structure ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Work ', ' image processing ', ' Procedures ', ' morphometry ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' biogerontology ', ' Gerontology ', ' Link ', ' prognostic ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Voluntary Muscle ', ' Skeletal Muscle Tissue ', ' Skeletal Muscle ', ' Skeletal muscle structure ', ' Human Figure ', ' Human body ', ' Descriptor ', ' Morphology ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pattern ', ' Techniques ', ' muscle strength ', ' interest ', ' early detection ', ' Early Diagnosis ', ' novel ', ' Participant ', ' graduate student ', ' Prevention ', ' sarcopenia ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' MRI Scans ', ' Metabolic syndrome ', ' Address ', ' Aging Process ', ' Aging-Related Process ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' in vivo ', ' Computational Technique ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Populations ', ' Underrepresented Groups ', ' Underrepresented Minority ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' age dependent ', ' age related ', ' image registration ', ' Imaging technology ', ' public health relevance ', ' effective treatment ', ' effective therapy ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' longitudinal analysis ', ' undergraduate student ', ' biophysical modeling ', ' biophysical model ', ' ']",NIGMS,DELAWARE STATE UNIVERSITY,SC3,2015,63363,DE-00,0.03471052522275593
"A Novel Pregnancy Prevention Intervention for Latino Middle School Girls     DESCRIPTION (provided by applicant): This new investigator-initiated R01 proposal will test the efficacy of a promising and innovative intervention (Mighty Girls) to reduce teen Latina sexual behavior and pregnancy that was developed in a successful R15 feasibility trial. US teen pregnancy rates have declined but are still high among Latinas (49.4%), and the socioeconomic costs associated with these pregnancies are considerable; e.g., $3.2 billion lost tax revenue (2008 dollars) for decreased maternal educational attainment and productivity. Mighty Girls is designed to empower middle school Latinas with the skills they need to resist peer pressure that would otherwise accelerate their involvement in sexual behavior, allowing them to delay their initiation of intercourse and ultimately reduce their risk for teen pregnancy and sexually transmitted infections.  Mighty Girls uses cutting-edge technology to create a novel, highly interactive, video game that provides a live, realistic simulation of peer pressure. Players talk directly with avatars as they would with peers in their everyday life. This intervention focuses on building communication skills for resistance that are derived from evidence-based programs that do not jeopardize friendships and incorporate Latino cultural values (Marianismo, Personalismo, Simpata) - skills valued by middle school Latinas.  In addition to efficacy testing, the proposed interdisciplinary study evaluates (1) the intervention's cost- effectiveness and (2) influence of participant characteristics and how well the intervention was delivered (implementation quality) on study outcomes. The study will be conducted with seventh grade Latinas enrolled in 20 middle schools in Florida's Miami-Dade County, and followed into ninth grade, a period in which risky behaviors typically increase. Half of these schools will be randomly assigned to receive the Mighty Girls intervention and booster in addition to standard in-school sex education, while the other half will receive only standard in-school sex education. Data will be collected before and after the intervention, and at 2 (pre-booster), 12, and 24 months post-intervention using computerized surveys. Growth curve analysis will compare changes in peer resistance and sexual behavior observed in the two study conditions over the course of the study. Cost-effectiveness analyses will weigh the benefit of the intervention when added to current in-school sex education against its cost of delivery. This proposal addresses Healthy People 2020 objectives to reduce pre-term birth, increase the proportion of women who use contraception to plan pregnancy, and eliminate health disparities. It lays the foundation for a dissemination study of the Mighty Girls intervention that would have a major impact on the lives of vulnerable adolescents and reduce the personal and public burden of early sexual initiation. Study results would also advance the science of communications, health games, and computer engineering by generating data on human-avatar interactions and the use of highly interactive game technology to build health-related interpersonal skills.         PUBLIC HEALTH RELEVANCE: The teen pregnancy rate continues to be high among U.S. Latinas and results in significant personal, health care related and other societal costs. This study will test the efficacy of a promising and innovative intervention (Mighty Girls) that uses classroom activities in combination with a highly interactive video game to empower middle school Latinas to resist peer pressure to engage in intercourse. Girls play the game by talking directly with avatars that represent typical middle school children (no keyboard input required); thereby developing the skills needed to decrease their risk for teen pregnancy and sexually transmitted infections. Study results will be helpful for developing similar interventions for othe at risk youth, including boys, and guiding development of other technology based games designed to promote health.            ",A Novel Pregnancy Prevention Intervention for Latino Middle School Girls,8935645,R01NR014851,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Attitude ', ' Awareness ', ' Behavior ', ' sibling order ', ' Birth Order ', ' Canada ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Coitus ', ' Communication ', ' Computers ', ' cost effectiveness ', ' Curriculum ', ' Educational Curriculum ', ' depression ', ' Mental Depression ', ' Engineering ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Learning ', ' Theoretic Models ', ' Theoretical model ', ' Names ', ' well-being ', ' Personal Satisfaction ', ' Play ', ' Gestation ', ' Pregnancy ', ' Underage Pregnancy ', ' Teenage Pregnancy ', ' Teen Pregnancy ', ' Pregnancy in Minors ', ' Adolescent Pregnancy ', ' Pregnancy in Adolescence ', ' Pregnancy Rate ', ' Planned Pregnancy ', ' pressure ', ' Productivity ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Schools ', ' Science ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sex Education ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Societies ', ' Survey Instrument ', ' Surveys ', ' Taxes ', ' Teaching ', ' Educational process of instructing ', ' Technology ', ' Testing ', ' Video Games ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Work ', ' County ', ' Relative ', ' Relative (related person) ', ' health care ', ' Healthcare ', ' Latino ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' base ', ' Friendships ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Evaluation ', ' full-term birth ', ' Fullterm Birth ', ' Term Birth ', ' Individual ', ' European ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Life ', ' programs ', ' Country ', ' Outcome Study ', ' empowered ', ' Peer Pressure ', ' experience ', ' Self Efficacy ', ' condoms ', ' skills ', ' simulation ', ' novel ', ' Participant ', ' peer ', ' intimacy ', ' intimate behavior ', ' public education ', ' 7th grade ', ' seventh grade ', ' high school freshman ', ' 9th grade ', ' ninth grade ', ' cultural values ', ' Prevention ', ' Reporting ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Contraceptive methods ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' positive youth development ', ' boys ', ' girls ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' health disparities ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' Health Communication ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' developmental ', ' Development ', ' post intervention ', ' pregnancy prevention ', ' effectiveness trial ', ' initiation of intercourse ', ' early sexual initiation ', ' early sex initiation ', ' cost ', ' computerized ', ' designing ', ' design ', ' efficacy trial ', ' developing resistance ', ' Resistant development ', ' Resistance development ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' fourteen year old ', ' age 14 years ', ' 14 year old ', ' resistant ', ' Resistance ', ' Evidence based program ', ' social learning theory ', ' social cognitive theory ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' multimodal intervention ', ' multifaceted intervention ', ' multicomponent intervention ', ' multi-modal intervention ', ' multi-faceted intervention ', ' multi-component intervention ', ' young woman ', ' Healthy People 2020 ', ' ']",NINR,UNIVERSITY OF MIAMI CORAL GABLES,R01,2015,652270,FL-27,0.06008087110215526
"Mentoring and research in applying digital technologies to prevent chronic Illnesses     DESCRIPTION (provided by applicant): For this K24 midcareer investigator award in patient-oriented research (POR) award, my goals are: 1) to become an international leader in the primary prevention of type 2 diabetes and cardiovascular diseases by applying emerging digital technologies and social media; 2) to conduct high-impact research in testing innovative, cost-effective lifestyle interventions (physical activity) using machine leaning; and 3) to provide a hih quality mentorship and training environment that supports the conduct of high POR impact research in cardiovascular and diabetes prevention. This K24 award will allow me to take on a broader and more formal mentorship role not only in the School of Nursing but also throughout the University of California, San Francisco campus. The overall goals of the new research in this application are to develop decision rule algorithms and quantitative models to optimize real-time predictions of future physical activity intervention adherences and to pilot test these algorithms and models in an intervention trial. The specific aims are: 1) to determine the extent to which baseline factors can predict adherence in self-monitoring (using mobile apps and wearing advanced accelerometers); 2) to determine the extent to which early app-based self-monitoring and evaluation (e.g., advanced accelerometers and diary use, and step counts in the first few weeks) can be optimized to make real-time predictions of future treatment failures; 3) to assess the feasibility of the ""Physical Activity Plus"" intervention using developed real-time prediction models (developed in Aim 2), compared to a ""regular physical activity"" intervention, for changes in total daily steps and duration of moderate and intensive physical activity over a three-month period. To tailor intervention intensity, we will evaluate the frequency of study visits and real-time feedback to minimize treatment failures and maximize adherence. Junior investigators in the POR have adapted digital mobile technologies as part of their research tools and have generated large volumes of continuous data. However, only a few training opportunities are available in this research area; in particular, for methods to rigorously and fully utilize the richness of the data collected. Therefore, the proposed K24 application will also meet these mentees' urgent needs across disciplines.         PUBLIC HEALTH RELEVANCE: This K24 application will allow Dr. Fukuoka to use her cardiovascular and diabetes research program as a platform to mentor and guide the careers of junior investigators in patient-oriented research (POR) and to further develop her leadership and mentoring skills.            ",Mentoring and research in applying digital technologies to prevent chronic Illnesses,8949658,K24NR015812,"['Accounting ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Award ', ' Dorsum ', ' Back ', ' Behavior ', ' California ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardiovascular system ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Email ', ' E-Mail ', ' Electronic Mail ', ' Environment ', ' Epidemic ', ' Feedback ', ' Future ', ' Goals ', ' sound perception ', ' hearing perception ', ' Hearing ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Methods ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Primary Prevention ', ' Recommendation ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Running ', ' San Francisco ', ' School Health Nursing ', ' School Nursing ', ' Technology ', ' Testing ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' United States ', ' Universities ', ' Work ', ' Measures ', ' Treatment Failure ', ' Clip ', ' base ', ' career ', ' improved ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Evaluation ', ' Training ', ' Physical activity ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Discipline ', ' Individual ', ' Sample Size ', ' Funding ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' diaries ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Visit ', ' meetings ', ' skills ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' social ', ' Intervention Trial ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient oriented study ', ' patient oriented research ', ' Cellular Telephone ', ' Cell Phone ', ' Cellular Phone ', ' Mobile Phones ', ' Car Phone ', ' preventing ', ' prevent ', ' Address ', ' Adherence ', ' Adherence (attribute) ', ' Data ', ' International ', ' K24 Award ', ' Mid-Career Clinical Scientist Award (K24) ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' K24 Program ', ' K24 Mechanism ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Emergent Technologies ', ' Emerging Technologies ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Principal Investigator ', ' To specify ', ' Text ', ' developmental ', ' Development ', ' Behavioral ', ' Diabetes prevention ', ' cost ', ' digital ', ' designing ', ' design ', ' cost-effective ', ' cost effective ', ' life style intervention ', ' lifestyle intervention ', ' innovative ', ' innovate ', ' innovation ', ' public health relevance ', ' Secure ', ' mobile app ', ' mobile application ', ' unique treatment ', ' targeted treatment ', ' tailored treatment ', ' individualized treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' ']",NINR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",K24,2015,188616,CA-12,0.021391706915573305
"A Novel Pregnancy Prevention Intervention for Latino Middle School Girls     DESCRIPTION (provided by applicant): This new investigator-initiated R01 proposal will test the efficacy of a promising and innovative intervention (Mighty Girls) to reduce teen Latina sexual behavior and pregnancy that was developed in a successful R15 feasibility trial. US teen pregnancy rates have declined but are still high among Latinas (49.4%), and the socioeconomic costs associated with these pregnancies are considerable; e.g., $3.2 billion lost tax revenue (2008 dollars) for decreased maternal educational attainment and productivity. Mighty Girls is designed to empower middle school Latinas with the skills they need to resist peer pressure that would otherwise accelerate their involvement in sexual behavior, allowing them to delay their initiation of intercourse and ultimately reduce their risk for teen pregnancy and sexually transmitted infections.  Mighty Girls uses cutting-edge technology to create a novel, highly interactive, video game that provides a live, realistic simulation of peer pressure. Players talk directly with avatars as they would with peers in their everyday life. This intervention focuses on building communication skills for resistance that are derived from evidence-based programs that do not jeopardize friendships and incorporate Latino cultural values (Marianismo, Personalismo, Simpata) - skills valued by middle school Latinas.  In addition to efficacy testing, the proposed interdisciplinary study evaluates (1) the intervention's cost- effectiveness and (2) influence of participant characteristics and how well the intervention was delivered (implementation quality) on study outcomes. The study will be conducted with seventh grade Latinas enrolled in 20 middle schools in Florida's Miami-Dade County, and followed into ninth grade, a period in which risky behaviors typically increase. Half of these schools will be randomly assigned to receive the Mighty Girls intervention and booster in addition to standard in-school sex education, while the other half will receive only standard in-school sex education. Data will be collected before and after the intervention, and at 2 (pre-booster), 12, and 24 months post-intervention using computerized surveys. Growth curve analysis will compare changes in peer resistance and sexual behavior observed in the two study conditions over the course of the study. Cost-effectiveness analyses will weigh the benefit of the intervention when added to current in-school sex education against its cost of delivery. This proposal addresses Healthy People 2020 objectives to reduce pre-term birth, increase the proportion of women who use contraception to plan pregnancy, and eliminate health disparities. It lays the foundation for a dissemination study of the Mighty Girls intervention that would have a major impact on the lives of vulnerable adolescents and reduce the personal and public burden of early sexual initiation. Study results would also advance the science of communications, health games, and computer engineering by generating data on human-avatar interactions and the use of highly interactive game technology to build health-related interpersonal skills.         PUBLIC HEALTH RELEVANCE: The teen pregnancy rate continues to be high among U.S. Latinas and results in significant personal, health care related and other societal costs. This study will test the efficacy of a promising and innovative intervention (Mighty Girls) that uses classroom activities in combination with a highly interactive video game to empower middle school Latinas to resist peer pressure to engage in intercourse. Girls play the game by talking directly with avatars that represent typical middle school children (no keyboard input required); thereby developing the skills needed to decrease their risk for teen pregnancy and sexually transmitted infections. Study results will be helpful for developing similar interventions for othe at risk youth, including boys, and guiding development of other technology based games designed to promote health.            ",A Novel Pregnancy Prevention Intervention for Latino Middle School Girls,9103906,R01NR014851,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Attitude ', ' Awareness ', ' Behavior ', ' sibling order ', ' Birth Order ', ' Canada ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Sexual Intercourse ', ' Coitus ', ' Communication ', ' cost effectiveness ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' depression ', ' Mental Depression ', ' Engineering ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Modern Man ', ' Human ', ' Theoretic Models ', ' Theoretical model ', ' Names ', ' well-being ', ' Personal Satisfaction ', ' Play ', ' Gestation ', ' Pregnancy ', ' adolescents who are pregnant ', ' Underage Pregnancy ', ' Teenage Pregnancy ', ' Teen Pregnancy ', ' Pregnancy in Minors ', ' Adolescent Pregnancy ', ' Pregnancy in Adolescence ', ' Pregnancy Rate ', ' Planned Pregnancy ', ' pressure ', ' Productivity ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Schools ', ' Science ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sex Education ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Societies ', ' Survey Instrument ', ' Surveys ', ' Taxes ', ' Teaching ', ' Educational process of instructing ', ' Technology ', ' Testing ', ' Video Games ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Work ', ' County ', ' Healthcare ', ' health care ', ' Latino ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Pre-term birth ', ' base ', ' Friendships ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Evaluation ', ' Individual ', ' European ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' Ethnicity ', ' Ethnic Origin ', ' Life ', ' programs ', ' Country ', ' Outcome Study ', ' empowered ', ' Peer Pressure ', ' experience ', ' Self Efficacy ', ' condoms ', ' skills ', ' simulation ', ' novel ', ' Participant ', ' peer ', ' intimacy ', ' intimate behavior ', ' public education ', ' 7th grade ', ' seventh grade ', ' high school freshman ', ' 9th grade ', ' ninth grade ', ' cultural values ', ' Prevention ', ' Reporting ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Contraceptive methods ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' positive youth development ', ' afterschool program ', ' after-school program ', ' boys ', ' girls ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' disparity in health ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effectiveness analyses ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' Health Communication ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' post intervention ', ' pregnancy prevention ', ' effectiveness trial ', ' initiation of intercourse ', ' early sexual initiation ', ' early sex initiation ', ' cost ', ' computerized ', ' designing ', ' design ', ' efficacy trial ', ' Resistance development ', ' developing resistance ', ' Resistant development ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' 14 year old ', ' fourteen year old ', ' age 14 years ', ' Resistance ', ' resistant ', ' Evidence based program ', ' social cognitive theory ', ' social learning theory ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' multi-component intervention ', ' multimodal intervention ', ' multifaceted intervention ', ' multicomponent intervention ', ' multi-modal intervention ', ' multi-faceted intervention ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' Healthy People 2020 ', ' vulnerable adolescent ', ' computer game ', ' learning strategy ', ' learning method ', ' learning activity ', ' ']",NINR,UNIVERSITY OF MIAMI CORAL GABLES,R01,2016,808034,FL-27,0.06008087110215526
"Statistical methods for healthcare in complex patients with diabetes     DESCRIPTION (provided by applicant): Diabetes affects 8.3% of the US population, and lead to costly adverse healthcare outcomes. Unfortunately, there may be a quality gap in the care of complex diabetes patients, that is, older patients (age>65 years) and those with comorbid conditions. Current practices, relying primarily on the presence of several factors, are not effective in capturing the risk of poor prognosis, i.e., multiple hospitalization and/or emergency department visits, and death. Hence, little evidence exists so far to help prioritize care for thes patients. The diabetes guidelines recognize that tight control of glycosylated hemoglobin (A1c) may not be appropriate for complex patients, and recommend individualizations in tight A1c control. However, neither the outcomes of tight A1c control, nor the effects of the typical treatment regimens used to achieve tight A1c control can be evaluated in clinical trials, with minimal, if any, enrollment of complex diabetes patients due to either their restrictive inclusion criteria or lack of encouragement of the patient and/or clinical investigator to consider the RCT. In order to deliver more effective, efficient and accountable health cares, it is important to help clinicians to examine the relationship between patient complexity and patients' A1c control level, and to modify guideline appropriately with an evidence base. The proposed research will analyze a cohort of 8,304 Medicare beneficiaries with diabetes who were cared for by one of the country's 10 largest physician group practices, the University of Wisconsin Medical Foundation during 2003-2011 to address the following aims: (1) to conduct risk prediction incorporating longitudinal outcomes, (2) to inform guidelines for complex diabetes patients, and (3) to create a patient-centered surveillance tool for detecting short-term negative outcomes. Our analytic approach involves the use of state- of-the-art statistics and machine learning methods to take advantage of the large electronic health records data. The proposed methods and results will help clinicians to identify and quantify risks of tight A1c control in complex diabetes patients an potentially lead to improved patient experiences, and reduce medical expenditures from excess adverse events.         PUBLIC HEALTH RELEVANCE: Sub-optimal glycosylated hemoglobin (A1c) control recommendations and treatment recommendations for diabetes patients can result in adverse events, and increased health care utilization. Unfortunately, current guidelines on the care for complex and/or older patients with diabetes are inadequate. We propose to develop an effective and patient-centered health care delivery system for complex diabetes patients, focusing on accurate prediction of adverse events, development of potential guidelines on targeting tight control of A1c and treatment regimens, and real-time monitoring of health conditions.            ",Statistical methods for healthcare in complex patients with diabetes,9145732,R01DK108073,"['Accounting ', ' Affect ', ' Age ', ' Algorithms ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Clinical Investigator ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' Clinical Trials ', ' Complement Proteins ', ' Complement ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' diabetes ', ' Diabetes Mellitus ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Expenditure ', ' Foundations ', ' Future ', ' Patient Care Delivery ', ' Patient Care ', ' Glycated Hemoglobins ', ' Glycosylated Hemoglobin ', ' Goals ', ' Group Practice ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Hospitalization ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' extended care ', ' Long-Term Care ', ' Methods ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patients ', ' Physicians ', ' Prognosis ', ' outcome forecast ', ' healthcare quality ', ' health care quality ', ' Recommendation ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' statistics ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' Trees ', ' United States ', ' Universities ', ' Wisconsin ', ' Work ', ' Healthcare ', ' health care ', ' Risk Assessment ', ' Glean ', ' Data Set ', ' Dataset ', ' Caring ', ' Guidelines ', ' base ', ' improved ', ' Area ', ' Chronic ', ' Clinical ', ' Medical ', ' Link ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Collaborations ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' System ', ' Country ', ' meetings ', ' experience ', ' user friendly computer software ', ' user friendly software ', ' cohort ', ' treatment planning ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Adverse Experience ', ' Adverse event ', ' Effectiveness ', ' Address ', ' Data ', ' Detection ', ' enroll ', ' Enrollment ', ' Exclusion Criteria ', ' Update ', ' Monitor ', ' developmental ', ' Development ', ' beneficiary ', ' Electronic Health Record ', ' cost ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' older patient ', ' elderly patient ', ' Outcome ', ' Population ', ' patient oriented ', ' patient centered ', ' inclusion criteria ', ' high risk ', ' public health relevance ', ' evidence base ', ' patient population ', ' clinical practice ', ' Regimen ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' learning strategy ', ' learning method ', ' learning activity ', ' ']",NIDDK,FRED HUTCHINSON CANCER RESEARCH CENTER,R01,2016,292485,WA-07,0.13368502284273018
"Adaptive Prediction of Blood Glucose Levels using Wearable Physiological Sensors     DESCRIPTION (provided by applicant): Type 1 diabetes is a chronic disease, which presently cannot be prevented or cured. It is treated with insulin therapy and actively managed through blood glucose (BG) control. To avoid serious diabetic complications, patients must monitor their BG levels throughout the day, striving to avoid both hyperglycemia (high BG levels) and hypoglycemia (low BG levels). While continuous glucose monitoring (CGM) sensors and insulin pumps with exible dosing may aid in achieving good BG control, management of diabetes is still difcult and laborious for patients and physicians. It is complicated by a wide variability among individual patients in terms of physiological responses to treatment as well as to life events such as stress, exercise, or changes in schedule and sleep. New portable sensing technologies have been recently developed for providing almost continuous measure- ments of an array of physiological parameters that include heart rate, skin conductance, skin temperature, and properties of body movements such as acceleration. The main research objective of this project is to leverage data acquired from wearable physiological sensors to build accurate, personalized blood glucose level prediction models for diabetes management. Predicting BG control problems before they occur would give patients time to intervene and prevent these problems. This would enhance patient safety and contribute to improved overall control, with its concomitant reduction in costly complications. Blood glucose level prediction is  very complex problem. Recent advances in unsupervised feature learning and deep learning have made it possible to learn complex models from data using simple algorithms. Inspired by these signicant developments in Articial Intelligence (AI), we propose to employ unsupervised feature learn- ing and deep learning techniques in order to build an architecture for modeling blood glucose behavior that can seamlessly incorporate data coming from any number of physiological sensors. A recurrent neu- ral network (RNN) will be trained to capture dependencies among the input physiological parameters that are relevant to BG prediction. To account for individual patient differences, a predictive model will be developed for each patient by training on the features discovered by the RNN. The primary impact of this work would be to improve the overall health and quality of life for the 1.25 million Americans with type 1 diabetes. Accurate prediction models would enable practical applications ranging from alerts of impending problems to decision support tools for evaluating the effects of different food or lifestyle choice. Additionally, the wealth of patient and sensor data collected for this work will lead to the creatin of de-identied datasets to be used by the research community in evaluating approaches to blood glucose prediction. The new approaches developed for this complex domain may aid in the development of time series forecasting models for a broad array of sensor-enabled applications in other health and wellness domains.         PUBLIC HEALTH RELEVANCE: To aid in diabetes management, machine learning models will be built to predict future blood glucose levels based on wearable sensor data from commercially available fitness bands in addition to blood glucose, insulin and meal data. These models could help the over one million Americans with type 1 diabetes to anticipate and prevent blood glucose control problems before they occur. This would enhance patient safety and contribute to improved overall blood glucose control, with its associated reduction in costly complications.        ",Adaptive Prediction of Blood Glucose Levels using Wearable Physiological Sensors,9112492,R21EB022356,"['Acceleration ', ' Accounting ', ' Algorithms ', ' Amputation ', ' Engineering / Architecture ', ' Architecture ', ' Behavior ', ' Blood Sugar ', ' Blood Glucose ', ' Carbohydrates ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communities ', ' computer vision ', ' Computer Vision Systems ', ' emotional dependency ', ' Dependency ', ' diabetes ', ' Diabetes Mellitus ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Engineering ', ' Exercise ', ' Expenditure ', ' Food or Food Product ', ' Food ', ' Future ', ' skin conductance ', ' Skin Electric Conductance ', ' Psychogalvanic Reflex ', ' Electrodermal Response ', ' Galvanic Skin Response ', ' Health ', ' Cardiac Chronotropism ', ' Heart Rate ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin ', ' insulin pump ', ' Insulin Infusion Systems ', ' Intelligence ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Lifestyle ', ' Life Style ', ' Manuals ', ' body movement ', ' Movement ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' Patient Training ', ' Patient Instruction ', ' Patient Education ', ' Patients ', ' Physicians ', ' QOL ', ' Quality of life ', ' Recurrent ', ' Recurrence ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Skin Temperature ', ' Sleep ', ' Stress ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Technology ', ' Time ', ' Work ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Schedule ', ' Data Set ', ' Dataset ', ' base ', ' sensor ', ' improved ', ' Area ', ' Physiologic ', ' Physiological ', ' Series ', ' Training ', ' Individual ', ' Measurement ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Complications of Diabetes Mellitus ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Scientist ', ' Complex ', ' Event ', ' Techniques ', ' System ', ' visual loss ', ' vision loss ', ' Blindness ', ' Equation ', ' American ', ' Performance ', ' speech recognition ', ' neural network ', ' Biological Neural Networks ', ' technology development ', ' collected works ', ' Speed ', ' Modeling ', ' Decision Support Systems ', ' Property ', ' glucose meter ', ' glucometer ', ' glucose monitor ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient safety ', ' preventing ', ' prevent ', ' Dose ', ' fitness ', ' Data ', ' Monitor ', ' developmental ', ' Development ', ' Behavioral ', ' cost ', ' data modeling ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' diabetic management ', ' diabetes management ', ' blood glucose regulation ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' direct application ', ' Consumption ', ' practical application ', ' application in practice ', ' multidisciplinary ', ' public health relevance ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' support tools ', ' individual patient ', ' treatment choice ', ' ']",NIBIB,OHIO UNIVERSITY ATHENS,R21,2016,225750,OH-15,0.06119049097307013
"A Novel Pregnancy Prevention Intervention for Latino Middle School Girls DESCRIPTION (provided by applicant): This new investigator-initiated R01 proposal will test the efficacy of a promising and innovative intervention (Mighty Girls) to reduce teen Latina sexual behavior and pregnancy that was developed in a successful R15 feasibility trial. US teen pregnancy rates have declined but are still high among Latinas (49.4%), and the socioeconomic costs associated with these pregnancies are considerable; e.g., $3.2 billion lost tax revenue (2008 dollars) for decreased maternal educational attainment and productivity. Mighty Girls is designed to empower middle school Latinas with the skills they need to resist peer pressure that would otherwise accelerate their involvement in sexual behavior, allowing them to delay their initiation of intercourse and ultimately reduce their risk for teen pregnancy and sexually transmitted infections.  Mighty Girls uses cutting-edge technology to create a novel, highly interactive, video game that provides a live, realistic simulation of peer pressure. Players talk directly with avatars as they would with peers in their everyday life. This intervention focuses on building communication skills for resistance that are derived from evidence-based programs that do not jeopardize friendships and incorporate Latino cultural values (Marianismo, Personalismo, Simpata) - skills valued by middle school Latinas.  In addition to efficacy testing, the proposed interdisciplinary study evaluates (1) the intervention's cost- effectiveness and (2) influence of participant characteristics and how well the intervention was delivered (implementation quality) on study outcomes. The study will be conducted with seventh grade Latinas enrolled in 20 middle schools in Florida's Miami-Dade County, and followed into ninth grade, a period in which risky behaviors typically increase. Half of these schools will be randomly assigned to receive the Mighty Girls intervention and booster in addition to standard in-school sex education, while the other half will receive only standard in-school sex education. Data will be collected before and after the intervention, and at 2 (pre-booster), 12, and 24 months post-intervention using computerized surveys. Growth curve analysis will compare changes in peer resistance and sexual behavior observed in the two study conditions over the course of the study. Cost-effectiveness analyses will weigh the benefit of the intervention when added to current in-school sex education against its cost of delivery. This proposal addresses Healthy People 2020 objectives to reduce pre-term birth, increase the proportion of women who use contraception to plan pregnancy, and eliminate health disparities. It lays the foundation for a dissemination study of the Mighty Girls intervention that would have a major impact on the lives of vulnerable adolescents and reduce the personal and public burden of early sexual initiation. Study results would also advance the science of communications, health games, and computer engineering by generating data on human-avatar interactions and the use of highly interactive game technology to build health-related interpersonal skills. PUBLIC HEALTH RELEVANCE: The teen pregnancy rate continues to be high among U.S. Latinas and results in significant personal, health care related and other societal costs. This study will test the efficacy of a promising and innovative intervention (Mighty Girls) that uses classroom activities in combination with a highly interactive video game to empower middle school Latinas to resist peer pressure to engage in intercourse. Girls play the game by talking directly with avatars that represent typical middle school children (no keyboard input required); thereby developing the skills needed to decrease their risk for teen pregnancy and sexually transmitted infections. Study results will be helpful for developing similar interventions for othe at risk youth, including boys, and guiding development of other technology based games designed to promote health.",A Novel Pregnancy Prevention Intervention for Latino Middle School Girls,9221647,R01NR014851,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Attitude ', ' Awareness ', ' Behavior ', ' sibling order ', ' Birth Order ', ' Canada ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Sexual Intercourse ', ' Coitus ', ' Communication ', ' cost effectiveness ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' depression ', ' Mental Depression ', ' Engineering ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Modern Man ', ' Human ', ' Theoretic Models ', ' Theoretical model ', ' Names ', ' well-being ', ' Personal Satisfaction ', ' Play ', ' Gestation ', ' Pregnancy ', ' adolescents who are pregnant ', ' Underage Pregnancy ', ' Teenage Pregnancy ', ' Teen Pregnancy ', ' Pregnancy in Minors ', ' Adolescent Pregnancy ', ' Pregnancy in Adolescence ', ' Pregnancy Rate ', ' Planned Pregnancy ', ' pressure ', ' Productivity ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Schools ', ' Science ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sex Education ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Societies ', ' Survey Instrument ', ' Surveys ', ' Taxes ', ' Teaching ', ' Educational process of instructing ', ' Technology ', ' Testing ', ' Video Games ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Work ', ' County ', ' Healthcare ', ' health care ', ' Latino ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Pre-term birth ', ' base ', ' Friendships ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Evaluation ', ' Individual ', ' European ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' Ethnicity ', ' Ethnic Origin ', ' Life ', ' programs ', ' Country ', ' Outcome Study ', ' empowered ', ' Peer Pressure ', ' experience ', ' Self Efficacy ', ' condoms ', ' skills ', ' simulation ', ' novel ', ' Participant ', ' peer ', ' intimacy ', ' intimate behavior ', ' public education ', ' 7th grade ', ' seventh grade ', ' high school freshman ', ' 9th grade ', ' ninth grade ', ' cultural values ', ' Prevention ', ' Reporting ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Contraceptive methods ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' positive youth development ', ' afterschool program ', ' after-school program ', ' boys ', ' girls ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' disparity in health ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effectiveness analyses ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' Health Communication ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' post intervention ', ' pregnancy prevention ', ' effectiveness trial ', ' initiation of intercourse ', ' early sexual initiation ', ' early sex initiation ', ' cost ', ' computerized ', ' designing ', ' design ', ' efficacy trial ', ' Resistance development ', ' developing resistance ', ' Resistant development ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' 14 year old ', ' fourteen year old ', ' age 14 years ', ' Resistance ', ' resistant ', ' Evidence based program ', ' social cognitive theory ', ' social learning theory ', ' intervention effect ', ' efficacy testing ', ' multi-component intervention ', ' multimodal intervention ', ' multifaceted intervention ', ' multicomponent intervention ', ' multi-modal intervention ', ' multi-faceted intervention ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' Healthy People 2020 ', ' vulnerable adolescent ', ' computer game ', ' learning strategy ', ' learning method ', ' learning activity ', ' ']",NINR,UNIVERSITY OF MIAMI CORAL GABLES,R01,2016,35738,FL-27,0.06008087110215526
"Optical Tomographic Imaging of Peripheral Arterial Disease DESCRIPTION (provided by applicant): We propose to build and test a dynamic vascular optical tomographic imaging (DVOTI) system that can be used to detect and monitor peripheral arterial disease (PAD). PAD is estimated to affect approximately 8 to 12 million individuals in the United States. However, the disease is considerably under-diagnosed, since most patients are asymptomatic and no single reliable screening modality has been established. Most of the undiagnosed and untreated patients are diabetics. They commonly suffer from peripheral neuropathy and hence do not sense and report symptoms (such as pain) that are early signs of the disease. Consequently more than 60% (~65,000 per year) of all lower extremity amputations in the United States are performed in diabetic patients with PAD. With the number of diabetic patients expected to triple and reach almost 100 million by 2050, the problems related to undiagnosed PAD will only rise in the years to come  The most widely used diagnostic test for PAD, determination of the ankle-brachial index (ABI) in conjunction with pulse-volume recordings (PVR), is known to be unreliable for diabetics. And even in non- diabetics, ABI with PVR and all other existing diagnostic tests (such as Duplex Ultrasound or Magnetic resonance angiography), only provides accurate information about proximal occlusions in major arteries of the leg. However, none of these tests assess the distal perfusion of the foot where most complications, such as ulcers and gangrene, typically occur. Monitoring the success of surgical interventions, such as angioplasty or bypass surgery, suffers from the same shortcomings, as physicians are limited to the same suite of tests that are inadequate to assess the perfusion of the foot.  Dynamic VOTI promises to overcome the limitations of current diagnostic and monitoring techniques and has the potential to initiate a paradigm shift concerning how vascular diseases are assessed. In preliminary studies we have shown that DVOTI can provide three-dimensional time-series images that provide valuable information about the perfusion of the vascular bed in feet of PAD patients. The near-infrared light used in the instrument has no adverse health effects and measurements can be repeated frequently to monitor post interventional progress. Therefore, we believe that DVOTI will prove to be a safe and accurate method to diagnose and monitor PAD in non-diabetic and diabetic patients. PUBLIC HEALTH RELEVANCE: We propose to build and test a novel optical imaging system that will allow for the diagnosis and monitoring of peripheral artery disease (PAD), which affects approximately 8 to 12 million individuals in the United States. The disease is considerably under-diagnosed, especially in diabetic patients, the elderly, and patients with kidney disease. The system will address an unmet need to directly assess the degree of blood perfusion in the feet, where most PAD-related complications occur, which lead to over 65,000 amputations each year.",Optical Tomographic Imaging of Peripheral Arterial Disease,9116282,R01HL115336,"['Accounting ', ' Affect ', ' Air ', ' Algorithms ', ' Amputation ', ' Variance Analyses ', ' ANOVA ', ' Analysis of Variance ', ' Tarsus ', ' Tarsal Bone ', ' Regio tarsalis ', ' Ankle ', ' Arteries ', ' vascular ', ' Blood Vessels ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Diffusion ', ' Disorder ', ' Disease ', ' foot ', ' Gangrene ', ' Head ', ' Health ', ' image construction ', ' Image Reconstructions ', ' indexing ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' Photoradiation ', ' Light ', ' Maps ', ' Methods ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' optical ', ' Optics ', ' Painful ', ' Pain ', ' Patients ', ' Perfusion ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Peripheral Nervous System Diseases ', ' Physicians ', ' Risk ', ' Sensitivity and Specificity ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Ulcer ', ' Ulceration ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' United States ', ' Vascular Diseases ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Treatment outcome ', ' Diagnostic tests ', ' Angioplasty ', ' intraluminal angioplasty ', ' evaluation/testing ', ' Procedures ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Distal ', ' Medical ', ' Series ', ' Ensure ', ' Individual ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' MRI Angiography ', ' Magnetic Resonance Angiography ', ' tool ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Diagnostic Procedure ', ' Techniques ', ' System ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' early detection ', ' Early Diagnosis ', ' experience ', ' light emission ', ' success ', ' vascular bed ', ' blood perfusion ', ' novel ', ' Modality ', ' Devices ', ' Reporting ', ' Bypass ', ' Coding System ', ' Code ', ' Statistical Methods ', ' Property ', ' theories ', ' Leg ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' post intervention ', ' optical imaging ', ' optic imaging ', ' designing ', ' design ', ' older patient ', ' elderly patient ', ' data acquisition ', ' healthy volunteer ', ' non-diabetic ', ' nondiabetic ', ' prototype ', ' tissue phantom ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' diabetic patient ', ' screening ', ' Geometry ', ' imaging system ', ' imaging biomarker ', ' imaging marker ', ' Preventive measure ', ' Preventative measure ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2016,553894,NY-13,0.010743813042986048
"Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury     DESCRIPTION (provided by applicant): Throughout human pregnancy, the placenta is indispensable for embryonic development, fetal growth and tissue differentiation. The placenta also protects the fetus against diverse insults, while preserving maternal health. Placental dysfunction is commonly implicated in complications of pregnancy that challenge maternal physiology (e.g., preeclampsia) and fetal development (e.g., fetal death or fetal growth restriction) or that leads to preterm birth. Within the placenta, the trophoblast constitutes the outermost layer, which is directly bathed in maternal blood and therefore positioned to regulate maternal-fetal gas exchange, nutrient delivery, waste removal and the production of hormones, faithfully balancing fetal needs and maternal supply. Trophoblast damage, which is common in dysfunctional placentas, may interrupt the delicate maternal-fetal balance, cause clinical disease, and leave a lifelong mark on health. A fundamental challenge in perinatal medicine arises from our limited ability to diagnose placental disorders in real time and throughout pregnancy. However, the recent discovery, by ourselves and others, that (a) placental trophoblasts release distinctive micro- and nanovesicles into the maternal circulation and (b) these vesicles contain trophoblast-specific non-coding RNA cargo, created a new opportunity for assessing trophoblast health. These vesicles are actively released by trophoblasts throughout pregnancy, and thus serve as a venipuncture-accessible ""natural biopsy"" of trophoblasts, which can furnish information on trophoblast health in real time. Our established perinatal biology group at Magee- Womens Research Institute includes expertise in perinatal medicine and placental pathology, developmental and molecular biology, and bioinformatics. Inspired by these recent advances, we have partnered with an experienced group of bioengineers that includes experts from Carnegie Mellon University, MIT, and Penn State University, with unique skills in biophysics-based vesicle analytics, including microfluidics, nanomechanics, micro/nano fabrication and vesicle sorting using acoustic tweezers. Together, our new transdisciplinary group will use integrated molecular and biophysical methodologies to directly assess the use of trophoblast-derived extracellular vesicles from maternal plasma as revelatory of trophoblast health in real time and as a technique that may be employed throughout pregnancy. Our approach is comprehensive, centering on miRNAs as well as lncRNAs and circRNAs, analyzed in exosome nanovesicles, as well as microvesicles and apoptotic bodies. As each vesicle features a unique bimolecular and biophysical signature, we will deploy our machine learning- based training and testing pipeline to informatively integrate these distinct signals into an innovative diagnostic tool. Lastly, our deployment of affordable acoustic tweezers technology to sort trophoblastic vesicles will facilitate the translation of our advances into a new ""lab on a chip"" placental diagnostic technology, suitable for small blood volumes. This technology may not only denote trophoblast pathology, but has potential to identify those who may benefit from intervention and to monitor therapeutic success. PUBLIC HEALTH RELEVANCE: Although the placenta is critical for fetal development and pregnancy outcome, it is not currently accessible for real-time diagnostics throughout pregnancy. Having developed tools for isolation and analysis of placenta- specific extracellular from the maternal plasma, we will study molecular and biophysical properties of these vesicles as indicators of placental health and disease.",Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury,9145745,R01HD086325,"['placental abruption ', ' Premature Separation of Placenta ', ' Abruptio Placentae ', ' Acoustic ', ' Acoustics ', ' Arteries ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' bioengineering ', ' Biomedical Engineering ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Biophysics ', ' Biopsy ', ' needle biopsy ', ' Needle biopsy procedure ', ' Blood Reticuloendothelial System ', ' Blood ', ' Circulation ', ' Bloodstream ', ' Blood Circulation ', ' Blood Volume ', ' Communication ', ' Developmental Biology ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' balance function ', ' balance ', ' Equilibrium ', ' fetus death ', ' Fetal Death ', ' Fetal Development ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Fetus ', ' Future ', ' Gases ', ' Au element ', ' Gold ', ' Health ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hormones ', ' Modern Man ', ' Human ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Maternal Health ', ' Methods ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Pathology ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Placental Diseases ', ' Placenta Disorders ', ' Placenta Diseases ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Plasma Proteins ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' Pregnancy Complications ', ' Pregnancy Outcome ', ' Pregnancy-Associated alpha-Plasma Protein ', ' PAPP-alpha ', ' PAPP-A ', ' Insulin-Like-Growth Factor Binding Protein-4 Protease ', ' Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease ', ' IGFBP-4-Specific Proteinase ', ' IGFBP-4 Protease ', ' IGFBP-4 Metalloproteinase ', ' Pregnancy-Associated Plasma Protein-A ', ' Production ', ' Research Institute ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Technology ', ' Testing ', ' Time ', ' tomography ', ' Translations ', ' trophoblast ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Universities ', ' Viscosity ', ' Woman ', ' circular RNA ', ' closed circular RNA ', ' Endoglin ', ' Transforming Growth Factor P Receptor III ', ' CD105 Antigen ', ' Postpartum Period ', ' post-partum ', ' Postpartum ', ' Glean ', ' Bathing ', ' Baths ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Pre-term birth ', ' pregnancy disorder ', ' Injury ', ' base ', ' Perinatal ', ' improved ', ' Left ', ' Clinical ', ' Diffuse ', ' Histologically ', ' Histologic ', ' Evaluation ', ' Training ', ' peripheral blood ', ' Blood flow ', ' wasting ', ' fetus tissue ', ' Fetal Tissues ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Therapeutic ', ' Shapes ', ' Vesicle ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' mechanical ', ' Mechanics ', ' Investigation ', ' Dimensions ', ' Techniques ', ' Location ', ' extracellular ', ' fetal ', ' experience ', ' success ', ' viscoelasticity ', ' Venipunctures ', ' Nutrient ', ' skills ', ' novel ', ' sorting ', ' Sorting - Cell Movement ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' Position ', ' Positioning Attribute ', ' intrauterine growth ', ' Fetal Growth ', ' Property ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Untranslated RNA ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' MicroRNAs ', ' Provider ', ' Bio-Informatics ', ' Bioinformatics ', ' Microfluidic ', ' Microfluidics ', ' Placental Growth Factor Gene ', ' PlGF ', ' PLGF-2 ', ' PGF gene ', ' fitness ', ' Data ', ' Maternal Physiology ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Molecular Profiling ', ' Predictive Value ', ' in vivo ', ' Apoptotic ', ' Tissue Differentiation ', ' Monitor ', ' Characteristics ', ' Molecular ', ' injured ', ' designing ', ' design ', ' nanofabricate ', ' nano fabrication ', ' nano fabricate ', ' nanofabrication ', ' nano mechanics ', ' nanomechanics ', ' cost effective ', ' cost-effective ', ' innovation ', ' innovative ', ' innovate ', ' micro-total analysis system ', ' mu-TAS ', ' Lab On a Chip ', ' stem ', ' clinical care ', ' nanovesicle ', ' nano vesicle ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' biophysical properties ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' biophysical techniques ', ' biophysical methods ', ' biophysical methodology ', ' biophysical approaches ', ' guided inquiry ', ' guided discovery ', ' perinatal medicine ', ' adverse pregnancy outcome ', ' microvesicles ', ' exosome ', ' extracellular vesicles ', ' ']",NICHD,MAGEE-WOMEN'S RES INST AND FOUNDATION,R01,2016,727321,PA-18,0.07382966896677148
"Mentoring and research in applying digital technologies to prevent chronic Illnesses     DESCRIPTION (provided by applicant): For this K24 midcareer investigator award in patient-oriented research (POR) award, my goals are: 1) to become an international leader in the primary prevention of type 2 diabetes and cardiovascular diseases by applying emerging digital technologies and social media; 2) to conduct high-impact research in testing innovative, cost-effective lifestyle interventions (physical activity) using machine leaning; and 3) to provide a hih quality mentorship and training environment that supports the conduct of high POR impact research in cardiovascular and diabetes prevention. This K24 award will allow me to take on a broader and more formal mentorship role not only in the School of Nursing but also throughout the University of California, San Francisco campus. The overall goals of the new research in this application are to develop decision rule algorithms and quantitative models to optimize real-time predictions of future physical activity intervention adherences and to pilot test these algorithms and models in an intervention trial. The specific aims are: 1) to determine the extent to which baseline factors can predict adherence in self-monitoring (using mobile apps and wearing advanced accelerometers); 2) to determine the extent to which early app-based self-monitoring and evaluation (e.g., advanced accelerometers and diary use, and step counts in the first few weeks) can be optimized to make real-time predictions of future treatment failures; 3) to assess the feasibility of the ""Physical Activity Plus"" intervention using developed real-time prediction models (developed in Aim 2), compared to a ""regular physical activity"" intervention, for changes in total daily steps and duration of moderate and intensive physical activity over a three-month period. To tailor intervention intensity, we will evaluate the frequency of study visits and real-time feedback to minimize treatment failures and maximize adherence. Junior investigators in the POR have adapted digital mobile technologies as part of their research tools and have generated large volumes of continuous data. However, only a few training opportunities are available in this research area; in particular, for methods to rigorously and fully utilize the richness of the data collected. Therefore, the proposed K24 application will also meet these mentees' urgent needs across disciplines. PUBLIC HEALTH RELEVANCE: This K24 application will allow Dr. Fukuoka to use her cardiovascular and diabetes research program as a platform to mentor and guide the careers of junior investigators in patient-oriented research (POR) and to further develop her leadership and mentoring skills.",Mentoring and research in applying digital technologies to prevent chronic Illnesses,9131810,K24NR015812,"['Accounting ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Award ', ' Dorsum ', ' Back ', ' Behavior ', ' California ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' electronic communication ', ' Email ', ' E-Mail ', ' Electronic Mail ', ' Environment ', ' Epidemic ', ' Feedback ', ' Future ', ' Goals ', ' Health ', ' sound perception ', ' hearing perception ', ' Hearing ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Methods ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Primary Prevention ', ' Recommendation ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Running ', ' San Francisco ', ' School Health Nursing ', ' School Nursing ', ' Technology ', ' Testing ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' United States ', ' Universities ', ' Work ', ' Measures ', ' Treatment Failure ', ' therapy failure ', ' Clip ', ' base ', ' career ', ' improved ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Evaluation ', ' Training ', ' Physical activity ', ' Failure ', ' Discipline ', ' Individual ', ' Sample Size ', ' Funding ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' diaries ', ' programs ', ' Frequencies ', ' Complex ', ' Visit ', ' meetings ', ' skills ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' Interventional trial ', ' Intervention Trial ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient oriented study ', ' patient oriented research ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Cellular Phone ', ' Mobile Phones ', ' Car Phone ', ' preventing ', ' prevent ', ' Address ', ' Adherence ', ' Data ', ' International ', ' K24 Award ', ' Mid-Career Clinical Scientist Award (K24) ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' K24 Program ', ' K24 Mechanism ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Emergent Technologies ', ' Emerging Technologies ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Principal Investigator ', ' To specify ', ' Text ', ' developmental ', ' Development ', ' Behavioral ', ' Diabetes prevention ', ' cost ', ' digital ', ' designing ', ' design ', ' cost effective ', ' cost-effective ', ' lifestyle intervention ', ' life style intervention ', ' innovation ', ' innovative ', ' innovate ', ' Secure ', ' mobile application ', ' mobile app ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' social media ', ' training opportunity ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' ']",NINR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",K24,2016,187000,CA-12,0.021391706915573305
"QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES     DESCRIPTION (provided by applicant): Tissue identification and quantification plays a significant role in the study of aging and age-related diseases. For example, the accumulation of fat in the human body and its regional distribution with aging is associated with type 2 diabetes and cardiovascular diseases. Changes in muscle composition are strongly linked to decline of muscle strength, decreased mobility caused by aging, or musculoskeletal disorders. Especially interesting is analysis of longitudinal changes of morphometric descriptors that is significant for studying the aging process and for the diagnosis and prevention of age-related diseases.  Medical imaging has emerged as a major tool for estimation of body composition mainly due to being non- invasive and producing multi-dimensional information. Nowadays MRI and CT acquisition is a central component of clinical trials. An abundance of imaging data is collected, but this wealth of information has not been utilized to full extent. Therefore research on image analysis techniques for tissue quantification that are reproducible and can be used on large-scale clinical trials is of particular importance.  The technical hypothesis of this work is that quantitative image processing can robustly and accurately segment, register, and fuse body composition data from modern MRI and CT imaging. The central hypothesis of this proposal is that qualitative body composition phenotypes on clinical imaging will differentiate individuals who are healthy versus those who are not. The goal of our work is to provide a foundation for image analysis of the abdomen and lower extremities and to study the relationship between body morphological changes and age-related pathologies.  We will build upon recent advances in medical image computing to segment muscle, regional adipose tissue, and bone in clinical CT and MRI scans. We will also develop image registration procedures to achieve intra- and inter-subject correspondence and make efficient use of information provided by multi-modal and multi-temporal imaging data collected in clinical trials (aim 1). After these methods have been developed, we will address the hypothesis that quantitative use of clinical imaging can increase the prognostic accuracy of age-related pathologies (aim2). PUBLIC HEALTH RELEVANCE: Age-related diseases such as type-2 diabetes, cardiovascular diseases, and sarcopenia have become a worldwide epidemic and affect the quality of life of millions. To give a global perspective, roughly 343.8 million people in the world have type-2 diabetes today, and 175 million don't know they have diabetes at all. Metabolic diseases are strongly linked to longitudinal changes in body composition, morphology and function. This project will contribute novel and non-invasive medical image analysis techniques for studying the human body composition and its changes with increasing age to achieve timely prognosis of these pathologies.",QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES,9044803,SC3GM113754,"['Abdominal ', ' Abdomen ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Adipose tissue ', ' Affect ', ' Age ', ' Aging ', ' Algorithms ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' Body Composition ', ' bone ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Trials ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Delaware ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fats ', ' Fatty acid glycerol esters ', ' Foundations ', ' Goals ', ' Health ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' long-term study ', ' Longitudinal Studies ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Medical Imaging ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Metabolic Diseases ', ' Methods ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' musculoskeletal disorder ', ' Musculoskeletal Diseases ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Noise ', ' Pathology ', ' Pennsylvania ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' QOL ', ' Quality of life ', ' Research ', ' social role ', ' Role ', ' statistics ', ' Thigh ', ' Thigh structure ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Work ', ' image processing ', ' Procedures ', ' morphometry ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' biogerontology ', ' Gerontology ', ' Link ', ' prognostic ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Human Figure ', ' Human body ', ' Descriptor ', ' Morphology ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pattern ', ' Techniques ', ' muscle strength ', ' interest ', ' early detection ', ' Early Diagnosis ', ' novel ', ' Participant ', ' graduate student ', ' Prevention ', ' sarcopenic ', ' sarcopenia ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Magnetic Resonance Imaging Scan ', ' MRI Scans ', ' Metabolic syndrome ', ' Address ', ' Aging Process ', ' Aging-Related Process ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' in vivo ', ' Computational Technique ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' age dependent ', ' age related ', ' image registration ', ' Imaging technology ', ' effective therapy ', ' effective treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' longitudinal analysis ', ' undergraduate student ', ' biophysical model ', ' biophysical modeling ', ' quantitative imaging ', ' reduced muscle strength ', ' muscle strength decline ', ' low muscle strength ', ' dynapenia ', ' decreased muscle strength ', ' Underrepresented Groups ', ' ']",NIGMS,DELAWARE STATE UNIVERSITY,SC3,2016,63620,DE-00,0.03471052522275593
"Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes PROJECT SUMMARY/ABSTRACT Dr. McCoy is an endocrinologist and primary care physician specializing in the care for patients with diabetes and other chronic health conditions. Her long-term goal is to become an independent researcher and leader in evaluating, improving, and individualizing diabetes care through effective use of big data completed by qualitative insights from patients and those involved in their care. The short-term training goals of this proposal are to acquire: 1) proficiency in statistics and data science; 2) experience in qualitative research; 3) skills in clinical trial design; and 4) communication and leadership skills to lead multi-disciplinary research. The proposal's research will be conducted at Mayo Clinic, which has a strong history of training physician scientists and a well-developed infrastructure for education and research. Dr. McCoy has access to an ideal set of data assets, the OptumLabs Data Warehouse and the Kaiser Permanente Northern California Diabetes Registry, and the support of an exceptional team of mentors and advisors who are national leaders in diabetes outcomes and health care delivery research, shared decision-making, qualitative research, and data science. Optimization of glycemic control, while avoiding severe hypoglycemia and hyperglycemia, is the cornerstone of diabetes management. Severe hypoglycemia and hyperglycemia are often preventable, yet continue to incur substantial morbidity, psychological distress, impaired quality of life, and economic burden. There are no validated tools to predict these events and as a result clinicians lack a practical and reliable means to identify high risk patients. The goal of Dr. McCoy's work is to address this critical gap in diabetes management. In Aim 1, she will use large database analysis and novel analytic methods to characterize the patterns of severe hypoglycemia and hyperglycemia among adults with diabetes in the U.S. In Aim 2, she will build on Aim 1 to develop and validate computationally efficient concurrent risk prediction models for severe hypoglycemia and hyperglycemia that could be used in clinical encounters. In Aim 3, she will directly engage patients and their clinicians in conversation about severe hypoglycemia /hyperglycemia risk in order to better understand how information about severe hypoglycemia/ hyperglycemia risk is perceived, interpreted, and used. These studies will serve as foundation for two R01 applications to be submitted during Years 4 and 5, and will advance the science and practice of personalized diabetes care through integration of data science and qualitative methods for the purpose of understanding, predicting, and ultimately preventing severe hypoglycemic/hyperglycemic events. Dr. McCoy has a proven track record of scientific productivity and innovation, and a strong foundation in using secondary data for health services and outcomes research in diabetes. In summary, the training, mentoring, and research proposed here are essential for Dr. McCoy's career development as she develops research independence and expertise in the crucial interface between patients and their clinical teams, evidence-based medicine, and big data. PROJECT NARRATIVE Severe hypoglycemic and hyperglycemic events in the management of diabetes mellitus continue to incur high morbidity, psychological distress, and economic costs; yet, these events may be prevented with individualization of treatment goals and regimens if high risk patients are identified prospectively. The proposed research will leverage big data analytics and qualitative research to 1) characterize the epidemiology of severe hypoglycemia and hyperglycemia in the U.S.; 2) develop and validate concurrent risk prediction models for severe hypoglycemia and hyperglycemia; and 3) enrich the understanding of severe hypoglycemia/ hyperglycemia risk and risk model utilization through qualitative patient and clinician engagement.",Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes,9369218,K23DK114497,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Algorithms ', ' Calibration ', ' California ', ' Clinical Trials ', ' Communication ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Sources ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' diabetes ', ' Diabetes Mellitus ', ' Cognitive Discrimination ', ' Discrimination ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' facial ', ' faces ', ' Face ', ' Foundations ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' Health ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Health Services Research ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Hospitalization ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' Patients ', ' Physicians ', ' Primary Care Physician ', ' Productivity ', ' Quality of life ', ' QOL ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Science ', ' Self Care ', ' personal care ', ' statistics ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' United States ', ' Work ', ' health care ', ' Healthcare ', ' Outcomes Research ', ' Dataset ', ' Data Set ', ' Caring ', ' Guidelines ', ' analytical method ', ' base ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' psychological ', ' psychologic ', ' Training ', ' insight ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Endocrinologist ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Evidence Based Medicine ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Event ', ' Clinic ', ' Pattern ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' skills ', ' novel ', ' member ', ' economic cost ', ' social ', ' psychological distress ', ' Modeling ', ' career development ', ' Qualitative Research ', ' prevent ', ' preventing ', ' Address ', ' Qualitative Methods ', ' qualitative reasoning ', ' Data ', ' Economic Burden ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Clinical Trials Design ', ' Risk Estimate ', ' Validation ', ' developmental ', ' Development ', ' point of care ', ' disease phenotype ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' data integration ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' Outcome ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' multidisciplinary ', ' patient oriented ', ' patient centered ', ' high risk ', ' clinical care ', ' shared decision making ', ' Regimen ', ' data registry ', ' Big Data ', ' BigData ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' Patient risk ', ' health data ', ' support tools ', ' education research ', ' Data Science ', ' Data Scientist ', ' Data Analytics ', ' individual patient ', ' ']",NIDDK,MAYO CLINIC ROCHESTER,K23,2017,170466,MN-01,0.08106836472278235
"Validation of Survey Questions to Distinguish Type 1 and Type 2 Diabetes Among Adults With Diabetes PROJECT SUMMARY/ABSTRACT Type 1 and Type 2 diabetes are distinct clinical conditions with different etiologies, ages of onset, management strategies, risk factors, and outcomes. Currently, the data sources that the Centers for Disease Control and Prevention (CDC) relies upon to monitor trends in diabetes prevalence and incidence are unable to reliably distinguish between types of diabetes. Most of the large federal surveys used for diabetes surveillance have not included questions on diabetes type, and few studies have reported survey-based algorithms for identifying diabetes type. None have compared survey-based identification algorithms with a gold standard case ascertainment in order to validate survey-based assignment of diabetes type. Methods for distinguishing between diabetes types in electronic health records (EHR) data have been tested for children and adults, but additional validation work is needed. Our approach to improving diabetes surveillance in these two areas is based on an integrated study design whereby survey data for diabetes patients are linked with data from their EHR and a gold standard case ascertainment derived from chart review. We will select a diverse sample of diabetes patients that is designed and powered to assess algorithm validity for subpopulations defined by age, sex, and race/ethnicity. We will use rigorous questionnaire development methods to build on items used in previous surveys, cognitively test the new survey module to optimize wording and question order, field the survey using data collection methods similar to established CDC surveys, and analyze the responses relative to a gold standard classification of diabetes type. In addition, we will develop and validate against the gold standard EHR-based algorithms, including a modeling approach that produces a parsimonious rule-based algorithm for determining diabetes type based on the most important clinical variables, and a machine learning approach that uses the gold standard dataset as a starting point to identify implicit patterns that distinguish T1DM and T2DM. PROJECT NARRATIVE The proposed project will result in a set of validated survey questions for distinguishing Type 1 diabetes (T1DM) and Type 2 diabetes (T2DM). It will also produce validated survey-based and EHR-based algorithms for identifying diabetes type. T1DM and T2DM are distinct clinical conditions with different etiologies, ages of onset, management strategies, risk factors, and outcomes. Currently, the data sources that CDC relies upon to monitor trends in diabetes prevalence and incidence are unable to reliably distinguish between types of diabetes. It is important for surveillance systems to be able to distinguish diabetes type to support type-specific analyses of morbidity, mortality, medical care costs, and health-related quality of life. Improved surveillance data by diabetes type can help guide and monitor federal, state, and local diabetes programs, enrich diabetes research, and support people with diabetes.",Validation of Survey Questions to Distinguish Type 1 and Type 2 Diabetes Among Adults With Diabetes,9438672,U01DP006327,[''],NCCDPHP,"WESTAT, INC.",U01,2017,498977,MD-08,0.15119595688309237
"Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy DESCRIPTION (provided by applicant): Our understanding of cervical remodeling during pregnancy and labor is incomplete, partly due to the lack of in vivo studies on the biochemical changes that occur in the cervix over the course of pregnancy. Elucidation of the mechanisms for cervical ripening could be used to predict the onset of preterm labor. Until recently, in vivo research methods were too invasive to be used as discovery tools, particularly in women who present with preterm labor. This proposal will use in vivo Raman spectroscopy, an optical technique that is sensitive to collagen content, collagen structure, hydration, lipids, proteins, ad other biomolecules to non-invasively investigate the biochemistry of the cervix throughout pregnancy. Using fiber optic in vivo Raman spectroscopy, we recently found significant differences in Raman spectra in at least four important peaks during the course of pregnancy in mice, including discrete signatures for lipids, collagen, amide bonds, and enriched amino acids (proline, tyrosine). Computational analysis of these spectra yielded predictive algorithms with 94% classification accuracy for stage of pregnancy. Studies performed in 2-hour windows at the end of pregnancy identified spectra predictive for the timing of parturition. This approach provides a detailed real-time biomolecular map of cervical ripening that is currently unavailable by other means. In this proposal, we hypothesize that the different mechanisms of premature cervical ripening have unique Raman spectral signatures that correspond to underlying biochemical and mechanical changes that precede preterm birth, which can be detected in vivo. Two Specific Aims are proposed: 1) Determine spectral changes in the cervix of mice with normal and abnormal pregnancy and parturition; 2) Identify specific mediators of cervical remodeling by comparing Raman spectra to mechanical and biochemical changes in the ex vivo cervix during normal and abnormal parturition. Raman spectroscopy has primarily been used for detection of disease. Collaboration between our reproductive biology and bioengineering groups will capitalize on our expertise in Raman analysis of cervical tissues to study dynamic changes in cervix composition during pregnancy. Key elements in cervical biochemistry will be identified. In vivo Raman spectroscopy will be combined with biomechanical studies and imaging mass spectrometry, a powerful tool for in situ proteomic analysis, to examine mice with premature or delayed cervical remodeling. Together, these highly innovative approaches will generate in-depth profiles of cervical biology that will translate into novel non-invasive methods to detect impending premature birth in women. PUBLIC HEALTH RELEVANCE: This proposal will use Raman Spectroscopy, a non-invasive, optical scattering technique, to investigate the composition of the cervix throughout pregnancy and provide detailed real-time information on cervical ripening. These studies will identify spectral differences in the cervix during normal and abnormal cervical maturation; optical and biochemical markers will be identified to help monitor pregnancy non-invasively, as the fiber optic probe only requires brief contact with the external surface of the cervix to obtain measurements. Elucidating the mechanisms that initiate cervical ripening will provide a critical step for early detection and treatment of preterm birth, which is the leading cause of infant morbidity and mortality.",Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy,9443649,R01HD081121,"['Algorithms ', ' Prostaglandin E1alpha ', ' Prostaglandin E1 ', ' PGE1alpha ', ' PGE1 ', ' Muse ', ' Lipo-PGE1 ', ' Caverject ', ' Alprostadil ', ' Amides ', ' aminoacid ', ' Amino Acids ', ' Biological Chemistry ', ' Biochemistry ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biological Sciences ', ' Biology ', ' biomechanical ', ' Biomechanics ', ' bioengineering ', ' Biomedical Engineering ', ' Parturition ', ' Birth ', ' Uterine Cervix ', ' Cervix ', ' Cervix Uteri ', ' Systematics ', ' Classification ', ' Collagen ', ' Disorder ', ' Disease ', ' Elasticity ', ' Elements ', ' Fetal Development ', ' Fiber Optics ', ' Foundations ', ' Goals ', ' Health ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Infant Mortality ', ' Postneonatal Mortality ', ' Infant Mortality Total ', ' Premature Labor ', ' Preterm Labor ', ' Premature Obstetric Labor ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lipids ', ' Maintenance ', ' Maps ', ' Methods ', ' Mifepristone ', ' RU486 ', ' RU38486 ', ' RU-486 ', ' RU-38486 ', ' R38486 ', ' R 38486 ', ' Mifeprex ', ' Mifegyne ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Optics ', ' optical ', ' Periodicity ', ' Rhythmicity ', ' Cyclicity ', ' Phenotype ', ' physical science ', ' Pregnancy ', ' Gestation ', ' Proline ', ' L-Proline ', ' Proteins ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Raman Spectrum Analysis ', ' Raman spectrometry ', ' Raman Spectroscopy ', ' IR/UV/Raman Spectroscopy ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Translations ', ' Tyrosine ', ' Woman ', ' Generations ', ' Measures ', ' Research Methods ', ' Research Methodology ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' Premature Birth ', ' in situ Hybridization Staining Method ', ' in situ Hybridization Genetics ', ' In Situ Hybridization ', ' base ', ' Cervical ', ' Surface ', ' Clinical ', ' prematurity ', ' premature ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Medical ', ' Biochemical Markers ', ' Link ', ' insight ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' High-Risk Pregnancy ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Mechanics ', ' mechanical ', ' Hour ', ' In Situ ', ' Techniques ', ' Hormonal ', ' Early Diagnosis ', ' early detection ', ' Cervical Ripening ', ' Cervical Ripenings ', ' Structure ', ' novel ', ' Prevention ', ' Modality ', ' infant morbidity ', ' Property ', ' response ', ' Proteomics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Hydration status ', ' Hydration ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Data ', ' Detection ', ' Applications Grants ', ' Grant Proposals ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Reproductive Biology ', ' in vivo ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Computer Analysis ', ' Emergent Technologies ', ' Emerging Technologies ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' clinical application ', ' clinical applicability ', ' Early treatment ', ' early therapy ', ' Computational algorithm ', ' computer algorithm ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' mouse model ', ' murine model ', ' pregnant ', ' public health relevance ', ' novel therapeutic intervention ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' learning strategy ', ' learning method ', ' learning activity ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' ']",NICHD,VANDERBILT UNIVERSITY MEDICAL CENTER,R01,2017,376620,TN-05,0.06547748270019423
"A Novel Pregnancy Prevention Intervention for Latino Middle School Girls     DESCRIPTION (provided by applicant): This new investigator-initiated R01 proposal will test the efficacy of a promising and innovative intervention (Mighty Girls) to reduce teen Latina sexual behavior and pregnancy that was developed in a successful R15 feasibility trial. US teen pregnancy rates have declined but are still high among Latinas (49.4%), and the socioeconomic costs associated with these pregnancies are considerable; e.g., $3.2 billion lost tax revenue (2008 dollars) for decreased maternal educational attainment and productivity. Mighty Girls is designed to empower middle school Latinas with the skills they need to resist peer pressure that would otherwise accelerate their involvement in sexual behavior, allowing them to delay their initiation of intercourse and ultimately reduce their risk for teen pregnancy and sexually transmitted infections.  Mighty Girls uses cutting-edge technology to create a novel, highly interactive, video game that provides a live, realistic simulation of peer pressure. Players talk directly with avatars as they would with peers in their everyday life. This intervention focuses on building communication skills for resistance that are derived from evidence-based programs that do not jeopardize friendships and incorporate Latino cultural values (Marianismo, Personalismo, Simpata) - skills valued by middle school Latinas.  In addition to efficacy testing, the proposed interdisciplinary study evaluates (1) the intervention's cost- effectiveness and (2) influence of participant characteristics and how well the intervention was delivered (implementation quality) on study outcomes. The study will be conducted with seventh grade Latinas enrolled in 20 middle schools in Florida's Miami-Dade County, and followed into ninth grade, a period in which risky behaviors typically increase. Half of these schools will be randomly assigned to receive the Mighty Girls intervention and booster in addition to standard in-school sex education, while the other half will receive only standard in-school sex education. Data will be collected before and after the intervention, and at 2 (pre-booster), 12, and 24 months post-intervention using computerized surveys. Growth curve analysis will compare changes in peer resistance and sexual behavior observed in the two study conditions over the course of the study. Cost-effectiveness analyses will weigh the benefit of the intervention when added to current in-school sex education against its cost of delivery. This proposal addresses Healthy People 2020 objectives to reduce pre-term birth, increase the proportion of women who use contraception to plan pregnancy, and eliminate health disparities. It lays the foundation for a dissemination study of the Mighty Girls intervention that would have a major impact on the lives of vulnerable adolescents and reduce the personal and public burden of early sexual initiation. Study results would also advance the science of communications, health games, and computer engineering by generating data on human-avatar interactions and the use of highly interactive game technology to build health-related interpersonal skills.         PUBLIC HEALTH RELEVANCE: The teen pregnancy rate continues to be high among U.S. Latinas and results in significant personal, health care related and other societal costs. This study will test the efficacy of a promising and innovative intervention (Mighty Girls) that uses classroom activities in combination with a highly interactive video game to empower middle school Latinas to resist peer pressure to engage in intercourse. Girls play the game by talking directly with avatars that represent typical middle school children (no keyboard input required); thereby developing the skills needed to decrease their risk for teen pregnancy and sexually transmitted infections. Study results will be helpful for developing similar interventions for othe at risk youth, including boys, and guiding development of other technology based games designed to promote health.            ",A Novel Pregnancy Prevention Intervention for Latino Middle School Girls,9285614,R01NR014851,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' ages ', ' Age ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Attitude ', ' Awareness ', ' Behavior ', ' sibling order ', ' Birth Order ', ' Canada ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Sexual Intercourse ', ' Coitus ', ' Communication ', ' Computers ', ' cost effectiveness ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' depression ', ' Mental Depression ', ' Engineering ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Human ', ' Immersion Investigative Technique ', ' Immersion ', ' Theoretical model ', ' Theoretic Models ', ' Names ', ' Play ', ' Pregnancy ', ' Gestation ', ' Pregnancy in Adolescence ', ' adolescents who are pregnant ', ' Underage Pregnancy ', ' Teenage Pregnancy ', ' Teen Pregnancy ', ' Pregnancy in Minors ', ' Adolescent Pregnancy ', ' Pregnancy Rate ', ' Planned Pregnancy ', ' pressure ', ' Productivity ', ' Program Effectiveness ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Schools ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Education ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social Interaction ', ' Societies ', ' Surveys ', ' Survey Instrument ', ' Taxes ', ' Technology ', ' Testing ', ' Video Games ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Work ', ' County ', ' health care ', ' Healthcare ', ' Latino ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' Premature Birth ', ' base ', ' Friendships ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Evaluation ', ' Individual ', ' European ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' Ethnicity ', ' Ethnic Origin ', ' Life ', ' programs ', ' Country ', ' Outcome Study ', ' Peer Pressure ', ' age group ', ' experience ', ' Self Efficacy ', ' condoms ', ' skills ', ' simulation ', ' novel ', ' Participant ', ' peer ', ' intimate behavior ', ' intimacy ', ' public education ', ' seventh grade ', ' 7th grade ', ' ninth grade ', ' high school freshman ', ' 9th grade ', ' cultural values ', ' Prevention ', ' Modality ', ' Reporting ', ' Contraceptive methods ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' positive youth development ', ' boys ', ' girls ', ' junior high school ', ' middle school ', ' junior high ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Latina ', ' Latinas ', ' health disparity ', ' disparity in health ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Length ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effectiveness analyses ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' teenage ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' post intervention ', ' pregnancy prevention ', ' effectiveness trial ', ' initiation of intercourse ', ' early sexual initiation ', ' early sex initiation ', ' cost ', ' computerized ', ' designing ', ' design ', ' efficacy trial ', ' Resistance development ', ' developing resistance ', ' Resistant development ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' 14 year old ', ' fourteen years of age ', ' fourteen year old ', ' age 14 years ', ' 14 years of age ', ' Resistance ', ' resistant ', ' Evidence based program ', ' social cognitive theory ', ' social learning theory ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' multi-component intervention ', ' multimodal intervention ', ' multifaceted intervention ', ' multicomponent intervention ', ' multi-modal intervention ', ' multi-faceted intervention ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' Healthy People 2020 ', ' vulnerable adolescent ', ' learning strategy ', ' learning method ', ' learning activity ', ' ']",NINR,UNIVERSITY OF MIAMI CORAL GABLES,R01,2017,747607,FL-27,0.06008087110215526
"Improving diabetes and depression self-management via adaptive mobile messaging Project Summary/Abstract Diabetes and depression are major public health problems that disproportionately affect racial/ethnic minorities and low-income individuals in the US. Efficacious interventions for depression and diabetes exist but are not often combined despite similar treatment recommendations (specifically physical activity) for both conditions. Especially in resource-constrained environments, mobile health (mHealth) technologies are cost effective and feasible methods for delivering self-management support given the more ubiquitous penetration across socioeconomic status. Existing mHealth interventions have shown preliminary success but have had difficulty sustaining engagement. When combined with machine learning algorithms, health messages can be adapted to specifically motivate individuals based on their unique profiles. In Aim 1, we will integrate content from interventions targeting diabetes, depression, and physical activity applying user design methods. We will utilize the existing HealthySMS platform as the basis for this intervention. This will be called the Diabetes and Mental Health Adaptive Notification Tracking and Evaluation (DIAMANTE) study. In Aim 2, we will test an mHealth intervention for diabetes and depression that will generate messages using an adaptive machine learning algorithm that learns from patient step count data (collected passively via a smartphone app) and patient entered blood glucose and mood ratings. We will compare this adaptive, personalized intervention with a static messaging intervention, typical of many existing text messaging interventions. In Aim 3, we will rerandomize non-responsive participants to receiving nurse outreach using a sequential, multiple assignment, randomized trial (SMART) design. We will leverage the SMART design to conserve more expensive one-on-one nurse outreach for the patients who are no longer engaged in the program and need the most support. We will test this intervention with 350 patients from a safety net setting in English and Spanish. The primary outcomes for this study are HbA1c levels and PHQ-9 scores. The results of this study will help us understand the impact of personalizing content utilizing machine learning algorithms as well as the impact of providing clinician support for those receiving mobile health interventions. Since we are testing this intervention in a resource-constrained environment, the results of this study will be relevant for a broader population. Project Narrative (Public Relevance Statement) Diabetes and depression are health problems that are often comorbid and are mutually detrimental when uncontrolled. This grant proposal seeks to develop and test a personalized motivational text messaging intervention to improve management of diabetes and depression with an emphasis on low-income populations. The findings from this study will aid in the development and dissemination of mobile health tools for chronic illness management in diverse patients.",Improving diabetes and depression self-management via adaptive mobile messaging,9368213,R01HS025429,[''],AHRQ,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2017,397661,CA-13,0.08739939243624692
"Adaptive Prediction of Blood Glucose Levels using Wearable Physiological Sensors     DESCRIPTION (provided by applicant): Type 1 diabetes is a chronic disease, which presently cannot be prevented or cured. It is treated with insulin therapy and actively managed through blood glucose (BG) control. To avoid serious diabetic complications, patients must monitor their BG levels throughout the day, striving to avoid both hyperglycemia (high BG levels) and hypoglycemia (low BG levels). While continuous glucose monitoring (CGM) sensors and insulin pumps with exible dosing may aid in achieving good BG control, management of diabetes is still difcult and laborious for patients and physicians. It is complicated by a wide variability among individual patients in terms of physiological responses to treatment as well as to life events such as stress, exercise, or changes in schedule and sleep. New portable sensing technologies have been recently developed for providing almost continuous measure- ments of an array of physiological parameters that include heart rate, skin conductance, skin temperature, and properties of body movements such as acceleration. The main research objective of this project is to leverage data acquired from wearable physiological sensors to build accurate, personalized blood glucose level prediction models for diabetes management. Predicting BG control problems before they occur would give patients time to intervene and prevent these problems. This would enhance patient safety and contribute to improved overall control, with its concomitant reduction in costly complications. Blood glucose level prediction is  very complex problem. Recent advances in unsupervised feature learning and deep learning have made it possible to learn complex models from data using simple algorithms. Inspired by these signicant developments in Articial Intelligence (AI), we propose to employ unsupervised feature learn- ing and deep learning techniques in order to build an architecture for modeling blood glucose behavior that can seamlessly incorporate data coming from any number of physiological sensors. A recurrent neu- ral network (RNN) will be trained to capture dependencies among the input physiological parameters that are relevant to BG prediction. To account for individual patient differences, a predictive model will be developed for each patient by training on the features discovered by the RNN. The primary impact of this work would be to improve the overall health and quality of life for the 1.25 million Americans with type 1 diabetes. Accurate prediction models would enable practical applications ranging from alerts of impending problems to decision support tools for evaluating the effects of different food or lifestyle choice. Additionally, the wealth of patient and sensor data collected for this work will lead to the creatin of de-identied datasets to be used by the research community in evaluating approaches to blood glucose prediction. The new approaches developed for this complex domain may aid in the development of time series forecasting models for a broad array of sensor-enabled applications in other health and wellness domains. PUBLIC HEALTH RELEVANCE: To aid in diabetes management, machine learning models will be built to predict future blood glucose levels based on wearable sensor data from commercially available fitness bands in addition to blood glucose, insulin and meal data. These models could help the over one million Americans with type 1 diabetes to anticipate and prevent blood glucose control problems before they occur. This would enhance patient safety and contribute to improved overall blood glucose control, with its associated reduction in costly complications.",Adaptive Prediction of Blood Glucose Levels using Wearable Physiological Sensors,9272400,R21EB022356,"['Acceleration ', ' Algorithms ', ' Amputation ', ' Engineering / Architecture ', ' Architecture ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Behavior ', ' Blood Sugar ', ' Blood Glucose ', ' Carbohydrates ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communities ', ' computer vision ', ' Computer Vision Systems ', ' emotional dependency ', ' Dependency ', ' diabetes ', ' Diabetes Mellitus ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Engineering ', ' Exercise ', ' Expenditure ', ' Food or Food Product ', ' Food ', ' Future ', ' skin conductance ', ' Skin Electric Conductance ', ' Psychogalvanic Reflex ', ' Electrodermal Response ', ' Galvanic Skin Response ', ' Health ', ' Cardiac Chronotropism ', ' Heart Rate ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Insulin ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin Infusion Systems ', ' insulin pump ', ' Intelligence ', ' Learning ', ' Life Style ', ' Lifestyle ', ' Manuals ', ' Mathematics ', ' Math ', ' Movement ', ' body movement ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Patient Education ', ' Patient Training ', ' Patient Instruction ', ' Patients ', ' Physicians ', ' Quality of life ', ' QOL ', ' Recurrence ', ' Recurrent ', ' Kidney Failure ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Research ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Skin Temperature ', ' Sleep ', ' Stress ', ' stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Technology ', ' Time ', ' Work ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Schedule ', ' Dataset ', ' Data Set ', ' base ', ' sensor ', ' improved ', ' Area ', ' Physiologic ', ' Physiological ', ' Series ', ' Training ', ' Individual ', ' Measurement ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Life ', ' Scientist ', ' Complex ', ' Event ', ' Techniques ', ' System ', ' Blindness ', ' visual loss ', ' vision loss ', ' Equation ', ' American ', ' Performance ', ' speech recognition ', ' Biological Neural Networks ', ' neural network ', ' technology development ', ' collected works ', ' Speed ', ' Modeling ', ' Decision Support Systems ', ' Property ', ' glucose monitor ', ' glucose meter ', ' glucometer ', ' portability ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient safety ', ' prevent ', ' preventing ', ' Dose ', ' fitness ', ' Data ', ' Monitor ', ' developmental ', ' Development ', ' Behavioral ', ' cost ', ' data modeling ', ' physiologic model ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' diabetic management ', ' diabetes management ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' direct application ', ' Consumption ', ' practical application ', ' application in practice ', ' multidisciplinary ', ' public health relevance ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' flexibility ', ' flexible ', ' support tools ', ' individual patient ', ' ']",NIBIB,OHIO UNIVERSITY ATHENS,R21,2017,188594,OH-15,0.06119049097307013
"QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES     DESCRIPTION (provided by applicant): Tissue identification and quantification plays a significant role in the study of aging and age-related diseases. For example, the accumulation of fat in the human body and its regional distribution with aging is associated with type 2 diabetes and cardiovascular diseases. Changes in muscle composition are strongly linked to decline of muscle strength, decreased mobility caused by aging, or musculoskeletal disorders. Especially interesting is analysis of longitudinal changes of morphometric descriptors that is significant for studying the aging process and for the diagnosis and prevention of age-related diseases.  Medical imaging has emerged as a major tool for estimation of body composition mainly due to being non- invasive and producing multi-dimensional information. Nowadays MRI and CT acquisition is a central component of clinical trials. An abundance of imaging data is collected, but this wealth of information has not been utilized to full extent. Therefore research on image analysis techniques for tissue quantification that are reproducible and can be used on large-scale clinical trials is of particular importance.  The technical hypothesis of this work is that quantitative image processing can robustly and accurately segment, register, and fuse body composition data from modern MRI and CT imaging. The central hypothesis of this proposal is that qualitative body composition phenotypes on clinical imaging will differentiate individuals who are healthy versus those who are not. The goal of our work is to provide a foundation for image analysis of the abdomen and lower extremities and to study the relationship between body morphological changes and age-related pathologies.  We will build upon recent advances in medical image computing to segment muscle, regional adipose tissue, and bone in clinical CT and MRI scans. We will also develop image registration procedures to achieve intra- and inter-subject correspondence and make efficient use of information provided by multi-modal and multi-temporal imaging data collected in clinical trials (aim 1). After these methods have been developed, we will address the hypothesis that quantitative use of clinical imaging can increase the prognostic accuracy of age-related pathologies (aim2). PUBLIC HEALTH RELEVANCE: Age-related diseases such as type-2 diabetes, cardiovascular diseases, and sarcopenia have become a worldwide epidemic and affect the quality of life of millions. To give a global perspective, roughly 343.8 million people in the world have type-2 diabetes today, and 175 million don't know they have diabetes at all. Metabolic diseases are strongly linked to longitudinal changes in body composition, morphology and function. This project will contribute novel and non-invasive medical image analysis techniques for studying the human body composition and its changes with increasing age to achieve timely prognosis of these pathologies.",QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES,9244841,SC3GM113754,"['Abdominal ', ' Abdomen ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Adipose tissue ', ' Affect ', ' ages ', ' Age ', ' Aging ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' Body Composition ', ' bone ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Trials ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Delaware ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fats ', ' Fatty acid glycerol esters ', ' Foundations ', ' Goals ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lower Extremity ', ' Membrum inferius ', ' Lower Limb ', ' Longitudinal Studies ', ' long-term study ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Medical Imaging ', ' Metabolic Diseases ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Methods ', ' Modernization ', ' Muscle ', ' muscular ', ' Muscle Tissue ', ' Musculoskeletal Diseases ', ' musculoskeletal disorder ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Noise ', ' Pathology ', ' Pennsylvania ', ' Pharmacology ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Quality of life ', ' QOL ', ' Research ', ' Role ', ' social role ', ' statistics ', ' Thigh structure ', ' Thigh ', ' Time ', ' Tissues ', ' Body Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Work ', ' image processing ', ' Procedures ', ' morphometry ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' biogerontology ', ' Gerontology ', ' Link ', ' prognostic ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Human Figure ', ' Human body ', ' Descriptor ', ' Morphology ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Pattern ', ' Techniques ', ' muscle strength ', ' interest ', ' Early Diagnosis ', ' early detection ', ' novel ', ' Participant ', ' graduate student ', ' Prevention ', ' Modality ', ' sarcopenia ', ' sarcopenic ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' MRI Scans ', ' Magnetic Resonance Imaging Scan ', ' Metabolic syndrome ', ' Address ', ' Aging-Related Process ', ' Aging Process ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Multimodal Imaging ', ' multimodality imaging ', ' multi-modality imaging ', ' Reproducibility ', ' in vivo ', ' Computational Technique ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' age dependent ', ' age related ', ' image registration ', ' Imaging technology ', ' public health relevance ', ' effective therapy ', ' effective treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' disease diagnosis ', ' longitudinal analysis ', ' undergraduate student ', ' undergraduate ', ' Algorithmic Analysis ', ' Analysis of Algorithms ', ' Analyses of Algorithms ', ' Algorithmic Analyses ', ' biophysical model ', ' biophysical modeling ', ' quantitative imaging ', ' reduced muscle strength ', ' muscle strength decline ', ' low muscle strength ', ' dynapenia ', ' decreased muscle strength ', ' Underrepresented Groups ', ' clinical imaging ', ' imaging study ', ' ']",NIGMS,DELAWARE STATE UNIVERSITY,SC3,2017,63883,DE-00,0.03471052522275593
"Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution PROJECT SUMMARY/ABSTRACT Many epidemiological investigations have associated exposure to traffic-derived air pollution from motor vehicles, air toxins from industry, and other environmental toxins with measures of poor birth outcomes consisting of preeclampsia (PE), preterm birth (PTB) and intra-uterine growth restriction (IUGR). These conditions, which collectively constitute ischemic placental disease, correlate strongly with infant morbidity and a host of adult diseases, ranging from coronary artery disease to cancer. Although it is widely believed that the pathophysiological mechanisms leading to complications of ischemic placental disease and placental insufficiency have similar biological origins, starting as early as defective placental implantation, to date there are no predictive studies that prospectively examine placental function. Thus, non-invasive assessment and prediction of normalcy versus aberrancy of placental function are lacking. Therefore, the overarching objective of this proposal is to develop and evaluate a suite of exosomal micro-transcriptomic and transcriptomic signatures (predictor) for predicting placental insufficiency. Moreover, we seek to use these novel signatures to assess the impact of environmental pollution exposure on placental aberrancy/insufficiency and related outcomes (PE, PTB and IUGR) (primary outcome). Our central hypothesis is that chronic exposure to environmental pollution, independent of socio-economic status (SES), increases the risk of placental insufficiency due to early gestational development of adverse placental function, and that these outcomes can be predicted non-invasively by developing maternal blood derived placental-enriched exosomal micro-transcriptomic and transcriptomic signatures. To test this hypothesis, our specific aims are to: AIM 1: Develop non-invasively in maternal blood, placenta-derived exosomal micro- transcriptomic and transcriptomic signatures that predict in-vivo placental function through all three trimesters. AIM 2: Use the micro-transcriptomic and transcriptomic data from Aim 1 to predict environmental pollution data collected during the course of this study. We will construct models to predict the environmental pollution state based on these signatures, so that they may be used as proxy of the pollution when this data is not available. AIM 3: Perform Epigenome Wide Association Studies using DNA methylation from placental tissues of the same cohort. We will use our Reduced Representation Bisulfite Sequencing to identify loci whose methylation is associated with placental insufficiency and environmental exposures. These studies will help identify genes confirmed by transcriptomic analysis that may be useful in future development of therapeutic interventions for women at high risk of placental insufficiency due to air pollution exposures. Identification of molecular signatures that predict the presence of environmental pollution and adverse pregnancy outcomes may become a game-changer. Obstetric practices may embrace these surveillance tactics in real-time to predict and perhaps reverse placental aberrancy/insufficiency. PROJECT NARRATIVE How environmental pollution contributes to poor pregnancy outcome is poorly understood, and the first trimester of pregnancy is a particularly vulnerable time period for the developing fetus, thus a mother's exposure to air pollution may alter the way that the placenta is established and how it functions throughout the rest of pregnancy. This project aims to identify new molecular markers reflecting normal and abnormal placental function that can be detected non-invasively in a pregnant woman's blood, towards assessing real- time placental function as pregnancy develops from the first to the third trimester. Thus, early detection, prevention strategies, and timely treatment of placental dysfunction as a result of environmental pollution exposures may be developed.",Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution,9354508,R01HD089714,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Air ', ' Air Pollution ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Coronary Arteriosclerosis ', ' Disorder ', ' Disease ', ' Environmental Exposure ', ' environmental contamination ', ' environmental contaminant ', ' Environmental Pollution ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Fetus ', ' Future ', ' Genes ', ' Goals ', ' Gold ', ' Grant ', ' Histology ', ' Industry ', ' Maps ', ' Methylation ', ' Mothers ', ' Discipline of obstetrics ', ' Obstetrics ', ' Pathology ', ' Placenta ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta Diseases ', ' Placental Diseases ', ' Placenta Disorders ', ' Placental Insufficiency ', ' Placentation ', ' Placental Development ', ' Pre-Eclampsia ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' First Pregnancy Trimester ', ' First Trimester ', ' Early Placental Phase ', ' Second Pregnancy Trimester ', ' Second Trimester ', ' Midtrimester ', ' Third Pregnancy Trimester ', ' Third Trimester ', ' Last Trimester ', ' Pregnant Women ', ' expecting mother ', ' expectant mother ', ' Prospective Studies ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Rest ', ' Risk ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxic Environmental Substances ', ' Toxin ', ' Measures ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' Premature Birth ', ' Motor Vehicles ', ' base ', ' Chronic ', ' Biological ', ' Histologically ', ' Histologic ', ' Training ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' women at high risk ', ' High Risk Woman ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Ecological impact ', ' Environmental Impact ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Pollution ', ' Early Diagnosis ', ' early detection ', ' cohort ', ' Proxy ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' epidemiology study ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Studies ', ' Epidemiologic Research ', ' infant morbidity ', ' Modeling ', ' response ', ' Normalcy ', ' Normalities ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' in vivo ', ' Validation ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Outcome ', ' Population ', ' prospective ', ' transcriptomics ', ' implantation ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapeutic development ', ' therapeutic agent development ', ' primary outcome ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' bisulfite sequencing ', ' bisulfite-seq ', ' BS-seq ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' adverse pregnancy outcome ', ' exosome ', ' predictive signature ', ' imaging study ', ' ']",NICHD,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2017,651353,CA-33,0.027065718717131884
"Statistical methods for healthcare in complex patients with diabetes     DESCRIPTION (provided by applicant): Diabetes affects 8.3% of the US population, and lead to costly adverse healthcare outcomes. Unfortunately, there may be a quality gap in the care of complex diabetes patients, that is, older patients (age>65 years) and those with comorbid conditions. Current practices, relying primarily on the presence of several factors, are not effective in capturing the risk of poor prognosis, i.e., multiple hospitalization and/or emergency department visits, and death. Hence, little evidence exists so far to help prioritize care for thes patients. The diabetes guidelines recognize that tight control of glycosylated hemoglobin (A1c) may not be appropriate for complex patients, and recommend individualizations in tight A1c control. However, neither the outcomes of tight A1c control, nor the effects of the typical treatment regimens used to achieve tight A1c control can be evaluated in clinical trials, with minimal, if any, enrollment of complex diabetes patients due to either their restrictive inclusion criteria or lack of encouragement of the patient and/or clinical investigator to consider the RCT. In order to deliver more effective, efficient and accountable health cares, it is important to help clinicians to examine the relationship between patient complexity and patients' A1c control level, and to modify guideline appropriately with an evidence base. The proposed research will analyze a cohort of 8,304 Medicare beneficiaries with diabetes who were cared for by one of the country's 10 largest physician group practices, the University of Wisconsin Medical Foundation during 2003-2011 to address the following aims: (1) to conduct risk prediction incorporating longitudinal outcomes, (2) to inform guidelines for complex diabetes patients, and (3) to create a patient-centered surveillance tool for detecting short-term negative outcomes. Our analytic approach involves the use of state- of-the-art statistics and machine learning methods to take advantage of the large electronic health records data. The proposed methods and results will help clinicians to identify and quantify risks of tight A1c control in complex diabetes patients an potentially lead to improved patient experiences, and reduce medical expenditures from excess adverse events. PUBLIC HEALTH RELEVANCE: Sub-optimal glycosylated hemoglobin (A1c) control recommendations and treatment recommendations for diabetes patients can result in adverse events, and increased health care utilization. Unfortunately, current guidelines on the care for complex and/or older patients with diabetes are inadequate. We propose to develop an effective and patient-centered health care delivery system for complex diabetes patients, focusing on accurate prediction of adverse events, development of potential guidelines on targeting tight control of A1c and treatment regimens, and real-time monitoring of health conditions.",Statistical methods for healthcare in complex patients with diabetes,9336291,R01DK108073,"['Affect ', ' ages ', ' Age ', ' Algorithms ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Clinical Investigator ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' Clinical Trials ', ' co-morbidity ', ' Comorbidity ', ' Complement Proteins ', ' Complement ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' diabetes ', ' Diabetes Mellitus ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Expenditure ', ' Foundations ', ' Future ', ' Patient Care Delivery ', ' Patient Care ', ' Glycated Hemoglobins ', ' Glycosylated Hemoglobin ', ' Goals ', ' Group Practice ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Hospitalization ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Long-Term Care ', ' extended care ', ' Methods ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Physicians ', ' Privatization ', ' outcome forecast ', ' Prognosis ', ' health care quality ', ' healthcare quality ', ' Recommendation ', ' Research ', ' Risk ', ' statistics ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' Trees ', ' United States ', ' Universities ', ' Wisconsin ', ' Work ', ' health care ', ' Healthcare ', ' Risk Assessment ', ' Glean ', ' Caring ', ' Guidelines ', ' base ', ' improved ', ' Area ', ' Chronic ', ' Clinical ', ' Medical ', ' Link ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' Country ', ' experience ', ' user friendly software ', ' user friendly computer software ', ' cohort ', ' treatment planning ', ' Patient observation ', ' Watchful Waiting ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Adverse event ', ' Adverse Experience ', ' Effectiveness ', ' Address ', ' Data ', ' Detection ', ' enroll ', ' Enrollment ', ' Exclusion Criteria ', ' Update ', ' Monitor ', ' developmental ', ' Development ', ' beneficiary ', ' Electronic Health Record ', ' cost ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' patient oriented ', ' patient centered ', ' inclusion criteria ', ' high risk ', ' public health relevance ', ' evidence base ', ' patient population ', ' clinical practice ', ' population health ', ' Regimen ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' learning strategy ', ' learning method ', ' learning activity ', ' longitudinal dataset ', ' longitudinal data set ', ' data resource ', ' ']",NIDDK,FRED HUTCHINSON CANCER RESEARCH CENTER,R01,2017,287228,WA-07,0.13368502284273018
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9326327,P50GM115318,"['Affect ', ' autophagy ', ' Autophagocytosis ', ' California ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Clinical Markers ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' coronary disorder ', ' atherosclerotic heart disease ', ' Coronary Disease ', ' Coronary heart disease ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Deoxyribonucleic Acid ', ' DNA ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethnicity group ', ' Ethnic group ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Human Genetics ', ' Hybrids ', ' hyperglycemic ', ' Hyperglycemia ', ' In Vitro ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Leadership ', ' Lipids ', ' Inbred Strains Mice ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Myopathy ', ' muscular disorder ', ' Myopathic disease or syndrome ', ' Myopathic Diseases and Syndromes ', ' Myopathic Conditions ', ' Muscular Diseases ', ' Muscle Disorders ', ' Muscle Disease ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Clinical Pharmacology ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Role ', ' social role ', ' statistics ', ' stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Testing ', ' United States ', ' Genetic Diversity ', ' Genetic Variation ', ' Synvinolin ', ' Simvastatin ', ' Treatment outcome ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Custom ', ' base ', ' improved ', ' Clinical ', ' Residual ', ' Residual state ', ' Variation ', ' Variant ', ' Biological ', ' Susceptibility ', ' Predisposition ', ' lymphoblast ', ' disability ', ' Muscle function ', ' Fostering ', ' Collaborations ', ' Metabolic ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Event ', ' System ', ' cardiovascular disorder prevention ', ' cardiovascular disease prevention ', ' cardiac disease prevention ', ' CVD prevention ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Informatics ', ' Disease Outcome ', ' novel ', ' lymphoblastoid cell line ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Drug effect disorder ', ' drug action ', ' genetic analysis ', ' Genetic analyses ', ' Modeling ', ' Sampling ', ' response ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Pharmacogenomics ', ' prevent ', ' preventing ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' genetic association ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Symptoms ', ' Data ', ' Recombinants ', ' in vivo ', ' Transcript ', ' Molecular ', ' Coronary ', ' Electronic Health Record ', ' pathway ', ' Pathway interactions ', ' clinical phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' data integration ', ' designing ', ' design ', ' clinical efficacy ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' visualization tool ', ' Visualization software ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' Resistance ', ' resistant ', ' transcriptomics ', ' Cell model ', ' Cellular model ', ' clinically relevant ', ' clinical relevance ', ' multidisciplinary ', ' mouse model ', ' murine model ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' public health relevance ', ' alternative treatment ', ' population based ', ' treatment strategy ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' clinical practice ', ' candidate validation ', ' risk minimization ', ' exome ', ' exomes ', ' adverse outcome ', ' adverse consequence ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' data visualization ', ' training opportunity ', ' genotyped patients ', ' inter-individual variation ', ' interindividual variation ', ' biomarker identification ', ' marker identification ', ' ']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2017,2688571,CA-13,0.046688146864863535
"Mentoring and research in applying digital technologies to prevent chronic Illnesses     DESCRIPTION (provided by applicant): For this K24 midcareer investigator award in patient-oriented research (POR) award, my goals are: 1) to become an international leader in the primary prevention of type 2 diabetes and cardiovascular diseases by applying emerging digital technologies and social media; 2) to conduct high-impact research in testing innovative, cost-effective lifestyle interventions (physical activity) using machine leaning; and 3) to provide a hih quality mentorship and training environment that supports the conduct of high POR impact research in cardiovascular and diabetes prevention. This K24 award will allow me to take on a broader and more formal mentorship role not only in the School of Nursing but also throughout the University of California, San Francisco campus. The overall goals of the new research in this application are to develop decision rule algorithms and quantitative models to optimize real-time predictions of future physical activity intervention adherences and to pilot test these algorithms and models in an intervention trial. The specific aims are: 1) to determine the extent to which baseline factors can predict adherence in self-monitoring (using mobile apps and wearing advanced accelerometers); 2) to determine the extent to which early app-based self-monitoring and evaluation (e.g., advanced accelerometers and diary use, and step counts in the first few weeks) can be optimized to make real-time predictions of future treatment failures; 3) to assess the feasibility of the ""Physical Activity Plus"" intervention using developed real-time prediction models (developed in Aim 2), compared to a ""regular physical activity"" intervention, for changes in total daily steps and duration of moderate and intensive physical activity over a three-month period. To tailor intervention intensity, we will evaluate the frequency of study visits and real-time feedback to minimize treatment failures and maximize adherence. Junior investigators in the POR have adapted digital mobile technologies as part of their research tools and have generated large volumes of continuous data. However, only a few training opportunities are available in this research area; in particular, for methods to rigorously and fully utilize the richness of the data collected. Therefore, the proposed K24 application will also meet these mentees' urgent needs across disciplines. PUBLIC HEALTH RELEVANCE: This K24 application will allow Dr. Fukuoka to use her cardiovascular and diabetes research program as a platform to mentor and guide the careers of junior investigators in patient-oriented research (POR) and to further develop her leadership and mentoring skills.",Mentoring and research in applying digital technologies to prevent chronic Illnesses,9297123,K24NR015812,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Award ', ' Dorsum ', ' Back ', ' Behavior ', ' California ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' electronic communication ', ' Email ', ' E-Mail ', ' Electronic Mail ', ' Environment ', ' Epidemic ', ' Feedback ', ' Future ', ' Goals ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Primary Prevention ', ' Recommendation ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Running ', ' San Francisco ', ' School Nursing ', ' School Health Nursing ', ' Technology ', ' Testing ', ' Thinness ', ' Leanness ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' United States ', ' Universities ', ' Measures ', ' therapy failure ', ' Treatment Failure ', ' Guidelines ', ' Clip ', ' base ', ' career ', ' improved ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Evaluation ', ' Training ', ' Physical activity ', ' Failure ', ' Discipline ', ' Individual ', ' Sample Size ', ' Funding ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' programs ', ' Frequencies ', ' Complex ', ' Visit ', ' physical model ', ' skills ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' Intervention Trial ', ' Interventional trial ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient oriented research ', ' patient oriented study ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Car Phone ', ' Mobile Phones ', ' prevent ', ' preventing ', ' Address ', ' Adherence ', ' Data ', ' International ', ' Mid-Career Clinical Scientist Award (K24) ', ' K24 Award ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' K24 Program ', ' K24 Mechanism ', ' Emergent Technologies ', ' Emerging Technologies ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Principal Investigator ', ' To specify ', ' Text ', ' developmental ', ' Development ', ' Behavioral ', ' Diabetes prevention ', ' cost ', ' digital ', ' designing ', ' design ', ' cost effective ', ' cost-effective ', ' lifestyle intervention ', ' life style intervention ', ' innovation ', ' innovative ', ' innovate ', ' public health relevance ', ' Secure ', ' mobile application ', ' mobile app ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' social media ', ' training opportunity ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' ']",NINR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",K24,2017,186090,CA-12,0.021391706915573305
"Optical Tomographic Imaging of Peripheral Arterial Disease DESCRIPTION (provided by applicant): We propose to build and test a dynamic vascular optical tomographic imaging (DVOTI) system that can be used to detect and monitor peripheral arterial disease (PAD). PAD is estimated to affect approximately 8 to 12 million individuals in the United States. However, the disease is considerably under-diagnosed, since most patients are asymptomatic and no single reliable screening modality has been established. Most of the undiagnosed and untreated patients are diabetics. They commonly suffer from peripheral neuropathy and hence do not sense and report symptoms (such as pain) that are early signs of the disease. Consequently more than 60% (~65,000 per year) of all lower extremity amputations in the United States are performed in diabetic patients with PAD. With the number of diabetic patients expected to triple and reach almost 100 million by 2050, the problems related to undiagnosed PAD will only rise in the years to come  The most widely used diagnostic test for PAD, determination of the ankle-brachial index (ABI) in conjunction with pulse-volume recordings (PVR), is known to be unreliable for diabetics. And even in non- diabetics, ABI with PVR and all other existing diagnostic tests (such as Duplex Ultrasound or Magnetic resonance angiography), only provides accurate information about proximal occlusions in major arteries of the leg. However, none of these tests assess the distal perfusion of the foot where most complications, such as ulcers and gangrene, typically occur. Monitoring the success of surgical interventions, such as angioplasty or bypass surgery, suffers from the same shortcomings, as physicians are limited to the same suite of tests that are inadequate to assess the perfusion of the foot.  Dynamic VOTI promises to overcome the limitations of current diagnostic and monitoring techniques and has the potential to initiate a paradigm shift concerning how vascular diseases are assessed. In preliminary studies we have shown that DVOTI can provide three-dimensional time-series images that provide valuable information about the perfusion of the vascular bed in feet of PAD patients. The near-infrared light used in the instrument has no adverse health effects and measurements can be repeated frequently to monitor post interventional progress. Therefore, we believe that DVOTI will prove to be a safe and accurate method to diagnose and monitor PAD in non-diabetic and diabetic patients. PUBLIC HEALTH RELEVANCE: We propose to build and test a novel optical imaging system that will allow for the diagnosis and monitoring of peripheral artery disease (PAD), which affects approximately 8 to 12 million individuals in the United States. The disease is considerably under-diagnosed, especially in diabetic patients, the elderly, and patients with kidney disease. The system will address an unmet need to directly assess the degree of blood perfusion in the feet, where most PAD-related complications occur, which lead to over 65,000 amputations each year.",Optical Tomographic Imaging of Peripheral Arterial Disease,9338285,R01HL115336,"['Affect ', ' Air ', ' Algorithms ', ' Amputation ', ' Variance Analyses ', ' ANOVA ', ' Analysis of Variance ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' Tarsus ', ' Tarsal Bone ', ' Regio tarsalis ', ' Ankle ', ' Arteries ', ' vascular ', ' Blood Vessels ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Diffusion ', ' Disorder ', ' Disease ', ' foot ', ' Gangrene ', ' Head ', ' Health ', ' image reconstruction ', ' image generation ', ' image construction ', ' indexing ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lower Extremity ', ' Membrum inferius ', ' Lower Limb ', ' Light ', ' Photoradiation ', ' Methods ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Optics ', ' optical ', ' Pain ', ' Painful ', ' Patients ', ' Perfusion ', ' Peripheral Nervous System Diseases ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Physicians ', ' Risk ', ' Sensitivity and Specificity ', ' stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Ulceration ', ' Ulcer ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' United States ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Foot Ulcer ', ' Treatment outcome ', ' Diagnostic tests ', ' intraluminal angioplasty ', ' Angioplasty ', ' Procedures ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Distal ', ' Medical ', ' Series ', ' Ensure ', ' Evaluation ', ' Individual ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' MRI Angiography ', ' Magnetic Resonance Angiography ', ' tool ', ' instrument ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Physiologic pulse ', ' Pulse ', ' Diagnostic Procedure ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Dimensions ', ' Techniques ', ' System ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Early Diagnosis ', ' early detection ', ' experience ', ' light emission ', ' success ', ' vascular bed ', ' blood perfusion ', ' novel ', ' Modality ', ' Devices ', ' Reporting ', ' Bypass ', ' Code ', ' Coding System ', ' Statistical Methods ', ' Property ', ' theories ', ' Leg ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' post intervention ', ' optic imaging ', ' optical imaging ', ' designing ', ' design ', ' elderly patient ', ' older patient ', ' prospective ', ' data acquisition ', ' healthy volunteer ', ' non-diabetic ', ' nondiabetic ', ' prototype ', ' tissue phantom ', ' spatiotemporal ', ' public health relevance ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' diabetic patient ', ' screening ', ' Geometry ', ' accurate diagnosis ', ' imaging system ', ' imaging biomarker ', ' imaging marker ', ' Preventive measure ', ' Preventative measure ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2017,557344,NY-13,0.010743813042986048
"Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury     DESCRIPTION (provided by applicant): Throughout human pregnancy, the placenta is indispensable for embryonic development, fetal growth and tissue differentiation. The placenta also protects the fetus against diverse insults, while preserving maternal health. Placental dysfunction is commonly implicated in complications of pregnancy that challenge maternal physiology (e.g., preeclampsia) and fetal development (e.g., fetal death or fetal growth restriction) or that leads to preterm birth. Within the placenta, the trophoblast constitutes the outermost layer, which is directly bathed in maternal blood and therefore positioned to regulate maternal-fetal gas exchange, nutrient delivery, waste removal and the production of hormones, faithfully balancing fetal needs and maternal supply. Trophoblast damage, which is common in dysfunctional placentas, may interrupt the delicate maternal-fetal balance, cause clinical disease, and leave a lifelong mark on health. A fundamental challenge in perinatal medicine arises from our limited ability to diagnose placental disorders in real time and throughout pregnancy. However, the recent discovery, by ourselves and others, that (a) placental trophoblasts release distinctive micro- and nanovesicles into the maternal circulation and (b) these vesicles contain trophoblast-specific non-coding RNA cargo, created a new opportunity for assessing trophoblast health. These vesicles are actively released by trophoblasts throughout pregnancy, and thus serve as a venipuncture-accessible ""natural biopsy"" of trophoblasts, which can furnish information on trophoblast health in real time. Our established perinatal biology group at Magee- Womens Research Institute includes expertise in perinatal medicine and placental pathology, developmental and molecular biology, and bioinformatics. Inspired by these recent advances, we have partnered with an experienced group of bioengineers that includes experts from Carnegie Mellon University, MIT, and Penn State University, with unique skills in biophysics-based vesicle analytics, including microfluidics, nanomechanics, micro/nano fabrication and vesicle sorting using acoustic tweezers. Together, our new transdisciplinary group will use integrated molecular and biophysical methodologies to directly assess the use of trophoblast-derived extracellular vesicles from maternal plasma as revelatory of trophoblast health in real time and as a technique that may be employed throughout pregnancy. Our approach is comprehensive, centering on miRNAs as well as lncRNAs and circRNAs, analyzed in exosome nanovesicles, as well as microvesicles and apoptotic bodies. As each vesicle features a unique bimolecular and biophysical signature, we will deploy our machine learning- based training and testing pipeline to informatively integrate these distinct signals into an innovative diagnostic tool. Lastly, our deployment of affordable acoustic tweezers technology to sort trophoblastic vesicles will facilitate the translation of our advances into a new ""lab on a chip"" placental diagnostic technology, suitable for small blood volumes. This technology may not only denote trophoblast pathology, but has potential to identify those who may benefit from intervention and to monitor therapeutic success. PUBLIC HEALTH RELEVANCE: Although the placenta is critical for fetal development and pregnancy outcome, it is not currently accessible for real-time diagnostics throughout pregnancy. Having developed tools for isolation and analysis of placenta- specific extracellular from the maternal plasma, we will study molecular and biophysical properties of these vesicles as indicators of placental health and disease.",Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury,9269122,R01HD086325,"['placental abruption ', ' Premature Separation of Placenta ', ' Abruptio Placentae ', ' Acoustic ', ' Acoustics ', ' Arteries ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' bioengineering ', ' Biomedical Engineering ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Biophysics ', ' Biopsy ', ' needle biopsy ', ' Needle biopsy procedure ', ' Blood Reticuloendothelial System ', ' Blood ', ' Circulation ', ' Bloodstream ', ' Blood Circulation ', ' Blood Volume ', ' Communication ', ' Developmental Biology ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' balance function ', ' balance ', ' Equilibrium ', ' fetus death ', ' Fetal Death ', ' Fetal Development ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Fetus ', ' Future ', ' Gases ', ' Gold ', ' Health ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hormones ', ' Modern Man ', ' Human ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Maternal Health ', ' Methods ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Pathology ', ' Placenta ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta Diseases ', ' Placental Diseases ', ' Placenta Disorders ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma Proteins ', ' Pre-Eclampsia ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pregnancy ', ' Gestation ', ' Pregnancy Complications ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnancy Outcome ', ' Pregnancy-Associated Plasma Protein-A ', ' Pregnancy-Associated alpha-Plasma Protein ', ' PAPP-alpha ', ' PAPP-A ', ' Insulin-Like-Growth Factor Binding Protein-4 Protease ', ' Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease ', ' IGFBP-4-Specific Proteinase ', ' IGFBP-4 Protease ', ' IGFBP-4 Metalloproteinase ', ' Production ', ' Research Institute ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Technology ', ' Testing ', ' Time ', ' tomography ', ' Translations ', ' trophoblast ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Universities ', ' Viscosity ', ' Woman ', ' closed circular RNA ', ' circular RNA ', ' Transforming Growth Factor P Receptor III ', ' CD105 Antigen ', ' Endoglin ', ' post-partum ', ' Postpartum ', ' Postpartum Period ', ' Glean ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' Premature Birth ', ' pregnancy disorder ', ' Injury ', ' base ', ' Peripartum ', ' Perinatal ', ' improved ', ' Clinical ', ' Diffuse ', ' Histologically ', ' Histologic ', ' Evaluation ', ' Training ', ' peripheral blood ', ' Blood flow ', ' wasting ', ' fetus tissue ', ' Fetal Tissues ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Therapeutic ', ' Shapes ', ' Vesicle ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Investigation ', ' Dimensions ', ' Techniques ', ' Location ', ' extracellular ', ' fetal ', ' experience ', ' success ', ' viscoelasticity ', ' Venipunctures ', ' Nutrient ', ' skills ', ' novel ', ' Sorting - Cell Movement ', ' sorting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Positioning Attribute ', ' Position ', ' Fetal Growth ', ' intrauterine growth ', ' Property ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Untranslated RNA ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Provider ', ' Bioinformatics ', ' Bio-Informatics ', ' Microfluidics ', ' Microfluidic ', ' PGF gene ', ' Placental Growth Factor Gene ', ' PlGF ', ' PLGF-2 ', ' Lab-On-A-Chips ', ' Lab On a Chip ', ' fitness ', ' Data ', ' Interruption ', ' Maternal Physiology ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Predictive Value ', ' in vivo ', ' Apoptotic ', ' Tissue Differentiation ', ' Monitor ', ' Characteristics ', ' Molecular ', ' injured ', ' designing ', ' design ', ' nanofabricate ', ' nano fabrication ', ' nano fabricate ', ' nanofabrication ', ' nano mechanics ', ' nanomechanics ', ' cost effective ', ' cost-effective ', ' innovation ', ' innovative ', ' innovate ', ' stem ', ' public health relevance ', ' clinical care ', ' nanovesicle ', ' nano vesicle ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' biophysical properties ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' biophysical techniques ', ' biophysical methods ', ' biophysical methodology ', ' biophysical approaches ', ' guided inquiry ', ' guided discovery ', ' perinatal medicine ', ' adverse pregnancy outcome ', ' microvesicles ', ' exosome ', ' extracellular vesicles ', ' mechanical properties ', ' clinical diagnostics ', ' high dimensionality ', ' Placental Biology ', ' Placenta Biology ', ' ']",NICHD,MAGEE-WOMEN'S RES INST AND FOUNDATION,R01,2017,725442,PA-18,0.07382966896677148
"Human Microbiome and Perinatal Depression Project Summary/Abstract Depression is the most common complication of pregnancy and affects 10-20% of women. Up to 75% of women with perinatal depression do not receive mental health care. In lower income African American and Hispanic women, the prevalence of perinatal depression (PND) is particularly high and the treatment rates are lower. Cognitive behavioral therapy (CBT) is an effective treatment but practical barriers such as time commitment, insurance coverage, and transportation, as well as stigma, limit uptake of CBT particularly for minority women. Similarly, concern about the adverse effects of antidepressant treatment on maternal and infant outcomes limits uptake of pharmacological treatments. A novel avenue for the development of safe therapeutics for depression focuses on the brain-gut axis and is supported by initial demonstrations that probiotics can improve mood symptoms. Our long-term goal is to assist in the discovery of potential microbes that are correlated with PND, and could be novel biomarkers for the diagnosis and treatment of this disorder, particularly in minority women. As a first step, we propose a multi-PI feasibility study involving the implementation and optimization of processes for participant recruitment and stool sample collection, as well as the initial assessments of longitudinal differences in gut microbiota between pregnant women with and without major depressive disorder (MDD). To meet these goals, we will leverage an established research infrastructure to conduct a prospective, nested case-control study. We will prospectively collect depression diagnoses and gut microbiome samples on 300 women at four points during pregnancy and after delivery to yield a total of 58 women, 29 cases with MDD and 29 controls without MDD. The two groups will be matched on key covariates (e.g., age, race, socio- economic status, gestational age, health). At their scheduled usual care, prenatal appointment, consented participants will complete mental health, demographics, microbiome-related, and dietary and physical habits questionnaires and provide a fecal sample either at that time of their appointment or at home. To achieve our first aim - to determine the feasibility of a larger similarly designed study - we will estimate the total number of potential participants, the number assessed and not assessed for eligibility (and reasons), the number excluded and reasons for exclusion, the number lost to follow-up, and the data available for analysis at each of the 4 visits. To achieve our second aim - to determine whether the gut microbiome dynamically differs in pregnant women with and without MDD - we will employ a suite of systems level approaches, including multivariate statistical techniques, network modeling and machine learning techniques. This R03 will allow us to optimize our research processes for the prospective collection of stool samples and mental health data in preparation for larger nested case-control studies, and ultimately clinical trials of probiotic therapies for PND. Project Narrative Up to 75% of women diagnosed with depression during pregnancy and the postpartum receive inadequate treatment, in large part due to concerns about the safety of antidepressants. Here we propose a feasibility study in preparation for a larger study to determine whether women with depression during their pregnancy and after their delivery have alterations in the bacterial communities in their intestine. Identifying which bacteria are associated with depression is a critical first step in the development of safe probiotic treatments for depression during pregnancy. !",Human Microbiome and Perinatal Depression,9507031,R03HD095056,"['Affect ', ' Age ', ' ages ', ' Antidepressive Agents ', ' anti-depressive agents ', ' anti-depressants ', ' anti-depressant drugs ', ' anti-depressant agent ', ' Antidepressants ', ' Antidepressant Drugs ', ' Antidepressant Agent ', ' Appointment ', ' Bacteria ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cognitive Therapy ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Complication ', ' Mental Depression ', ' depression ', ' Diagnosis ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Endocrine system ', ' endocrine gland/system ', ' Metabolic/Endocrine Body System ', ' Hormonal System ', ' Endocrine/Metabolic Organ System ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Family ', ' Feasibility Studies ', ' Feces ', ' stool ', ' Gestational Age ', ' Fetal Age ', ' Chronologic Fetal Maturity ', ' Goals ', ' Habits ', ' Health ', ' Human ', ' Modern Man ', ' Immune system ', ' allergic/immunologic organ system ', ' allergic/immunologic body system ', ' Infant ', ' Intestines ', ' bowel ', ' Intestinal ', ' Longitudinal Studies ', ' long-term study ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Microbiology ', ' Mothers ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Nested Case-Control Study ', ' Neurotransmitters ', ' Nerve Transmitter Substances ', ' nutrition ', ' Phenotype ', ' Pregnancy ', ' Gestation ', ' Pregnancy Complications ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnant Women ', ' pregnant mothers ', ' expecting mother ', ' expectant mother ', ' Prenatal care ', ' prenatal visit ', ' prenatal checkup ', ' prenatal appointment ', ' pregnancy care ', ' Questionnaires ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Role ', ' social role ', ' Safety ', ' Testing ', ' Time ', ' Transportation ', ' Woman ', ' Work ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Healthcare ', ' health care ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Postpartum Period ', ' post-partum ', ' Postpartum ', ' Schedule ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' Immunology ', ' Guidelines ', ' Peripartum ', ' Perinatal ', ' improved ', ' specimen collection ', ' sample collection ', ' Clinical ', ' Neurological ', ' Neurologic ', ' Link ', ' insight ', ' Sample Size ', ' participant recruitment ', ' Patient Recruitments ', ' uptake ', ' Therapeutic ', ' Depressed mood ', ' sadness ', ' depressed ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Complex ', ' Home environment ', ' Home ', ' microorganism ', ' Techniques ', ' System ', ' Hormonal ', ' Probiotics ', ' pro-biotic ', ' Visit ', ' microbial ', ' relating to nervous system ', ' neural ', ' Structure ', ' novel ', ' Participant ', ' Exclusion ', ' Reporting ', ' maternal stress ', ' stressed mothers ', ' Sampling ', ' neuropsychiatry ', ' neuropsychiatric ', ' social stigma ', ' stigma ', ' drug development ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Bioinformatics ', ' Bio-Informatics ', ' Major Depressive Disorder ', ' major depression disorder ', ' major depression ', ' clinical depression ', ' Low income ', ' Address ', ' Systems Biology ', ' Adherence ', ' Consent ', ' Data ', ' Research Infrastructure ', ' Infrastructure ', ' Collection ', ' Germ-Free ', ' Observational research ', ' Observation study ', ' Observation research ', ' Observational Study ', ' Pharmacological Treatment ', ' nutritious ', ' Nutritional ', ' Monitor ', ' Preparation ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' microbiome ', ' human-associated microbiome ', ' Human Microbiome ', ' Minority ', ' Prevalence ', ' prospective ', ' community microbes ', ' microbial community ', ' Microbe ', ' infant outcome ', ' demographics ', ' network models ', ' alternative treatment ', ' effective treatment ', ' effective therapy ', ' usual care ', ' treatment as usual ', ' novel biomarker ', ' new marker ', ' novel marker ', ' prenatal depressive symptoms ', ' prenatal depression ', ' depression in pregnancy ', ' depression during pregnancy ', ' antenatal depression ', ' antepartum depression ', ' process optimization ', ' intestinal tract microflora ', ' intestinal microflora ', ' intestinal microbiota ', ' intestinal microbes ', ' intestinal flora ', ' gut microflora ', ' gut microbiotic ', ' gut microbial consortia ', ' gut microbial composition ', ' gut microbial community ', ' gut microbe community ', ' gut flora ', ' gut community ', ' gut commensal ', ' gastrointestinal microbial flora ', ' enteric microbiota ', ' enteric microbial community ', ' Gastrointestinal microbiota ', ' GI microbiota ', ' gut microbiota ', ' adverse consequence ', ' adverse outcome ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' perinatal depression ', ' peripartum depression ', ' health data ', ' intestinal microbiome ', ' intestinal biome ', ' gut-associated microbiome ', ' gastrointestinal microbiome ', ' enteric microbiome ', ' digestive tract microbiome ', ' GI microbiome ', ' gut microbiome ', ' anti-depressant effect ', ' antidepressant effect ', ' fecal transplant ', ' fecal microbiota transplantation ', ' fecal microbiota transplant ', ' fecal microbiome transplantation ', ' fecal microbial transplantation ', ' fecal transplantation ', ' probiotic therapeutic ', ' probiotic therapy ', ' mood symptom ', ' perinatal mental health ', ' Prospective cohort study ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' dysbiosis ', ' gut-brain signaling ', ' gut-brain relationship ', ' gut-brain interactions ', ' gut-brain communication ', ' gut to brain axis ', ' gut-brain axis ', ' stool-associated microbiome ', ' stool microbiome ', ' fecal microbiome ', ' bacterial community ', ' stool specimen ', ' stool sample ', ' analyze microbiome ', ' microbiome analysis ', ' ']",NICHD,UNIVERSITY OF ILLINOIS AT CHICAGO,R03,2018,92360,IL-07,-0.018041686005611002
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9560840,P50GM115318,"['Affect ', ' Autophagocytosis ', ' autophagy ', ' California ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Clinical Markers ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Coronary heart disease ', ' coronary disorder ', ' atherosclerotic heart disease ', ' Coronary Disease ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' ethnicity group ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Human ', ' Modern Man ', ' Human Genetics ', ' Hybrids ', ' Hyperglycemia ', ' hyperglycemic ', ' In Vitro ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Leadership ', ' Lipids ', ' Inbred Strains Mice ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Myopathy ', ' muscular disorder ', ' Myopathic disease or syndrome ', ' Myopathic Diseases and Syndromes ', ' Myopathic Conditions ', ' Muscular Diseases ', ' Muscle Disorders ', ' Muscle Disease ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Clinical Pharmacology ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Role ', ' social role ', ' statistics ', ' Stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Testing ', ' United States ', ' Genetic Variation ', ' Genetic Diversity ', ' Simvastatin ', ' Synvinolin ', ' Treatment outcome ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Custom ', ' base ', ' improved ', ' Clinical ', ' Residual ', ' Residual state ', ' Variation ', ' Variant ', ' Biological ', ' Susceptibility ', ' Predisposition ', ' lymphoblast ', ' disability ', ' Muscle function ', ' Fostering ', ' Collaborations ', ' Metabolic ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Event ', ' System ', ' cardiovascular disorder prevention ', ' cardiovascular disease prevention ', ' cardiac disease prevention ', ' CVD prevention ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Informatics ', ' Disease Outcome ', ' novel ', ' lymphoblastoid cell line ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Drug effect disorder ', ' drug action ', ' genetic analysis ', ' Genetic analyses ', ' Modeling ', ' Sampling ', ' response ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Pharmacogenomics ', ' prevent ', ' preventing ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' genetic association ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Symptoms ', ' Data ', ' Recombinants ', ' in vivo ', ' Transcript ', ' Molecular ', ' Electronic Health Record ', ' pathway ', ' Pathway interactions ', ' clinical phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' data integration ', ' designing ', ' design ', ' clinical efficacy ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' visualization tool ', ' Visualization software ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' innovative ', ' innovate ', ' innovation ', ' Heritability ', ' resistant ', ' Resistance ', ' transcriptomics ', ' Cellular model ', ' Cell model ', ' clinical relevance ', ' clinically relevant ', ' multidisciplinary ', ' murine model ', ' mouse model ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' public health relevance ', ' alternative treatment ', ' population based ', ' treatment strategy ', ' novel biomarker ', ' new marker ', ' novel marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' genomewide ', ' genome scale ', ' genome-wide ', ' clinical practice ', ' candidate validation ', ' risk minimization ', ' exomes ', ' exome ', ' adverse consequence ', ' adverse outcome ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' predictive marker ', ' data visualization ', ' training opportunity ', ' genotyped patients ', ' interindividual variation ', ' inter-individual variability ', ' inter-individual variation ', ' marker identification ', ' biomarker identification ', ' coronary event ', ' ']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2018,2667664,CA-13,0.046688146864863535
"Resource Curation and Evaluation for EHR Note Comprehension Title: Resource Curation and Evaluation for EHR Note Comprehension The American Diabetes Association estimates that over 25.8 million Americans have diabetes. Proper patient self-management is perhaps the most critical and under-exercised element for patients to achieve appropriate glycemic control and thus mitigate complications and comorbid conditions, and implement appropriate preventive strategies (e.g., vaccines, exercise, healthy diet). In previous work we have shown that educating patients by using content in their medical records improved diabetes outcomes and that NoteAid, a multi- module natural language processing system that links medical jargon in electronic health records to definitions, has improved self-reported comprehension. Here we propose to develop NoteAid with a high-quality resource of expert-curated lay definitions and evaluation methods for diabetes patients note comprehension. ! ! Title: Resource Curation and Evaluation for EHR Note Comprehension The American Diabetes Association estimates that over 25.8 million Americans have diabetes. In previous work we have shown that educating patients by using content in their medical records improved diabetes outcomes and that NoteAid, a natural language processing system that links medical jargon in electronic health records to definitions, has improved self-reported comprehension. Here we propose to develop NoteAid with a high-quality resource of expert-curated lay definitions and evaluation methods for diabetes patients note comprehension. ! !",Resource Curation and Evaluation for EHR Note Comprehension,9670540,R01LM012817,"['Physicians ', ' Questionnaires ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Reading ', ' Resources ', ' Research Resources ', ' Risk ', ' Medical Students ', ' Nursing Students ', ' Pupil Nurses ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Vaccines ', ' Visual Aid ', ' Visual Aide ', ' Vocabulary ', ' Vocabulary Words ', ' Work ', ' Caregivers ', ' Care Givers ', ' Healthcare ', ' health care ', ' Self Management ', ' Caring ', ' Comprehension ', ' base ', ' improved ', ' Clinical ', ' Medical ', ' Link ', ' Evaluation ', ' Individual ', ' Trust ', ' Measurement ', ' Ethnicity ', ' Ethnic Origin ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Mechanics ', ' mechanical ', ' Complex ', ' Techniques ', ' System ', ' good diet ', ' balanced diet ', ' Healthy diet ', ' Country ', ' American ', ' Informatics ', ' Speed ', ' skills ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' Modeling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' Ontology ', ' Characteristics ', ' sex ', ' Electronic Health Record ', ' cost ', ' designing ', ' design ', ' glycemic control ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' usability ', ' diabetic patient ', ' Data Scientist ', ' Data Science ', ' AIDS education ', ' healthcare outcomes ', ' health care outcomes ', ' care outcomes ', ' deep learning ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Attitude ', ' Back ', ' Dorsum ', ' Behavior ', ' Communication ', ' Comorbidity ', ' co-morbidity ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Education ', ' Educational aspects ', ' Elements ', ' Exercise ', ' Eye diseases ', ' ophthalmopathy ', ' eye disorder ', ' Health ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Hospitals ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Language ', ' Learning ', ' Libraries ', ' Massachusetts ', ' Medical Records ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Natural Language Processing ', ' natural language understanding ', ' Patient Education ', ' Patient Training ', ' Patient Instruction ', ' Patients ', ' ']",NLM,UNIVERSITY OF MASSACHUSETTS LOWELL,R01,2018,370291,MA-03,0.07830025409843754
"Improving glucose control with advanced technology designed for high risk patients with type 1 diabetes Summary The objective of this proposal is to optimize the design and evaluate a robust artificial pancreas (R-AP) system for use in patients with uncontrolled type 1 diabetes (T1D) with HbA1C greater than 8% and compare HbA1C outcomes in these patients relative to a decision support system that utilizes continuous glucose monitoring (CGM) and multiple daily injection (MDI) therapy. Although high risk patients have possibly the most to gain from usage of AP technology, they are oftentimes under-represented or excluded from clinical trials. This has been because of the increased risk of failure of these AP systems that were not designed to handle inconsistent reporting of meals, variable activity level, and infusion set failures. An AP system for high risk patients needs to be designed to achieve maximal benefit, including reducing the risk of acute and chronic complications. A major obstacle for enabling the AP for usage by high-risk patients is that these patients may be less compliant with use guidelines for the system including missed meal announcements, infrequent sensor calibrations, and prolonged infusion set wear leading to infusion set failures. In this grant, we will integrate new risk-mitigation features into the OHSU single-hormone AP to enable usage by high-risk patients that fall into the categories described above. We present new algorithms for automating the detection of missed meal announcements, missed calibrations, and robust handling of hybrid usage mode. While AP systems may be an optimal choice for improving glycemic control, many people with T1D prefer MDI therapy. Decision support systems such as the DailyDose decision support system developed at OHSU can be used to improve glycemic control for patients who prefer MDI therapy. The DailyDose decision support system is designed for CGM augmented MDI therapy. It enables on-demand calculation of insulin doses, automates insulin dose adjustments based on pattern recognition, and uses machine learning approaches to alert the patients to events such as predicted hypoglycemia and missed meal doses.The benefit of the DailyDose system is that it is a simple system and does not require use of an insulin pump, which may be a challenge for some patients with uncontrolled type 1 diabetes as pump therapy is more intensive and requires infusion set changes. It is unknown in this high risk group of people whether patient needs, quality of life, and glycemic control are best addressed with an AP system or decision support tool or if both treatments are appropriate. We have designed a 3-month clinical study to compare glycemic outcomes during AP vs. decision support interventions in a high- risk T1D cohort (HbA1C 8-10.5%), with the aim of demonstrating a significant clinically relevant reduction in HbA1C. Our hypothesis is that both AP and decision support therapies will decrease HbA1C relative to baseline but that the AP will provide further benefit over DailyDose. Project Narrative Diabetes is the leading cause of blindness, kidney failure, and non-traumatic amputations. We propose to integrate features into the OHSU artificial pancreas to optimize it for high risk patients with type 1 diabetes (HbA1c>8-10.5%) and compare it to DailyDose, a decision support system that uses multiple daily injections.",Improving glucose control with advanced technology designed for high risk patients with type 1 diabetes,9691740,R01DK120367,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Algorithms ', ' Awareness ', ' Calibration ', ' Carbohydrates ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Diabetic Ketoacidosis ', ' diabetic ketoacidotic ', ' Diabetic Ketosis ', ' Diabetic Acidosis ', ' Exercise ', ' Fright ', ' Fear ', ' Grant ', ' Glycosylated hemoglobin A ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Human ', ' Modern Man ', ' Hybrids ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Injection of therapeutic agent ', ' injection therapy ', ' Inpatients ', ' Insulin ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin Infusion Systems ', ' insulin pump ', ' Manuals ', ' Outpatients ', ' Out-patients ', ' Patients ', ' Personality ', ' Quality of life ', ' QOL ', ' Questionnaires ', ' Kidney Failure ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Risk ', ' Running ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Testing ', ' Time ', ' falls ', ' Outcome Measure ', ' Guidelines ', ' base ', ' Pump ', ' sensor ', ' improved ', ' Acute ', ' Chronic ', ' Multi-center trial ', ' Multicenter Trials ', ' Randomized Clinical Trials ', ' Failure ', ' Distress ', ' Artificial Pancreas ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Event ', ' System ', ' Blindness ', ' visual loss ', ' vision loss ', ' Outcome Study ', ' Infusion procedures ', ' Infusion ', ' Performance ', ' cohort ', ' expectation ', ' Categories ', ' Reporting ', ' Emotional ', ' Decision Support Systems ', ' response ', ' glucose monitor ', ' glucose meter ', ' glucometer ', ' Adverse event ', ' Adverse Experience ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Address ', ' Dose ', ' Detection ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Cognitive ', ' Pattern Recognition ', ' Update ', ' Characteristics ', ' Modification ', ' Behavioral ', ' designing ', ' design ', ' glycemic control ', ' Outcome ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' clinical relevance ', ' clinically relevant ', ' clinical significance ', ' clinically significant ', ' engineering design ', ' high risk ', ' patient population ', ' primary outcome ', ' secondary outcome ', ' risk minimization ', ' risk mitigation ', ' arm ', ' Patient risk ', ' support tools ', ' high risk group ', ' high risk population ', ' Bluetooth ', ' smart watch ', ' Injections ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,R01,2018,591323,OR-03,0.05961180450961011
"DFU Clinical Research Unit Abstract Diabetic foot ulcers (DFUs) are a prevalent diabetes complications affecting up to 25% of patients and leading to ~80,000 Americans having non-traumatic amputations each year, with five-year mortality rates of up to 40%. Recent evidence suggests that non-traumatic lower extremity amputations are on the rise, after decades of decline, in spite of advances in targeted wound care products, establishment of interdisciplinary clinical and surgical teams, and improving diabetes medical care. Given the worldwide epidemic of diabetes, the burden associated with DFU are high, including high costs of $9 billion-$13 billion per year and besides those associated with high morbidity and mortality. Thus, the establishment of a Diabetic Foot Consortium comprised of experienced DFU Clinical Research Units (CRU) for reliable DFU biomarker discovery cannot be understated. The main objective of this proposal is to integrate the robust infrastructure at Michigan Medicine with our highly skilled clinical and translational team to establish a DFU CRU as a strong contender and contributor within the DFC network that will be uniquely poised to participate in all DFU biomarker discovery and related wound healing projects undertaken by the Consortium. Additional aims are to The aims are to : identify, recruit, and phenotype a broad spectrum of DFU participants from the large base of patients with these conditions who are currently being followed at Michigan Medicine, according to the Consortium requirements; implement standardized mechanisms and protocols for effective longitudinal sample collection and retention; and actively participate in the DFC intellectually and provide all available resources to develop and support clinical study protocols to validate DFU biomarkers, including complex quantifications of wound image features; single cell, genetic, molecular, metabolomics, and microbiome analyses; and assessing additive predictors of DFU healing beyond clinical markers alone using multi-modal approaches. The expected outcome of this work is that the Michigan Medicine DFU Clinical Center will be an integral part of the Consortia collaborative network, with a highly positive impact for the entire spectrum of biomarker discovery and future novel therapies projects. Narrative This project has major public health relevance because diabetic foot ulcers (DFUs) remain one of the most common secondary complications of diabetes and are the leading cause of lower extremity amputation in the US. Current treatments are ineffective and given the recent surge in major lower extremity amputations in diabetic patients despite the previous decades of decline, identification of novel treatment avenues is of critical importance. The main objective of the Diabetic Foot Clinical Center at the University of Michigan is to use our robust infrastructure and highly skilled clinical and translational research team to generate a unique platform for investigating individual contributions to DFU wound healing from clinical samples, single cell genetic and molecular analyses from DFU samples, and image analyses.",DFU Clinical Research Unit,9627190,U01DK119083,"['Affect ', ' Age ', ' ages ', ' Amputation ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cells ', ' Cell Body ', ' Clinical Markers ', ' Clinical Research ', ' Clinical Study ', ' Cohort Studies ', ' Concurrent Studies ', ' Comorbidity ', ' co-morbidity ', ' Data Collection ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Mental Depression ', ' depression ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Sterile coverings ', ' Dressing ', ' Engineering ', ' Epidemic ', ' Future ', ' Heart failure ', ' cardiac failure ', ' Heterogeneity ', ' Infection ', ' Institutes ', ' Lower Extremity ', ' Membrum inferius ', ' Lower Limb ', ' male ', ' Marketing ', ' Medicine ', ' Methodology ', ' Michigan ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patient Outcomes Assessments ', ' Patient Reported Outcomes ', ' Patients ', ' Peripheral Nervous System Diseases ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Phenotype ', ' Psychosocial Factor ', ' psychosocial variables ', ' Publishing ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Schools ', ' Self Care ', ' personal care ', ' Standardization ', ' Technology ', ' Time ', ' Ulcer ', ' Ulceration ', ' Universities ', ' Vision ', ' visual function ', ' Sight ', ' Work ', ' Wound Healing ', ' Wound Repair ', ' Gender ', ' Walking ', ' Foot Ulcer ', ' Caring ', ' base ', ' Label ', ' improved ', ' specimen collection ', ' sample collection ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Area ', ' Surface ', ' Clinical ', ' Biological ', ' Medical ', ' Charcot foot ', ' Diabetic Foot ', ' Individual ', ' European ', ' data base ', ' Data Bases ', ' Databases ', ' participant recruitment ', ' Patient Recruitments ', ' Liquid substance ', ' liquid ', ' fluid ', ' Genetic ', ' tool ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' cognitive function ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Location ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' interest ', ' American ', ' experience ', ' cohort ', ' novel ', ' Participant ', ' Modality ', ' Devices ', ' Positioning Attribute ', ' Position ', ' genetic analysis ', ' Genetic analyses ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' Tissue Sample ', ' prevent ', ' preventing ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Diabetic Foot Ulcer ', ' Adherence ', ' Data ', ' Molecular Analysis ', ' Research Infrastructure ', ' Infrastructure ', ' Collection ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Molecular ', ' Behavioral ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' microbiome ', ' cost ', ' healing ', ' clinical site ', ' clinical research site ', ' Outcome ', ' wound ', ' prospective ', ' transcriptomics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' public health relevance ', ' FDA approved ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' diabetic patient ', ' BigData ', ' Big Data ', ' precision-based medicine ', ' precision medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' biomarker discovery ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' ineffective treatment ', ' ineffective therapies ', ' recruit ', ' practice setting ', ' analyze microbiome ', ' microbiome analysis ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2018,423400,MI-12,0.07566355151654874
"Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution PROJECT SUMMARY/ABSTRACT Many epidemiological investigations have associated exposure to traffic-derived air pollution from motor vehicles, air toxins from industry, and other environmental toxins with measures of poor birth outcomes consisting of preeclampsia (PE), preterm birth (PTB) and intra-uterine growth restriction (IUGR). These conditions, which collectively constitute ischemic placental disease, correlate strongly with infant morbidity and a host of adult diseases, ranging from coronary artery disease to cancer. Although it is widely believed that the pathophysiological mechanisms leading to complications of ischemic placental disease and placental insufficiency have similar biological origins, starting as early as defective placental implantation, to date there are no predictive studies that prospectively examine placental function. Thus, non-invasive assessment and prediction of normalcy versus aberrancy of placental function are lacking. Therefore, the overarching objective of this proposal is to develop and evaluate a suite of exosomal micro-transcriptomic and transcriptomic signatures (predictor) for predicting placental insufficiency. Moreover, we seek to use these novel signatures to assess the impact of environmental pollution exposure on placental aberrancy/insufficiency and related outcomes (PE, PTB and IUGR) (primary outcome). Our central hypothesis is that chronic exposure to environmental pollution, independent of socio-economic status (SES), increases the risk of placental insufficiency due to early gestational development of adverse placental function, and that these outcomes can be predicted non-invasively by developing maternal blood derived placental-enriched exosomal micro-transcriptomic and transcriptomic signatures. To test this hypothesis, our specific aims are to: AIM 1: Develop non-invasively in maternal blood, placenta-derived exosomal micro- transcriptomic and transcriptomic signatures that predict in-vivo placental function through all three trimesters. AIM 2: Use the micro-transcriptomic and transcriptomic data from Aim 1 to predict environmental pollution data collected during the course of this study. We will construct models to predict the environmental pollution state based on these signatures, so that they may be used as proxy of the pollution when this data is not available. AIM 3: Perform Epigenome Wide Association Studies using DNA methylation from placental tissues of the same cohort. We will use our Reduced Representation Bisulfite Sequencing to identify loci whose methylation is associated with placental insufficiency and environmental exposures. These studies will help identify genes confirmed by transcriptomic analysis that may be useful in future development of therapeutic interventions for women at high risk of placental insufficiency due to air pollution exposures. Identification of molecular signatures that predict the presence of environmental pollution and adverse pregnancy outcomes may become a game-changer. Obstetric practices may embrace these surveillance tactics in real-time to predict and perhaps reverse placental aberrancy/insufficiency. PROJECT NARRATIVE How environmental pollution contributes to poor pregnancy outcome is poorly understood, and the first trimester of pregnancy is a particularly vulnerable time period for the developing fetus, thus a mother's exposure to air pollution may alter the way that the placenta is established and how it functions throughout the rest of pregnancy. This project aims to identify new molecular markers reflecting normal and abnormal placental function that can be detected non-invasively in a pregnant woman's blood, towards assessing real- time placental function as pregnancy develops from the first to the third trimester. Thus, early detection, prevention strategies, and timely treatment of placental dysfunction as a result of environmental pollution exposures may be developed.",Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution,9514218,R01HD089714,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Air ', ' Air Pollution ', ' Birth ', ' Parturition ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Coronary Arteriosclerosis ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Disease ', ' Disorder ', ' Environmental Exposure ', ' Environmental Pollution ', ' environmental contamination ', ' environmental contaminant ', ' Fetal Development ', ' Developing fetus ', ' Fetal Growth Retardation ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Future ', ' Genes ', ' Goals ', ' Gold ', ' Grant ', ' Histology ', ' Industry ', ' Maps ', ' Methylation ', ' Mothers ', ' Discipline of obstetrics ', ' Obstetrics ', ' Pathology ', ' Placenta ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta Diseases ', ' placental disorders ', ' Placental Diseases ', ' Placenta Disorders ', ' Placental Insufficiency ', ' Placentation ', ' Placental Development ', ' Pre-Eclampsia ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' First Pregnancy Trimester ', ' First Trimester ', ' Early Placental Phase ', ' 1st trimester ', ' Second Pregnancy Trimester ', ' Second Trimester ', ' Midtrimester ', ' 2nd trimester ', ' Third Pregnancy Trimester ', ' Third Trimester ', ' Last Trimester ', ' 3rd trimester ', ' Pregnant Women ', ' pregnant mothers ', ' expecting mother ', ' expectant mother ', ' Prospective Studies ', ' Rest ', ' Risk ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Toxic Environmental Substances ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxin ', ' Measures ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' Motor Vehicles ', ' base ', ' Chronic ', ' Biological ', ' Histologically ', ' Histologic ', ' Training ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' women at high risk ', ' High Risk Woman ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Ecological impact ', ' Environmental Impact ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Pollution ', ' Early Diagnosis ', ' early detection ', ' cohort ', ' Proxy ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' epidemiology study ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Studies ', ' Epidemiologic Research ', ' Therapeutic Intervention ', ' intervention therapy ', ' infant morbidity ', ' Modeling ', ' response ', ' Normalcy ', ' Normalities ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' in vivo ', ' Validation ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Outcome ', ' Population ', ' prospective ', ' transcriptomics ', ' implantation ', ' therapeutic agent development ', ' therapeutic development ', ' primary outcome ', ' molecular biomarker ', ' molecular marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' bisulfite sequencing ', ' microRNA sequencing ', ' micro RNA expression profiling ', ' miRNA-seq ', ' miRNA sequencing ', ' global miRNA profiling ', ' MicroRNA Expression Profiling ', ' miRNA expression profiling ', ' epigenome wide association analysis ', ' EWAS ', ' epigenome-wide association studies ', ' predictors of outcomes ', ' predictive outcomes ', ' outcome prediction ', ' adverse pregnancy outcome ', ' exosome ', ' predictive signature ', ' imaging study ', ' recruit ', ' ']",NICHD,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2018,632298,CA-33,0.027065718717131884
"A Novel Pregnancy Prevention Intervention for Latino Middle School Girls DESCRIPTION (provided by applicant): This new investigator-initiated R01 proposal will test the efficacy of a promising and innovative intervention (Mighty Girls) to reduce teen Latina sexual behavior and pregnancy that was developed in a successful R15 feasibility trial. US teen pregnancy rates have declined but are still high among Latinas (49.4%), and the socioeconomic costs associated with these pregnancies are considerable; e.g., $3.2 billion lost tax revenue (2008 dollars) for decreased maternal educational attainment and productivity. Mighty Girls is designed to empower middle school Latinas with the skills they need to resist peer pressure that would otherwise accelerate their involvement in sexual behavior, allowing them to delay their initiation of intercourse and ultimately reduce their risk for teen pregnancy and sexually transmitted infections.  Mighty Girls uses cutting-edge technology to create a novel, highly interactive, video game that provides a live, realistic simulation of peer pressure. Players talk directly with avatars as they would with peers in their everyday life. This intervention focuses on building communication skills for resistance that are derived from evidence-based programs that do not jeopardize friendships and incorporate Latino cultural values (Marianismo, Personalismo, Simpata) - skills valued by middle school Latinas.  In addition to efficacy testing, the proposed interdisciplinary study evaluates (1) the intervention's cost- effectiveness and (2) influence of participant characteristics and how well the intervention was delivered (implementation quality) on study outcomes. The study will be conducted with seventh grade Latinas enrolled in 20 middle schools in Florida's Miami-Dade County, and followed into ninth grade, a period in which risky behaviors typically increase. Half of these schools will be randomly assigned to receive the Mighty Girls intervention and booster in addition to standard in-school sex education, while the other half will receive only standard in-school sex education. Data will be collected before and after the intervention, and at 2 (pre-booster), 12, and 24 months post-intervention using computerized surveys. Growth curve analysis will compare changes in peer resistance and sexual behavior observed in the two study conditions over the course of the study. Cost-effectiveness analyses will weigh the benefit of the intervention when added to current in-school sex education against its cost of delivery. This proposal addresses Healthy People 2020 objectives to reduce pre-term birth, increase the proportion of women who use contraception to plan pregnancy, and eliminate health disparities. It lays the foundation for a dissemination study of the Mighty Girls intervention that would have a major impact on the lives of vulnerable adolescents and reduce the personal and public burden of early sexual initiation. Study results would also advance the science of communications, health games, and computer engineering by generating data on human-avatar interactions and the use of highly interactive game technology to build health-related interpersonal skills. PUBLIC HEALTH RELEVANCE: The teen pregnancy rate continues to be high among U.S. Latinas and results in significant personal, health care related and other societal costs. This study will test the efficacy of a promising and innovative intervention (Mighty Girls) that uses classroom activities in combination with a highly interactive video game to empower middle school Latinas to resist peer pressure to engage in intercourse. Girls play the game by talking directly with avatars that represent typical middle school children (no keyboard input required); thereby developing the skills needed to decrease their risk for teen pregnancy and sexually transmitted infections. Study results will be helpful for developing similar interventions for othe at risk youth, including boys, and guiding development of other technology based games designed to promote health.",A Novel Pregnancy Prevention Intervention for Latino Middle School Girls,9519046,R01NR014851,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Attitude ', ' Awareness ', ' Behavior ', ' Birth Order ', ' sibling order ', ' Canada ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Coitus ', ' Sexual Intercourse ', ' Communication ', ' Computers ', ' cost effectiveness ', ' Educational Curriculum ', ' lesson plans ', ' Curriculum ', ' Mental Depression ', ' depression ', ' Engineering ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Health ', ' Health Promotion ', ' promoting health ', ' Salutogenesis ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Human ', ' Modern Man ', ' Immersion Investigative Technique ', ' Immersion ', ' Theoretical model ', ' Theoretic Models ', ' Names ', ' Personal Satisfaction ', ' wellbeing ', ' well-being ', ' Play ', ' Pregnancy ', ' Gestation ', ' Pregnancy in Adolescence ', ' adolescents who are pregnant ', ' Underage Pregnancy ', ' Teenage Pregnancy ', ' Teen Pregnancy ', ' Pregnancy in Minors ', ' Adolescent Pregnancy ', ' Pregnancy Rate ', ' Planned Pregnancy ', ' pressure ', ' Productivity ', ' Program Effectiveness ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Schools ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Education ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social Interaction ', ' Societies ', ' Surveys ', ' Survey Instrument ', ' Taxes ', ' Technology ', ' Testing ', ' Video Games ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Work ', ' County ', ' Healthcare ', ' health care ', ' Latino ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' base ', ' Friendships ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Evaluation ', ' Individual ', ' European ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' Ethnicity ', ' Ethnic Origin ', ' Life ', ' programs ', ' Country ', ' Outcome Study ', ' Peer Pressure ', ' age group ', ' experience ', ' Self Efficacy ', ' condoms ', ' skills ', ' simulation ', ' novel ', ' Participant ', ' peer ', ' intimate behavior ', ' intimacy ', ' public education ', ' seventh grade ', ' 7th grade ', ' ninth grade ', ' high school freshman ', ' 9th grade ', ' cultural values ', ' Prevention ', ' Modality ', ' Reporting ', ' Contraceptive methods ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' positive youth development ', ' boys ', ' girls ', ' junior high school ', ' middle school ', ' junior high ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Latina ', ' Latinas ', ' health disparity ', ' disparity in health ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Length ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effectiveness analyses ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' teenage ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' post intervention ', ' pregnancy prevention ', ' effectiveness trial ', ' initiation of intercourse ', ' early sexual initiation ', ' early sex initiation ', ' cost ', ' computerized ', ' designing ', ' design ', ' efficacy trial ', ' developing resistance ', ' Resistant development ', ' Resistance development ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' fourteen years of age ', ' fourteen year old ', ' age 14 years ', ' 14 years of age ', ' 14 year old ', ' resistant ', ' Resistance ', ' Evidence based program ', ' social learning theory ', ' social cognitive theory ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' multimodal intervention ', ' multifaceted intervention ', ' multicomponent intervention ', ' multi-modal intervention ', ' multi-faceted intervention ', ' multi-component intervention ', ' adolescent women ', ' adolescent woman ', ' young woman ', ' Healthy People 2020 ', ' vulnerable adolescent ', ' learning method ', ' learning activity ', ' learning strategy ', ' evaluate cost-effectiveness ', ' cost-effectiveness evaluation ', ' intervention cost ', ' societal costs ', ' feasibility trial ', ' ']",NINR,UNIVERSITY OF MIAMI CORAL GABLES,R01,2018,620198,FL-27,0.06008087110215526
"Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy DESCRIPTION (provided by applicant): Our understanding of cervical remodeling during pregnancy and labor is incomplete, partly due to the lack of in vivo studies on the biochemical changes that occur in the cervix over the course of pregnancy. Elucidation of the mechanisms for cervical ripening could be used to predict the onset of preterm labor. Until recently, in vivo research methods were too invasive to be used as discovery tools, particularly in women who present with preterm labor. This proposal will use in vivo Raman spectroscopy, an optical technique that is sensitive to collagen content, collagen structure, hydration, lipids, proteins, ad other biomolecules to non-invasively investigate the biochemistry of the cervix throughout pregnancy. Using fiber optic in vivo Raman spectroscopy, we recently found significant differences in Raman spectra in at least four important peaks during the course of pregnancy in mice, including discrete signatures for lipids, collagen, amide bonds, and enriched amino acids (proline, tyrosine). Computational analysis of these spectra yielded predictive algorithms with 94% classification accuracy for stage of pregnancy. Studies performed in 2-hour windows at the end of pregnancy identified spectra predictive for the timing of parturition. This approach provides a detailed real-time biomolecular map of cervical ripening that is currently unavailable by other means. In this proposal, we hypothesize that the different mechanisms of premature cervical ripening have unique Raman spectral signatures that correspond to underlying biochemical and mechanical changes that precede preterm birth, which can be detected in vivo. Two Specific Aims are proposed: 1) Determine spectral changes in the cervix of mice with normal and abnormal pregnancy and parturition; 2) Identify specific mediators of cervical remodeling by comparing Raman spectra to mechanical and biochemical changes in the ex vivo cervix during normal and abnormal parturition. Raman spectroscopy has primarily been used for detection of disease. Collaboration between our reproductive biology and bioengineering groups will capitalize on our expertise in Raman analysis of cervical tissues to study dynamic changes in cervix composition during pregnancy. Key elements in cervical biochemistry will be identified. In vivo Raman spectroscopy will be combined with biomechanical studies and imaging mass spectrometry, a powerful tool for in situ proteomic analysis, to examine mice with premature or delayed cervical remodeling. Together, these highly innovative approaches will generate in-depth profiles of cervical biology that will translate into novel non-invasive methods to detect impending premature birth in women. PUBLIC HEALTH RELEVANCE: This proposal will use Raman Spectroscopy, a non-invasive, optical scattering technique, to investigate the composition of the cervix throughout pregnancy and provide detailed real-time information on cervical ripening. These studies will identify spectral differences in the cervix during normal and abnormal cervical maturation; optical and biochemical markers will be identified to help monitor pregnancy non-invasively, as the fiber optic probe only requires brief contact with the external surface of the cervix to obtain measurements. Elucidating the mechanisms that initiate cervical ripening will provide a critical step for early detection and treatment of preterm birth, which is the leading cause of infant morbidity and mortality.",Detecting biochemical changes in the pregnant mouse cervix by Raman spectroscopy,9505946,R01HD081121,"['Algorithms ', ' Alprostadil ', ' Prostaglandin E1alpha ', ' Prostaglandin E1 ', ' PGE1alpha ', ' PGE1 ', ' Muse ', ' Lipo-PGE1 ', ' Caverject ', ' Amides ', ' Amino Acids ', ' aminoacid ', ' Biochemistry ', ' Biological Chemistry ', ' Biological Sciences ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biology ', ' Biomechanics ', ' biomechanical ', ' Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' Birth ', ' Parturition ', ' Cervix Uteri ', ' Uterine Cervix ', ' Cervix ', ' Classification ', ' Systematics ', ' Collagen ', ' Disease ', ' Disorder ', ' Elasticity ', ' Elements ', ' Fetal Development ', ' Developing fetus ', ' Fiber Optics ', ' Foundations ', ' Goals ', ' Health ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Premature Labor ', ' pre-term labor ', ' Preterm Labor ', ' Premature Obstetric Labor ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lipids ', ' Maintenance ', ' Maps ', ' Methods ', ' Mifepristone ', ' RU486 ', ' RU38486 ', ' RU-486 ', ' RU-38486 ', ' R38486 ', ' R 38486 ', ' Mifeprex ', ' Mifegyne ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Optics ', ' optical ', ' Periodicity ', ' Rhythmicity ', ' Cyclicity ', ' Phenotype ', ' physical science ', ' Pregnancy ', ' Gestation ', ' Proline ', ' L-Proline ', ' Proteins ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Raman Spectrum Analysis ', ' Raman spectrometry ', ' Raman Spectroscopy ', ' IR/UV/Raman Spectroscopy ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Translations ', ' Tyrosine ', ' Woman ', ' Generations ', ' Measures ', ' Research Methodology ', ' Research Methods ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' in situ Hybridization Staining Method ', ' in situ Hybridization Genetics ', ' In Situ Hybridization ', ' base ', ' Cervical ', ' Surface ', ' Clinical ', ' prematurity ', ' premature ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Medical ', ' Biochemical Markers ', ' Link ', ' insight ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' High-Risk Pregnancy ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Mechanics ', ' mechanical ', ' Hour ', ' In Situ ', ' Techniques ', ' Hormonal ', ' Early Diagnosis ', ' early detection ', ' Cervical Ripening ', ' Cervical Ripenings ', ' Structure ', ' novel ', ' Prevention ', ' Modality ', ' Property ', ' response ', ' Proteomics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Hydration status ', ' Hydration ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Data ', ' Detection ', ' Applications Grants ', ' Grant Proposals ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Reproductive Biology ', ' in vivo ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Computer Analysis ', ' Emergent Technologies ', ' Emerging Technologies ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' innovative ', ' innovate ', ' innovation ', ' Impairment ', ' clinical applicability ', ' clinical application ', ' early therapy ', ' Early treatment ', ' computer algorithm ', ' Computational algorithm ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' murine model ', ' mouse model ', ' pregnant ', ' public health relevance ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' novel therapeutic intervention ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' infant morbidity/mortality ', ' learning method ', ' learning activity ', ' learning strategy ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' ']",NICHD,VANDERBILT UNIVERSITY MEDICAL CENTER,R01,2018,387714,TN-05,0.06547748270019423
"Statistical methods for healthcare in complex patients with diabetes     DESCRIPTION (provided by applicant): Diabetes affects 8.3% of the US population, and lead to costly adverse healthcare outcomes. Unfortunately, there may be a quality gap in the care of complex diabetes patients, that is, older patients (age>65 years) and those with comorbid conditions. Current practices, relying primarily on the presence of several factors, are not effective in capturing the risk of poor prognosis, i.e., multiple hospitalization and/or emergency department visits, and death. Hence, little evidence exists so far to help prioritize care for thes patients. The diabetes guidelines recognize that tight control of glycosylated hemoglobin (A1c) may not be appropriate for complex patients, and recommend individualizations in tight A1c control. However, neither the outcomes of tight A1c control, nor the effects of the typical treatment regimens used to achieve tight A1c control can be evaluated in clinical trials, with minimal, if any, enrollment of complex diabetes patients due to either their restrictive inclusion criteria or lack of encouragement of the patient and/or clinical investigator to consider the RCT. In order to deliver more effective, efficient and accountable health cares, it is important to help clinicians to examine the relationship between patient complexity and patients' A1c control level, and to modify guideline appropriately with an evidence base. The proposed research will analyze a cohort of 8,304 Medicare beneficiaries with diabetes who were cared for by one of the country's 10 largest physician group practices, the University of Wisconsin Medical Foundation during 2003-2011 to address the following aims: (1) to conduct risk prediction incorporating longitudinal outcomes, (2) to inform guidelines for complex diabetes patients, and (3) to create a patient-centered surveillance tool for detecting short-term negative outcomes. Our analytic approach involves the use of state- of-the-art statistics and machine learning methods to take advantage of the large electronic health records data. The proposed methods and results will help clinicians to identify and quantify risks of tight A1c control in complex diabetes patients an potentially lead to improved patient experiences, and reduce medical expenditures from excess adverse events. PUBLIC HEALTH RELEVANCE: Sub-optimal glycosylated hemoglobin (A1c) control recommendations and treatment recommendations for diabetes patients can result in adverse events, and increased health care utilization. Unfortunately, current guidelines on the care for complex and/or older patients with diabetes are inadequate. We propose to develop an effective and patient-centered health care delivery system for complex diabetes patients, focusing on accurate prediction of adverse events, development of potential guidelines on targeting tight control of A1c and treatment regimens, and real-time monitoring of health conditions.",Statistical methods for healthcare in complex patients with diabetes,9547377,R01DK108073,"['data resource ', ' healthcare outcomes ', ' health care outcomes ', ' care outcomes ', ' treatment guidelines ', ' optimal therapies ', ' optimal treatments ', ' real time monitoring ', ' Affect ', ' Age ', ' ages ', ' Algorithms ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Clinical Investigator ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Clinical Trials ', ' Comorbidity ', ' co-morbidity ', ' Complement ', ' Complement Proteins ', ' Data Sources ', ' Cessation of life ', ' Death ', ' Decision Making ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Diabetes Mellitus ', ' diabetes ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Expenditure ', ' Foundations ', ' Future ', ' Patient Care ', ' Patient Care Delivery ', ' Glycosylated Hemoglobin ', ' Glycated Hemoglobins ', ' Goals ', ' Group Practice ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Glycosylated hemoglobin A ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Hospitalization ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Long-Term Care ', ' longterm care ', ' extended care ', ' Methods ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Physicians ', ' Privatization ', ' outcome forecast ', ' Prognosis ', ' health care quality ', ' healthcare quality ', ' Recommendation ', ' Research ', ' Risk ', ' statistics ', ' Time ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' Trees ', ' United States ', ' Universities ', ' Wisconsin ', ' Work ', ' Healthcare ', ' health care ', ' Risk Assessment ', ' Glean ', ' Caring ', ' Guidelines ', ' base ', ' improved ', ' Area ', ' Chronic ', ' Clinical ', ' Medical ', ' Link ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' Country ', ' experience ', ' user friendly software ', ' user friendly computer software ', ' cohort ', ' treatment planning ', ' Patient observation ', ' Watchful Waiting ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Adverse event ', ' Adverse Experience ', ' Effectiveness ', ' Address ', ' Data ', ' Detection ', ' enroll ', ' Enrollment ', ' Exclusion Criteria ', ' Update ', ' Monitor ', ' developmental ', ' Development ', ' beneficiary ', ' Electronic Health Record ', ' cost ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' patient centered ', ' patient oriented ', ' inclusion criteria ', ' high risk ', ' public health relevance ', ' evidence base ', ' patient population ', ' clinical practice ', ' population health ', ' Regimen ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' Emergency department visit ', ' learning method ', ' learning activity ', ' learning strategy ', ' longitudinal data set ', ' longitudinal dataset ', ' ']",NIDDK,FRED HUTCHINSON CANCER RESEARCH CENTER,R01,2018,285285,WA-07,0.13368502284273018
"Improving diabetes and depression self-management via adaptive mobile messaging Project Summary/Abstract Diabetes and depression are major public health problems that disproportionately affect racial/ethnic minorities and low-income individuals in the US. Efficacious interventions for depression and diabetes exist but are not often combined despite similar treatment recommendations (specifically physical activity) for both conditions. Especially in resource-constrained environments, mobile health (mHealth) technologies are cost effective and feasible methods for delivering self-management support given the more ubiquitous penetration across socioeconomic status. Existing mHealth interventions have shown preliminary success but have had difficulty sustaining engagement. When combined with machine learning algorithms, health messages can be adapted to specifically motivate individuals based on their unique profiles. In Aim 1, we will integrate content from interventions targeting diabetes, depression, and physical activity applying user design methods. We will utilize the existing HealthySMS platform as the basis for this intervention. This will be called the Diabetes and Mental Health Adaptive Notification Tracking and Evaluation (DIAMANTE) study. In Aim 2, we will test an mHealth intervention for diabetes and depression that will generate messages using an adaptive machine learning algorithm that learns from patient step count data (collected passively via a smartphone app) and patient entered blood glucose and mood ratings. We will compare this adaptive, personalized intervention with a static messaging intervention, typical of many existing text messaging interventions. In Aim 3, we will rerandomize non-responsive participants to receiving nurse outreach using a sequential, multiple assignment, randomized trial (SMART) design. We will leverage the SMART design to conserve more expensive one-on-one nurse outreach for the patients who are no longer engaged in the program and need the most support. We will test this intervention with 350 patients from a safety net setting in English and Spanish. The primary outcomes for this study are HbA1c levels and PHQ-9 scores. The results of this study will help us understand the impact of personalizing content utilizing machine learning algorithms as well as the impact of providing clinician support for those receiving mobile health interventions. Since we are testing this intervention in a resource-constrained environment, the results of this study will be relevant for a broader population. Project Narrative (Public Relevance Statement) Diabetes and depression are health problems that are often comorbid and are mutually detrimental when uncontrolled. This grant proposal seeks to develop and test a personalized motivational text messaging intervention to improve management of diabetes and depression with an emphasis on low-income populations. The findings from this study will aid in the development and dissemination of mobile health tools for chronic illness management in diverse patients.",Improving diabetes and depression self-management via adaptive mobile messaging,9547265,R01HS025429,[''],AHRQ,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2018,395830,CA-13,0.08739939243624692
"Mentoring and research in applying digital technologies to prevent chronic Illnesses     DESCRIPTION (provided by applicant): For this K24 midcareer investigator award in patient-oriented research (POR) award, my goals are: 1) to become an international leader in the primary prevention of type 2 diabetes and cardiovascular diseases by applying emerging digital technologies and social media; 2) to conduct high-impact research in testing innovative, cost-effective lifestyle interventions (physical activity) using machine leaning; and 3) to provide a hih quality mentorship and training environment that supports the conduct of high POR impact research in cardiovascular and diabetes prevention. This K24 award will allow me to take on a broader and more formal mentorship role not only in the School of Nursing but also throughout the University of California, San Francisco campus. The overall goals of the new research in this application are to develop decision rule algorithms and quantitative models to optimize real-time predictions of future physical activity intervention adherences and to pilot test these algorithms and models in an intervention trial. The specific aims are: 1) to determine the extent to which baseline factors can predict adherence in self-monitoring (using mobile apps and wearing advanced accelerometers); 2) to determine the extent to which early app-based self-monitoring and evaluation (e.g., advanced accelerometers and diary use, and step counts in the first few weeks) can be optimized to make real-time predictions of future treatment failures; 3) to assess the feasibility of the ""Physical Activity Plus"" intervention using developed real-time prediction models (developed in Aim 2), compared to a ""regular physical activity"" intervention, for changes in total daily steps and duration of moderate and intensive physical activity over a three-month period. To tailor intervention intensity, we will evaluate the frequency of study visits and real-time feedback to minimize treatment failures and maximize adherence. Junior investigators in the POR have adapted digital mobile technologies as part of their research tools and have generated large volumes of continuous data. However, only a few training opportunities are available in this research area; in particular, for methods to rigorously and fully utilize the richness of the data collected. Therefore, the proposed K24 application will also meet these mentees' urgent needs across disciplines. PUBLIC HEALTH RELEVANCE: This K24 application will allow Dr. Fukuoka to use her cardiovascular and diabetes research program as a platform to mentor and guide the careers of junior investigators in patient-oriented research (POR) and to further develop her leadership and mentoring skills.",Mentoring and research in applying digital technologies to prevent chronic Illnesses,9507942,K24NR015812,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Algorithms ', ' Award ', ' Back ', ' Dorsum ', ' Behavior ', ' California ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Electronic Mail ', ' electronic communication ', ' Email ', ' E-Mail ', ' Environment ', ' Epidemic ', ' Feedback ', ' Future ', ' Goals ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Primary Prevention ', ' Recommendation ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Running ', ' San Francisco ', ' School Nursing ', ' School Health Nursing ', ' Technology ', ' Testing ', ' Thinness ', ' Leanness ', ' Time ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' United States ', ' Universities ', ' Measures ', ' therapy failure ', ' Treatment Failure ', ' Guidelines ', ' Clip ', ' base ', ' career ', ' improved ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Evaluation ', ' Training ', ' Physical activity ', ' Failure ', ' Discipline ', ' Individual ', ' Sample Size ', ' Funding ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' programs ', ' Frequencies ', ' Complex ', ' Visit ', ' physical model ', ' skills ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' Intervention Trial ', ' Interventional trial ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient oriented research ', ' patient oriented study ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Car Phone ', ' Mobile Phones ', ' prevent ', ' preventing ', ' Address ', ' Adherence ', ' Data ', ' International ', ' Mid-Career Clinical Scientist Award (K24) ', ' K24 Award ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' K24 Program ', ' K24 Mechanism ', ' Emergent Technologies ', ' Emerging Technologies ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Principal Investigator ', ' To specify ', ' developmental ', ' Development ', ' Behavioral ', ' Diabetes prevention ', ' cost ', ' digital ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' cost-effective ', ' cost effective ', ' life style intervention ', ' lifestyle intervention ', ' innovative ', ' innovate ', ' innovation ', ' public health relevance ', ' Secure ', ' mobile app ', ' mobile application ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' social media ', ' training opportunity ', ' mobile technology ', ' mobile platform ', ' mobile computing ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' Accelerometer ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' Text Messaging ', ' ']",NINR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",K24,2018,184769,CA-12,0.021391706915573305
"QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES     DESCRIPTION (provided by applicant): Tissue identification and quantification plays a significant role in the study of aging and age-related diseases. For example, the accumulation of fat in the human body and its regional distribution with aging is associated with type 2 diabetes and cardiovascular diseases. Changes in muscle composition are strongly linked to decline of muscle strength, decreased mobility caused by aging, or musculoskeletal disorders. Especially interesting is analysis of longitudinal changes of morphometric descriptors that is significant for studying the aging process and for the diagnosis and prevention of age-related diseases.  Medical imaging has emerged as a major tool for estimation of body composition mainly due to being non- invasive and producing multi-dimensional information. Nowadays MRI and CT acquisition is a central component of clinical trials. An abundance of imaging data is collected, but this wealth of information has not been utilized to full extent. Therefore research on image analysis techniques for tissue quantification that are reproducible and can be used on large-scale clinical trials is of particular importance.  The technical hypothesis of this work is that quantitative image processing can robustly and accurately segment, register, and fuse body composition data from modern MRI and CT imaging. The central hypothesis of this proposal is that qualitative body composition phenotypes on clinical imaging will differentiate individuals who are healthy versus those who are not. The goal of our work is to provide a foundation for image analysis of the abdomen and lower extremities and to study the relationship between body morphological changes and age-related pathologies.  We will build upon recent advances in medical image computing to segment muscle, regional adipose tissue, and bone in clinical CT and MRI scans. We will also develop image registration procedures to achieve intra- and inter-subject correspondence and make efficient use of information provided by multi-modal and multi-temporal imaging data collected in clinical trials (aim 1). After these methods have been developed, we will address the hypothesis that quantitative use of clinical imaging can increase the prognostic accuracy of age-related pathologies (aim2). PUBLIC HEALTH RELEVANCE: Age-related diseases such as type-2 diabetes, cardiovascular diseases, and sarcopenia have become a worldwide epidemic and affect the quality of life of millions. To give a global perspective, roughly 343.8 million people in the world have type-2 diabetes today, and 175 million don't know they have diabetes at all. Metabolic diseases are strongly linked to longitudinal changes in body composition, morphology and function. This project will contribute novel and non-invasive medical image analysis techniques for studying the human body composition and its changes with increasing age to achieve timely prognosis of these pathologies.",QUANTITATIVE IMAGE ANALYSIS TECHNIQUES FOR STUDIES OF AGING PHENOTYPES AND AGE-RELATED DISEASES,9449456,SC3GM113754,"['Abdomen ', ' Abdominal ', ' Adipose tissue ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Affect ', ' Age ', ' ages ', ' Aging ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Body Composition ', ' bone ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Clinical Trials ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Delaware ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Fatty acid glycerol esters ', ' Fats ', ' Foundations ', ' Goals ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lower Extremity ', ' Membrum inferius ', ' Lower Limb ', ' Longitudinal Studies ', ' long-term study ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Medical Imaging ', ' Metabolic Diseases ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Methods ', ' Modernization ', ' Muscle ', ' muscular ', ' Muscle Tissue ', ' Musculoskeletal Diseases ', ' musculoskeletal disorder ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Noise ', ' Pathology ', ' Pennsylvania ', ' Pharmacology ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Quality of life ', ' QOL ', ' Research ', ' Role ', ' social role ', ' statistics ', ' Thigh structure ', ' Thigh ', ' Time ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Work ', ' image processing ', ' Procedures ', ' morphometry ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' biogerontology ', ' Gerontology ', ' Link ', ' prognostic ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Human Figure ', ' Human body ', ' Descriptor ', ' Morphology ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Pattern ', ' Techniques ', ' muscle strength ', ' interest ', ' Early Diagnosis ', ' early detection ', ' novel ', ' Participant ', ' graduate student ', ' Prevention ', ' Modality ', ' sarcopenia ', ' sarcopenic ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' MRI Scans ', ' Magnetic Resonance Imaging Scan ', ' Metabolic syndrome ', ' Address ', ' Aging-Related Process ', ' Aging Process ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Multimodal Imaging ', ' multimodality imaging ', ' multi-modality imaging ', ' Reproducibility ', ' in vivo ', ' Computational Technique ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' age dependent ', ' age related ', ' image registration ', ' Imaging technology ', ' public health relevance ', ' effective treatment ', ' effective therapy ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' disease diagnosis ', ' longitudinal analysis ', ' undergraduate ', ' undergraduate student ', ' Analysis of Algorithms ', ' Analyses of Algorithms ', ' Algorithmic Analyses ', ' Algorithmic Analysis ', ' biophysical modeling ', ' biophysical model ', ' quantitative imaging ', ' muscle strength decline ', ' low muscle strength ', ' dynapenia ', ' decreased muscle strength ', ' reduced muscle strength ', ' Underrepresented Groups ', ' clinical imaging ', ' imaging study ', ' ']",NIGMS,DELAWARE STATE UNIVERSITY,SC3,2018,64155,DE-00,0.03471052522275593
"Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54) Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed atypical diabetes (AD), that do not fit into either category. We hypothesize that AD comprises a spectrum that includes numerous forms, both known (e.g, MODY/monogenic, Latent Autoimmune Diabetes of Adults, Ketosis-Prone Diabetes) and unknown. We propose to establish the Center for Atypical Diabetes Research and Evaluation (CADRE). The goals of CADRE are to (1) identify and define comprehensively the forms of AD; and (2) establish an extensive database and repository of biosamples from AD patients. Defining the forms of AD is challenging because the etiology of AD can range from a single gene variant to a highly complex mixture of genetics, epigenetics and environmental factors. To identify patients with AD, and then to define the forms, we will use a two-pronged approach. Approach (a) will use clustering analysis of genotypic and phenotypic data from diverse groups of patients with diabetes. We have recruited 15 domestic and international population cohorts with data on more than 33,000 patients with diabetes. Further, we have recruited six diabetes study clinics (Baylor College of Medicine [BCM], University of Washington [UW], Indiana University [IU], Emory University, University of Colorado, and SUNY Downstate) who will prospectively recruit patients. The Juvenile Diabetes Research Foundation will facilitate recruitment from patient groups. The Administrative Core at BCM will work with cohorts and clinics to obtain data. The University of South Florida (USF) will filter data for AD and separate patients into phenotypically homogenous clusters that can be diagnosed based on genetic and clinical features unique to the cluster. Approach (b) will identify monogenic, oligogenic and mitochondrial forms of AD from patients enrolled in genetics registries (BCM) and a family study with genetic data (Botnia). The BCM registries include patients referred to the Undiagnosed Disease Network. All patients will undergo whole-exome and mitochondrial genome sequencing (Cores at BCM), single-nucleotide polymorphism variant analysis (Oxford), metabolomic analysis (Duke) and phenotypic analysis of C-peptide, adiponectin, proinsulin, islet autoantibodies, and serum insulin DNA levels (Cores at UW and IU). To establish the database and biorepository, we will invite patients with AD to participate in sample donation and longitudinal follow-up via the cohorts and clinics. Data and samples will be transferred to the Database and Biorepository Core at USF, with input and tracking implemented using the successful framework developed by USF for large multicenter trials. Data will be made available through the NIDDK and a CADRE website and samples will be made available through ancillary study application. Ongoing patient recruitment to expand the database and biorepository will occur through the study clinics and clinician referral through the CADRE website. Overall, CADRE will be built on a foundation of existing, successful core facilities and computational systems to create a lasting resource that will substantially advance AD research. PROJECT NARRATIVE For many people with diabetes, their symptoms do not match those usually associated with type 1 or type 2 diabetes. We will use medical and genetic information from a large number of patients with diabetes to find all the forms of atypical diabetes, so doctors can better diagnose and treat these patients. We will also make the Center for Atypical Diabetes Research and Evaluation (CADRE) to keep data and samples from patients with atypical diabetes, so scientists can study these forms of diabetes.",Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54),9597055,U54DK118638,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Autoantibodies ', ' self reactive antibody ', ' autoimmune antibody ', ' C-Peptide ', ' Connecting Peptide ', ' Classification ', ' Systematics ', ' Clinical Protocols ', ' Cluster Analysis ', ' Cluster Analyses ', ' Colorado ', ' Communication ', ' Complication ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Florida ', ' Foundations ', ' Future ', ' Medical Genetics ', ' Clinical genetics ', ' Genome ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Indiana ', ' Insulin ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Longitudinal Studies ', ' long-term study ', ' Medicine ', ' Mining ', ' Mission ', ' Mitochondria ', ' mitochondrial ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Patients ', ' Phenotype ', ' Physiology ', ' Proinsulin ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Syndrome ', ' Universities ', ' Washington ', ' Work ', ' polypeptide C ', ' peptide C ', ' Youth ', ' Youth 10-21 ', ' Immunology ', ' Natural History ', ' base ', ' improved ', ' Family Study ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Autoimmune Diabetes ', ' Multi-center trial ', ' Multicenter Trials ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' insight ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' data storage ', ' data retrieval ', ' Data Storage and Retrieval ', ' participant recruitment ', ' Patient Recruitments ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' adiponectin ', ' apM1 (adipose-specific) protein ', ' apM-1 protein ', ' adipocyte, C1q and collagen domain containing protein ', ' adipocyte complement-related protein 30-kDa ', ' ACRP30 protein ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' Autoimmune Process ', ' Autoimmune ', ' System ', ' college ', ' collegiate ', ' diabetes mellitus genetics ', ' diabetes genetics ', ' cohort ', ' novel ', ' Participant ', ' Categories ', ' outreach ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Pathogenesis ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic analysis ', ' Genetic analyses ', ' Sampling ', ' repository ', ' genetic registry ', ' patient registry ', ' Complex Mixtures ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Symptoms ', ' Core Facility ', ' DNA Sequencing Facility ', ' Sequencing Core ', ' Data ', ' International ', ' Molecular Diagnosis ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Subgroup ', ' Ancillary Study ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' mitochondrial genome ', ' website ', ' web site ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' islet ', ' Population ', ' prospective ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' biorepository ', ' biobank ', ' exomes ', ' exome ', ' sharing data ', ' Secure ', ' genetic information ', ' learning method ', ' learning activity ', ' learning strategy ', ' phenotypic data ', ' recruit ', ' unsupervised machine learning ', ' unsupervised learning ', ' ']",NIDDK,BAYLOR COLLEGE OF MEDICINE,U54,2018,2500000,TX-09,0.005170802675141143
"Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes PROJECT SUMMARY/ABSTRACT Dr. McCoy is an endocrinologist and primary care physician specializing in the care for patients with diabetes and other chronic health conditions. Her long-term goal is to become an independent researcher and leader in evaluating, improving, and individualizing diabetes care through effective use of big data completed by qualitative insights from patients and those involved in their care. The short-term training goals of this proposal are to acquire: 1) proficiency in statistics and data science; 2) experience in qualitative research; 3) skills in clinical trial design; and 4) communication and leadership skills to lead multi-disciplinary research. The proposal's research will be conducted at Mayo Clinic, which has a strong history of training physician scientists and a well-developed infrastructure for education and research. Dr. McCoy has access to an ideal set of data assets, the OptumLabs Data Warehouse and the Kaiser Permanente Northern California Diabetes Registry, and the support of an exceptional team of mentors and advisors who are national leaders in diabetes outcomes and health care delivery research, shared decision-making, qualitative research, and data science. Optimization of glycemic control, while avoiding severe hypoglycemia and hyperglycemia, is the cornerstone of diabetes management. Severe hypoglycemia and hyperglycemia are often preventable, yet continue to incur substantial morbidity, psychological distress, impaired quality of life, and economic burden. There are no validated tools to predict these events and as a result clinicians lack a practical and reliable means to identify high risk patients. The goal of Dr. McCoy's work is to address this critical gap in diabetes management. In Aim 1, she will use large database analysis and novel analytic methods to characterize the patterns of severe hypoglycemia and hyperglycemia among adults with diabetes in the U.S. In Aim 2, she will build on Aim 1 to develop and validate computationally efficient concurrent risk prediction models for severe hypoglycemia and hyperglycemia that could be used in clinical encounters. In Aim 3, she will directly engage patients and their clinicians in conversation about severe hypoglycemia /hyperglycemia risk in order to better understand how information about severe hypoglycemia/ hyperglycemia risk is perceived, interpreted, and used. These studies will serve as foundation for two R01 applications to be submitted during Years 4 and 5, and will advance the science and practice of personalized diabetes care through integration of data science and qualitative methods for the purpose of understanding, predicting, and ultimately preventing severe hypoglycemic/hyperglycemic events. Dr. McCoy has a proven track record of scientific productivity and innovation, and a strong foundation in using secondary data for health services and outcomes research in diabetes. In summary, the training, mentoring, and research proposed here are essential for Dr. McCoy's career development as she develops research independence and expertise in the crucial interface between patients and their clinical teams, evidence-based medicine, and big data. PROJECT NARRATIVE Severe hypoglycemic and hyperglycemic events in the management of diabetes mellitus continue to incur high morbidity, psychological distress, and economic costs; yet, these events may be prevented with individualization of treatment goals and regimens if high risk patients are identified prospectively. The proposed research will leverage big data analytics and qualitative research to 1) characterize the epidemiology of severe hypoglycemia and hyperglycemia in the U.S.; 2) develop and validate concurrent risk prediction models for severe hypoglycemia and hyperglycemia; and 3) enrich the understanding of severe hypoglycemia/ hyperglycemia risk and risk model utilization through qualitative patient and clinician engagement.",Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes,9535990,K23DK114497,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Algorithms ', ' Calibration ', ' California ', ' Clinical Trials ', ' Communication ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Sources ', ' Decision Making ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Diabetes Mellitus ', ' diabetes ', ' Discrimination ', ' Cognitive Discrimination ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Face ', ' facial ', ' faces ', ' Foundations ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Hospitalization ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' Patients ', ' Physicians ', ' Primary Care Physician ', ' Productivity ', ' Quality of life ', ' QOL ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Science ', ' Self Care ', ' personal care ', ' statistics ', ' Time ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' United States ', ' Work ', ' Healthcare ', ' health care ', ' Outcomes Research ', ' Data Set ', ' Dataset ', ' Caring ', ' Guidelines ', ' analytical method ', ' base ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' psychological ', ' psychologic ', ' Training ', ' insight ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Endocrinologist ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Evidence Based Medicine ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Event ', ' Clinic ', ' Pattern ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' skills ', ' novel ', ' member ', ' economic cost ', ' social ', ' psychological distress ', ' Modeling ', ' career development ', ' Qualitative Research ', ' prevent ', ' preventing ', ' Address ', ' Qualitative Methods ', ' qualitative reasoning ', ' Data ', ' Economic Burden ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Clinical Trials Design ', ' Outcomes and Health Services Research ', ' Risk Estimate ', ' Validation ', ' developmental ', ' Development ', ' point of care ', ' disease phenotype ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' data integration ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' Outcome ', ' prospective ', ' innovative ', ' innovate ', ' innovation ', ' Impairment ', ' multidisciplinary ', ' patient centered ', ' patient oriented ', ' high risk ', ' clinical care ', ' shared decision making ', ' Regimen ', ' data registry ', ' BigData ', ' Big Data ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' Patient risk ', ' health data ', ' support tools ', ' education research ', ' Data Scientist ', ' Data Science ', ' Data Analytics ', ' individual patient ', ' clinical decision support ', ' data repository ', ' Databanks ', ' Data Banks ', ' data warehouse ', ' ']",NIDDK,MAYO CLINIC ROCHESTER,K23,2018,169112,MN-01,0.08106836472278235
"Modeling the Effect of Athletic Competition Anxiety on Blood Glucose Dynamics in Type 1 Diabetes Exercise is a challenge for people with type 1 diabetes (T1D) because different activity types and intensities have different impacts on glucose concentrations. This challenge is amplified on competition days, as the added stress and high-intensity activity causes drastically different glucose responses than during exercise on non- competition days. This can occur due to a combination of increased hepatic glycogenolysis anaerobic exercise and the counterregulatory hormone response associated with the stress of competition. Thus, many people with T1D limit their physical activity due to fear of hypoglycemia during or after the activity and the majority of people with T1D do not engage in enough physical activity with less than 20% performing aerobic exercise more than twice per week. Regardless of the desire to exercise, people with T1D may be caught in scenarios where they are doing physical activity such running to catch a bus to commute to work may cause a spike in blood glucose concentration due to the anaerobic nature of the sprint and the added stress of arriving late if he or she were to miss the bus. One would not have had time to consider the appropriate insulin dose to prevent hyperglycemia and would benefit greatly from a system that would monitor these states and make corrections without requiring user input. Artificial pancreas (AP) systems will simplify the treatment of T1D and more advanced research is needed to increase their efficacy during and after exercise. The AP automates the computation of the proper insulin dose by using a continuous subcutaneous glucose sensor (CGM), an automatic control system, and an insulin pump that continuously infuses insulin into the subcutaneous tissue. The limitation of this configuration is its reliance on a single measurement, the glucose concentration, which varies in response to changes in many factors such as meals and exercise. The Cinar group at Illinois Institute of Technology pioneered the multivariable AP development. Signals streamed in real time from wearable devices complement glucose data to build accurate models to predict future variations in glucose levels. These models are updated recursively with each new set of measurements and used in hypoglycemia prediction and adaptive control. A new generation multivariable AP system that will incorporate the presence of competition stress with knowledge of physical activity type and intensity with well-developed machine learning algorithms for data interpretation in real-time, hypoglycemia early-warning systems, and automatic control will be more effective in improving glucose control in physically-active people with T1D. Additionally, this technology will be safer by dramatically reducing the number and duration of hypoglycemic and hyperglycemic events, as compared to the current guidelines for maintaining euglycemia in exercise. Such AP systems can only be developed by using a sophisticated multivariable approach that includes glucose concentrations and a number of other physiological variables that impact glucose homeostasis during physical activity and under the presence of competition stress. PROJECT NARRATIVE The development of an exercise-smart artificial pancreas will improve the overall health and quality of life for people with type 1 diabetes through minimizing the number of treatment decisions required to maintain glucose homeostasis. This project will evaluate the glucose response during competitive and non-competitive exercise of various intensities, will build specific adaptive models that use data from glucose sensors and wearable devices to predict glucose trajectories for various exercise and stress conditions which will optimize insulin dosing with the exercise-smart artificial pancreas.",Modeling the Effect of Athletic Competition Anxiety on Blood Glucose Dynamics in Type 1 Diabetes,9682871,F31DK116524,"['Aerobic Exercise ', ' Aerobic fitness ', ' Aerobic Activity ', ' Algorithms ', ' Anxiety ', ' Anaerobic Bacteria ', ' anaerobe ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Glucose ', ' Blood Sugar ', ' Commuting ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Dehydration ', ' body water dehydration ', ' Insulin-Dependent Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Environment ', ' Exercise ', ' Fright ', ' Fear ', ' Feedback ', ' Foundations ', ' Future ', ' Glucose ', ' Dextrose ', ' D-Glucose ', ' Health ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hydrocortisone ', ' Proctocort ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Illinois ', ' Institutes ', ' Insulin ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin Infusion Systems ', ' insulin pump ', ' Ketosis ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Persons ', ' Physical Fitness ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recommendation ', ' Research ', ' Running ', ' Safety ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Time ', ' Work ', ' Generations ', ' Measures ', ' Guidelines ', ' base ', ' improved ', ' Hepatic ', ' sedentary ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Training ', ' Physical activity ', ' Personality Traits ', ' Individual ', ' Measurement ', ' Tela Subcutanea ', ' Superficial Fascia ', ' Subcutis ', ' Hypodermis ', ' Subcutaneous Tissue ', ' Artificial Pancreas ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Event ', ' Stream ', ' Reaction ', ' subcutaneous ', ' Techniques ', ' System ', ' meter ', ' experience ', ' glycogenolysis ', ' Performance ', ' treatment planning ', ' member ', ' Reporting ', ' Modeling ', ' response ', ' glucose sensor ', ' prevent ', ' preventing ', ' Dose ', ' Athletic ', ' Data ', ' Detection ', ' Exercise Physiology ', ' Observational research ', ' Observation study ', ' Observation research ', ' Observational Study ', ' Societal Factors ', ' Update ', ' Monitor ', ' pancreas development ', ' developmental ', ' Development ', ' physiologic model ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' blood glucose regulation ', ' Impairment ', ' nondiabetic ', ' non-diabetic ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' exercise intensity ', ' wearable sensor ', ' wearable device ', ' ']",NIDDK,ILLINOIS INSTITUTE OF TECHNOLOGY,F31,2018,40644,IL-01,0.04936497009329091
"The initial care of younger adults with newly diagnosed type 2 diabetes PROJECT SUMMARY Dr. Anjali Gopalan, MD, MSHP is a board-certified Internist at the Kaiser Permanente Northern California (KPNC) Oakland Medical Center and a Research Scientist I (equivalent to Assistant Professor) at the KPNC Division of Research (DOR). With the proposed K23 mentored career development award, Dr. Gopalan will gain the advanced training and expertise necessary to become an independent investigator who can develop and implement tailored interventions for patients with early-onset type 2 diabetes (EOT2D). By focusing on adults with EOT2D, she seeks to address the comparatively poor micro- and macrovascular outcomes in this population that may result partly from inadequate management of hyperglycemia and other cardiovascular disease risk factors. Dr. Gopalans research premise posits that it is particularly critical for newly diagnosed patients with EOT2D to achieve early disease control, since tighter glycemic control during the year following diagnosis confers long-lasting micro- and macrovascular benefits. In support of the premise, the Research Aims of this K23 are to: 1) use electronic health record [EHR] data to identify EOT2D patient subgroups at highest risk of inadequate early disease control, 2) identify barriers to and facilitators of initial EOT2D management, and 3) examine prospective associations between patient-reported factors (e.g., disease-related distress, health literacy) and inadequate early disease control. The proposed research will be supported by experienced mentors and advisors, as well as advanced training in the following areas: 1) the use of advanced statistical modeling, 2) qualitative data analysis to inform intervention development, 3) the role of social determinants in health, and 4) implementation science. KPNC and DOR are ideal environments for the proposed work. KPNC is an integrated learning healthcare delivery system with a diverse membership of 4.2 million people (>350,000 with diabetes). DOR has a long track record of effectively training early stage investigators and has well-established internal research programs and collaborative relationships with nearby institutions that provide the infrastructure needed for career development. This environment, along with the proposed Research and Training Plans and an outstanding mentorship team, will enable Dr. Gopalan to continue to build the skills and generate the foundational data needed to submit an R01-level proposal during the final years of the proposed award period. In this planned R01, Dr. Gopalan will refine and implement an intervention (with a design based on the results of the three K23 Research Aims) to improve early care for newly diagnosed EOT2D patients and evaluate its impact on early outcomes in this growing, high-risk population. In summary, the proposed K23 award will support the career development of Dr. Gopalan and is vital to her acquiring the skill set and expertise required to become a successful, independent investigator. PROJECT NARRATIVE Adults diagnosed with type 2 diabetes at a younger age have higher rates of complications than those diagnosed later in life. Given the lasting benefit conferred by early disease control, the initial care provided to this growing, high-risk population is particularly crucial. With this proposed career development award, Dr. Gopalan will acquire the research skills necessary to identify patients at highest risk for inadequate early disease control, define barriers to initial disease management, and develop an intervention designed to improve the care of adults (ages 21-44) with newly diagnosed type 2 diabetes.",The initial care of younger adults with newly diagnosed type 2 diabetes,9666625,K23DK116968,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Award ', ' California ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Data Reporting ', ' data representation ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Environment ', ' Face ', ' facial ', ' faces ', ' Foundations ', ' Future ', ' Goals ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Hyperglycemia ', ' hyperglycemic ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Interview ', ' Learning ', ' literacy ', ' Mentors ', ' Mentorship ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Population Characteristics ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Risk Management ', ' Hospital Risk Reporting ', ' Role ', ' social role ', ' Smoke ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Trees ', ' United Kingdom ', ' Work ', ' Latino ', ' Research Methodology ', ' Research Methods ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Training ', ' Distress ', ' insight ', ' young adulthood ', ' adult youth ', ' young adult ', ' Internist ', ' integrated healthcare systems ', ' integrated health system ', ' Integrated Health Care Systems ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Disease Management ', ' Disorder Management ', ' programs ', ' Scientist ', ' System ', ' Medical center ', ' diabetes education ', ' experience ', ' professor ', ' cohort ', ' Familiarity ', ' skills ', ' member ', ' Patient Self-Report ', ' Self-Report ', ' Reporting ', ' Modeling ', ' Sampling ', ' career development ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' disorder control ', ' disease control ', ' Qualitative Research ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Risk Reduction ', ' Provider ', ' Institution ', ' Address ', ' Data ', ' Health Sciences ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Clinical Data ', ' Newly Diagnosed ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Electronic Health Record ', ' early onset ', ' health literacy ', ' macrovascular complication ', ' macrovascular disease ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' prospective ', ' protective effect ', ' racial and ethnic ', ' comparative ', ' implementation science ', ' treatment design ', ' intervention design ', ' therapy design ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' high risk ', ' patient population ', ' e-Health ', ' eHealth ', ' Patient risk ', ' individual patient ', ' improved outcome ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' patient subsets ', ' ethnically diverse ', ' ethnic diversity ', ' high risk group ', ' high risk population ', ' Retrospective cohort ', ' obstacle to healthcare ', ' obstacle to care ', ' barrier to treatment ', ' barrier to healthcare ', ' barrier to health care ', ' barrier to care ', ' ']",NIDDK,KAISER FOUNDATION RESEARCH INSTITUTE,K23,2018,194005,CA-13,0.06730211780386315
"Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury     DESCRIPTION (provided by applicant): Throughout human pregnancy, the placenta is indispensable for embryonic development, fetal growth and tissue differentiation. The placenta also protects the fetus against diverse insults, while preserving maternal health. Placental dysfunction is commonly implicated in complications of pregnancy that challenge maternal physiology (e.g., preeclampsia) and fetal development (e.g., fetal death or fetal growth restriction) or that leads to preterm birth. Within the placenta, the trophoblast constitutes the outermost layer, which is directly bathed in maternal blood and therefore positioned to regulate maternal-fetal gas exchange, nutrient delivery, waste removal and the production of hormones, faithfully balancing fetal needs and maternal supply. Trophoblast damage, which is common in dysfunctional placentas, may interrupt the delicate maternal-fetal balance, cause clinical disease, and leave a lifelong mark on health. A fundamental challenge in perinatal medicine arises from our limited ability to diagnose placental disorders in real time and throughout pregnancy. However, the recent discovery, by ourselves and others, that (a) placental trophoblasts release distinctive micro- and nanovesicles into the maternal circulation and (b) these vesicles contain trophoblast-specific non-coding RNA cargo, created a new opportunity for assessing trophoblast health. These vesicles are actively released by trophoblasts throughout pregnancy, and thus serve as a venipuncture-accessible ""natural biopsy"" of trophoblasts, which can furnish information on trophoblast health in real time. Our established perinatal biology group at Magee- Womens Research Institute includes expertise in perinatal medicine and placental pathology, developmental and molecular biology, and bioinformatics. Inspired by these recent advances, we have partnered with an experienced group of bioengineers that includes experts from Carnegie Mellon University, MIT, and Penn State University, with unique skills in biophysics-based vesicle analytics, including microfluidics, nanomechanics, micro/nano fabrication and vesicle sorting using acoustic tweezers. Together, our new transdisciplinary group will use integrated molecular and biophysical methodologies to directly assess the use of trophoblast-derived extracellular vesicles from maternal plasma as revelatory of trophoblast health in real time and as a technique that may be employed throughout pregnancy. Our approach is comprehensive, centering on miRNAs as well as lncRNAs and circRNAs, analyzed in exosome nanovesicles, as well as microvesicles and apoptotic bodies. As each vesicle features a unique bimolecular and biophysical signature, we will deploy our machine learning- based training and testing pipeline to informatively integrate these distinct signals into an innovative diagnostic tool. Lastly, our deployment of affordable acoustic tweezers technology to sort trophoblastic vesicles will facilitate the translation of our advances into a new ""lab on a chip"" placental diagnostic technology, suitable for small blood volumes. This technology may not only denote trophoblast pathology, but has potential to identify those who may benefit from intervention and to monitor therapeutic success. PUBLIC HEALTH RELEVANCE: Although the placenta is critical for fetal development and pregnancy outcome, it is not currently accessible for real-time diagnostics throughout pregnancy. Having developed tools for isolation and analysis of placenta- specific extracellular from the maternal plasma, we will study molecular and biophysical properties of these vesicles as indicators of placental health and disease.",Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury,9503015,R01HD086325,"['Abruptio Placentae ', ' placental abruption ', ' Premature Separation of Placenta ', ' Acoustics ', ' Acoustic ', ' Arteries ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' Biophysics ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Biopsy ', ' Needle biopsy procedure ', ' needle biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Blood Volume ', ' Communication ', ' Developmental Biology ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Embryonic Development ', ' Embryogenesis ', ' Embryo Development ', ' Equilibrium ', ' balance function ', ' balance ', ' Fetal Death ', ' fetus death ', ' Fetal Development ', ' Developing fetus ', ' Fetal Growth Retardation ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetus ', ' Future ', ' Gases ', ' Gold ', ' Health ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Human ', ' Modern Man ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Maternal Health ', ' Methods ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Pathology ', ' Placenta ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta Diseases ', ' placental disorders ', ' Placental Diseases ', ' Placenta Disorders ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma Proteins ', ' Pre-Eclampsia ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pregnancy ', ' Gestation ', ' Pregnancy Complications ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnancy Outcome ', ' Pregnancy-Associated Plasma Protein-A ', ' Pregnancy-Associated alpha-Plasma Protein ', ' PAPP-alpha ', ' PAPP-A ', ' Insulin-Like-Growth Factor Binding Protein-4 Protease ', ' Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease ', ' IGFBP-4-Specific Proteinase ', ' IGFBP-4 Protease ', ' IGFBP-4 Metalloproteinase ', ' Production ', ' Research Institute ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Technology ', ' Testing ', ' Time ', ' tomography ', ' Translations ', ' trophoblast ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Universities ', ' Viscosity ', ' Woman ', ' circular RNA ', ' closed circular RNA ', ' Endoglin ', ' Transforming Growth Factor P Receptor III ', ' CD105 Antigen ', ' Postpartum Period ', ' post-partum ', ' Postpartum ', ' Glean ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Pre-term birth ', ' pregnancy disorder ', ' Injury ', ' base ', ' Peripartum ', ' Perinatal ', ' improved ', ' Clinical ', ' Diffuse ', ' Histologically ', ' Histologic ', ' Evaluation ', ' Training ', ' peripheral blood ', ' Blood flow ', ' wasting ', ' fetus tissue ', ' Fetal Tissues ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Therapeutic ', ' Shapes ', ' Vesicle ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Investigation ', ' Dimensions ', ' Techniques ', ' Location ', ' extracellular ', ' fetal ', ' experience ', ' success ', ' viscoelasticity ', ' Venipunctures ', ' Nutrient ', ' skills ', ' novel ', ' Sorting - Cell Movement ', ' sorting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Positioning Attribute ', ' Position ', ' Fetal Growth ', ' intrauterine growth ', ' Property ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Provider ', ' Bioinformatics ', ' Bio-Informatics ', ' Microfluidics ', ' Microfluidic ', ' PGF gene ', ' Placental Growth Factor Gene ', ' PlGF ', ' PLGF-2 ', ' Lab-On-A-Chips ', ' Lab On a Chip ', ' fitness ', ' Data ', ' Interruption ', ' Maternal Physiology ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Predictive Value ', ' in vivo ', ' Apoptotic ', ' Tissue Differentiation ', ' Monitor ', ' Characteristics ', ' Molecular ', ' injured ', ' designing ', ' design ', ' nanofabricate ', ' nano fabrication ', ' nano fabricate ', ' nanofabrication ', ' nano mechanics ', ' nanomechanics ', ' cost-effective ', ' cost effective ', ' innovative ', ' innovate ', ' innovation ', ' stem ', ' public health relevance ', ' clinical care ', ' nano vesicle ', ' nanovesicle ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' biophysical properties ', ' biophysical methods ', ' biophysical methodology ', ' biophysical approaches ', ' biophysical techniques ', ' guided discovery ', ' guided inquiry ', ' perinatal medicine ', ' adverse pregnancy outcome ', ' microvesicles ', ' exosome ', ' extracellular vesicles ', ' mechanical properties ', ' clinical diagnostics ', ' high dimensionality ', ' Placenta Biology ', ' Placental Biology ', ' Fetal health ', ' ']",NICHD,MAGEE-WOMEN'S RES INST AND FOUNDATION,R01,2018,664486,PA-18,0.07382966896677148
"Physical Activity, Sedentary Behavior, and Cancer Incidence in Women Abstract In the United States in 2016, an estimated 600,000 people will die from cancer and 1.7 million new cases of cancer will be diagnosed. Considering the life span, almost 40% of women and men will be diagnosed with cancer at some point in their lifetime. Understanding amenable risk factors that contribute to this large public health burden is essential. Observational studies consistently indicate associations between self-reported physical activity and increased risk of many types of cancer, especially breast cancer. However, there is insufficient evidence regarding the amount, intensity, duration, and types of physical activity required to reduce cancer risk, especially for older women. Sedentary behavior may provide a more feasible intervention target, especially for older adults. However, even less is known about sedentary behavior and cancer risk. To date, no prospective studies have examined accelerometry-derived physical activity and sedentary behavior to risk of incident cancer outcomes. Advances have been made in new measurement methods by our team, but have not been applied to health outcomes to assess their value. In this application, we propose to assemble accelerometry-assessed physical activity and sedentary behavior and cancer incident events and deaths from two cohort studies of women: the Women's Health Study (WHS) and the Women's Health Initiative (WHI) Study. We will apply sophisticated, yet directly interpretable, methods to determine which physical activity and sedentary behavior features are most important for reducing cancer risk among more than 22,000 women 63 to 101 years of age. For both cohorts, one-week of accelerometry data were collected in a similar manner during 2011-2014. Follow-up of both cohorts for adjudicated cancer outcomes is planned through 2020 and likely beyond. We propose three aims. Aim 1 will apply novel and translational measures of accelerometry- assessed physical activity and sedentary behavior using latent class analysis, an activity index, and machine learning algorithms of raw accelerometry data for use in Aims 2 and 3. We will then investigate the association of accelerometry-assessed physical activity (Aim 2) and sedentary behavior (Aim 3) to overall and site-specific (e.g., breast, uterine, ovarian) incident and fatal cancer. This cost-efficient study will investigate in detail whether and how patterns of frequency, duration, intensity, bouts, and type of physical activity and sedentary behavior predict cancer outcomes. Identification of new cancer-protective patterns of physical activity and sedentary behavior will provide much-needed evidence to inform physical activity and sedentary behavior guidelines for disease prevention, can be used in interventions to reduce risk, and could revolutionize the monitoring of human responses in physical activity and sedentary behavior interventions. Project Narrative We will develop novel exposure metrics to determine the association of accelerometry-assessed physical activity and sedentary behavior to overall and site-specific incident and fatal cancer. This cost efficient project will provide much-needed evidence to inform physical activity and sedentary behavior guidelines for disease prevention in older women. Our findings can be applied to intervention studies to reduce risk. The exposure developments made from this project could revolutionize the monitoring of human responses to physical activity and sedentary behavior.","Physical Activity, Sedentary Behavior, and Cancer Incidence in Women",9661385,R01CA227122,"['Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Breast ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cause of Death ', ' Concurrent Studies ', ' Cohort Studies ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Health ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Modern Man ', ' Human ', ' Incidence ', ' indexing ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Intervention Studies ', ' Photoradiation ', ' Light ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', "" men's "", ' men ', ' Methods ', ' Methodology ', ' mortality ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Prospective Studies ', ' Public Health ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Science ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Time ', ' Translating ', ' United States ', ' womb ', ' Uterus ', ' Woman ', ' Measures ', ' Walking ', ' Female Health ', "" Women's Health "", ' Leisures ', ' Guidelines ', ' analytical method ', ' base ', ' improved ', ' Cervical ', ' Ovarian ', ' Site ', ' Chronic ', ' sedentary ', ' Physical activity ', ' insight ', ' young adult ', ' young adulthood ', ' adult youth ', ' Measurement ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Event ', ' Pattern ', ' age group ', ' cancer risk ', ' cohort ', ' novel ', ' disorder prevention ', ' disease prevention ', ' NIH Program Announcements ', ' Program Announcement ', ' Laboratory Study ', ' Patient Self-Report ', ' Self-Report ', ' Reporting ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' data processing ', ' computerized data processing ', ' Address ', ' Dose ', ' Age-Years ', ' Data ', ' Interruption ', ' Resolution ', ' Collection ', ' Light Exercise ', ' Light Activity ', ' Observational Study ', ' Observational research ', ' Observation study ', ' Observation research ', ' Monitor ', ' sex ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' cost ', ' adjudicate ', ' Outcome ', ' cost efficient ', ' cancer type ', ' older women ', ' sedentary lifestyle ', ' Sedentary life-style ', ' Sedentary behavior ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' vigorous intensity ', ' machine learning algorithm ', ' ']",NCI,UNIV OF NORTH CAROLINA CHAPEL HILL,R01,2019,688906,NC-04,-0.002291334903876643
"The initial care of younger adults with newly diagnosed type 2 diabetes PROJECT SUMMARY Dr. Anjali Gopalan, MD, MSHP is a board-certified Internist at the Kaiser Permanente Northern California (KPNC) Oakland Medical Center and a Research Scientist I (equivalent to Assistant Professor) at the KPNC Division of Research (DOR). With the proposed K23 mentored career development award, Dr. Gopalan will gain the advanced training and expertise necessary to become an independent investigator who can develop and implement tailored interventions for patients with early-onset type 2 diabetes (EOT2D). By focusing on adults with EOT2D, she seeks to address the comparatively poor micro- and macrovascular outcomes in this population that may result partly from inadequate management of hyperglycemia and other cardiovascular disease risk factors. Dr. Gopalans research premise posits that it is particularly critical for newly diagnosed patients with EOT2D to achieve early disease control, since tighter glycemic control during the year following diagnosis confers long-lasting micro- and macrovascular benefits. In support of the premise, the Research Aims of this K23 are to: 1) use electronic health record [EHR] data to identify EOT2D patient subgroups at highest risk of inadequate early disease control, 2) identify barriers to and facilitators of initial EOT2D management, and 3) examine prospective associations between patient-reported factors (e.g., disease-related distress, health literacy) and inadequate early disease control. The proposed research will be supported by experienced mentors and advisors, as well as advanced training in the following areas: 1) the use of advanced statistical modeling, 2) qualitative data analysis to inform intervention development, 3) the role of social determinants in health, and 4) implementation science. KPNC and DOR are ideal environments for the proposed work. KPNC is an integrated learning healthcare delivery system with a diverse membership of 4.2 million people (>350,000 with diabetes). DOR has a long track record of effectively training early stage investigators and has well-established internal research programs and collaborative relationships with nearby institutions that provide the infrastructure needed for career development. This environment, along with the proposed Research and Training Plans and an outstanding mentorship team, will enable Dr. Gopalan to continue to build the skills and generate the foundational data needed to submit an R01-level proposal during the final years of the proposed award period. In this planned R01, Dr. Gopalan will refine and implement an intervention (with a design based on the results of the three K23 Research Aims) to improve early care for newly diagnosed EOT2D patients and evaluate its impact on early outcomes in this growing, high-risk population. In summary, the proposed K23 award will support the career development of Dr. Gopalan and is vital to her acquiring the skill set and expertise required to become a successful, independent investigator. PROJECT NARRATIVE Adults diagnosed with type 2 diabetes at a younger age have higher rates of complications than those diagnosed later in life. Given the lasting benefit conferred by early disease control, the initial care provided to this growing, high-risk population is particularly crucial. With this proposed career development award, Dr. Gopalan will acquire the research skills necessary to identify patients at highest risk for inadequate early disease control, define barriers to initial disease management, and develop an intervention designed to improve the care of adults (ages 21-44) with newly diagnosed type 2 diabetes.",The initial care of younger adults with newly diagnosed type 2 diabetes,9785527,K23DK116968,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Award ', ' California ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' data representation ', ' Data Reporting ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Foundations ', ' Future ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' hyperglycemic ', ' Hyperglycemia ', ' Hyperlipemia ', ' Hyperlipidemia ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Interview ', ' Learning ', ' literacy ', ' Mentors ', ' Mentorship ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Pharmacies ', ' Pharmacy facility ', ' Population Characteristics ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Risk Management ', ' social role ', ' Role ', ' Smoke ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Trees ', ' United Kingdom ', ' Work ', ' Latino ', ' Research Methods ', ' Research Methodology ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Training ', ' Distress ', ' insight ', ' young adult ', ' young adulthood ', ' adult youth ', ' Internist ', ' Integrated Health Care Systems ', ' integrated healthcare systems ', ' integrated health system ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Disease Management ', ' Disorder Management ', ' programs ', ' Scientist ', ' System ', ' Medical center ', ' diabetes education ', ' experience ', ' professor ', ' cohort ', ' Familiarity ', ' skills ', ' member ', ' Patient Self-Report ', ' Self-Report ', ' Reporting ', ' Modeling ', ' Sampling ', ' career development ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' disorder control ', ' disease control ', ' Qualitative Research ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Risk Reduction ', ' Provider ', ' Institution ', ' Address ', ' Data ', ' Health Sciences ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Training ', ' Clinical Data ', ' Newly Diagnosed ', ' Characteristics ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' early onset ', ' health literacy ', ' macrovascular disease ', ' macrovascular complication ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' design ', ' designing ', ' diabetes management ', ' diabetic management ', ' glycemic control ', ' older patient ', ' elderly patient ', ' Outcome ', ' Population ', ' prospective ', ' protective effect ', ' racial and ethnic ', ' comparative ', ' implementation science ', ' therapy design ', ' treatment design ', ' intervention design ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' patient population ', ' eHealth ', ' e-Health ', ' individual patient ', ' improved outcome ', ' patient subsets ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' ethnic diversity ', ' ethnically diverse ', ' high risk population ', ' high risk group ', ' Retrospective cohort ', ' barrier to care ', ' obstacle to healthcare ', ' obstacle to care ', ' barrier to treatment ', ' barrier to healthcare ', ' barrier to health care ', ' Infrastructure ', ' ']",NIDDK,KAISER FOUNDATION RESEARCH INSTITUTE,K23,2019,192917,CA-13,0.06730211780386315
"Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes PROJECT SUMMARY/ABSTRACT Dr. McCoy is an endocrinologist and primary care physician specializing in the care for patients with diabetes and other chronic health conditions. Her long-term goal is to become an independent researcher and leader in evaluating, improving, and individualizing diabetes care through effective use of big data completed by qualitative insights from patients and those involved in their care. The short-term training goals of this proposal are to acquire: 1) proficiency in statistics and data science; 2) experience in qualitative research; 3) skills in clinical trial design; and 4) communication and leadership skills to lead multi-disciplinary research. The proposal's research will be conducted at Mayo Clinic, which has a strong history of training physician scientists and a well-developed infrastructure for education and research. Dr. McCoy has access to an ideal set of data assets, the OptumLabs Data Warehouse and the Kaiser Permanente Northern California Diabetes Registry, and the support of an exceptional team of mentors and advisors who are national leaders in diabetes outcomes and health care delivery research, shared decision-making, qualitative research, and data science. Optimization of glycemic control, while avoiding severe hypoglycemia and hyperglycemia, is the cornerstone of diabetes management. Severe hypoglycemia and hyperglycemia are often preventable, yet continue to incur substantial morbidity, psychological distress, impaired quality of life, and economic burden. There are no validated tools to predict these events and as a result clinicians lack a practical and reliable means to identify high risk patients. The goal of Dr. McCoy's work is to address this critical gap in diabetes management. In Aim 1, she will use large database analysis and novel analytic methods to characterize the patterns of severe hypoglycemia and hyperglycemia among adults with diabetes in the U.S. In Aim 2, she will build on Aim 1 to develop and validate computationally efficient concurrent risk prediction models for severe hypoglycemia and hyperglycemia that could be used in clinical encounters. In Aim 3, she will directly engage patients and their clinicians in conversation about severe hypoglycemia /hyperglycemia risk in order to better understand how information about severe hypoglycemia/ hyperglycemia risk is perceived, interpreted, and used. These studies will serve as foundation for two R01 applications to be submitted during Years 4 and 5, and will advance the science and practice of personalized diabetes care through integration of data science and qualitative methods for the purpose of understanding, predicting, and ultimately preventing severe hypoglycemic/hyperglycemic events. Dr. McCoy has a proven track record of scientific productivity and innovation, and a strong foundation in using secondary data for health services and outcomes research in diabetes. In summary, the training, mentoring, and research proposed here are essential for Dr. McCoy's career development as she develops research independence and expertise in the crucial interface between patients and their clinical teams, evidence-based medicine, and big data. PROJECT NARRATIVE Severe hypoglycemic and hyperglycemic events in the management of diabetes mellitus continue to incur high morbidity, psychological distress, and economic costs; yet, these events may be prevented with individualization of treatment goals and regimens if high risk patients are identified prospectively. The proposed research will leverage big data analytics and qualitative research to 1) characterize the epidemiology of severe hypoglycemia and hyperglycemia in the U.S.; 2) develop and validate concurrent risk prediction models for severe hypoglycemia and hyperglycemia; and 3) enrich the understanding of severe hypoglycemia/ hyperglycemia risk and risk model utilization through qualitative patient and clinician engagement.",Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes,9747912,K23DK114497,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Calibration ', ' California ', ' Clinical Trials ', ' Communication ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Sources ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' diabetes ', ' Diabetes Mellitus ', ' Cognitive Discrimination ', ' Discrimination ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' facial ', ' faces ', ' Face ', ' Foundations ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' Health ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Hospital Admission ', ' Hospitalization ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' Patients ', ' Physicians ', ' Primary Care Physician ', ' Productivity ', ' QOL ', ' Quality of life ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Science ', ' personal care ', ' Self Care ', ' statistics ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' United States ', ' Work ', ' health care ', ' Healthcare ', ' Outcomes Research ', ' Dataset ', ' Data Set ', ' Caring ', ' Guidelines ', ' analytical method ', ' base ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' psychologic ', ' psychological ', ' Training ', ' insight ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Development Plans ', ' Endocrinologist ', ' tool ', ' Evidence Based Medicine ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Event ', ' Clinic ', ' Pattern ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' skills ', ' novel ', ' member ', ' economic cost ', ' social ', ' psychological distress ', ' Modeling ', ' career development ', ' Qualitative Research ', ' preventing ', ' prevent ', ' Address ', ' Qualitative Methods ', ' qualitative reasoning ', ' Data ', ' Economic Burden ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Research Training ', ' Clinical Trials Design ', ' Outcomes and Health Services Research ', ' Risk Estimate ', ' Validation ', ' Development ', ' developmental ', ' point of care ', ' disease phenotype ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' data integration ', ' diabetes management ', ' diabetic management ', ' glycemic control ', ' Outcome ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' multidisciplinary ', ' patient oriented ', ' patient centered ', ' high risk ', ' clinical care ', ' shared decision making ', ' Regimen ', ' data registry ', ' Big Data ', ' BigData ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' Patient risk ', ' health data ', ' support tools ', ' education research ', ' Data Science ', ' individual patient ', ' clinical decision support ', ' data warehouse ', ' data repository ', ' Databanks ', ' Data Banks ', ' Infrastructure ', ' machine learning algorithm ', ' Big Data Methods ', ' Big Data Tools ', ' Big Data Analytics ', ' risk prediction model ', ' ']",NIDDK,MAYO CLINIC ROCHESTER,K23,2019,168896,MN-01,0.08106836472278235
"Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution PROJECT SUMMARY/ABSTRACT Many epidemiological investigations have associated exposure to traffic-derived air pollution from motor vehicles, air toxins from industry, and other environmental toxins with measures of poor birth outcomes consisting of preeclampsia (PE), preterm birth (PTB) and intra-uterine growth restriction (IUGR). These conditions, which collectively constitute ischemic placental disease, correlate strongly with infant morbidity and a host of adult diseases, ranging from coronary artery disease to cancer. Although it is widely believed that the pathophysiological mechanisms leading to complications of ischemic placental disease and placental insufficiency have similar biological origins, starting as early as defective placental implantation, to date there are no predictive studies that prospectively examine placental function. Thus, non-invasive assessment and prediction of normalcy versus aberrancy of placental function are lacking. Therefore, the overarching objective of this proposal is to develop and evaluate a suite of exosomal micro-transcriptomic and transcriptomic signatures (predictor) for predicting placental insufficiency. Moreover, we seek to use these novel signatures to assess the impact of environmental pollution exposure on placental aberrancy/insufficiency and related outcomes (PE, PTB and IUGR) (primary outcome). Our central hypothesis is that chronic exposure to environmental pollution, independent of socio-economic status (SES), increases the risk of placental insufficiency due to early gestational development of adverse placental function, and that these outcomes can be predicted non-invasively by developing maternal blood derived placental-enriched exosomal micro-transcriptomic and transcriptomic signatures. To test this hypothesis, our specific aims are to: AIM 1: Develop non-invasively in maternal blood, placenta-derived exosomal micro- transcriptomic and transcriptomic signatures that predict in-vivo placental function through all three trimesters. AIM 2: Use the micro-transcriptomic and transcriptomic data from Aim 1 to predict environmental pollution data collected during the course of this study. We will construct models to predict the environmental pollution state based on these signatures, so that they may be used as proxy of the pollution when this data is not available. AIM 3: Perform Epigenome Wide Association Studies using DNA methylation from placental tissues of the same cohort. We will use our Reduced Representation Bisulfite Sequencing to identify loci whose methylation is associated with placental insufficiency and environmental exposures. These studies will help identify genes confirmed by transcriptomic analysis that may be useful in future development of therapeutic interventions for women at high risk of placental insufficiency due to air pollution exposures. Identification of molecular signatures that predict the presence of environmental pollution and adverse pregnancy outcomes may become a game-changer. Obstetric practices may embrace these surveillance tactics in real-time to predict and perhaps reverse placental aberrancy/insufficiency. PROJECT NARRATIVE How environmental pollution contributes to poor pregnancy outcome is poorly understood, and the first trimester of pregnancy is a particularly vulnerable time period for the developing fetus, thus a mother's exposure to air pollution may alter the way that the placenta is established and how it functions throughout the rest of pregnancy. This project aims to identify new molecular markers reflecting normal and abnormal placental function that can be detected non-invasively in a pregnant woman's blood, towards assessing real- time placental function as pregnancy develops from the first to the third trimester. Thus, early detection, prevention strategies, and timely treatment of placental dysfunction as a result of environmental pollution exposures may be developed.",Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution,9729825,R01HD089714,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Air ', ' Air Pollution ', ' Birth ', ' Parturition ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Coronary Arteriosclerosis ', ' Disorder ', ' Disease ', ' Environmental Exposure ', ' environmental contamination ', ' environmental contaminant ', ' Environmental Pollution ', ' Developing fetus ', ' Fetal Development ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Future ', ' Genes ', ' Goals ', ' Gold ', ' Grant ', ' Histology ', ' Industry ', ' Maps ', ' Methylation ', ' Mothers ', ' Obstetrics ', ' Discipline of obstetrics ', ' Pathology ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' placental disorders ', ' Placental Diseases ', ' Placenta Disorders ', ' Placenta Diseases ', ' Placental Insufficiency ', ' Placental Development ', ' Placentation ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' Pregnancy Outcome ', ' First Trimester ', ' Early Placental Phase ', ' 1st trimester ', ' First Pregnancy Trimester ', ' Second Trimester ', ' Midtrimester ', ' 2nd trimester ', ' Second Pregnancy Trimester ', ' Third Trimester ', ' Last Trimester ', ' 3rd trimester ', ' Third Pregnancy Trimester ', ' pregnant mothers ', ' expecting mother ', ' expectant mother ', ' Pregnant Women ', ' Prospective Studies ', ' Rest ', ' Risk ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxic Environmental Substances ', ' Toxin ', ' Measures ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Premature Birth ', ' Motor Vehicles ', ' base ', ' Chronic ', ' Biological ', ' Histologic ', ' Histologically ', ' Training ', ' Individual ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' High Risk Woman ', ' women at high risk ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Environmental Impact ', ' Ecological impact ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Pollution ', ' Early Diagnosis ', ' early detection ', ' cohort ', ' Proxy ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' epidemiology study ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Studies ', ' Epidemiologic Research ', ' Therapeutic Intervention ', ' intervention therapy ', ' infant morbidity ', ' Modeling ', ' response ', ' Normalcy ', ' Normalities ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' in vivo ', ' Validation ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' Outcome ', ' Population ', ' prospective ', ' transcriptomics ', ' implantation ', ' therapeutic development ', ' therapeutic agent development ', ' primary outcome ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' bisulfite sequencing ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' miRNA expression profiling ', ' microRNA sequencing ', ' micro RNA expression profiling ', ' miRNA-seq ', ' miRNA sequencing ', ' global miRNA profiling ', ' MicroRNA Expression Profiling ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' adverse pregnancy outcome ', ' exosome ', ' predictive signature ', ' imaging study ', ' recruit ', ' ']",NICHD,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2019,623441,CA-33,0.027065718717131884
"Human Microbiome and Perinatal Depression Project Summary/Abstract Depression is the most common complication of pregnancy and affects 10-20% of women. Up to 75% of women with perinatal depression do not receive mental health care. In lower income African American and Hispanic women, the prevalence of perinatal depression (PND) is particularly high and the treatment rates are lower. Cognitive behavioral therapy (CBT) is an effective treatment but practical barriers such as time commitment, insurance coverage, and transportation, as well as stigma, limit uptake of CBT particularly for minority women. Similarly, concern about the adverse effects of antidepressant treatment on maternal and infant outcomes limits uptake of pharmacological treatments. A novel avenue for the development of safe therapeutics for depression focuses on the brain-gut axis and is supported by initial demonstrations that probiotics can improve mood symptoms. Our long-term goal is to assist in the discovery of potential microbes that are correlated with PND, and could be novel biomarkers for the diagnosis and treatment of this disorder, particularly in minority women. As a first step, we propose a multi-PI feasibility study involving the implementation and optimization of processes for participant recruitment and stool sample collection, as well as the initial assessments of longitudinal differences in gut microbiota between pregnant women with and without major depressive disorder (MDD). To meet these goals, we will leverage an established research infrastructure to conduct a prospective, nested case-control study. We will prospectively collect depression diagnoses and gut microbiome samples on 300 women at four points during pregnancy and after delivery to yield a total of 58 women, 29 cases with MDD and 29 controls without MDD. The two groups will be matched on key covariates (e.g., age, race, socio- economic status, gestational age, health). At their scheduled usual care, prenatal appointment, consented participants will complete mental health, demographics, microbiome-related, and dietary and physical habits questionnaires and provide a fecal sample either at that time of their appointment or at home. To achieve our first aim - to determine the feasibility of a larger similarly designed study - we will estimate the total number of potential participants, the number assessed and not assessed for eligibility (and reasons), the number excluded and reasons for exclusion, the number lost to follow-up, and the data available for analysis at each of the 4 visits. To achieve our second aim - to determine whether the gut microbiome dynamically differs in pregnant women with and without MDD - we will employ a suite of systems level approaches, including multivariate statistical techniques, network modeling and machine learning techniques. This R03 will allow us to optimize our research processes for the prospective collection of stool samples and mental health data in preparation for larger nested case-control studies, and ultimately clinical trials of probiotic therapies for PND. Project Narrative Up to 75% of women diagnosed with depression during pregnancy and the postpartum receive inadequate treatment, in large part due to concerns about the safety of antidepressants. Here we propose a feasibility study in preparation for a larger study to determine whether women with depression during their pregnancy and after their delivery have alterations in the bacterial communities in their intestine. Identifying which bacteria are associated with depression is a critical first step in the development of safe probiotic treatments for depression during pregnancy. !",Human Microbiome and Perinatal Depression,9767273,R03HD095056,"['Affect ', ' Age ', ' ages ', ' Antidepressive Agents ', ' anti-depressive agents ', ' anti-depressants ', ' anti-depressant drugs ', ' anti-depressant agent ', ' Antidepressants ', ' Antidepressant Drugs ', ' Antidepressant Agent ', ' Appointment ', ' Bacteria ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Cognitive Therapy ', ' Complication ', ' depression ', ' Mental Depression ', ' Diagnosis ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Protocol Screening ', ' Eligibility ', ' Eligibility Determination ', ' endocrine gland/system ', ' Metabolic/Endocrine Body System ', ' Hormonal System ', ' Endocrine/Metabolic Organ System ', ' Endocrine system ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Feasibility Studies ', ' stool ', ' Feces ', ' Fetal Age ', ' Chronologic Fetal Maturity ', ' Gestational Age ', ' Goals ', ' Habits ', ' Health ', ' Modern Man ', ' Human ', ' allergic/immunologic organ system ', ' allergic/immunologic body system ', ' Immune system ', ' Infant ', ' bowel ', ' Intestinal ', ' Intestines ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Microbiology ', ' Mothers ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Nested Case-Control Study ', ' Nerve Transmitter Substances ', ' Neurotransmitters ', ' nutrition ', ' Phenotype ', ' Gestation ', ' Pregnancy ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnancy Complications ', ' pregnant mothers ', ' expecting mother ', ' expectant mother ', ' Pregnant Women ', ' prenatal visit ', ' prenatal checkup ', ' prenatal appointment ', ' pregnancy care ', ' Prenatal care ', ' Questionnaires ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Risk ', ' social role ', ' Role ', ' Safety ', ' Testing ', ' Time ', ' Transportation ', ' Woman ', ' Work ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' health care ', ' Healthcare ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' post-partum ', ' Postpartum ', ' Postpartum Period ', ' Schedule ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Premature Birth ', ' Immunology ', ' Guidelines ', ' Perinatal ', ' Peripartum ', ' improved ', ' sample collection ', ' specimen collection ', ' Clinical ', ' Neurologic ', ' Neurological ', ' Link ', ' insight ', ' Sample Size ', ' Patient Recruitments ', ' participant recruitment ', ' uptake ', ' Therapeutic ', ' Depressed mood ', ' sadness ', ' depressed ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Complex ', ' Home environment ', ' Home ', ' microorganism ', ' Techniques ', ' System ', ' Hormonal ', ' Probiotics ', ' Visit ', ' microbial ', ' relating to nervous system ', ' neural ', ' Structure ', ' novel ', ' Participant ', ' Exclusion ', ' Reporting ', ' maternal stress ', ' stressed mothers ', ' Sampling ', ' neuropsychiatry ', ' neuropsychiatric ', ' social stigma ', ' stigma ', ' drug development ', ' Adverse effects ', ' Bioinformatics ', ' Bio-Informatics ', ' major depression disorder ', ' major depression ', ' clinical depression ', ' Major Depressive Disorder ', ' Low income ', ' Address ', ' Systems Biology ', ' Adherence ', ' Consent ', ' Data ', ' Research Infrastructure ', ' Collection ', ' Germ-Free ', ' Observational Study ', ' Observational research ', ' Observation study ', ' Observation research ', ' Pharmacological Treatment ', ' Nutritional ', ' nutritious ', ' Monitor ', ' Preparation ', ' Process ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Behavioral ', ' microbiome ', ' Human Microbiome ', ' human-associated microbiome ', ' Minority ', ' Prevalence ', ' prospective ', ' microbial community ', ' community microbes ', ' Microbe ', ' infant outcome ', ' demographics ', ' network models ', ' alternative treatment ', ' effective therapy ', ' effective treatment ', ' treatment as usual ', ' usual care ', ' novel marker ', ' novel biomarker ', ' new marker ', ' antepartum depression ', ' prenatal depressive symptoms ', ' prenatal depression ', ' depression in pregnancy ', ' depression during pregnancy ', ' antenatal depression ', ' process optimization ', ' gut microbiota ', ' intestinal tract microflora ', ' intestinal microflora ', ' intestinal microbiota ', ' intestinal microbes ', ' intestinal flora ', ' gut microflora ', ' gut microbiotic ', ' gut microbial consortia ', ' gut microbial composition ', ' gut microbial community ', ' gut microbe community ', ' gut flora ', ' gut community ', ' gut commensal ', ' gastrointestinal microbial flora ', ' enteric microbiota ', ' enteric microbial community ', ' Gastrointestinal microbiota ', ' GI microbiota ', ' adverse outcome ', ' adverse consequence ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' peripartum depression ', ' perinatal depression ', ' health data ', ' gut microbiome ', ' intestinal microbiome ', ' intestinal biome ', ' gut-associated microbiome ', ' gastrointestinal microbiome ', ' enteric microbiome ', ' digestive tract microbiome ', ' GI microbiome ', ' antidepressant effect ', ' anti-depressant effect ', ' fecal transplantation ', ' fecal transplant ', ' fecal microbiota transplantation ', ' fecal microbiota transplant ', ' fecal microbiome transplantation ', ' fecal microbial transplantation ', ' probiotic therapy ', ' probiotic therapeutic ', ' mood symptom ', ' perinatal mental health ', ' Prospective cohort study ', ' dysbiosis ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' gut-brain axis ', ' gut-brain signaling ', ' gut-brain relationship ', ' gut-brain interactions ', ' gut-brain communication ', ' gut to brain axis ', ' fecal microbiome ', ' stool-associated microbiome ', ' stool microbiome ', ' bacterial community ', ' stool sample ', ' stool specimen ', ' microbiome analysis ', ' analyze microbiome ', ' ']",NICHD,UNIVERSITY OF ILLINOIS AT CHICAGO,R03,2019,83193,IL-07,-0.018041686005611002
"Deep Learning Based Genetic Risk Prediction for Type 1 Diabetes Project Summary Type I diabetes (T1D) is an autoimmune disease of childhood caused by a combination of genetic and environmental factors. In a subset of individuals with a genetic predisposition to T1D, environmental triggers instigate an autoimmune response which targets and damages pancreatic islets, leading to pre-diabetes and ultimately diabetes. A critical barrier in T1D prevention research is to identify and directly enroll children with a strong genetic predisposition for developing T1D into prevention trials. A robust genetic risk score (GRS) would allow for the identification of children at high-risk of T1D, their recruitment into T1D prevention trials, and subsequent testing of novel interventions. I aim to 1) optimize a multi-layer feedforward neural network genetic risk predictor that can be used to enroll newborns directly into T1D prevention trials; and 2) identify putative, novel T1D-causing SNPs, and their interactions. Completion of aim 1 would provide a better GRS to the T1D research community, which can be used to identify children with higher genetic risk of T1D development, increasing the statistical power of future T1D prevention clinical trials. Completion of aim 2 will provide a deeper biological understanding of the molecular drivers of T1D development, and potential new therapeutic targets for T1D prevention trials. Successful completion of this project will both help understand the genetic causes of type 1 diabetes and help prevent the disease. Project Narrative Type I diabetes (T1D) is an autoimmune disease of childhood caused by a combination of genetic and environmental factors. In a subset of individuals with a genetic predisposition to T1D, environmental triggers instigate an autoimmune response which targets and damages pancreatic islets, ultimately leading to diabetes. Successful completion of this project will both help understand the genetic causes of type 1 diabetes and help prevent the disease.",Deep Learning Based Genetic Risk Prediction for Type 1 Diabetes,9836287,F30DK121461,"['Alleles ', ' Allelomorphs ', ' Alternative Splicing ', ' Alternative RNA Splicing ', ' Alternate Splicing ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmune Responses ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Decision Making ', ' diabetes ', ' Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Future ', ' Genes ', ' Genotype ', ' Leukocyte Antigens ', ' Human Leukocyte Antigens ', ' HL-A Antigens ', ' HLA Antigens ', ' newborn children ', ' newborn child ', ' Newborns ', ' 0-4 weeks old ', ' Newborn Infant ', ' islet progenitor ', ' Pars endocrina pancreatis ', ' Pancreatic Islets ', ' Nesidioblasts ', ' Islands of Langerhans ', ' Endocrine Pancreas ', ' B9 endocrine pancreas ', ' Islets of Langerhans ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Publishing ', ' Receiver Operator Characteristics ', ' Receiver Operating Characteristics ', ' Research ', ' Risk ', ' Sensitivity and Specificity ', ' Testing ', ' Time ', ' Measures ', ' Enhancers ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Premature Birth ', ' base ', ' improved ', ' Area ', ' Variant ', ' Variation ', ' Biological ', ' Medical ', ' Logistic Regressions ', ' Training ', ' Childhood ', ' pediatric ', ' Individual ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Prediabetes syndrome ', ' prediabetic ', ' pre-diabetic ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Adopted ', ' Complex ', ' Quantitative Trait Loci ', ' QTL ', ' novel ', ' Prevention Research ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Pathogenesis ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Neural Network Simulation ', ' Perceptrons ', ' Neural Network Models ', ' Connectionist Models ', ' case control ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Bioinformatics ', ' Bio-Informatics ', ' preventing ', ' prevent ', ' Data ', ' Enrollment ', ' enroll ', ' Genetic Population Study ', ' Genetic Risk ', ' Molecular ', ' Development ', ' developmental ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic profiling ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Population ', ' prevention clinical trial ', ' high risk ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' Prevention trial ', ' molecular subtypes ', ' molecular subsets ', ' molecular sub-types ', ' expression subtypes ', ' recruit ', ' feedforward neural network ', ' deep learning ', ' neural network ', ' ']",NIDDK,AUGUSTA UNIVERSITY,F30,2019,40570,GA-12,0.0661273791130121
"Statistical methods for healthcare in complex patients with diabetes     DESCRIPTION (provided by applicant): Diabetes affects 8.3% of the US population, and lead to costly adverse healthcare outcomes. Unfortunately, there may be a quality gap in the care of complex diabetes patients, that is, older patients (age>65 years) and those with comorbid conditions. Current practices, relying primarily on the presence of several factors, are not effective in capturing the risk of poor prognosis, i.e., multiple hospitalization and/or emergency department visits, and death. Hence, little evidence exists so far to help prioritize care for thes patients. The diabetes guidelines recognize that tight control of glycosylated hemoglobin (A1c) may not be appropriate for complex patients, and recommend individualizations in tight A1c control. However, neither the outcomes of tight A1c control, nor the effects of the typical treatment regimens used to achieve tight A1c control can be evaluated in clinical trials, with minimal, if any, enrollment of complex diabetes patients due to either their restrictive inclusion criteria or lack of encouragement of the patient and/or clinical investigator to consider the RCT. In order to deliver more effective, efficient and accountable health cares, it is important to help clinicians to examine the relationship between patient complexity and patients' A1c control level, and to modify guideline appropriately with an evidence base. The proposed research will analyze a cohort of 8,304 Medicare beneficiaries with diabetes who were cared for by one of the country's 10 largest physician group practices, the University of Wisconsin Medical Foundation during 2003-2011 to address the following aims: (1) to conduct risk prediction incorporating longitudinal outcomes, (2) to inform guidelines for complex diabetes patients, and (3) to create a patient-centered surveillance tool for detecting short-term negative outcomes. Our analytic approach involves the use of state- of-the-art statistics and machine learning methods to take advantage of the large electronic health records data. The proposed methods and results will help clinicians to identify and quantify risks of tight A1c control in complex diabetes patients an potentially lead to improved patient experiences, and reduce medical expenditures from excess adverse events. PUBLIC HEALTH RELEVANCE: Sub-optimal glycosylated hemoglobin (A1c) control recommendations and treatment recommendations for diabetes patients can result in adverse events, and increased health care utilization. Unfortunately, current guidelines on the care for complex and/or older patients with diabetes are inadequate. We propose to develop an effective and patient-centered health care delivery system for complex diabetes patients, focusing on accurate prediction of adverse events, development of potential guidelines on targeting tight control of A1c and treatment regimens, and real-time monitoring of health conditions.",Statistical methods for healthcare in complex patients with diabetes,9749124,R01DK108073,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Clinical Investigator ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' Clinical Trials ', ' co-morbidity ', ' Comorbidity ', ' Complement Proteins ', ' Complement ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' diabetes ', ' Diabetes Mellitus ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Expenditure ', ' Foundations ', ' Future ', ' Patient Care Delivery ', ' Patient Care ', ' Glycated Hemoglobins ', ' Glycosylated Hemoglobin ', ' Goals ', ' Group Practice ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Hospital Admission ', ' Hospitalization ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' longterm care ', ' extended care ', ' Long-Term Care ', ' Methods ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patients ', ' Physicians ', ' Privatization ', ' Prognosis ', ' outcome forecast ', ' healthcare quality ', ' health care quality ', ' Recommendation ', ' Research ', ' Risk ', ' statistics ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' Trees ', ' United States ', ' Universities ', ' Wisconsin ', ' Work ', ' health care ', ' Healthcare ', ' Risk Assessment ', ' Glean ', ' Caring ', ' Guidelines ', ' base ', ' improved ', ' Area ', ' Chronic ', ' Clinical ', ' Medical ', ' Link ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' Country ', ' experience ', ' user friendly software ', ' user friendly computer software ', ' cohort ', ' treatment planning ', ' Patient observation ', ' Watchful Waiting ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Adverse event ', ' Adverse Experience ', ' Effectiveness ', ' Address ', ' Data ', ' Detection ', ' Enrollment ', ' enroll ', ' Exclusion Criteria ', ' Update ', ' Monitor ', ' Development ', ' developmental ', ' beneficiary ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' cost ', ' design ', ' designing ', ' diabetes management ', ' diabetic management ', ' older patient ', ' elderly patient ', ' Outcome ', ' Population ', ' patient oriented ', ' patient centered ', ' inclusion criteria ', ' high risk ', ' public health relevance ', ' evidence base ', ' patient population ', ' clinical practice ', ' population health ', ' Regimen ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' learning strategy ', ' learning method ', ' learning activity ', ' longitudinal dataset ', ' longitudinal data set ', ' data resource ', ' care outcomes ', ' healthcare outcomes ', ' health care outcomes ', ' treatment guidelines ', ' optimal treatments ', ' optimal therapies ', ' real time monitoring ', ' realtime monitoring ', ' adverse event risk ', ' learning algorithm ', ' ']",NIDDK,FRED HUTCHINSON CANCER RESEARCH CENTER,R01,2019,283296,WA-07,0.13368502284273018
"Targeting Senescence for Biomarkers and Therapeutics Type 1 Diabetes is an organ-specific autoimmune disease characterized by hyperglycemia due to progressive loss of pancreatic beta cells. While there has been significant progress in understanding immune-mediated beta cell destruction, the role of beta cell dysfunction in the underlying etiology of T1D is less clear. We have discovered that pancreatic beta cells acquire a proinflammatory secretome reminiscent of SASP during T1D in mice and human. SASP beta cells can remodel the islet environment in a paracrine manner by promoting bystander senescence and immune surveillance. We have developed drugs that selectively eliminated SASP beta cells without altering the abundance of the major immune cell types involved in the disease. Significantly, elimination of SASP beta cells halted progression of beta cell destruction and was sufficient to prevent diabetes. In this proposal, we focus on human beta cells and characterize the non-cell autonomous effects of SASP on islet microenvironment and develop drugs that can selectively target human SASP beta cells. We utilize the secretory properties of SASP beta cells to identify biomarkers that can report on the efficacy of drug treatment and progression of the disease. Recent work from our laboratory has shown that beta cells acquire a proinflammatory secretome reminiscent of SASP during T1D and selective clearing of these cells prevented diabetes. In this proposal, we characterize the non-cell autonomous effects of senescent human beta cells on the islet microenvironment and develop senolytic compounds that can selectively target human SASP beta cells. We propose to identify biomarkers for assessing the efficacy of senolytic treatment and progression of the disease to pioneer new therapeutic approaches for T1D.",Targeting Senescence for Biomarkers and Therapeutics,9798318,R01DK121794,"['Autoimmune Diseases ', ' autoimmune disorder ', ' Automobile Driving ', ' driving ', ' Basement membrane ', ' Cell Body ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Chemotaxis ', ' diabetes ', ' Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Drug Design ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Family ', ' Ferritin ', ' Modern Man ', ' Human ', ' Human Activities ', ' hyperglycemic ', ' Hyperglycemia ', ' Immunological Surveillances ', ' Immunological Surveillance ', ' Immunologic Surveillances ', ' Immune Surveillance ', ' Immunologic Surveillance ', ' In Vitro ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Organ Donor ', ' pancreatic b-cell ', ' pancreas  cell ', ' pancreas beta cell ', ' Pancreatic -Cell ', ' Pancreatic beta Cell ', ' Structure of beta Cell of islet ', ' Pharmacology ', ' Phenotype ', ' Proteins ', ' social role ', ' Role ', ' Specificity ', ' Testing ', ' Thrombopenia ', ' Thrombocytopenia ', ' Body Tissues ', ' Tissues ', ' Translating ', ' transplant ', ' Transplantation ', ' Work ', ' Generations ', ' Measures ', ' nonobese diabetic (NOD) mice ', ' non-obese diabetic (NOD) mice ', ' Nonobese Diabetic Mouse ', ' Non-Obese Diabetic Mice ', ' NOD Mouse ', ' Inbred NOD Mice ', ' Mediating ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Natural History ', ' Organ ', ' Blood specimen ', ' Blood Sample ', ' Peripheral ', ' Chemicals ', ' Serum ', ' Blood Serum ', ' Disease Progression ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Morphology ', ' Infiltration ', ' tool ', ' scaffold ', ' scaffolding ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' BCL2 gene ', ' ced9 homolog ', ' bcl-2 Genes ', ' Bcl-2 ', ' BCL2 ', ' B-cell lymphoma/leukemia-2 ', ' B-Cell CLL/Lymphoma 2 Gene ', ' B cell lymphoma 2 ', ' Cellular biology ', ' cell biology ', ' Immune ', ' Immunes ', ' cell type ', ' paracrine ', ' drug efficacy ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' member ', ' Disease model ', ' disorder model ', ' Reporting ', ' Sampling ', ' Property ', ' repository ', ' Cell ', ' -cells ', ' -cell ', ' Insulin Secreting Cell ', ' Insulin Cell ', ' Beta Cell ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' small molecule ', ' Address ', ' Dose-Limiting ', ' in vitro Assay ', ' in vivo ', ' Cellular Stress Response ', ' Invaded ', ' Characteristics ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' virtual ', ' design ', ' designing ', ' islet ', ' migration ', ' clinically relevant ', ' clinical relevance ', ' mouse model ', ' murine model ', ' senescence ', ' senescent ', ' novel therapeutic intervention ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' screening ', ' learning strategy ', ' learning method ', ' learning activity ', ' biomarker discovery ', ' humanized mouse ', ' humanized mice ', ' experimental study ', ' experimental research ', ' experiment ', ' preservation ', ' lead optimization ', ' ']",NIDDK,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2019,550024,CA-12,0.039281793900743406
"Resource Curation and Evaluation for EHR Note Comprehension Title: Resource Curation and Evaluation for EHR Note Comprehension The American Diabetes Association estimates that over 25.8 million Americans have diabetes. Proper patient self-management is perhaps the most critical and under-exercised element for patients to achieve appropriate glycemic control and thus mitigate complications and comorbid conditions, and implement appropriate preventive strategies (e.g., vaccines, exercise, healthy diet). In previous work we have shown that educating patients by using content in their medical records improved diabetes outcomes and that NoteAid, a multi- module natural language processing system that links medical jargon in electronic health records to definitions, has improved self-reported comprehension. Here we propose to develop NoteAid with a high-quality resource of expert-curated lay definitions and evaluation methods for diabetes patients note comprehension. ! ! Title: Resource Curation and Evaluation for EHR Note Comprehension The American Diabetes Association estimates that over 25.8 million Americans have diabetes. In previous work we have shown that educating patients by using content in their medical records improved diabetes outcomes and that NoteAid, a natural language processing system that links medical jargon in electronic health records to definitions, has improved self-reported comprehension. Here we propose to develop NoteAid with a high-quality resource of expert-curated lay definitions and evaluation methods for diabetes patients note comprehension. ! !",Resource Curation and Evaluation for EHR Note Comprehension,9794757,R01LM012817,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Attitude ', ' Back ', ' Dorsum ', ' Behavior ', ' Communication ', ' co-morbidity ', ' Comorbidity ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Educational aspects ', ' Education ', ' Elements ', ' Exercise ', ' ophthalmopathy ', ' eye disorder ', ' Eye diseases ', ' Health ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Hospitals ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' Language ', ' Learning ', ' Libraries ', ' Massachusetts ', ' Medical Records ', ' Methods ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' Patient Training ', ' Patient Instruction ', ' Patient Education ', ' Patients ', ' Physicians ', ' Questionnaires ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Reading ', ' Research Resources ', ' Resources ', ' Risk ', ' medical school students ', ' Medical Students ', ' Pupil Nurses ', ' Nursing Students ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Vaccines ', ' Visual Aide ', ' Visual Aid ', ' Vocabulary Words ', ' Vocabulary ', ' Work ', ' Care Givers ', ' Caregivers ', ' health care ', ' Healthcare ', ' Self Management ', ' Caring ', ' Comprehension ', ' base ', ' improved ', ' Clinical ', ' Medical ', ' Link ', ' Evaluation ', ' Individual ', ' Trust ', ' Measurement ', ' Ethnic Origin ', ' Ethnicity ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Mechanics ', ' mechanical ', ' Complex ', ' Techniques ', ' System ', ' good diet ', ' balanced diet ', ' Healthy diet ', ' Country ', ' American ', ' Informatics ', ' Speed ', ' skills ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' Modeling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' Ontology ', ' Characteristics ', ' sex ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' cost ', ' design ', ' designing ', ' glycemic control ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' clinically relevant ', ' clinical relevance ', ' usability ', ' diabetic patient ', ' Data Science ', ' care outcomes ', ' healthcare outcomes ', ' health care outcomes ', ' deep learning ', ' ']",NLM,UNIVERSITY OF MASSACHUSETTS LOWELL,R01,2019,337238,MA-03,0.07830025409843754
"Calcium oscillations and cell motility with corneal injury According to the World Health Organization, corneal blindness from disease and injury is one of the top causes of blindness. Diabetes increases the risk of improper wound repair after minor scratches, corneal transplantation, and removal of epithelium during vitrectomy or refractive surgery. Altered focal adhesion, hemidesmosome, and cell-cell junction dynamics are common hallmarks of poor wound healing. Our group has demonstrated increased expression of the ATP-binding purinoreceptor, P2X7 in human diabetic corneas and in a murine model of Type II diabetes (DIO) accompanied by impaired wound healing. Furthermore, changes in P2X7 alters focal adhesion turnover and actin bundling in vitro that may lead to impaired wound healing. We have preliminary data from both wounded corneal epithelial cultures and explants demonstrating that sustained calcium oscillations occur after stimulation and travel between cells for hours. We found that when calcium mobilizations were absent between cells at the leading edge, that lamellipodial protrusions were absent. It is not known which receptor is required for this activity; however, we predict that the oscillations are a result of a highly-orchestrated activation of purinoreceptors. Previously we demonstrated that knockdown of specific purinoreceptors altered downstream signaling pathways that involve cell motility and adhesion proteins.  Our goal in this innovative proposal is to use image processing and machine learning to understand the events that occur in cell-cell communication that induce cell migration in corneal epithelia and to examine how these events are mediated in corneas from a diabetic induced obesity murine model. The proposal challenges the accepted paradigm that the cell-cell communication wave in the wounded cornea is a short-lived on-and-off signal, but that it is a prolonged oscillating signal needed for healthy epithelial cell migration to effectively heal the wounded cornea. As the calcium and motility assays yield large data sets and complex patterns, we are collaborating with a neuroscientist and a computer scientist to utilize machine learning to determine when cells will interact if specific receptors or complexes of receptors are activated. To address these questions, we will simultaneously perform live cell imaging of calcium mobilization, actin and ATP release in epithelium of wounded corneas under normal and diabetic conditions. The aims are: 1. To determine if there are specific response signatures elicited by the sustained calcium mobilizations and signaling generated with injury in control corneas and corneas from diet induced obesity mice; and 2. To determine if the intercellular calcium mobilizations required for the initiation of lamellipodial ruffling are necessary for proper migration? Narrative Injury to the cornea can be both painful and compromise vision. We and others have shown that repair and innervation of the diabetic cornea is compromised. Our goal is to use a combination of live cell imaging, computational modeling and molecular tools to determine the changes in signals that tell corneal epithelial cells to heal under control conditions compared to those under pathologic conditions such as diabetes.",Calcium oscillations and cell motility with corneal injury,9668324,R21EY029097,"['Actins ', ' Affect ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Calcium ', ' cell adhesion protein ', ' Cell Adhesion Molecule Gene ', ' Adhesion Molecule ', ' Cell Adhesion Molecules ', ' Cell-to-Cell Interaction ', ' Cell Interaction ', ' Cell Communication ', ' Motility ', ' Cellular Motility ', ' Cellular Migration ', ' Cell Movement ', ' Cell Migration ', ' Cell Locomotion ', ' cell motility ', ' Cell Body ', ' Cells ', ' Communication ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Computers ', ' corneal ', ' Cornea ', ' corneal transplant ', ' corneal keratoplasty ', ' Corneal Transplantation ', ' Corneal Grafting ', ' Cornea Transplantation ', ' Keratoplasty ', ' intracellular skeleton ', ' Cytoskeletal System ', ' Cellular Matrix ', ' Cytoskeleton ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' Epithelial Cells ', ' Epithelium Part ', ' Epithelium ', ' Exhibits ', ' Fingerprint ', ' Goals ', ' Modern Man ', ' Human ', ' In Vitro ', ' innervation ', ' nerve supply ', ' Cell Junctions ', ' Intercellular Junctions ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' ob/ob mouse ', ' Obese Mice ', ' Minor ', ' Neurosciences ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Painful ', ' Pain ', ' Pathology ', ' Patients ', ' QOL ', ' Quality of life ', ' Risk ', ' Signal Pathway ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Travel ', ' visual function ', ' Sight ', ' Vision ', ' Vitrectomy ', ' World Health Organization ', ' Wound Repair ', ' Wound Healing ', ' Mediating ', ' Dataset ', ' Data Set ', ' Injury ', ' image processing ', ' repaired ', ' repair ', ' Hemidesmosomes ', ' insight ', ' diabetic ', ' tool ', ' Corneal Injury ', ' corneal wound ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Hour ', ' Complex ', ' Event ', ' Pattern ', ' Blindness ', ' visual loss ', ' vision loss ', ' corneal epithelium ', ' corneal epithelial ', ' Abnormal coordination ', ' Lack of Coordination ', ' Incoordination ', ' Dyscoordination ', ' Coordination Disorder ', ' Co-ordination disorder ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' release of sequestered calcium ion into cytoplasm ', ' calcium mobilization ', ' calcium flux ', ' receptor ', ' Receptor Protein ', ' computer science ', ' Calcium Oscillations ', ' Calcium Waves ', ' Calcium Signaling ', ' Calcium Ion Signaling ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Regulation ', ' response ', ' Focal Adhesions ', ' Focal Contacts ', ' Cell-Matrix Adherens Junctions ', ' Adhesion Plaques ', ' Molecular Interaction ', ' Binding ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Resolution ', ' in vivo ', ' Pathologic ', ' Molecular ', ' Process ', ' healing ', ' knock-down ', ' knockdown ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' response to injury ', ' injury response ', ' wound ', ' Impaired wound healing ', ' delayed wound healing ', ' abnormal tissue repair ', ' Impaired tissue repair ', ' Impaired healing ', ' Healing delayed ', ' Healing abnormal ', ' Population ', ' migration ', ' Bundling ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' mouse model ', ' murine model ', ' therapeutic development ', ' therapeutic agent development ', ' novel therapeutic intervention ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' quantitative imaging ', ' live cell imaging ', ' live cellular imaging ', ' live cellular image ', ' live cell image ', ' wound closure ', ' ']",NEI,BOSTON UNIVERSITY MEDICAL CAMPUS,R21,2019,247500,MA-07,0.04118587543606654
"Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54) Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed atypical diabetes (AD), that do not fit into either category. We hypothesize that AD comprises a spectrum that includes numerous forms, both known (e.g, MODY/monogenic, Latent Autoimmune Diabetes of Adults, Ketosis-Prone Diabetes) and unknown. We propose to establish the Center for Atypical Diabetes Research and Evaluation (CADRE). The goals of CADRE are to (1) identify and define comprehensively the forms of AD; and (2) establish an extensive database and repository of biosamples from AD patients. Defining the forms of AD is challenging because the etiology of AD can range from a single gene variant to a highly complex mixture of genetics, epigenetics and environmental factors. To identify patients with AD, and then to define the forms, we will use a two-pronged approach. Approach (a) will use clustering analysis of genotypic and phenotypic data from diverse groups of patients with diabetes. We have recruited 15 domestic and international population cohorts with data on more than 33,000 patients with diabetes. Further, we have recruited six diabetes study clinics (Baylor College of Medicine [BCM], University of Washington [UW], Indiana University [IU], Emory University, University of Colorado, and SUNY Downstate) who will prospectively recruit patients. The Juvenile Diabetes Research Foundation will facilitate recruitment from patient groups. The Administrative Core at BCM will work with cohorts and clinics to obtain data. The University of South Florida (USF) will filter data for AD and separate patients into phenotypically homogenous clusters that can be diagnosed based on genetic and clinical features unique to the cluster. Approach (b) will identify monogenic, oligogenic and mitochondrial forms of AD from patients enrolled in genetics registries (BCM) and a family study with genetic data (Botnia). The BCM registries include patients referred to the Undiagnosed Disease Network. All patients will undergo whole-exome and mitochondrial genome sequencing (Cores at BCM), single-nucleotide polymorphism variant analysis (Oxford), metabolomic analysis (Duke) and phenotypic analysis of C-peptide, adiponectin, proinsulin, islet autoantibodies, and serum insulin DNA levels (Cores at UW and IU). To establish the database and biorepository, we will invite patients with AD to participate in sample donation and longitudinal follow-up via the cohorts and clinics. Data and samples will be transferred to the Database and Biorepository Core at USF, with input and tracking implemented using the successful framework developed by USF for large multicenter trials. Data will be made available through the NIDDK and a CADRE website and samples will be made available through ancillary study application. Ongoing patient recruitment to expand the database and biorepository will occur through the study clinics and clinician referral through the CADRE website. Overall, CADRE will be built on a foundation of existing, successful core facilities and computational systems to create a lasting resource that will substantially advance AD research. PROJECT NARRATIVE For many people with diabetes, their symptoms do not match those usually associated with type 1 or type 2 diabetes. We will use medical and genetic information from a large number of patients with diabetes to find all the forms of atypical diabetes, so doctors can better diagnose and treat these patients. We will also make the Center for Atypical Diabetes Research and Evaluation (CADRE) to keep data and samples from patients with atypical diabetes, so scientists can study these forms of diabetes.",Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54),9781712,U54DK118638,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Autoantibodies ', ' self reactive antibody ', ' autoimmune antibody ', ' C-Peptide ', ' Connecting Peptide ', ' Systematics ', ' Classification ', ' Clinical Protocols ', ' Cluster Analyses ', ' Cluster Analysis ', ' Colorado ', ' Communication ', ' Complication ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Florida ', ' Foundations ', ' Future ', ' Clinical genetics ', ' Medical Genetics ', ' Genome ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Indiana ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' Medicine ', ' Mining ', ' Mission ', ' mitochondrial ', ' Mitochondria ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Phenotype ', ' Physiology ', ' Proinsulin ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Syndrome ', ' Universities ', ' Washington ', ' Work ', ' peptide C ', ' polypeptide C ', ' Youth 10-21 ', ' Youth ', ' Immunology ', ' Natural History ', ' base ', ' improved ', ' Family Study ', ' Surface ', ' Clinical ', ' Variant ', ' Variation ', ' Autoimmune Diabetes ', ' Multicenter Trials ', ' Multi-center trial ', ' Evaluation ', ' Serum ', ' Blood Serum ', ' insight ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Data Storage and Retrieval ', ' data storage ', ' data retrieval ', ' Patient Recruitments ', ' participant recruitment ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Collaborations ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' adiponectin ', ' apM1 (adipose-specific) protein ', ' apM-1 protein ', ' adipocyte, C1q and collagen domain containing protein ', ' adipocyte complement-related protein 30-kDa ', ' ACRP30 protein ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' Autoimmune Process ', ' Autoimmune ', ' System ', ' college ', ' collegiate ', ' diabetes mellitus genetics ', ' diabetes genetics ', ' cohort ', ' novel ', ' Participant ', ' Categories ', ' outreach ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Pathogenesis ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic analysis ', ' Genetic analyses ', ' Sampling ', ' repository ', ' genetic registry ', ' patient registry ', ' Complex Mixtures ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Symptoms ', ' Core Facility ', ' DNA Sequencing Facility ', ' Sequencing Core ', ' Data ', ' International ', ' Molecular Diagnosis ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Subgroup ', ' Ancillary Study ', ' Collection ', ' Enrollment ', ' enroll ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' mitochondrial genome ', ' web site ', ' website ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' design ', ' designing ', ' islet ', ' Population ', ' prospective ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' database of Genotypes and Phenotypes ', ' dbGaP ', ' biobank ', ' biorepository ', ' exome ', ' exomes ', ' data sharing ', ' Secure ', ' genetic information ', ' learning strategy ', ' learning method ', ' learning activity ', ' phenotypic data ', ' recruit ', ' unsupervised learning ', ' unsupervised machine learning ', ' ']",NIDDK,BAYLOR COLLEGE OF MEDICINE,U54,2019,2500000,TX-09,0.005170802675141143
"Analytics-Based Platform for Diabetic Retinopathy Care Management ABSTRACT Despite the over 90% efficacy of diabetic retinopathy (DR) treatment, it continues to be the leading cause of blindness in working age Americans. Over 30 million adults in the US have diabetes. Of these, 28% will develop DR and 4.4% will develop vision-threatening DR (VTDR). Currently, less than half of all patients with diabetes receive the recommended annual dilated eye exam and, of those diagnosed with VTDR, only 30% undergo timely treatment. New screening protocols are increasing screening effectiveness, however, even if every patient is screened, the majority of those at increased risk do not receive evidence-based follow-up care; a classic public health failure common to population-based screening. With expertise in health systems engineering and ophthalmology, the research team is uniquely suited to eliminate the root causes of this failure; resulting in a new, comprehensive care model designed to prevent blindness for the 8.9 million Americans with DR. Retinal Care Inc. (RCI)s focus is on eliminating blindness by applying targeted care coordination for patients at increased risk for VTDR; ensuring they progress through the care path to treatment. However, two significant deficiencies weaken RCIs ability to deliver effective care coordination. The first is insufficient capacity due to coordinating care for 35% of all patients, though less than 5% actually have VTDR. This derives from the low positive predictive value of the current system, based on a handheld electroretinography and pupillography device deployed in a primary care setting. The first aim is to improve the ability to classify a patient as low- risk for VTDR, thereby reducing the care coordination burden and improving quality and effectiveness. Aim 1: Improve the ability to accurately identify patients at increased risk for VTDR by including patient  health and demographic attributes in a machine learning based predictive algorithm for VTDR diagnosis.  Patient clusters will be identified (a) and used to create sub-population specific risk models (b). The second deficiency is the lack of adherence to follow-up and treatment after identification as increased risk for VTDR. Once a patient is identified as increased risk, the care coordination of the RCI DR program has averaged over five phone calls per patient to achieve follow-up with an eye care provider. The second aim is to identify and eliminate these barriers to coordinated care between patient and provider. Aim 2 Apply text analytics and simulation to improve access, compliance, cost, and equity by enhancing care coordination, from diagnosis to treatment, for patients at increased risk for VTDR. The application of data analytics and systems engineering methods to integrate and improve each critical component of the care path, access to care, accuracy of diagnosis, and adherence to follow-up and treatment, will enable a paradigm shift in DR treatment. RCIs platform is designed to eliminate deficiencies of the current care delivery model by delivering a first-of-its-kind, end-to-end solution for diabetic retinopathy care. PROJECT NARRATIVE Diabetic retinopathy (DR), affecting 8.9 million Americans, is the leading cause of blindness in working age Americans, yet, blindness is preventable in 90% of the cases with timely detection and treatment. To reach the 30 million adults living with diabetes in the US, the Retinal Care DR platform is designed to eliminate deficiencies of the current care delivery model via a first-of- its-kind end-to-end solution for DR care implementable in any care setting. This will be accomplished via the application of data analytics (machine learning and statistical analysis) and systems engineering (sentiment analysis and simulation) methods to integrate and improve each of the three critical components of the care path: access to care, accuracy of diagnosis, and adherence to follow-up and treatment.",Analytics-Based Platform for Diabetic Retinopathy Care Management,9679729,R41EY029917,"['Accounting ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Age ', ' ages ', ' Blood Vessels ', ' vascular ', ' Systematics ', ' Classification ', ' Cluster Analyses ', ' Cluster Analysis ', ' comprehensive care ', ' Comprehensive Healthcare ', ' Comprehensive Health Care ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' diabetes ', ' Diabetes Mellitus ', ' Diabetic Retinopathy ', ' Diagnosis ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' electroretinogram ', ' Electroretinography ', ' Protocol Screening ', ' Eligibility ', ' Eligibility Determination ', ' Engineering ', ' Eyeball ', ' Eye ', ' Health ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' Investments ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Models ', ' Medical Records ', ' Methods ', ' Methodology ', ' nurse ', ' Nurses ', ' Ophthalmology ', ' Patients ', ' Patient Rights ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Research ', ' Retina ', ' Risk ', ' social role ', ' Role ', ' Social Workers ', ' Specificity ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' visual function ', ' Sight ', ' Vision ', ' Gender ', ' Specialist ', ' Caring ', ' analytical method ', ' base ', ' improved ', ' Ophthalmic examination and evaluation ', ' Eye Examination ', ' Eye Exam ', ' Logistic Regressions ', ' Ensure ', ' Failure ', ' Plant Roots ', ' root ', ' Funding ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Severities ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' System ', ' Blindness ', ' visual loss ', ' vision loss ', ' interest ', ' Visit ', ' American ', ' pupillography ', ' diagnostic accuracy ', ' Accuracy of Diagnosis ', ' Structure ', ' simulation ', ' novel ', ' models and simulation ', ' model-based simulation ', ' Devices ', ' Statistical Methods ', ' Modeling ', ' response ', ' model design ', ' Provider ', ' Effectiveness ', ' preventing ', ' prevent ', ' treatment compliance ', ' therapy cooperation ', ' therapy compliance ', ' patient cooperation ', ' patient adherence ', ' Patient Compliance ', ' compliance behavior ', ' Address ', ' Health system ', ' Adherence ', ' Data ', ' Detection ', ' Improve Access ', ' Predictive Value ', ' Clinical Management ', ' Enrollment ', ' enroll ', ' Process ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Text ', ' cost ', ' design ', ' designing ', ' diabetes management ', ' diabetic management ', ' Outcome ', ' Retinal ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' evidence base ', ' patient population ', ' population based ', ' primary care setting ', ' screening ', ' accurate diagnosis ', ' Data Analytics ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' Text Messaging ', ' texting ', ' short message service ', ' care providers ', ' primary care provider ', ' care costs ', ' Service delivery model ', ' healthcare delivery model ', ' health care delivery model ', ' care delivery model ', ' Service model ', ' barrier to care ', ' obstacle to healthcare ', ' obstacle to care ', ' barrier to treatment ', ' barrier to healthcare ', ' barrier to health care ', ' care coordination ', ' coordinating care ', ' decision tree learning ', ' sociodemographics ', ' socio-demographics ', ' classification trees ', ' ']",NEI,"RETINAL CARE, INC.",R41,2019,219356,OK-05,-0.010950595965239888
"Associating retinal nerve fiber layer thickness with glucose metabolism and diabetic retinopathy Project Summary/Abstract Type 2 diabetes mellitus (T2DM), a metabolic disease that affects over 300 million people worldwide and that can be accompanied by serious health complications such as heart disease, kidney failure, stroke, and damage to the eyes, in particular diabetic retinopathy (DR), which is diagnosed in a third of people with diabetes and which is the leading cause of blindness within the age group between 20 and 64 years. T2DM is clinically diagnosed by parameters related to glucose metabolism obtained by blood tests. Due to its long pre- symptomatic phase, an estimate of 25% of diabetics in the US are undiagnosed. In this project, the relationship between spatial patterns of retinal nerve fiber layer (RNFL) thickness (RNFLT), measured by spectral-domain optical coherence tomography (OCT), and blood test levels as well as levels of DR severity is investigated in 9,261 participants of a population based study.  In a first step, OCT RNFLT measurements of the macular and the circumpapillary area around optic nerve head are segmented into spatial sectors, and representative spatial patterns of RNFLT are calculated by an unsupervised machine learning method. Afterwards, a multivariate linear model comparison is performed with the coefficients of the spatial RNFLT patterns as regressors and diagnostic blood test results as dependent variable. The optimal combination of the RNFLT patterns, determined by an established model selection criterion (Bayes Factor), is expected to reveal insight into the association between the specific retinal locations of RNFL thinning accompanying the change in parameters related glucose metabolism during the development and progression of T2DM. Furthermore, fundus images are graded by DR severity following a nine-step scale derived from the Early Treatment Diabetic Retinopathy Study from no DR to severe proliferative DR. The spatial RNFLT patterns and metabolic blood test scores are then compared with respect to modeling DR severity by linear regression. An optimal model of DR severity combining glucose metabolism parameters and RNFLT patterns is developed. Finally, in an analogous procedure, DR severity of the follow-up measurement, five years after baseline, is statistically predicted from RNFLT and metabolic blood parameters and from their change over time.  To summarize, the proposed research identifies spatial patterns of RNFLT associated with parameters of glucose metabolism and their development over DR severity. Once accomplished, the proposed project would provide the details to establish RNFLT as an alternative manifestation of T2DM that complements diagnostic blood tests and thereby, for instance, lay the foundations for the development of novel and more accurate T2DM progression monitoring or the prediction of the onset of DR. Project Narrative Parameters related to glucose metabolism obtained by blood tests are clinically used to diagnose diabetes, a metabolic disease that affects over 300 million people worldwide and that can be accompanied by serious health complications, such as diabetic retinopathy (DR), the leading cause of blindness within the age group between 20 and 64 years. Decreased levels of blood glucose tolerance have been associated with retinal nerve fiber layer (RNFL) thinning, but these results were based on comparisons between small populations of diagnosed diabetics and healthy controls, and RNFL was typically represented by coarse summary parameters which neglect retinal anatomy. This project contributes directly and immediately to public health by exploring the relationship between spatial patterns of RNFL thickness, present and future DR severity, and diagnostic blood test results in 9,261 participants of a population based study, with the final goal to establish and quantify RNFL thickness as an alternative manifestation of diabetes that complements diagnostic blood tests and lays the foundations for the development of novel and more accurate disease progression monitoring or the prediction of DR onset.",Associating retinal nerve fiber layer thickness with glucose metabolism and diabetic retinopathy,9809589,R21EY030631,"['Affect ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Glucose ', ' Blood Sugar ', ' Complement Proteins ', ' Complement ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diabetic Retinopathy ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Eyeball ', ' Eye ', ' Foundations ', ' Future ', ' Goals ', ' Health ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Blood Tests ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Linear Models ', ' Linear Regressions ', ' Maps ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Metabolic Diseases ', ' Optic Papilla ', ' Optic Nerve Head ', ' Optic Disk ', ' Oral Glucose Tolerance Test ', ' OGTT ', ' Patients ', ' Public Health ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Research ', ' Retina ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Testing ', ' Leanness ', ' Thinness ', ' Time ', ' Measures ', ' proliferative diabetic retinopathy ', ' base ', ' glucose tolerance ', ' Procedures ', ' Area ', ' Clinical ', ' Phase ', ' insight ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' Selection Criteria ', ' Metabolic ', ' clinical Diagnosis ', ' Diagnostic ', ' Dimensions ', ' Severities ', ' Scanning ', ' Pattern ', ' Techniques ', ' Location ', ' Blindness ', ' visual loss ', ' vision loss ', ' Test Result ', ' Severity of illness ', ' disease severity ', ' age group ', ' glucose metabolism ', ' novel ', ' Participant ', ' Population Study ', ' study of the population ', ' studies of populations ', ' population-level study ', ' population-based study ', ' Modeling ', ' Optical Coherence Tomography ', ' optical coherence Doppler tomography ', ' optical Doppler tomography ', ' OCT Tomography ', ' Doppler OCT ', ' Thickness ', ' Thick ', ' Data ', ' Sum ', ' Validation ', ' Monitor ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' fasting plasma glucose ', ' neglect ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' macula ', ' macular ', ' Retinal ', ' Population ', ' Early treatment ', ' early therapy ', ' retinal nerve fiber layer ', ' RNFL ', ' public health relevance ', ' Bayesian Modeling ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' learning strategy ', ' learning method ', ' learning activity ', ' fundus imaging ', ' unsupervised learning ', ' unsupervised machine learning ', ' ']",NEI,SCHEPENS EYE RESEARCH INSTITUTE,R21,2019,313837,MA-08,-0.04240159114915743
"DFU Clinical Research Unit Abstract Diabetic foot ulcers (DFUs) are a prevalent diabetes complications affecting up to 25% of patients and leading to ~80,000 Americans having non-traumatic amputations each year, with five-year mortality rates of up to 40%. Recent evidence suggests that non-traumatic lower extremity amputations are on the rise, after decades of decline, in spite of advances in targeted wound care products, establishment of interdisciplinary clinical and surgical teams, and improving diabetes medical care. Given the worldwide epidemic of diabetes, the burden associated with DFU are high, including high costs of $9 billion-$13 billion per year and besides those associated with high morbidity and mortality. Thus, the establishment of a Diabetic Foot Consortium comprised of experienced DFU Clinical Research Units (CRU) for reliable DFU biomarker discovery cannot be understated. The main objective of this proposal is to integrate the robust infrastructure at Michigan Medicine with our highly skilled clinical and translational team to establish a DFU CRU as a strong contender and contributor within the DFC network that will be uniquely poised to participate in all DFU biomarker discovery and related wound healing projects undertaken by the Consortium. Additional aims are to The aims are to : identify, recruit, and phenotype a broad spectrum of DFU participants from the large base of patients with these conditions who are currently being followed at Michigan Medicine, according to the Consortium requirements; implement standardized mechanisms and protocols for effective longitudinal sample collection and retention; and actively participate in the DFC intellectually and provide all available resources to develop and support clinical study protocols to validate DFU biomarkers, including complex quantifications of wound image features; single cell, genetic, molecular, metabolomics, and microbiome analyses; and assessing additive predictors of DFU healing beyond clinical markers alone using multi-modal approaches. The expected outcome of this work is that the Michigan Medicine DFU Clinical Center will be an integral part of the Consortia collaborative network, with a highly positive impact for the entire spectrum of biomarker discovery and future novel therapies projects. Narrative This project has major public health relevance because diabetic foot ulcers (DFUs) remain one of the most common secondary complications of diabetes and are the leading cause of lower extremity amputation in the US. Current treatments are ineffective and given the recent surge in major lower extremity amputations in diabetic patients despite the previous decades of decline, identification of novel treatment avenues is of critical importance. The main objective of the Diabetic Foot Clinical Center at the University of Michigan is to use our robust infrastructure and highly skilled clinical and translational research team to generate a unique platform for investigating individual contributions to DFU wound healing from clinical samples, single cell genetic and molecular analyses from DFU samples, and image analyses.",DFU Clinical Research Unit,9782944,U01DK119083,"['Affect ', ' Age ', ' ages ', ' Amputation ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cell Body ', ' Cells ', ' Clinical Markers ', ' Clinical Study ', ' Clinical Research ', ' Concurrent Studies ', ' Cohort Studies ', ' co-morbidity ', ' Comorbidity ', ' Data Collection ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' depression ', ' Mental Depression ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Dressing ', ' Sterile coverings ', ' Engineering ', ' Epidemic ', ' Future ', ' cardiac failure ', ' Heart failure ', ' Heterogeneity ', ' Infection ', ' Institutes ', ' Membrum inferius ', ' Lower Limb ', ' Lower Extremity ', ' male ', ' Marketing ', ' Medicine ', ' Methodology ', ' Michigan ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patient Reported Outcomes ', ' Patient Outcomes Assessments ', ' Patients ', ' Peripheral Neuropathy ', ' Peripheral Nervous System Disorders ', ' Peripheral Nerve Diseases ', ' PNS Diseases ', ' Peripheral Nervous System Diseases ', ' Phenotype ', ' psychosocial variables ', ' Psychosocial Factor ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk Factors ', ' Schools ', ' personal care ', ' Self Care ', ' Standardization ', ' Technology ', ' Time ', ' Ulceration ', ' Ulcer ', ' Universities ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' Wound Repair ', ' Wound Healing ', ' Gender ', ' Walking ', ' Foot Ulcer ', ' Caring ', ' base ', ' Label ', ' improved ', ' sample collection ', ' specimen collection ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Area ', ' Surface ', ' Clinical ', ' Biological ', ' Medical ', ' Diabetic Foot ', ' Charcot foot ', ' Individual ', ' European ', ' Databases ', ' data base ', ' Data Bases ', ' Patient Recruitments ', ' participant recruitment ', ' Liquid substance ', ' liquid ', ' fluid ', ' Genetic ', ' tool ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' cognitive function ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Location ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' interest ', ' American ', ' experience ', ' cohort ', ' novel ', ' Participant ', ' Devices ', ' Positioning Attribute ', ' Position ', ' genetic analysis ', ' Genetic analyses ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Tissue Sample ', ' preventing ', ' prevent ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Diabetic Foot Ulcer ', ' Adherence ', ' Data ', ' Molecular Analysis ', ' Collection ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Molecular ', ' Behavioral ', ' Peripheral arterial disease ', ' peripheral artery disease ', ' Image ', ' imaging ', ' microbiome ', ' cost ', ' healing ', ' clinical research site ', ' clinical site ', ' Outcome ', ' wound ', ' prospective ', ' transcriptomics ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' public health relevance ', ' multimodality ', ' multi-modality ', ' FDA approved ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' diabetic patient ', ' Big Data ', ' BigData ', ' precision medicine ', ' precision-based medicine ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' biomarker discovery ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' ineffective therapies ', ' ineffective treatment ', ' recruit ', ' practice setting ', ' microbiome analysis ', ' analyze microbiome ', ' Infrastructure ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2019,429000,MI-12,0.07566355151654874
"ChartGlucose4Moms: Characterizing, by Trimester, Continuous Glucose Monitoring Measurements for determining effects on Maternal & Offspring Metabolic Sequelae PROJECT SUMMARY/ABSTRACT: Gestational diabetes (GDM) rates are on the rise in the US, particularly among racial and ethnic minorities. GDM is associated with higher rates of large for gestational age (LGA) infants, C-section, and serious perinatal complications, and increased long-term risks of Type 2 diabetes and morbidity in both mothers and infants. Women who get treatment for GDM are less likely to experience perinatal complications and give birth to LGA infants than those who do not; therefore, rapid detection of GDM may be critical to reducing perinatal complications and disparities in birth outcomes. GDM is normally diagnosed by oral glucose tolerance testing (OGTT) at 24-28 weeks gestation, but clinically important insulin resistance and metabolic dysfunction may be missed by not testing earlier. A metabolically unhealthy uterine environment in early pregnancy may lead to long-term negative impacts on mother and child, but how and when to test for insulin resistance and associated metabolic dysfunction in pregnancy is poorly defined. More data are needed on how glucose levels and other metabolic measures change across pregnancy to better evaluate women's metabolic risks and how those risks relate to perinatal and long-term outcomes. Using continuous glucose monitoring (CGM) and metabolic biomarker assays, we will describe detailed metabolic phenotype profiles over the course of pregnancy and examine how they are associated with perinatal and postpartum outcomes. We propose to recruit a diverse sample of 400 women in their first trimester from Kaiser Permanente Northwest and Kaiser Permanente Hawaii and to perform CGM, OGTT, and obtain biomarkers at 12 weeks, 20 weeks, and 28 weeks of gestation to examine how these measures relate to each other and to perinatal outcomes. Aim 1 and Aim 3 will assess the effects of CGM variables (Aim 1) and OGTT and other biomarkers (Aim 3) at each time point on the risk of LGA, other perinatal outcomes, and postpartum diabetes. Aim 2 will assess the relationship between CGM variables and diagnosis of GDM by OGTT, as well as the relationship between CGM variables and other metabolic biomarkers. We hypothesize that dysglycemia is just one marker of a much larger metabolic dysregulation that can be characterized through the work of this consortium. Characterizing a broader spectrum of metabolic dysregulation and its association with adverse perinatal outcomes will lead to improved screening regimens and treatments for pregnant women and better outcomes for both mothers and babies. PROJECT NARRATIVE Gestational diabetes (GDM) is a type of diabetes that develops during pregnancy that increases the risk of pregnancy and birth complications. New tests may allow doctors to identify women with GDM earlier and more accurately than the tests currently being used, but we need to understand them better. We will recruit 400 pregnant women and screen them using both traditional and new GDM screening tools at 12, 20, and 28 weeks of pregnancy to determine how well these tools identify women who are at risk of complications and need treatment.","ChartGlucose4Moms: Characterizing, by Trimester, Continuous Glucose Monitoring Measurements for determining effects on Maternal & Offspring Metabolic Sequelae",9900630,U01DK123791,"['Adipose tissue ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Affect ', ' Age ', ' ages ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Birth ', ' Parturition ', ' Brachial plexus structure ', ' Brachial Plexus ', ' C-Peptide ', ' Connecting Peptide ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cesarean ', ' C section ', ' Abdominal Delivery ', ' Cesarean section ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' Oral Diagnosis ', ' Dystocia ', ' Environment ', ' fasts ', ' fasted ', ' Fasting ', ' Free Fatty Acids ', ' Nonesterified Fatty Acids ', ' bone fracture ', ' Fracture ', ' Future ', ' Fetal Age ', ' Chronologic Fetal Maturity ', ' Gestational Age ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Hawaii ', ' Health ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' hyperglycemic ', ' Hyperglycemia ', ' increased triglycerides ', ' high triglycerides ', ' elevated triglyceride ', ' elevated tg ', ' Raised triglycerides ', ' Raised TG ', ' Hyperglyceridemia ', ' Hypertriglyceridemia ', ' Infant ', ' Inflammation ', ' insulin resistant ', ' Insulin Resistance ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Mothers ', ' Oral Glucose Tolerance Test ', ' OGTT ', ' Out-patients ', ' Outpatients ', ' Phenotype ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnancy Complications ', ' First Trimester ', ' Early Placental Phase ', ' 1st trimester ', ' First Pregnancy Trimester ', ' Third Trimester ', ' Last Trimester ', ' 3rd trimester ', ' Third Pregnancy Trimester ', ' pregnant mothers ', ' expecting mother ', ' expectant mother ', ' Pregnant Women ', ' Risk ', ' Shoulder ', ' Technology ', ' Testing ', ' Time ', ' Triacylglycerol ', ' Triglycerides ', ' womb ', ' Uterus ', ' Woman ', ' Work ', ' peptide C ', ' polypeptide C ', ' Measures ', ' pregnancy diabetes ', ' Pregnancy-Induced Diabetes ', ' Gestational Diabetes Mellitus ', ' Gestational Diabetes ', ' post-partum ', ' Postpartum ', ' Postpartum Period ', ' Injury ', ' Perinatal ', ' Peripartum ', ' improved ', ' Clinical ', ' Ensure ', ' Screening procedure ', ' screening tools ', ' Organogenesis ', ' Measurement ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Metabolic ', ' Deposition ', ' Deposit ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' neonatal death ', ' neonatal demise ', ' fetal ', ' pregnancy hypertension ', ' hypertensive disease of pregnancy ', ' Pregnancy Associated Hypertension ', ' Hypertension-Associated Pregnancy Disorder ', ' Hypertension induced by pregnancy ', ' Gestational Hypertension ', ' stillbirth ', ' stillborn ', ' experience ', ' Participant ', ' offspring ', ' reproductive ', ' Modeling ', ' Sampling ', ' glucose monitor ', ' glucose meter ', ' glucometer ', ' Symptoms ', ' Data ', ' Detection ', ' Development ', ' developmental ', ' rapid detection ', ' Outcome ', ' ethnic minority population ', ' ethnic minority ', ' high risk ', ' primary outcome ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' obesogenic ', ' obesigenic ', ' Regimen ', ' screening ', ' delivery complications ', ' birth complications ', ' perinatal outcomes ', ' metabolic phenotype ', ' metabotype ', ' metabolic profile ', ' perinatal complications ', ' biomarker identification ', ' marker identification ', ' racial minority ', ' recruit ', ' Metabolic dysfunction ', ' early pregnancy ', ' ']",NIDDK,KAISER FOUNDATION RESEARCH INSTITUTE,U01,2019,800511,CA-13,0.06928491964330337
"Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury     DESCRIPTION (provided by applicant): Throughout human pregnancy, the placenta is indispensable for embryonic development, fetal growth and tissue differentiation. The placenta also protects the fetus against diverse insults, while preserving maternal health. Placental dysfunction is commonly implicated in complications of pregnancy that challenge maternal physiology (e.g., preeclampsia) and fetal development (e.g., fetal death or fetal growth restriction) or that leads to preterm birth. Within the placenta, the trophoblast constitutes the outermost layer, which is directly bathed in maternal blood and therefore positioned to regulate maternal-fetal gas exchange, nutrient delivery, waste removal and the production of hormones, faithfully balancing fetal needs and maternal supply. Trophoblast damage, which is common in dysfunctional placentas, may interrupt the delicate maternal-fetal balance, cause clinical disease, and leave a lifelong mark on health. A fundamental challenge in perinatal medicine arises from our limited ability to diagnose placental disorders in real time and throughout pregnancy. However, the recent discovery, by ourselves and others, that (a) placental trophoblasts release distinctive micro- and nanovesicles into the maternal circulation and (b) these vesicles contain trophoblast-specific non-coding RNA cargo, created a new opportunity for assessing trophoblast health. These vesicles are actively released by trophoblasts throughout pregnancy, and thus serve as a venipuncture-accessible ""natural biopsy"" of trophoblasts, which can furnish information on trophoblast health in real time. Our established perinatal biology group at Magee- Womens Research Institute includes expertise in perinatal medicine and placental pathology, developmental and molecular biology, and bioinformatics. Inspired by these recent advances, we have partnered with an experienced group of bioengineers that includes experts from Carnegie Mellon University, MIT, and Penn State University, with unique skills in biophysics-based vesicle analytics, including microfluidics, nanomechanics, micro/nano fabrication and vesicle sorting using acoustic tweezers. Together, our new transdisciplinary group will use integrated molecular and biophysical methodologies to directly assess the use of trophoblast-derived extracellular vesicles from maternal plasma as revelatory of trophoblast health in real time and as a technique that may be employed throughout pregnancy. Our approach is comprehensive, centering on miRNAs as well as lncRNAs and circRNAs, analyzed in exosome nanovesicles, as well as microvesicles and apoptotic bodies. As each vesicle features a unique bimolecular and biophysical signature, we will deploy our machine learning- based training and testing pipeline to informatively integrate these distinct signals into an innovative diagnostic tool. Lastly, our deployment of affordable acoustic tweezers technology to sort trophoblastic vesicles will facilitate the translation of our advances into a new ""lab on a chip"" placental diagnostic technology, suitable for small blood volumes. This technology may not only denote trophoblast pathology, but has potential to identify those who may benefit from intervention and to monitor therapeutic success. PUBLIC HEALTH RELEVANCE: Although the placenta is critical for fetal development and pregnancy outcome, it is not currently accessible for real-time diagnostics throughout pregnancy. Having developed tools for isolation and analysis of placenta- specific extracellular from the maternal plasma, we will study molecular and biophysical properties of these vesicles as indicators of placental health and disease.",Extracellular vesicles and their ncRNA cargo as markers of trophoblast injury,9701262,R01HD086325,"['Abruptio Placentae ', ' placental abruption ', ' Premature Separation of Placenta ', ' Acoustics ', ' Acoustic ', ' Arteries ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' Biophysics ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Biopsy ', ' Needle biopsy procedure ', ' needle biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Blood Volume ', ' Communication ', ' Developmental Biology ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' balance function ', ' balance ', ' Equilibrium ', ' fetus death ', ' Fetal Death ', ' Developing fetus ', ' Fetal Development ', ' prenatal growth disorder ', ' intrauterine growth restriction ', ' intra-uterine growth retardation ', ' intra-uterine growth restriction ', ' impaired fetal growth ', ' Intrauterine Growth Retardation ', ' IUGR ', ' Fetal Growth Restriction ', ' Fetal Growth Retardation ', ' Fetus ', ' Future ', ' Gases ', ' Gold ', ' Health ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hormones ', ' Modern Man ', ' Human ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Maternal Health ', ' Methods ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Pathology ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' placental disorders ', ' Placental Diseases ', ' Placenta Disorders ', ' Placenta Diseases ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Plasma Proteins ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnancy Complications ', ' Pregnancy Outcome ', ' Pregnancy-Associated alpha-Plasma Protein ', ' PAPP-alpha ', ' PAPP-A ', ' Insulin-Like-Growth Factor Binding Protein-4 Protease ', ' Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease ', ' IGFBP-4-Specific Proteinase ', ' IGFBP-4 Protease ', ' IGFBP-4 Metalloproteinase ', ' Pregnancy-Associated Plasma Protein-A ', ' Production ', ' Research Institute ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Technology ', ' Testing ', ' Time ', ' tomography ', ' Translations ', ' trophoblast ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Universities ', ' womb ', ' Uterus ', ' Viscosity ', ' Woman ', ' closed circular RNA ', ' circular RNA ', ' Transforming Growth Factor P Receptor III ', ' CD105 Antigen ', ' Endoglin ', ' post-partum ', ' Postpartum ', ' Postpartum Period ', ' Glean ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Prematurely delivering ', ' Premature Birth ', ' pregnancy disorder ', ' Injury ', ' base ', ' Perinatal ', ' Peripartum ', ' improved ', ' Clinical ', ' Diffuse ', ' Histologic ', ' Histologically ', ' Evaluation ', ' Training ', ' peripheral blood ', ' Blood flow ', ' wasting ', ' Fetal Tissues ', ' fetus tissue ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Therapeutic ', ' Shapes ', ' Vesicle ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Investigation ', ' Dimensions ', ' Techniques ', ' Location ', ' extracellular ', ' fetal ', ' experience ', ' success ', ' viscoelasticity ', ' Venipunctures ', ' Nutrient ', ' skills ', ' novel ', ' Sorting - Cell Movement ', ' sorting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Positioning Attribute ', ' Position ', ' Fetal Growth ', ' intrauterine growth ', ' Property ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Provider ', ' Bioinformatics ', ' Bio-Informatics ', ' fluidic ', ' Microfluidics ', ' PGF gene ', ' Placental Growth Factor Gene ', ' PlGF ', ' PLGF-2 ', ' Lab-On-A-Chips ', ' Lab On a Chip ', ' fitness ', ' Data ', ' Interruption ', ' Maternal Physiology ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Predictive Value ', ' in vivo ', ' Apoptotic ', ' Tissue Differentiation ', ' Monitor ', ' Characteristics ', ' Molecular ', ' injured ', ' design ', ' designing ', ' nanofabrication ', ' nanofabricate ', ' nano fabrication ', ' nano fabricate ', ' nanomechanics ', ' nano mechanics ', ' cost effective ', ' innovation ', ' innovative ', ' innovate ', ' stem ', ' public health relevance ', ' clinical care ', ' nanovesicle ', ' nano vesicle ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' biophysical properties ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' biophysical techniques ', ' biophysical methods ', ' biophysical methodology ', ' biophysical approaches ', ' guided inquiry ', ' guided discovery ', ' perinatal medicine ', ' adverse pregnancy outcome ', ' microvesicles ', ' exosome ', ' extracellular vesicles ', ' mechanical properties ', ' clinical diagnostics ', ' Placental Biology ', ' Placenta Biology ', ' preservation ', ' Fetal health ', ' multidimensional data ', ' high dimensional data ', ' ']",NICHD,MAGEE-WOMEN'S RES INST AND FOUNDATION,R01,2019,650539,PA-18,0.07382966896677148
"Chronic Inflammation and Type 2 Diabetes: A Multi-omics Approach ABSTRACT The etiology of type 2 diabetes (T2D) likely involves a complex interaction of polygenic, metabolic, and environmental factors including diet. Accumulating experimental, epidemiological, and clinical evidence supports a pathogenic role of chronic inflammation in T2D development. However, the precise mechanisms underlying these findings are largely unknown, and current evidence on the causal relationships between specific inflammatory pathways and T2D risk is inconclusive. Advances in omics technologies have led to the identification of genes and metabolites associated with T2D risk, but data on mechanisms and causality are still very limited. Multi-omics integration in the framework of systems epidemiology may provide new avenues to enhance our understanding of disease mechanisms. To systematically investigate the relation between chronic inflammation and T2D, I propose to examine 3 Specific Aims by leveraging the rich resources in the UK Biobank, Nurses Health Studies (NHS), Health Professional Follow-up Study (HPFS), Hispanic Community Health Study/Study of Latinos (SOL), and Genotype-Tissue Expression project (GTEx). In Aim 1 [K99], I will integrate existing genomic data from the UK Biobank, NHS/HPFS, SOL, and transcriptomic data in the GTEx to examine shared genetic architectures between systemic inflammatory markers and T2D and whether polygenic susceptibility to chronic inflammation confers T2D risk. Meanwhile, I will receive extensive training in T2D systems biology and cutting-edge high-dimensional data analytics and bioinformatics. In Aim 2 [R00], I will integrate dietary and metabolomic data to examine metabolomic profiles mediating the association between dietary inflammatory potentials and T2D risk in the prospective NHS/HPFS and the SOL. In Aim 3 [R00], I will conduct plasma proteomic profiling in a nested case-control study within the NHS to identify inflammatory protein networks in relation to T2D risk, and as a Secondary Aim, integrate findings from Aim 1-3 to explore T2D-related pathways co-regulating at multiple biological dimensions. Findings from this project may improve the understanding of inflammatory mechanisms underlying T2D and identify novel targets/pathways suitable for early detection and prevention. I will be mentored/advised by an interdisciplinary team that includes Dr. JoAnn Manson (diabetes epidemiologist), Dr. Liming Liang (expert in statistical omics methodologies), Dr. Frank Hu (nutritional epidemiologist), Dr. Peter Kraft, (statistical geneticist), Dr. Qibin Qi (genetic epidemiologist), Dr. Towia Libermann (expert in proteomics), and Dr. Clary Clish (expert in metabolomics). The outstanding training opportunities with key leaders in these areas will provide me advanced knowledge and skills, positioning me for a successful, independent career as a diabetes epidemiologist with expertise in systems biology and integrated-omics. This project aligns with the NIDDKs goal of integrating multi-omics technologies into diabetes research. PROJECT NARRATIVE This project seeks to systematically examine the relationship between chronic inflammation and type 2 diabetes (T2D) by incorporating multi-omics data from several large prospective cohort studies. The proposed research will yield novel evidence on the biological mechanisms underlying the relationship between chronic inflammation and T2D risk. Novel pathways, and specific genes, proteins, and metabolites identified in this research will serve as the critical first steps for future development of biomarkers and therapeutic targets for T2D prevention and treatment.",Chronic Inflammation and Type 2 Diabetes: A Multi-omics Approach,9805982,K99DK122128,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Followup Studies ', ' Follow-Up Studies ', ' Food or Food Product ', ' Food ', ' Future ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Goals ', ' indexing ', ' Inflammation ', ' interferon beta 2 ', ' Plasmacytoma Growth Factor ', ' Myeloid Differentiation-Inducing Protein ', ' MGI-2 ', ' IL6 Protein ', ' IL-6 ', ' IFNB2 ', ' IFN-beta 2 ', ' Hybridoma Growth Factor ', ' Hepatocyte-Stimulating Factor ', ' HPGF ', ' BSF2 ', ' BSF-2 ', ' BCDF ', ' B-Cell Stimulatory Factor-2 ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Differentiation Factor ', ' B cell stimulating factor 2 ', ' B cell differentiation factor ', ' Interleukin-6 ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' White Blood Cell Count ', ' Leukocyte Number ', ' Leukocyte Count ', ' White Blood Cell Count procedure ', ' Mentors ', ' Methods ', ' Methodology ', ' mortality ', ' Nested Case-Control Study ', ' Phenotype ', ' pilot study ', ' Pilot Projects ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Proteins ', ' Public Health ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' retinopathy ', ' retina disorder ', ' retina disease ', ' Retinal Disorder ', ' Retinal Diseases ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Technology ', ' Work ', ' cytokine ', ' Mediating ', ' base ', ' career ', ' improved ', ' Area ', ' Chronic ', ' Clinical ', ' Biological ', ' Physiological ', ' Physiologic ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Metabolic ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Qi ', "" Ch'i "", ' adiponectin ', ' apM1 (adipose-specific) protein ', ' apM-1 protein ', ' adipocyte, C1q and collagen domain containing protein ', ' adipocyte complement-related protein 30-kDa ', ' ACRP30 protein ', ' Dimensions ', ' Complex ', ' Pattern ', ' System ', ' Early Diagnosis ', ' early detection ', ' cohort ', ' skills ', ' novel ', ' disorder prevention ', ' disease prevention ', ' Patient Self-Report ', ' Self-Report ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' Positioning Attribute ', ' Position ', ' Gene Proteins ', ' Protein Gene Products ', ' Proteome ', ' Dietary Assessment ', ' Modeling ', ' response ', ' case control ', ' Proteomics ', ' Genomics ', ' Limes ', ' Pathogenicity ', ' Bioinformatics ', ' Bio-Informatics ', ' diabetes risk ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' IL6 gene ', ' Interleukin-6 Gene ', ' Interleukin 6 (Interferon, Beta 2) Gene ', ' IL6 ', ' IL-6 Gene ', ' IFNB2 Gene ', ' Hybridoma Growth Factor Gene ', ' Hepatocyte Stimulatory Factor Gene ', ' HSF Gene ', ' Beta-2 Gene Interferon ', ' BSF2 Gene ', ' BSF-2 Gene ', ' B-Cell Stimulatory Factor 2 Gene ', ' B-Cell Differentiation Factor Gene ', ' TNFRSF1A gene ', ' tumor necrosis factor  receptor ', ' tumor necrosis factor receptor 1A ', ' tumor necrosis factor alpha receptor ', ' Tumor Necrosis Factor Receptor 55 ', ' Tumor Necrosis Factor Receptor 1 ', ' TNF receptor ', ' TNFalpha receptor ', ' TNFRSF1A Receptor ', ' TNFRSF1A ', ' TNFR60 ', ' TNFR55 ', ' TNFR1 ', ' TNFR-I ', ' TNFR, 60-kD ', ' TNFR, 55-kD ', ' TNFR p60 ', ' TNFAR ', ' TNF- receptor ', ' TNF-sR55 ', ' TNF Receptor p55 ', ' CD120a Antigens ', ' CD 120a Antigen ', ' Systems Biology ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Intake ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Regulatory Element ', ' i(19) ', ' Epidemiologist ', "" Nurses' Health Study "", ' Nutritional ', ' nutritious ', ' Development ', ' developmental ', ' Diabetes prevention ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' Pathway interactions ', ' pathway ', ' protein metabolite ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' transcriptomics ', ' therapeutic target ', ' inflammatory marker ', ' inflammation marker ', ' novel marker ', ' novel biomarker ', ' new marker ', ' biobank ', ' biorepository ', ' training opportunity ', ' Data Analytics ', ' biomarker development ', ' Hispanic Community Health Study/Study of Latinos ', ' HCHS/SOL cohort ', ' HCHS/SOL Study ', ' multiple omics ', ' multiomics ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' Study of Latinos ', ' metabolome ', ' metabonome ', ' Genotype-Tissue Expression Project ', ' GTEx ', ' whole genome ', ' full genome ', ' entire genome ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' Prospective cohort study ', ' high dimensionality ', ' cardiometabolism ', ' cardiometabolic ', ' genetic architecture ', ' multidimensional data ', ' high dimensional data ', ' Multiomic Data ', ' multiple omic data ', ' ']",NIDDK,HARVARD SCHOOL OF PUBLIC HEALTH,K99,2019,91499,MA-07,0.07074839585937691
"Design and Evaluation of a Decision Support Engine for Advanced Treatment of Type 1 Diabetes Project Summary Type 1 diabetes (T1D) is a disease characterized by pancreatic beta destruction with subsequent insulin depletion. The alterations in glucose dynamics are incredibly difficult to manage and are confounded by meals, exercise, menstruation, and stress. Although automated insulin delivery systems are becoming commercially available, the large majority of people with T1D are treated with multiple daily injections of insulin (MDI). Dangerous complications of hypoglycemia and diabetic ketoacidosis can occur from failure to dose insulin correctly, however vigilant adherence to tedious insulin dosing strategies are difficult for MDI users maintain. This difficulty is magnified during exercise, which is critical to ameliorating long-term complications of diabetes; even when guidelines for insulin dosage adjustments are followed, acute hypoglycemia during exercise and night-time hypoglycemia can occur. In our recent survey of 1400 subjects living with T1D, the majority of subjects on MDI therapy were not confident in managing their glucose during exercise and felt they lacked tools to do so. In aggregate, difficult treatment schedules and bolus calculations, associated acute complications from daily activities, and the emotional and psychological toll of this chronic disease can result in treatment non-adherence and poor glycemic outcomes. Therefore, there is a critical need for decision support tools designed for MDI users to improve glycemic control surrounding meals, daily activities and exercise. The goal of this proposal to develop a decision support tool for patients with type 1 diabetes who utilize continuous glucose monitoring systems and multiple daily injection therapy. This tool will be called miTREAT, the multiple injection treatment recommender system for exercise-aware therapies. We hypothesize that use of a novel decision support tool equipped with content-based collaborative filtering methods and dynamic exercise hypoglycemia prediction algorithms will improve overall euglycemia and reduce time spent in hypoglycemia for patients on MDI therapy. In our first aim, we will leverage decades of research in computer science recommender systems and machine learning optimization strategies to develop a novel decision support system that identifies issues in glycemic control and recommends appropriate insulin dose and behavioral modifications. In our second aim, we will develop a new exercise model that reflects both the dynamics of rapid-uptake of glucose through GLUT-4 channels and the longitudinal biphasic insulin sensitivity profile. This new model structure will be used to predict hypoglycemia during and after the exercise period. In our third aim, we will explore the performance of our decision support engine in an in-vivo clinical trial. This clinical trial will assess the usability of a new smart-phone app designed to assist MDI users that we have developed at OHSU. In achieving these goals, we will develop the first decision support system that provides treatment and behavioral recommendations to patients on CGM-augmented MDI therapy. This system will improve overall time in euglycemia, and reduce the occurrence of acute complications surrounding exercise. Project Narrative Type 1 Diabetes is difficult to manage through multiple daily injections, and there is a paucity of tools available to assist patients with treatment decisions. In this proposal, the fields of computer science, machine learning, constrained optimization and clinical science are united to develop a novel decision support tool for multiple daily injection users. This is accomplished in three parts: 1) we will tune a decision support system to correctly identify issues in patient glycemic control and recommend appropriate treatment modifications; 2) we will develop a new hypoglycemia prediction tool that reflects the longitudinal dynamics of glucose uptake during and after exercise; and 3) we will explore the performance of this decision support system and hypoglycemia prediction tool in a clinical trial.",Design and Evaluation of a Decision Support Engine for Advanced Treatment of Type 1 Diabetes,9758549,F31DK121436,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Aerobic Exercise ', ' Aerobic fitness ', ' Aerobic Activity ', ' Awareness ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Clinical Trials ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Dangerousness ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' diabetic ketoacidotic ', ' Diabetic Ketosis ', ' Diabetic Acidosis ', ' Diabetic Ketoacidosis ', ' Disorder ', ' Disease ', ' Exercise ', ' Fear ', ' Fright ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' History ', ' Recording of previous events ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' injection therapy ', ' Injection of therapeutic agent ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin ', ' monthly period ', ' menstrual period ', ' Menses ', ' Menstruation ', ' Methods ', ' Structural Models ', ' Pancreatic ', ' Pancreas ', ' Patients ', ' pilot study ', ' Pilot Projects ', ' Recommendation ', ' Recurrent ', ' Recurrence ', ' Research ', ' Running ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Medical Technology ', ' Phone ', ' Telephone ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' Weight ', ' Assimilations ', ' Mediating ', ' Outcome Measure ', ' Guidelines ', ' base ', ' dosage ', ' human subject ', ' improved ', ' Site ', ' Acute ', ' Variant ', ' Variation ', ' psychologic ', ' psychological ', ' Evaluation ', ' Cutaneous ', ' Failure ', ' Trust ', ' Measurement ', ' Plant Roots ', ' root ', ' tool ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Event ', ' Pattern ', ' System ', ' Closure by clamp ', ' Clampings ', ' Outcome Study ', ' Infusion procedures ', ' Infusion ', ' Performance ', ' heuristics ', ' computer science ', ' glucose uptake ', ' novel ', ' Study Subject ', ' Emotional ', ' Modeling ', ' Decision Support Systems ', ' response ', ' glucose monitor ', ' glucose meter ', ' glucometer ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' insulin sensitivity ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' preventing ', ' prevent ', ' SLC2A1 gene ', ' Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1 ', ' SLC2A1 ', ' Glucose Transporter 1 ', ' GLUT1 ', ' GLUT ', ' Erythrocyte/Hepatoma Glucose Transporter ', ' Dose ', ' Adherence ', ' Bolus Infusion ', ' Bolus ', ' Data ', ' in vivo ', ' Clinical Sciences ', ' Exercise Physiology ', ' Modification ', ' Tracer ', ' Behavioral ', ' Output ', ' design ', ' designing ', ' diabetes management ', ' diabetic management ', ' glycemic control ', ' glucose disposal ', ' insulin stimulated glucose disposal ', ' Outcome ', ' blood glucose regulation ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' e-commerce ', ' internet commerce ', ' ecommerce ', ' usability ', ' primary outcome ', ' secondary outcome ', ' standard of care ', ' Regimen ', ' Cross-Over Trials ', ' Crossover Trials ', ' support tools ', ' exercise intensity ', ' resistance exercise ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' smartphone Application ', ' iPhone Application ', ' iPhone App ', ' iOS application ', ' iOS app ', ' Smartphone App ', ' Smart Phone Application ', ' Smart Phone App ', ' Cellular Phone Application ', ' Cellular Phone App ', ' Cell phone App ', ' Cell Phone Application ', ' Android Application ', ' Android App ', ' Injections ', ' euglycemia ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,F31,2019,50016,OR-03,0.04619476568835987
"Planning for a Cohort Study on Neurocognitive Complication of Type 1 Diabetes in Children Project Summary. Children with type 1 diabetes (T1D) suffer from subtle cognitive impairments and structural alterations in the brain. These impairments progress with age and may eventually lead to increased difficulty managing the disease, resulting in worsening glycemic control, potentially life-threatening complications, and reductions in quality of life. Causes of cognitive decline in T1D are not well understood. Episodes of hypoglycemia, chronic hyperglycemia, glycemic variability and diabetic ketoacidosis (DKA) have all been suggested to play roles. Increased understanding of factors linked to cognitive decline in T1D, and the mechanisms responsible for these associations, is essential such that interventions to preserve cognition could be proposed. Recent data suggest that neuroinflammation resulting from hyperglycemia and episodes of DKA may be play a prominent role in causing cognitive decline. There is also evidence that modifiable factors such as nutrition, exercise, and sleep quality might modulate effects of chronic neuroinflammation and influence cognitive outcomes. In this project, we will engage in efforts to plan a comprehensive study of factors associated with cognition in children with T1D. At the completion of the proposed planning project, we will be prepared to conduct a longitudinal cohort study of children with newly diagnosed T1D. This study will determine how glycemic control and DKA exposure predict altered brain structure and cognition and establish whether markers of neuronal injury and inflammatory processes explain these longitudinal relations. Proposed assessments will include T1D-related factors (glycemic control, glycemic variability, hypoglycemia, DKA), brain structure and cognitive function (attention, memory and IQ). In addition, we will plan measurements of inflammatory mediators and markers of neuroinflammation using blood assays (cytokine measurements, exosome analyses, RNA microarrays), and evaluate factors that might modify inflammation such as diet (nutrient content), sleep quality and exercise. To optimize the study design, we will utilize the expertise of a multidisciplinary team to develop the study protocol, including experts in pediatric diabetes, cognitive development, neural and systemic inflammation, MR imaging, nutrition, sleep medicine, and data science. The team will work together to finalizing the protocol, work-flow and outcome measures, and identify the necessary computational infrastructure and data analysis strategies. The team will also assess study feasibility (factors affecting enrollment success and tolerance of the protocol) and determine necessary sample size by evaluating variability in biochemical and imaging measures. Alternative approaches to increase participant retention, such as remote (online) versus in person cognitive testing, will be explored. At the conclusion of this planning project, we will have developed and optimized a protocol to explore factors associated with cognitive decline in children with T1D, laying a foundation for future studies aimed at preserving cognitive function. Narrative. Individuals with type 1 diabetes often have declines in cognitive function over time, with a high risk of cognitive impairments and dementia as older adults. The physiological events responsible for cognitive damage in T1D are not understood, and it is unclear how cognitive decline might be prevented. In the proposed project, we will plan a comprehensive, multi-center study to investigate factors associated with declines in cognition in children with T1D at onset of the disease and over time.",Planning for a Cohort Study on Neurocognitive Complication of Type 1 Diabetes in Children,9913812,U34DK123894,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Aerobic Exercise ', ' Aerobic fitness ', ' Aerobic Activity ', ' Affect ', ' Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Antibodies ', ' Attention ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood - brain barrier anatomy ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Brain Chemistry ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Cognition ', ' Concurrent Studies ', ' Cohort Studies ', ' Complication ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' diabetic ketoacidotic ', ' Diabetic Ketosis ', ' Diabetic Acidosis ', ' Diabetic Ketoacidosis ', ' dietary ', ' Diet ', ' Brain Inflammation ', ' Encephalitis ', ' balance function ', ' balance ', ' Equilibrium ', ' Exercise ', ' family structure/dynamics ', ' Family dynamics ', ' Feasibility Studies ', ' Foundations ', ' Future ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Inflammation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Photoradiation ', ' Light ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' MR Spectroscopy ', ' Magnetic Resonance Spectroscopy ', ' Medicine ', ' Memory ', ' working memory ', ' Shortterm Memory ', ' Immediate Memory ', ' Short-Term Memory ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Persons ', ' nutrition ', ' Patients ', ' Play ', ' QOL ', ' Quality of life ', ' study design ', ' Study Type ', ' Research Design ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Siblings ', ' Sleep ', ' Testing ', ' Time ', ' Work ', ' cytokine ', ' Measures ', ' Outcome Measure ', ' Procedures ', ' Site ', ' Chronic ', ' Phase ', ' Physiological ', ' Physiologic ', ' Biochemical ', ' Link ', ' Evaluation ', ' Individual ', ' Measurement ', ' Sample Size ', ' Inflammation Mediators ', ' inflammatory mediator ', ' Brain Injuries ', ' brain-injured ', ' brain damage ', ' Acquired brain injury ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Multicenter Studies ', ' Multi-center studies ', ' Inflammatory ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Disease Management ', ' Disorder Management ', ' cognitive function ', ' long term memory ', ' longterm memory ', ' Severities ', ' Event ', ' Protocols documentation ', ' Protocol ', ' Dementia ', ' Amentia ', ' Neurocognitive ', ' success ', ' neuron loss ', ' neuronal loss ', ' neuronal death ', ' neuronal cell loss ', ' neuronal cell death ', ' neuron death ', ' neuron cell loss ', ' neuron cell death ', ' nerve cell loss ', ' nerve cell death ', ' cohort ', ' relating to nervous system ', ' neural ', ' Structure ', ' Nutrient ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' preventing ', ' prevent ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Data ', ' Cognitive ', ' Enrollment ', ' enroll ', ' Newly Diagnosed ', ' Rodent Model ', ' Process ', ' Image ', ' imaging ', ' cost ', ' Neuronal Injury ', ' neuron injury ', ' neuroinflammation ', ' neuroinflammatory ', ' diet and exercise ', ' glycemic control ', ' Outcome ', ' prospective ', ' 10 year old ', ' ten years of age ', ' ten year old ', ' age 10 years ', ' 10 years of age ', ' Impairment ', ' multidisciplinary ', ' non-diabetic ', ' nondiabetic ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' inflammatory marker ', ' inflammation marker ', ' insulin dependent diabetes mellitus onset ', ' type 1 diabetes onset ', ' computer infrastructure ', ' computational infrastructure ', ' Big Data ', ' BigData ', ' cognitive testing ', ' cognitive assessment ', ' cognitive development ', ' cognitive ability ', ' Data Science ', ' exosome ', ' Longitudinal cohort study ', ' Longterm cohort study ', ' Long-term cohort study ', ' participant retention ', ' preservation ', ' sleep quality ', ' quality of sleep ', ' dementia risk ', ' risk for dementia ', ' risk factor for\xa0dementia ', ' Childhood diabetes ', ' pediatric diabetes ', ' diabetes in children ', ' diabetes in childhood ', ' diabetes during childhood ', ' ']",NIDDK,UNIVERSITY OF CALIFORNIA AT DAVIS,U34,2019,366502,CA-03,-0.019643541039112342
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9772486,P50GM115318,"['Affect ', ' Autophagocytosis ', ' autophagy ', ' Biocompatible Materials ', ' biological material ', ' Biomaterials ', ' California ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Clinical Markers ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' coronary disorder ', ' atherosclerotic heart disease ', ' Coronary Disease ', ' Coronary heart disease ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Deoxyribonucleic Acid ', ' DNA ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethnicity group ', ' Ethnic group ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Human Genetics ', ' Hybrids ', ' hyperglycemic ', ' Hyperglycemia ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Leadership ', ' Lipids ', ' Inbred Strains Mice ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' muscular disorder ', ' Myopathic disease or syndrome ', ' Myopathic Diseases and Syndromes ', ' Myopathic Conditions ', ' Muscular Diseases ', ' Muscle Disorders ', ' Muscle Disease ', ' Myopathy ', ' Patients ', ' Pharmacies ', ' Pharmacy facility ', ' Clinical Pharmacology ', ' Public Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' statistics ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Testing ', ' United States ', ' Genetic Diversity ', ' Genetic Variation ', ' Synvinolin ', ' Simvastatin ', ' Treatment outcome ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Custom ', ' base ', ' improved ', ' Clinical ', ' Residual state ', ' Residual ', ' Variant ', ' Variation ', ' Biological ', ' Predisposition ', ' Susceptibility ', ' lymphoblast ', ' disability ', ' Muscle function ', ' Fostering ', ' Collaborations ', ' Metabolic ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Event ', ' System ', ' cardiovascular disorder prevention ', ' cardiovascular disease prevention ', ' cardiac disease prevention ', ' CVD prevention ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Informatics ', ' Disease Outcome ', ' novel ', ' lymphoblastoid cell line ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Drug effect disorder ', ' drug action ', ' genetic analysis ', ' Genetic analyses ', ' Modeling ', ' Sampling ', ' response ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' Genomics ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Pharmacogenomics ', ' preventing ', ' prevent ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' genetic association ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Symptoms ', ' Data ', ' Recombinants ', ' in vivo ', ' Transcript ', ' Molecular ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' Pathway interactions ', ' pathway ', ' clinical phenotype ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' data integration ', ' design ', ' designing ', ' clinical efficacy ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Visualization software ', ' visualization tool ', ' blood glucose regulation ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' Resistance ', ' resistant ', ' transcriptomics ', ' Cell model ', ' Cellular model ', ' clinically relevant ', ' clinical relevance ', ' multidisciplinary ', ' mouse model ', ' murine model ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' public health relevance ', ' alternative treatment ', ' population based ', ' treatment strategy ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' clinical practice ', ' biological systems ', ' candidate validation ', ' risk minimization ', ' exome ', ' exomes ', ' adverse outcome ', ' adverse consequence ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' data visualization ', ' training opportunity ', ' genotyped patients ', ' inter-individual variation ', ' interindividual variation ', ' inter-individual variability ', ' biomarker identification ', ' marker identification ', ' coronary event ', ' informatics\xa0tool ', ' side effect ', ' ']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2019,1524688,CA-13,0.046688146864863535
"HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME Abstract Metabolic syndrome (MetS) is a constellation of risk factors elevated triglycerides (TG), insufficient high- density lipoprotein cholesterol (HDL-C), elevated blood pressure (BP), elevated fasting blood glucose (FBG), and above-threshold waist circumference (WC)that is associated with increased cardiovascular disease, type 2 diabetes mellitus, and some forms of cancer. Research suggests that addressing MetS through the workplace could significantly benefit employee health and employer healthcare costs. Habit Design, Inc., has developed an enhanced behavioral health coaching system called Habit Design (HD) that is the first to integrate habit formation, contingency management, and social learning approaches within a smartphone app to support to behavior change in corporate or employee health contexts. In this Fast Track project, we will adapt the HD approach to address MetS. In Phase I, we will 1) refine and extend existing functional prototypes of the HD app to support the latest versions of iOS and Android, 2) conduct usability testing with 8 targeted end users, and 3) prepare standard treatment manuals for the Phase II clinical trial. In Phase II, we will 1) make indicated changes to the HD app based on findings from the Phase I usability test and 2) evaluate the effectiveness of HD coaching compared to standard health coaching in a randomized trial with 424 corporate wellness program participants who have MetS, with follow-up spanning one year. Participants will employees of TriHealth in Cincinnati who have completed a health screening as part of their corporate wellness program and been identified as having at least 3/5 of the following: 1) TG 150 mg/dL), 2) HDL-C <40 mg/dL in males and <50 mg/dL in females, 3) BP 130/85 mm Hg, 4) FBG 100 mg/dl, and 5) WC 102 cm in males and 80 cm in females.. All participants will be coached to increase physical activity, which will be monitored with a waist-worn FitBit and Fitabase software. Additionally, participants will choose prior to randomization a goal of increasing fruit and vegetable intake or substituting water for sugar-sweetened beverages. Conditions will be stratified by choice of goal and gender. In both conditions coaching will be monitored for fidelity and delivered in 12 weekly in-person 30-minute sessions followed by one 30-minute maintenance session per month for 4 months. The primary outcome will be average daily step count measured over the course of at least one week at baseline, 4 months, 8 months, and 12 months. The secondary outcome will be standard units increase of fruit/vegetable intake or water intake, according to the participant's choice. Tertiary outcomes will consist of FBG, TG, HDL, BP, WC, and body mass index, measured at each time point. Additionally, we will conduct web-based assessment of self-reported physical activity, junk food, and sugar-sweetened beverage consumption; automaticity of exercise and fruit, vegetable, and water consumption; self-efficacy and social support for target behaviors; and health-related quality of life. Ratings of usability and satisfaction and app usage metrics will be examined. Analyses will be intent-to-treat assuming 15% loss to follow-up. Project Narrative/Relevance Metabolic syndrome is a major public health problem that affects over one in three American adults and increases the risk of cardiovascular disease, type 2 diabetes, and some forms of cancer. Habit Design, Inc., has developed an integrated health coaching system that uses a smartphone app to promote healthy behaviors. We will adapt it for metabolic syndrome and evaluate its effectiveness in a corporate health setting.",HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME,9776030,R44HL142328,"['interventional strategy ', ' Intervention Strategies ', ' Metabolic syndrome ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Effectiveness ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' Address ', ' Adherence ', ' Intake ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Monitor ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Behavioral ', ' sweetened beverage ', ' Behavioral Model ', ' health related quality of life ', ' design ', ' designing ', ' Outcome ', ' Consumption ', ' innovation ', ' innovative ', ' innovate ', ' fruits and vegetables ', ' usability ', ' prototype ', ' primary outcome ', ' secondary outcome ', ' standard care ', ' standard treatment ', ' financial incentive ', ' monetary incentive ', ' financial reward ', ' randomized trial ', ' Randomization trial ', ' screening ', ' social learning ', ' crowdsourcing ', ' crowdsource ', ' crowd-sourcing ', ' crowd source ', ' peer coaching ', ' peer teaching ', ' peer mentoring ', ' peer led team learning ', ' peer instruction ', ' peer support ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' fitbit ', ' Android ', ' smartphone Application ', ' iPhone Application ', ' iPhone App ', ' iOS application ', ' iOS app ', ' Smartphone App ', ' Smart Phone Application ', ' Smart Phone App ', ' Cellular Phone Application ', ' Cellular Phone App ', ' Cell phone App ', ' Cell Phone Application ', ' Android Application ', ' Android App ', ' web-based assessment ', ' web-based screening ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Behavior ', ' Blood Glucose ', ' Blood Sugar ', ' Blood Pressure ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cues ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Water Intake ', ' Water consumption ', ' Environment ', ' Exercise ', ' fasts ', ' fasted ', ' Fasting ', ' Feedback ', ' Female ', ' Food or Food Product ', ' Food ', ' Goals ', ' Habits ', ' Health ', ' Health behavior ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' increased triglycerides ', ' high triglycerides ', ' elevated triglyceride ', ' elevated tg ', ' Raised triglycerides ', ' Raised TG ', ' Hyperglyceridemia ', ' Hypertriglyceridemia ', ' alpha-Lipoproteins ', ' High density lipoprotein ', ' Heavy Lipoproteins ', ' HDL Lipoproteins ', ' HDL ', ' High Density Lipoproteins ', ' alpha-Lipoprotein Cholesterol ', ' HDL Cholesterol Lipoproteins ', ' HDL Cholesterol ', ' High Density Lipoprotein Cholesterol ', ' Maintenance ', ' male ', ' Manuals ', ' Persons ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Psychology ', ' Public Health ', ' Reinforcement ', ' Psychological reinforcement ', ' Research ', ' Rewards ', ' Risk Factors ', ' Science ', ' social support network ', ' Social support ', ' Software ', ' Computer software ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Translating ', ' Triacylglycerol ', ' Triglycerides ', ' Hydrogen Oxide ', ' Water ', ' Wellness Program ', ' Employee Health ', ' Gender ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Workplace ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' base ', ' improved ', ' Chronic ', ' Phase ', ' Link ', ' Physical activity ', ' sugar ', ' Fostering ', ' satisfaction ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Phase II Clinical Trials ', ' phase II protocol ', ' phase 2 trial ', ' Phase 2 Clinical Trials ', ' Central obesity ', ' waist-predominant obesity ', ' visceral obesity ', ' trunk obesity ', ' male-type obesity ', ' excess adiposity in midsection ', ' Truncal obesity ', ' Obesity of face and trunk, sparing limbs ', ' Obese face+trunk sparing limbs ', ' Fat body with thin limbs ', ' Centripetal obesity ', ' Android fat distribution ', ' Abdominal obesity ', ' Companions ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' System ', ' Location ', ' waist circumference ', ' Test Result ', ' behavior change ', ' American ', ' experience ', ' Employee ', ' Self Efficacy ', ' novel ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' contingency management ', ' Modeling ', ' behavioral health ', ' Intervention ', ' ']",NHLBI,"HABIT DESIGN, INC.",R44,2019,224991,WA-08,0.03462082017780084
"Improving glucose control with advanced technology designed for high risk patients with type 1 diabetes Summary The objective of this proposal is to optimize the design and evaluate a robust artificial pancreas (R-AP) system for use in patients with uncontrolled type 1 diabetes (T1D) with HbA1C greater than 8% and compare HbA1C outcomes in these patients relative to a decision support system that utilizes continuous glucose monitoring (CGM) and multiple daily injection (MDI) therapy. Although high risk patients have possibly the most to gain from usage of AP technology, they are oftentimes under-represented or excluded from clinical trials. This has been because of the increased risk of failure of these AP systems that were not designed to handle inconsistent reporting of meals, variable activity level, and infusion set failures. An AP system for high risk patients needs to be designed to achieve maximal benefit, including reducing the risk of acute and chronic complications. A major obstacle for enabling the AP for usage by high-risk patients is that these patients may be less compliant with use guidelines for the system including missed meal announcements, infrequent sensor calibrations, and prolonged infusion set wear leading to infusion set failures. In this grant, we will integrate new risk-mitigation features into the OHSU single-hormone AP to enable usage by high-risk patients that fall into the categories described above. We present new algorithms for automating the detection of missed meal announcements, missed calibrations, and robust handling of hybrid usage mode. While AP systems may be an optimal choice for improving glycemic control, many people with T1D prefer MDI therapy. Decision support systems such as the DailyDose decision support system developed at OHSU can be used to improve glycemic control for patients who prefer MDI therapy. The DailyDose decision support system is designed for CGM augmented MDI therapy. It enables on-demand calculation of insulin doses, automates insulin dose adjustments based on pattern recognition, and uses machine learning approaches to alert the patients to events such as predicted hypoglycemia and missed meal doses.The benefit of the DailyDose system is that it is a simple system and does not require use of an insulin pump, which may be a challenge for some patients with uncontrolled type 1 diabetes as pump therapy is more intensive and requires infusion set changes. It is unknown in this high risk group of people whether patient needs, quality of life, and glycemic control are best addressed with an AP system or decision support tool or if both treatments are appropriate. We have designed a 3-month clinical study to compare glycemic outcomes during AP vs. decision support interventions in a high- risk T1D cohort (HbA1C 8-10.5%), with the aim of demonstrating a significant clinically relevant reduction in HbA1C. Our hypothesis is that both AP and decision support therapies will decrease HbA1C relative to baseline but that the AP will provide further benefit over DailyDose. Project Narrative Diabetes is the leading cause of blindness, kidney failure, and non-traumatic amputations. We propose to integrate features into the OHSU artificial pancreas to optimize it for high risk patients with type 1 diabetes (HbA1c>8-10.5%) and compare it to DailyDose, a decision support system that uses multiple daily injections.",Improving glucose control with advanced technology designed for high risk patients with type 1 diabetes,9789266,R01DK120367,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Algorithms ', ' Awareness ', ' Calibration ', ' Carbohydrates ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' diabetes ', ' Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' diabetic ketoacidotic ', ' Diabetic Ketosis ', ' Diabetic Acidosis ', ' Diabetic Ketoacidosis ', ' Exercise ', ' Fear ', ' Fright ', ' Grant ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hormones ', ' Modern Man ', ' Human ', ' Hybrids ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' injection therapy ', ' Injection of therapeutic agent ', ' Inpatients ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin ', ' insulin pump ', ' Insulin Infusion Systems ', ' Manuals ', ' Out-patients ', ' Outpatients ', ' Patients ', ' Personality ', ' QOL ', ' Quality of life ', ' Questionnaires ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Risk ', ' Running ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Testing ', ' Time ', ' falls ', ' Outcome Measure ', ' Guidelines ', ' base ', ' Pump ', ' sensor ', ' improved ', ' Acute ', ' Chronic ', ' Multicenter Trials ', ' Multi-center trial ', ' Randomized Clinical Trials ', ' Failure ', ' Distress ', ' Artificial Pancreas ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Event ', ' System ', ' Blindness ', ' visual loss ', ' vision loss ', ' Outcome Study ', ' Infusion procedures ', ' Infusion ', ' Performance ', ' cohort ', ' expectation ', ' Categories ', ' Reporting ', ' Emotional ', ' Decision Support Systems ', ' response ', ' glucose monitor ', ' glucose meter ', ' glucometer ', ' Adverse event ', ' Adverse Experience ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Address ', ' Dose ', ' Detection ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' research clinical testing ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' Cognitive ', ' Pattern Recognition ', ' Update ', ' Characteristics ', ' Modification ', ' Behavioral ', ' design ', ' designing ', ' glycemic control ', ' Outcome ', ' blood glucose regulation ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' clinically relevant ', ' clinical relevance ', ' clinically significant ', ' clinical significance ', ' engineering design ', ' high risk ', ' patient population ', ' primary outcome ', ' secondary outcome ', ' risk minimization ', ' risk mitigation ', ' arm ', ' support tools ', ' high risk population ', ' high risk group ', ' Bluetooth ', ' smart watch ', ' smartwatch ', ' Injections ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,R01,2019,621247,OR-03,0.05961180450961011
"Improving diabetes and depression self-management via adaptive mobile messaging Project Summary/Abstract Diabetes and depression are major public health problems that disproportionately affect racial/ethnic minorities and low-income individuals in the US. Efficacious interventions for depression and diabetes exist but are not often combined despite similar treatment recommendations (specifically physical activity) for both conditions. Especially in resource-constrained environments, mobile health (mHealth) technologies are cost effective and feasible methods for delivering self-management support given the more ubiquitous penetration across socioeconomic status. Existing mHealth interventions have shown preliminary success but have had difficulty sustaining engagement. When combined with machine learning algorithms, health messages can be adapted to specifically motivate individuals based on their unique profiles. In Aim 1, we will integrate content from interventions targeting diabetes, depression, and physical activity applying user design methods. We will utilize the existing HealthySMS platform as the basis for this intervention. This will be called the Diabetes and Mental Health Adaptive Notification Tracking and Evaluation (DIAMANTE) study. In Aim 2, we will test an mHealth intervention for diabetes and depression that will generate messages using an adaptive machine learning algorithm that learns from patient step count data (collected passively via a smartphone app) and patient entered blood glucose and mood ratings. We will compare this adaptive, personalized intervention with a static messaging intervention, typical of many existing text messaging interventions. In Aim 3, we will rerandomize non-responsive participants to receiving nurse outreach using a sequential, multiple assignment, randomized trial (SMART) design. We will leverage the SMART design to conserve more expensive one-on-one nurse outreach for the patients who are no longer engaged in the program and need the most support. We will test this intervention with 350 patients from a safety net setting in English and Spanish. The primary outcomes for this study are HbA1c levels and PHQ-9 scores. The results of this study will help us understand the impact of personalizing content utilizing machine learning algorithms as well as the impact of providing clinician support for those receiving mobile health interventions. Since we are testing this intervention in a resource-constrained environment, the results of this study will be relevant for a broader population. Project Narrative (Public Relevance Statement) Diabetes and depression are health problems that are often comorbid and are mutually detrimental when uncontrolled. This grant proposal seeks to develop and test a personalized motivational text messaging intervention to improve management of diabetes and depression with an emphasis on low-income populations. The findings from this study will aid in the development and dissemination of mobile health tools for chronic illness management in diverse patients.",Improving diabetes and depression self-management via adaptive mobile messaging,9735228,R01HS025429,[''],AHRQ,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2019,397016,CA-13,0.08739939243624692
"Modeling the Effect of Athletic Competition Anxiety on Blood Glucose Dynamics in Type 1 Diabetes Exercise is a challenge for people with type 1 diabetes (T1D) because different activity types and intensities have different impacts on glucose concentrations. This challenge is amplified on competition days, as the added stress and high-intensity activity causes drastically different glucose responses than during exercise on non- competition days. This can occur due to a combination of increased hepatic glycogenolysis anaerobic exercise and the counterregulatory hormone response associated with the stress of competition. Thus, many people with T1D limit their physical activity due to fear of hypoglycemia during or after the activity and the majority of people with T1D do not engage in enough physical activity with less than 20% performing aerobic exercise more than twice per week. Regardless of the desire to exercise, people with T1D may be caught in scenarios where they are doing physical activity such running to catch a bus to commute to work may cause a spike in blood glucose concentration due to the anaerobic nature of the sprint and the added stress of arriving late if he or she were to miss the bus. One would not have had time to consider the appropriate insulin dose to prevent hyperglycemia and would benefit greatly from a system that would monitor these states and make corrections without requiring user input. Artificial pancreas (AP) systems will simplify the treatment of T1D and more advanced research is needed to increase their efficacy during and after exercise. The AP automates the computation of the proper insulin dose by using a continuous subcutaneous glucose sensor (CGM), an automatic control system, and an insulin pump that continuously infuses insulin into the subcutaneous tissue. The limitation of this configuration is its reliance on a single measurement, the glucose concentration, which varies in response to changes in many factors such as meals and exercise. The Cinar group at Illinois Institute of Technology pioneered the multivariable AP development. Signals streamed in real time from wearable devices complement glucose data to build accurate models to predict future variations in glucose levels. These models are updated recursively with each new set of measurements and used in hypoglycemia prediction and adaptive control. A new generation multivariable AP system that will incorporate the presence of competition stress with knowledge of physical activity type and intensity with well-developed machine learning algorithms for data interpretation in real-time, hypoglycemia early-warning systems, and automatic control will be more effective in improving glucose control in physically-active people with T1D. Additionally, this technology will be safer by dramatically reducing the number and duration of hypoglycemic and hyperglycemic events, as compared to the current guidelines for maintaining euglycemia in exercise. Such AP systems can only be developed by using a sophisticated multivariable approach that includes glucose concentrations and a number of other physiological variables that impact glucose homeostasis during physical activity and under the presence of competition stress. PROJECT NARRATIVE The development of an exercise-smart artificial pancreas will improve the overall health and quality of life for people with type 1 diabetes through minimizing the number of treatment decisions required to maintain glucose homeostasis. This project will evaluate the glucose response during competitive and non-competitive exercise of various intensities, will build specific adaptive models that use data from glucose sensors and wearable devices to predict glucose trajectories for various exercise and stress conditions which will optimize insulin dosing with the exercise-smart artificial pancreas.",Modeling the Effect of Athletic Competition Anxiety on Blood Glucose Dynamics in Type 1 Diabetes,9780348,F31DK116524,"['Aerobic Exercise ', ' Aerobic fitness ', ' Aerobic Activity ', ' Algorithms ', ' Anxiety ', ' Anaerobic Bacteria ', ' anaerobe ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Glucose ', ' Blood Sugar ', ' Commuting ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' body water dehydration ', ' Dehydration ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Metabolism and Endocrinology ', ' Endocrinology ', ' Environment ', ' Exercise ', ' Fear ', ' Fright ', ' Feedback ', ' Foundations ', ' Future ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Health ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hormones ', ' Proctocort ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Illinois ', ' Institutes ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin ', ' insulin pump ', ' Insulin Infusion Systems ', ' Ketosis ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Persons ', ' Physical Fitness ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' QOL ', ' Quality of life ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Research ', ' Running ', ' Safety ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Time ', ' Work ', ' Generations ', ' Measures ', ' Guidelines ', ' base ', ' improved ', ' Hepatic ', ' sedentary ', ' Variant ', ' Variation ', ' Physiological ', ' Physiologic ', ' Training ', ' Physical activity ', ' Personality Traits ', ' Individual ', ' Measurement ', ' Subcutaneous Tissue ', ' Tela Subcutanea ', ' Superficial Fascia ', ' Subcutis ', ' Hypodermis ', ' Artificial Pancreas ', ' Nature ', ' Knowledge ', ' Event ', ' Stream ', ' Reaction ', ' subcutaneous ', ' Techniques ', ' System ', ' meter ', ' experience ', ' glycogenolysis ', ' Performance ', ' treatment planning ', ' member ', ' Reporting ', ' Modeling ', ' response ', ' glucose sensor ', ' preventing ', ' prevent ', ' Dose ', ' Athletic ', ' Data ', ' Detection ', ' Exercise Physiology ', ' Observational Study ', ' Observational research ', ' Observation study ', ' Observation research ', ' Societal Factors ', ' Update ', ' Monitor ', ' pancreas development ', ' Development ', ' developmental ', ' physiologic model ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' blood glucose regulation ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' Impairment ', ' non-diabetic ', ' nondiabetic ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' exercise intensity ', ' wearable device ', ' wearable sensor ', ' body worn sensor ', ' body sensor ', ' machine learning algorithm ', ' euglycemia ', ' ']",NIDDK,ILLINOIS INSTITUTE OF TECHNOLOGY,F31,2019,41136,IL-01,0.04936497009329091
"Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Cohort Abstract: Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) are responsible for considerable morbidity and mortality, and are expected to pose an increasing burden because the US population is aging. Technological advances in magnetic resonance imaging (MRI) and analytic algorithms facilitate increasingly precise measurement and characterization of structural and functional brain changes that may be early indicators of pathologic processes leading to AD/ADRD. Early detection of these changes is critical during preclinical stages before the pathologic change has advanced to an irreversible state, as this is a period when treatment may be most effective. Type 2 diabetes mellitus (T2DM) appears to accelerate the trajectory of brain aging. As Type 1 diabetes mellitus (T1DM) patients live longer, they might be at increased risk for AD/ADRD but little is known about the impact of T1DM on accelerated brain aging and ADRD. We are responding to NOT-AG-18-039 to seek an administrative supplement to DP3114812 -(Effects of Biomedical Risk Factors on Neuro-cognition Using MRI) to leverage the long term follow-up of the Diabetes Control & Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications Study (EDIC) Cohort to investigate associations with AD-related changes on brain MRI. The participants have been studied for over 35 years, with detailed longitudinal biomedical and cognitive data gathered from baseline and are entering the age of increased risk for AD/ADRD. Our project addresses action item 1.C.1 of the National Alzheimer's Project Act 2018 update: identify imaging and biomarkers to monitor disease progression. Enhanced neuroimaging methods for early diagnosis can serve as foundations for designing and following subjects in clinical trials and selecting patients at greatest risk for therapeutic interventions. The primary goal of this supplement is to evaluate the presence of AD-like patterns of brain atrophy in the DCCT/EDIC population. We plan to construct robust imaging markers of clinical and preclinical AD, as well as to systematically characterize the heterogeneity of brain aging and its associations with various risk factors by leveraging multiple advances since the original proposal including a large NIA-funded study led by our group that pools together data from approximately 20,000 individuals, called iSTAGING. These new advances will permit us to develop a new focus on ADRD, addressing our Specific Aims: 1) Harmonize the EDIC MRI datasets with a large brain aging and AD consortium (iSTAGING), using state of the art statistical imaging analytics methods, as well as an enriched set of healthy control individuals scanned in the same sites and by the same protocol. 2) Evaluate the presence of patterns of brain atrophy that have been established in MCI and AD, and to relate those patterns to biomedical predictors and cognitive decline in EDIC. This plan builds upon the currently funded project to now include explicit ADRD research objectives. Our study will help determine whether T1DM is associated with pre-clinical brain imaging patterns of AD. The effects of type 1 diabetes on brain structure and thinking processes are poorly understood and understudied especially among the growing population of older patients who are at greatest risk for these problems. The Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions & Complications (DCCT/EDIC) study affords an unparalleled opportunity to use blood sugar control and other information gathered over a 30 year period from early in the course of illness, among this well-characterized group of patients, to examine important and unresolved questions about the frequency and causes of these problems using magnetic resonance imaging (MRI) techniques and cognitive testing. By achieving these aims we will determine key predictors of neuro-cognitive impairments and guide strategies to mitigate this risk, and address a topic of considerable concern, for which little definitive information is available to clinicians and patients, particularly those with long-standing type 1 diabetes who are over 50 years of age.",Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Cohort,9879993,DP3DK114812,"['Affect ', ' Age ', ' ages ', ' Aging ', ' Algorithms ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Blood Glucose ', ' Blood Sugar ', ' Blood Pressure ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Clinical Markers ', ' Clinical Trials ', ' Cognition ', ' Concurrent Studies ', ' Cohort Studies ', ' diabetes ', ' Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Goals ', ' Heterogeneity ', ' Lipids ', ' Literature ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Study of magnetics ', ' Methods ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Pathological Processes ', ' Pathologic Processes ', ' Patients ', ' Pennsylvania ', ' Population Control ', ' Research ', ' Risk ', ' Risk Factors ', ' Testing ', ' Time ', ' Universities ', ' Imaging Technics ', ' Imaging Procedures ', ' Imaging Techniques ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Dataset ', ' Data Set ', ' analytical method ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Brain imaging ', ' brain visualization ', ' Site ', ' Clinical ', ' premature ', ' prematurity ', ' Phase ', ' Variant ', ' Variation ', ' Evaluation ', ' Renal function ', ' kidney function ', ' cerebral atrophy ', ' cortical atrophy ', ' brain atrophy ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Funding ', ' Atrophic ', ' Atrophy ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Techniques ', ' Early Diagnosis ', ' early detection ', ' cohort ', ' Structure ', ' neuroimaging ', ' neuro-imaging ', ' Participant ', ' General Population ', ' General Public ', ' Reporting ', ' Therapeutic Intervention ', ' intervention therapy ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Address ', ' Administrative Supplement ', ' Data ', ' Cognitive ', ' Longterm Follow-up ', ' longterm followup ', ' long-term followup ', ' Long-term Follow-up ', ' Update ', ' Pathologic ', ' Monitor ', ' Process ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Image ', ' imaging ', ' pre-clinical ', ' preclinical ', ' macrovascular disease ', ' macrovascular complication ', ' design ', ' designing ', ' glycemic control ', ' Population ', ' Neurocognition ', ' aging brain ', ' aged brain ', "" Alzheimer's disease risk "", ' alzheimer risk ', ' Alzheimer risk factor ', ' clinical epidemiology ', ' high risk ', ' diabetes control ', ' mild cognitive impairment ', ' mild cognitive disorder ', ' Microvascular Dysfunction ', ' small vessel disease ', ' microvascular disease ', ' microvascular complications ', ' imaging biomarker ', ' imaging-based marker ', ' imaging-based biomarker ', ' imaging-based biological marker ', ' imaging marker ', ' learning strategy ', ' learning method ', ' learning activity ', ' study population ', ' recruit ', ' automated image analysis ', "" Alzheimer's disease related dementia "", ' Alzheimer related dementia ', ' ADRD ', ' ']",NIDDK,NYU WINTHROP HOSPITAL,DP3,2019,323566,NY-04,-0.010879813508939849
"Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery System Project Summary Automated insulin delivery (AID) systems offer substantial opportunities for helping people with type 1 diabetes (T1D) to improve glucose control and lower HbA1c. However, the AID has only shown a benefit during the nighttime when meals, exercise, and stress do not significantly challenge the AID. Furthermore, hypoglycemia (<70 mg/dL) remains a common occurrence in people with type 1 diabetes and continues to occur even in the setting of AID, particularly with exercise. Integrating context awareness into an AID has the potential to improve glycemic time in range (70-180 mg/dL) during the daytime and reduce and possibly eliminate hypoglycemia. Contextual information can include inferred food intake, insulin dosing, inferred exercise type and duration, as well as movement patterns. An AID can be designed to recognize contextual patterns that relate to poor glycemic responses to meals and hypoglycemia and then adjust insulin dosing in response to these patterns in advance and help mitigate these problems. In this grant, we will explore how contextual information may be used within an AID to help (1) avoid hypoglycemia and (2) reduce postprandial dysglycemia. We will first conduct a data gathering study whereby we will collect a rich data set from people with T1D who will use sensor augmented pump therapy to manage their glucose. Data will be collected from these 30 patients over 28 days; data will include multivariable contextual information including continuous glucose monitoring (CGM) data, insulin data, food data, physical activity data (heart rate and accelerometry), as well as indoor/outdoor contextual movement patterns gathered using a novel beacon-based context-aware sensing system called MotioWear developed by our group in collaboration with our industry partner MotioSens. Next, we will utilize this contextual data set to construct a Bayesian glucose prediction algorithm. This will include a clustering algorithm that will group contextual sequences that are similar with each other and which lead to similar glycemic outcomes. This context-aware glucose prediction algorithm will be integrated into an adaptive, personalized, smartwatch-based context-aware AID (CA-AID) system. Contextual patterns that have a high likelihood of leading to hypoglycemia or postprandial dysglycemia will inform an insulin dosing aggressiveness factor to be adjusted for similar contextual sequences observed in the future (i.e. the CA-AID will reduce insulin for contextual sequences with high likelihood of hypoglycemia such as aerobic exercise). We expect that integrating context awareness into an AID will lead to significant improvements in time in target range during the day and will help reduce time in hypoglycemia. The CA-AID will be evaluated for safety in a small pilot study. We will then evaluate the CA-AID within a 6 week clinical study in 40 adults with type 1 diabetes on insulin pump therapy. Twenty will receive the CA-AID while the other 20 will receive a standard (non-context-aware) AID. The primary outcome measures of this study is the percent time in range. We hypothesize that the CA-AID will increase time in range by 10% as compared with a non-context aware AID. Project Narrative Diabetes is the leading cause of blindness, kidney failure, and non-traumatic amputations. While automated insulin delivery systems can help people with type 1 diabetes better manage their glucose levels during the night, improved glycemic control during the day has not been demonstrated and hypoglycemia continues to be a problem, especially during exercise. We propose to develop and evaluate in a clinical study a context-aware automated insulin delivery system that learns patterns of daily living, meal patterns, glucose patterns, insulin dosing patterns, and physical activity patterns that relate to dysglycemia and adapts the gains within the AID to improve postprandial time in target range (70-180 mg/dL) and reduce hypoglycemia.",Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery System,9832864,R01DK122583,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Aerobic Exercise ', ' Aerobic fitness ', ' Aerobic Activity ', ' Algorithms ', ' Awareness ', ' Beds ', ' Behavior ', ' Calibration ', ' Clinical Study ', ' Clinical Research ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' diabetes ', ' Diabetes Mellitus ', ' type one diabetes ', ' type I diabetes ', ' ketosis prone diabetes ', ' juvenile diabetes mellitus ', ' juvenile diabetes ', ' insulin dependent diabetes ', ' Type I Diabetes Mellitus ', ' Type 1 diabetes ', ' Type 1 Diabetes Mellitus ', ' T1DM ', ' T1D ', ' T1 diabetes ', ' T1 DM ', ' Sudden-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Juvenile-Onset Diabetes Mellitus ', ' IDDM ', ' Brittle Diabetes Mellitus ', ' Insulin-Dependent Diabetes Mellitus ', ' Food Intake ', ' Eating ', ' Engineering ', ' Exercise ', ' Fats ', ' Fatty acid glycerol esters ', ' Food or Food Product ', ' Food ', ' Future ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Grant ', ' Cardiac Chronotropism ', ' Heart Rate ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' hyperglycemic ', ' Hyperglycemia ', ' hypoglycemic episodes ', ' hypoglycemic ', ' Hypoglycemia ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Insulin ', ' insulin pump ', ' Insulin Infusion Systems ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Maps ', ' body movement ', ' Movement ', ' Out-patients ', ' Outpatients ', ' Patients ', ' pilot study ', ' Pilot Projects ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Restaurants ', ' Risk ', ' Running ', ' Safety ', ' Stress ', ' Testing ', ' Time ', ' Wrist ', ' Measures ', ' Outcome Measure ', ' Schedule ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' Pump ', ' sensor ', ' improved ', ' Physiological ', ' Physiologic ', ' Randomized Clinical Trials ', ' Physical activity ', ' Collaborations ', ' Knowledge ', ' Life ', ' Tactile ', ' Event ', ' Home environment ', ' Home ', ' Clinic ', ' Pattern ', ' System ', ' Blindness ', ' visual loss ', ' vision loss ', ' cohort ', ' expectation ', ' novel ', ' Participant ', ' response ', ' glucose monitor ', ' glucose meter ', ' glucometer ', ' glucose sensor ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Effectiveness ', ' Dose ', ' fitness ', ' Data ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' research clinical testing ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' design ', ' designing ', ' glycemic control ', ' Outcome ', ' blood glucose regulation ', ' glucose regulation ', ' glucose homeostasis ', ' glucose control ', ' usability ', ' high risk ', ' primary outcome ', ' industry partner ', ' industry partnership ', ' industrial partnership ', ' arm ', ' two-arm study ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' fitbit ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' recruit ', ' smart watch ', ' smartwatch ', ' wearable device ', ' wearable sensor ', ' body worn sensor ', ' body sensor ', ' machine learning algorithm ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,R01,2019,669616,OR-03,0.06659708097455712
"Wound management through quantitative documentation and prediction Project Summary:  We propose in this SBIR effort to develop a mobile health software system for clinicians to conveniently and/or remotely manage and quantitatively document the healing process of chronic ulcers such as diabetic foot ulcers. Timely, frequent, and accurate documentation on wound appearance and dimension is vital for the growth assessment and tracking of treatment effectiveness. However, current practice is subjective, inconsistent, and even invasive. The absence of easily accessible, repeatable, and quantitative data affects care coordination among the medical staffs and handicaps the best treatment planning for individual patients. For chronic wound sufferers, countless routine visits and the ever increasing high treatment costs also hinders their chance of timely treatment and urgently calls for a convenient alternative.  Built on a seamlessly integrated client-server framework, the proposed management software allows clinicians to easily exchange wound data with the cloud server, analyze the wound healing information, and manage patient's treatment. Together with potentially other wound sensor data, our software system offers objective and quantitative assessment on wound tissue healing status, avoiding misinterpretation or inconsistent grading among medical staffers. With large patient data to be collected, the proposed software is perceived to assist clinicians with evidence based healing prediction and more effective personalized treatment planning.  Every year, approximately 6.5 million Americans suffer from chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous stasis ulcers. The number is projected to grow rapidly due to the aging baby boomer population and a sharp rise in diabetes and obesity. Chronic wound healing is a lengthy process with months or even years of treatment time. Absence of personalized attention could easily cause infections and complications, leading to loss of limb. Evidence suggests that 80% of amputations are actually preventable through access of good quality and routine care. With the ever increasing high healthcare costs and the likelihood of early discharge to home care, patients are highly vulnerable to complications due to the lack of routine checkup or personalized care. All of these validates the urgent need of an alternative, convenient, and low cost clinical practice as what our mobile health app is able to provide. Project Narrative  The proposed mobile health software system to be developed under this SBIR project will provide clinicians a convenient yet comprehensive diagnosis and treatment tool, empowering them to provide personalized and timely care for chronic ulcer sufferers. With its unique client-server framework and many advantages over existing standard of care, the proposed management system will have a reasonably large market share in this rapidly growing multi-billion dollar industry. Lastly, the proprietary mobile health technology can be used for the treatment of other type of wounds and diseases such as burns, acute wounds, battle wounds, and endoscopic diseases.",Wound management through quantitative documentation and prediction,10081799,R44AG067799,"['Affect ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Aging ', ' Algorithms ', ' Amputation ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Attention ', ' Burn injury ', ' Burns ', ' burned ', ' Classification ', ' Systematics ', ' Client ', ' decubitus ulcer ', ' Bed Sores ', ' Bedsore ', ' Pressure Sore ', ' Pressure Ulcer ', ' pressure injury ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Information Management ', ' Epithelium ', ' Epithelium Part ', ' Limb structure ', ' Extremities ', ' Limbs ', ' Non-Trunk ', ' Feasibility Studies ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Industry ', ' Infection ', ' Laboratories ', ' Medical Staff ', ' Methods ', ' Necrosis ', ' Necrotic ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Outpatients ', ' Out-patients ', ' Patients ', ' Sensitivity and Specificity ', ' Computer software ', ' Software ', ' Technology ', ' Testing ', ' Texas ', ' Time ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Visual Perception ', ' wound healing ', ' Wound Repair ', ' wound resolution ', ' Measures ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' Treatment Cost ', ' Treatment Effectiveness ', ' base ', ' sensor ', ' Home Care ', ' patient homecare ', ' patient home care ', ' Area ', ' Clinical ', ' Phase ', ' Medical ', ' Evaluation ', ' Epithelial ', ' diabetic ', ' Measurement ', ' tool ', ' Venous ', ' programs ', ' Dimensions ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Visit ', ' empowered ', ' Medical center ', ' American ', ' data management ', ' success ', ' Check-up ', ' checkup ', ' checkup examination ', ' treatment planning ', ' Appearance ', ' Health Care Technology ', ' Healthcare Technology ', ' Health Technology ', ' QOC ', ' Quality of Care ', ' Documentation ', ' data processing ', ' computerized data processing ', ' Address ', ' diabetic foot wound ', ' Diabetic Foot Ulcer ', ' Data ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Monitor ', ' trend ', ' Process ', ' developmental ', ' Development ', ' Stasis Ulcer ', ' imaging ', ' Image ', ' Evidence based treatment ', ' cost ', ' healing ', ' digital ', ' software systems ', ' designing ', ' design ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' tissue wound ', ' wounding ', ' wounds ', ' wound ', ' Population ', ' Chronic Care ', ' evidence base ', ' standard of care ', ' routine care ', ' clinical practice ', ' data transfer ', ' data transmission ', ' data exchange ', ' Secure ', ' m-Health ', ' mobile health ', ' mHealth ', ' cloud based ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' Precision care ', ' individualized care ', ' individualized patient care ', ' personalized patient care ', ' personalized care ', ' dimensional analysis ', ' chronic skin wound ', ' chronic wound ', ' individual patient ', ' data access ', ' cloud server ', ' cloud platform ', ' Mobile Health App ', ' m-Health app ', ' m-Health application ', ' mHealth app ', ' mHealth application ', ' Mobile Health Application ', ' coordinating care ', ' care coordination ', ' baby boomer ', ' phase I designs ', ' phase 1 designs ', ' Infrastructure ', ' augmented intelligence ', ' wound assessment ', ' wound monitoring ', ' wound care ', ' treat wound ', ' wound management ', ' wound therapeutics ', ' wound therapy ', ' wound treatment ', ' non-healing ulcer ', ' nonhealing ulcer ', ' chronic ulcer ', ' acute wound ', ' wound healing models ', ' Wound models ', ' ']",NIA,"XYKEN, LLC",R44,2020,298277,VA-11,0.0151806931457457
"A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications PROJECT SUMMARY/ABSTRACT A role for glycemic variation in optimizing management of diabetes and vascular complications It is well demonstrated that high glucose levels lead to more rapid development of macrovascular and microvascular complications in people with diabetes. However, there is less consistent evidence that lowering glucose levels to near normal levels prevent or slows vascular complications, particularly in more advanced stages of type 2 diabetes. The recent VADT, ACCORD, and ADVANCE trials demonstrated that intensive efforts to lower glucose had only modest effects on the rate of vascular complications. Why glycemic control strategies that focused on reduction of glucose levels and HbA1c did not have the anticipated success in reducing vascular outcomes is not clear. This has raised the possibility that (1) there are glycemic metrics beyond those that reflect average glucose control, such as HbA1c, that can explain this paradox, and (2) there exists heterogeneous treatment effects of intensive glycemic therapy for macrovascular and microvascular complications, with subgroups of patients who do less well with intensive treatment counter-balancing those that do respond. In recent reports we have demonstrated long-term glycemic variability was associated with risk of cardiovascular disease (CVD) events, even after adjusting for traditional markers of glycemic control. Importantly, this appeared most relevant to those receiving intensive glycemic control. These preliminary findings support careful examination of determinants and consequences of glycemic variability. In this proposal, we therefore propose to (a) evaluate and compare the importance of glycemic variation, both short-term measured by 1,5-anhydroglucitol and long-term in the development of macro and microvascular complications; (b) to study whether intensive treatment is beneficial in preventing vascular outcomes when glycemic variation is constrained; (c) genetic variants associated with glycemic variation in T2D patients will explain additional risk in progression to vascular complications beyond the genetic variants associated with mean glycemic levels. PROJECT NARRATIVE The major goals of glucose-lowering therapy in T2D are to reduce the incidence and progression of both microvascular and macrovascular complications. However, several large clinical trials that focused on reduction of glucose levels and HbA1c did not have the anticipated success in reducing macrovascular outcomes. Our proposal focuses on filling the gap of identifying the role of glycemic variability (short-term and long-term) in optimizing management of diabetes and vascular complications.",A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications,10040813,R21HL150374,"['Characteristics ', ' developmental ', ' Development ', ' macrovascular complication ', ' macrovascular disease ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' Outcome ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' treatment effect ', ' standard treatment ', ' standard care ', ' genome scale ', ' genomewide ', ' genome-wide ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' microvascular complications ', ' microvascular disease ', ' small vessel disease ', ' Microvascular Dysfunction ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' Patient risk ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' Risk stratification ', ' secondary analysis ', ' intervention arm ', ' treatment arm ', ' random forest ', ' machine learned algorithm ', ' machine learning algorithm ', ' Algorithms ', ' Blood Vessels ', ' vascular ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Clinical Trials ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Equilibrium ', ' balance ', ' balance function ', ' Genetic Markers ', ' genetic biomarker ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Incidence ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Life Style ', ' Lifestyle ', ' Long-Term Effects ', ' Longterm Effects ', ' Patients ', ' Play ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Testing ', ' Time ', ' Measures ', ' base ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Genetic ', ' Event ', ' Visit ', ' success ', ' cohort ', ' Reporting ', ' Modeling ', ' Sampling ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' preventing ', ' prevent ', ' Data ', ' Subgroup ', ' Genetic Risk ', ' Principal Investigator ', ' ']",NHLBI,UNIVERSITY OF ARIZONA,R21,2020,122816,AZ-03,0.04506976080172376
"Large-scale annotation-free disease correlation analysis of the iHMP Project Summary We will work with the iHMP data resource to apply novel tools and data analysis methodologies to the challenge of disease association between large microbiome data sets, Inflammatory Bowel Disease, and the onset of diabetes. We will start with an annotation-free approach using k-mers to preprocess IBD and diabetes cohorts. We then will apply a novel scaling technology implemented in the sourmash software to reduce the data set size by a factor of 2000, rendering it tractable to machine learning approaches. We next will use random forests to determine a subset of predictive k-mers, and will measure their accuracy on validation data sets not used in the initial training. Finally, we will annotate the predictive k-mers using all available genome databases as well as a novel method to infer the metagenomic presence of accessory genomes of known genomes. Our outcomes will include a catalog of microbial genomes that correlate with IBD subtype and the onset of diabetes, as well as automated workflows to apply similar approaches to other data sets. Project Narrative We propose to work with the iHMP data, a large central microbiome resource, to study disease correlations with inflammatory bowel disease and diabetes. We will work to associate specific microbial species with the disease conditions. We will also produce resources that will help other researchers perform similar studies.",Large-scale annotation-free disease correlation analysis of the iHMP,10112077,R03OD030596,"['Communities ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Ecology ', ' Environmental Science ', ' Genome ', ' Human ', ' Modern Man ', ' Inflammatory Bowel Diseases ', ' Inflammatory Bowel Disorder ', ' Inflammatory Intestinal Disease ', ' Inflammatory Intestinal Disorder ', ' Methods ', ' Methodology ', ' Organism ', ' living system ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Computer software ', ' Software ', ' Technology ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' Variation ', ' Variant ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' disease onset ', ' disorder onset ', ' Onset of illness ', ' tool ', ' machine learned ', ' Machine Learning ', ' Catalogs ', ' Viral ', ' Genbank ', ' cohort ', ' microbial ', ' novel ', ' member ', ' Reporting ', ' genome database ', ' Ig Variable Region ', ' Immunoglobulin V ', ' Variable Region ', ' Immunoglobulin Variable Region ', ' Data ', ' Update ', ' Validation ', ' meta data ', ' Metadata ', ' microbiome ', ' metagenome ', ' Outcome ', ' microbes genome ', ' microbial genome ', ' Functional Metagenomics ', ' Metagenomics ', ' data resource ', ' metatranscriptomics ', ' metatranscriptome ', ' random forest ', ' ']",OD,UNIVERSITY OF CALIFORNIA AT DAVIS,R03,2020,304918,CA-03,0.052173712647027026
"HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME Abstract Metabolic syndrome (MetS) is a constellation of risk factors elevated triglycerides (TG), insufficient high- density lipoprotein cholesterol (HDL-C), elevated blood pressure (BP), elevated fasting blood glucose (FBG), and above-threshold waist circumference (WC)that is associated with increased cardiovascular disease, type 2 diabetes mellitus, and some forms of cancer. Research suggests that addressing MetS through the workplace could significantly benefit employee health and employer healthcare costs. Habit Design, Inc., has developed an enhanced behavioral health coaching system called Habit Design (HD) that is the first to integrate habit formation, contingency management, and social learning approaches within a smartphone app to support to behavior change in corporate or employee health contexts. In this Fast Track project, we will adapt the HD approach to address MetS. In Phase I, we will 1) refine and extend existing functional prototypes of the HD app to support the latest versions of iOS and Android, 2) conduct usability testing with 8 targeted end users, and 3) prepare standard treatment manuals for the Phase II clinical trial. In Phase II, we will 1) make indicated changes to the HD app based on findings from the Phase I usability test and 2) evaluate the effectiveness of HD coaching compared to standard health coaching in a randomized trial with 424 corporate wellness program participants who have MetS, with follow-up spanning one year. Participants will employees of TriHealth in Cincinnati who have completed a health screening as part of their corporate wellness program and been identified as having at least 3/5 of the following: 1) TG 150 mg/dL), 2) HDL-C <40 mg/dL in males and <50 mg/dL in females, 3) BP 130/85 mm Hg, 4) FBG 100 mg/dl, and 5) WC 102 cm in males and 80 cm in females.. All participants will be coached to increase physical activity, which will be monitored with a waist-worn FitBit and Fitabase software. Additionally, participants will choose prior to randomization a goal of increasing fruit and vegetable intake or substituting water for sugar-sweetened beverages. Conditions will be stratified by choice of goal and gender. In both conditions coaching will be monitored for fidelity and delivered in 12 weekly in-person 30-minute sessions followed by one 30-minute maintenance session per month for 4 months. The primary outcome will be average daily step count measured over the course of at least one week at baseline, 4 months, 8 months, and 12 months. The secondary outcome will be standard units increase of fruit/vegetable intake or water intake, according to the participant's choice. Tertiary outcomes will consist of FBG, TG, HDL, BP, WC, and body mass index, measured at each time point. Additionally, we will conduct web-based assessment of self-reported physical activity, junk food, and sugar-sweetened beverage consumption; automaticity of exercise and fruit, vegetable, and water consumption; self-efficacy and social support for target behaviors; and health-related quality of life. Ratings of usability and satisfaction and app usage metrics will be examined. Analyses will be intent-to-treat assuming 15% loss to follow-up. Project Narrative/Relevance Metabolic syndrome is a major public health problem that affects over one in three American adults and increases the risk of cardiovascular disease, type 2 diabetes, and some forms of cancer. Habit Design, Inc., has developed an integrated health coaching system that uses a smartphone app to promote healthy behaviors. We will adapt it for metabolic syndrome and evaluate its effectiveness in a corporate health setting.",HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME,10084515,R44HL142328,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Behavior ', ' Blood Glucose ', ' Blood Sugar ', ' Blood Pressure ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cues ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Water consumption ', ' Water Intake ', ' Environment ', ' Exercise ', ' Fasting ', ' fasted ', ' fasts ', ' Feedback ', ' Female ', ' Food ', ' Food or Food Product ', ' Goals ', ' Habits ', ' Health ', ' Health behavior ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Hypertriglyceridemia ', ' Hyperglyceridemia ', ' Raised TG ', ' Raised triglycerides ', ' elevated tg ', ' elevated triglyceride ', ' high triglycerides ', ' increased triglycerides ', ' High Density Lipoproteins ', ' HDL ', ' HDL Lipoproteins ', ' Heavy Lipoproteins ', ' High density lipoprotein ', ' alpha-Lipoproteins ', ' High Density Lipoprotein Cholesterol ', ' HDL Cholesterol ', ' HDL Cholesterol Lipoproteins ', ' alpha-Lipoprotein Cholesterol ', ' Maintenance ', ' male ', ' Manuals ', ' Persons ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Psychology ', ' Public Health ', ' Psychological reinforcement ', ' Reinforcement ', ' Research ', ' Rewards ', ' Risk Factors ', ' Science ', ' Social support ', ' social support network ', ' Computer software ', ' Software ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Translating ', ' Triglycerides ', ' Triacylglycerol ', ' Water ', ' Hydrogen Oxide ', ' Wellness Program ', ' Employee Health ', ' Gender ', ' Measures ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' Job Location ', ' Job Place ', ' Job Setting ', ' Job Site ', ' Work Location ', ' Work Place ', ' Work-Site ', ' Worksite ', ' work setting ', ' Workplace ', ' base ', ' improved ', ' Chronic ', ' Phase ', ' Link ', ' Physical activity ', ' sugar ', ' Fostering ', ' satisfaction ', ' Randomized Controlled Trials ', ' Phase 2 Clinical Trials ', ' phase II protocol ', ' Phase II Clinical Trials ', ' Abdominal obesity ', ' Android fat distribution ', ' Centripetal obesity ', ' Fat body with thin limbs ', ' Obese face+trunk sparing limbs ', ' Obesity of face and trunk, sparing limbs ', ' Truncal obesity ', ' excess adiposity in midsection ', ' male-type obesity ', ' trunk obesity ', ' visceral obesity ', ' waist-predominant obesity ', ' Central obesity ', ' Companions ', ' machine learned ', ' Machine Learning ', ' programs ', ' System ', ' Location ', ' waist circumference ', ' Test Result ', ' behavior change ', ' American ', ' experience ', ' Employee ', ' Self Efficacy ', ' novel ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' contingency management ', ' Modeling ', ' behavioral health ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Metabolic syndrome ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Effectiveness ', ' BMI percentile ', ' BMI z-score ', ' Quetelet index ', ' Body mass index ', ' Address ', ' Adherence ', ' Intake ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Monitor ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' sweetened beverage ', ' Behavioral Model ', ' health related quality of life ', ' designing ', ' design ', ' Outcome ', ' Consumption ', ' innovate ', ' innovative ', ' innovation ', ' fruits and vegetables ', ' usability ', ' prototype ', ' primary outcome ', ' secondary outcome ', ' standard treatment ', ' standard care ', ' financial reward ', ' monetary incentive ', ' financial incentive ', ' Randomization trial ', ' randomized trial ', ' screening ', ' social learning ', ' crowd source ', ' crowd-sourcing ', ' crowdsource ', ' crowdsourcing ', ' peer instruction ', ' peer led team learning ', ' peer mentoring ', ' peer teaching ', ' peer coaching ', ' peer support ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' fitbit ', ' Android ', ' Android App ', ' Android Application ', ' Cell Phone Application ', ' Cell phone App ', ' Cellular Phone App ', ' Cellular Phone Application ', ' Smart Phone App ', ' Smart Phone Application ', ' Smartphone App ', ' iOS app ', ' iOS application ', ' iPhone App ', ' iPhone Application ', ' smartphone Application ', ' web-based screening ', ' web-based assessment ', ' evaluate effectiveness ', ' effectiveness evaluation ', ' ']",NHLBI,"HABIT DESIGN, INC.",R44,2020,726708,WA-08,0.03462082017780084
"Deep Learning Based Genetic Risk Prediction for Type 1 Diabetes Project Summary Type I diabetes (T1D) is an autoimmune disease of childhood caused by a combination of genetic and environmental factors. In a subset of individuals with a genetic predisposition to T1D, environmental triggers instigate an autoimmune response which targets and damages pancreatic islets, leading to pre-diabetes and ultimately diabetes. A critical barrier in T1D prevention research is to identify and directly enroll children with a strong genetic predisposition for developing T1D into prevention trials. A robust genetic risk score (GRS) would allow for the identification of children at high-risk of T1D, their recruitment into T1D prevention trials, and subsequent testing of novel interventions. I aim to 1) optimize a multi-layer feedforward neural network genetic risk predictor that can be used to enroll newborns directly into T1D prevention trials; and 2) identify putative, novel T1D-causing SNPs, and their interactions. Completion of aim 1 would provide a better GRS to the T1D research community, which can be used to identify children with higher genetic risk of T1D development, increasing the statistical power of future T1D prevention clinical trials. Completion of aim 2 will provide a deeper biological understanding of the molecular drivers of T1D development, and potential new therapeutic targets for T1D prevention trials. Successful completion of this project will both help understand the genetic causes of type 1 diabetes and help prevent the disease. Project Narrative Type I diabetes (T1D) is an autoimmune disease of childhood caused by a combination of genetic and environmental factors. In a subset of individuals with a genetic predisposition to T1D, environmental triggers instigate an autoimmune response which targets and damages pancreatic islets, ultimately leading to diabetes. Successful completion of this project will both help understand the genetic causes of type 1 diabetes and help prevent the disease.",Deep Learning Based Genetic Risk Prediction for Type 1 Diabetes,9976989,F30DK121461,"['Alleles ', ' Allelomorphs ', ' Alternative Splicing ', ' Alternate Splicing ', ' Alternative RNA Splicing ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmune Responses ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Communities ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Decision Making ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Disease ', ' Disorder ', ' Future ', ' Genes ', ' Genotype ', ' HLA Antigens ', ' HL-A Antigens ', ' Human Leukocyte Antigens ', ' Leukocyte Antigens ', ' Newborn Infant ', ' 0-4 weeks old ', ' Newborns ', ' newborn child ', ' newborn children ', ' Islets of Langerhans ', ' B9 endocrine pancreas ', ' Endocrine Pancreas ', ' Islands of Langerhans ', ' Nesidioblasts ', ' Pancreatic Islets ', ' Pars endocrina pancreatis ', ' islet progenitor ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Publishing ', ' Receiver Operating Characteristics ', ' Receiver Operator Characteristics ', ' Research ', ' Risk ', ' Sensitivity and Specificity ', ' Testing ', ' Time ', ' Measures ', ' Enhancers ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' base ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Logistic Regressions ', ' Training ', ' pediatric ', ' Childhood ', ' Individual ', ' Genetic ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Prediabetes ', ' Prediabetic State ', ' pre-diabetes ', ' pre-diabetic ', ' prediabetic ', ' Prediabetes syndrome ', ' Adopted ', ' Complex ', ' QTL ', ' Quantitative Trait Loci ', ' novel ', ' Prevention Research ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Pathogenesis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Connectionist Models ', ' Neural Network Models ', ' Perceptrons ', ' Neural Network Simulation ', ' case control ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Bio-Informatics ', ' Bioinformatics ', ' preventing ', ' prevent ', ' Data ', ' enroll ', ' Enrollment ', ' Genetic Population Study ', ' Genetic Risk ', ' Molecular ', ' developmental ', ' Development ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' genetic profiling ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Population ', ' prevention clinical trial ', ' high risk ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' Prevention trial ', ' expression subtypes ', ' molecular sub-types ', ' molecular subsets ', ' molecular subtypes ', ' recruit ', ' feedforward neural network ', ' deep learning ', ' neural network ', ' statistical and machine learning ', ' ']",NIDDK,AUGUSTA UNIVERSITY,F30,2020,41074,GA-12,0.0661273791130121
"Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54) Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed atypical diabetes (AD), that do not fit into either category. We hypothesize that AD comprises a spectrum that includes numerous forms, both known (e.g, MODY/monogenic, Latent Autoimmune Diabetes of Adults, Ketosis-Prone Diabetes) and unknown. We propose to establish the Center for Atypical Diabetes Research and Evaluation (CADRE). The goals of CADRE are to (1) identify and define comprehensively the forms of AD; and (2) establish an extensive database and repository of biosamples from AD patients. Defining the forms of AD is challenging because the etiology of AD can range from a single gene variant to a highly complex mixture of genetics, epigenetics and environmental factors. To identify patients with AD, and then to define the forms, we will use a two-pronged approach. Approach (a) will use clustering analysis of genotypic and phenotypic data from diverse groups of patients with diabetes. We have recruited 15 domestic and international population cohorts with data on more than 33,000 patients with diabetes. Further, we have recruited six diabetes study clinics (Baylor College of Medicine [BCM], University of Washington [UW], Indiana University [IU], Emory University, University of Colorado, and SUNY Downstate) who will prospectively recruit patients. The Juvenile Diabetes Research Foundation will facilitate recruitment from patient groups. The Administrative Core at BCM will work with cohorts and clinics to obtain data. The University of South Florida (USF) will filter data for AD and separate patients into phenotypically homogenous clusters that can be diagnosed based on genetic and clinical features unique to the cluster. Approach (b) will identify monogenic, oligogenic and mitochondrial forms of AD from patients enrolled in genetics registries (BCM) and a family study with genetic data (Botnia). The BCM registries include patients referred to the Undiagnosed Disease Network. All patients will undergo whole-exome and mitochondrial genome sequencing (Cores at BCM), single-nucleotide polymorphism variant analysis (Oxford), metabolomic analysis (Duke) and phenotypic analysis of C-peptide, adiponectin, proinsulin, islet autoantibodies, and serum insulin DNA levels (Cores at UW and IU). To establish the database and biorepository, we will invite patients with AD to participate in sample donation and longitudinal follow-up via the cohorts and clinics. Data and samples will be transferred to the Database and Biorepository Core at USF, with input and tracking implemented using the successful framework developed by USF for large multicenter trials. Data will be made available through the NIDDK and a CADRE website and samples will be made available through ancillary study application. Ongoing patient recruitment to expand the database and biorepository will occur through the study clinics and clinician referral through the CADRE website. Overall, CADRE will be built on a foundation of existing, successful core facilities and computational systems to create a lasting resource that will substantially advance AD research. PROJECT NARRATIVE For many people with diabetes, their symptoms do not match those usually associated with type 1 or type 2 diabetes. We will use medical and genetic information from a large number of patients with diabetes to find all the forms of atypical diabetes, so doctors can better diagnose and treat these patients. We will also make the Center for Atypical Diabetes Research and Evaluation (CADRE) to keep data and samples from patients with atypical diabetes, so scientists can study these forms of diabetes.",Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54),9988405,U54DK118638,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' C-Peptide ', ' connecting peptide ', ' Classification ', ' Systematics ', ' Clinical Protocols ', ' Cluster Analysis ', ' Cluster Analyses ', ' Colorado ', ' Communication ', ' Complication ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Florida ', ' Foundations ', ' Future ', ' Medical Genetics ', ' Clinical genetics ', ' Genome ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Indiana ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Medicine ', ' Mining ', ' Mission ', ' Mitochondria ', ' mitochondrial ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Phenotype ', ' Physiology ', ' Proinsulin ', ' Registries ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Syndrome ', ' Universities ', ' Washington ', ' Work ', ' Youth 10-21 ', ' Youth ', ' Immunology ', ' Natural History ', ' base ', ' improved ', ' Family Study ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Autoimmune Diabetes ', ' Multi-center trial ', ' Multicenter Trials ', ' Biological Substance Banks ', ' biological specimen repository ', ' biosample repository ', ' biospecimen repository ', ' specimen bank ', ' specimen repository ', ' Biological Specimen Banks ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' insight ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' data retrieval ', ' data storage ', ' Data Storage and Retrieval ', ' participant recruitment ', ' Patient Recruitments ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' ACRP30 protein ', ' adipocyte complement-related protein 30-kDa ', ' adipocyte, C1q and collagen domain containing protein ', ' apM-1 protein ', ' apM1 (adipose-specific) protein ', ' adiponectin ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' Autoimmune ', ' Autoimmune Process ', ' System ', ' collegiate ', ' college ', ' diabetes genetics ', ' diabetes mellitus genetics ', ' cohort ', ' novel ', ' Participant ', ' Categories ', ' outreach ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Single Base Polymorphism ', ' single nucleotide variant ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Sampling ', ' genetic registry ', ' patient registry ', ' Complex Mixtures ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Symptoms ', ' Core Facility ', ' Sequencing Core ', ' DNA Sequencing Facility ', ' Data ', ' International ', ' Molecular Diagnosis ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Subgroup ', ' Ancillary Study ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' mitochondrial genome ', ' website ', ' web site ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' designing ', ' design ', ' islet ', ' Population ', ' prospective ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' biorepository ', ' biobank ', ' exomes ', ' exome ', ' data sharing ', ' Secure ', ' genetic information ', ' learning activity ', ' learning method ', ' learning strategy ', ' phenotypic data ', ' recruit ', ' unsupervised machine learning ', ' unsupervised learning ', ' data diversity ', ' diverse data ', ' diabetes pathogenesis ', ' ']",NIDDK,BAYLOR COLLEGE OF MEDICINE,U54,2020,2500000,TX-09,0.005170802675141143
"Resource Curation and Evaluation for EHR Note Comprehension Title: Resource Curation and Evaluation for EHR Note Comprehension The American Diabetes Association estimates that over 25.8 million Americans have diabetes. Proper patient self-management is perhaps the most critical and under-exercised element for patients to achieve appropriate glycemic control and thus mitigate complications and comorbid conditions, and implement appropriate preventive strategies (e.g., vaccines, exercise, healthy diet). In previous work we have shown that educating patients by using content in their medical records improved diabetes outcomes and that NoteAid, a multi- module natural language processing system that links medical jargon in electronic health records to definitions, has improved self-reported comprehension. Here we propose to develop NoteAid with a high-quality resource of expert-curated lay definitions and evaluation methods for diabetes patients note comprehension. ! ! Title: Resource Curation and Evaluation for EHR Note Comprehension The American Diabetes Association estimates that over 25.8 million Americans have diabetes. In previous work we have shown that educating patients by using content in their medical records improved diabetes outcomes and that NoteAid, a natural language processing system that links medical jargon in electronic health records to definitions, has improved self-reported comprehension. Here we propose to develop NoteAid with a high-quality resource of expert-curated lay definitions and evaluation methods for diabetes patients note comprehension. ! !",Resource Curation and Evaluation for EHR Note Comprehension,9925807,R01LM012817,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Attitude ', ' Back ', ' Dorsum ', ' Behavior ', ' Communication ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Education ', ' Educational aspects ', ' Elements ', ' Exercise ', ' Eye diseases ', ' eye disorder ', ' ophthalmopathy ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Hospitals ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Language ', ' Learning ', ' Libraries ', ' Massachusetts ', ' Medical Records ', ' Methods ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Natural Language Processing ', ' natural language understanding ', ' Patient Education ', ' Patient Instruction ', ' Patient Training ', ' Patients ', ' Physicians ', ' Questionnaires ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Reading ', ' Resources ', ' Research Resources ', ' Risk ', ' Medical Students ', ' medical school students ', ' Nursing Students ', ' Pupil Nurses ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Vaccines ', ' Visual Aid ', ' Vocabulary ', ' Vocabulary Words ', ' Work ', ' Caregivers ', ' Care Givers ', ' health care ', ' Healthcare ', ' Self Management ', ' Caring ', ' Comprehension ', ' base ', ' improved ', ' Clinical ', ' Medical ', ' Link ', ' Evaluation ', ' Individual ', ' Trust ', ' Measurement ', ' Ethnicity ', ' Ethnic Origin ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' instrument ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' mechanical ', ' Mechanics ', ' Complex ', ' Techniques ', ' System ', ' Healthy diet ', ' balanced diet ', ' good diet ', ' Country ', ' American ', ' Informatics ', ' Speed ', ' skills ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Self-Report ', ' Patient Self-Report ', ' General Public ', ' General Population ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Cognitive ', ' Ontology ', ' Characteristics ', ' sex ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' cost ', ' designing ', ' design ', ' glycemic control ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' usability ', ' diabetic patient ', ' Data Science ', ' health care outcomes ', ' healthcare outcomes ', ' care outcomes ', ' deep learning ', ' ']",NLM,UNIVERSITY OF MASSACHUSETTS LOWELL,R01,2020,335875,MA-03,0.07830025409843754
"Planning for a Cohort Study on Neurocognitive Complication of Type 1 Diabetes in Children Project Summary. Children with type 1 diabetes (T1D) suffer from subtle cognitive impairments and structural alterations in the brain. These impairments progress with age and may eventually lead to increased difficulty managing the disease, resulting in worsening glycemic control, potentially life-threatening complications, and reductions in quality of life. Causes of cognitive decline in T1D are not well understood. Episodes of hypoglycemia, chronic hyperglycemia, glycemic variability and diabetic ketoacidosis (DKA) have all been suggested to play roles. Increased understanding of factors linked to cognitive decline in T1D, and the mechanisms responsible for these associations, is essential such that interventions to preserve cognition could be proposed. Recent data suggest that neuroinflammation resulting from hyperglycemia and episodes of DKA may be play a prominent role in causing cognitive decline. There is also evidence that modifiable factors such as nutrition, exercise, and sleep quality might modulate effects of chronic neuroinflammation and influence cognitive outcomes. In this project, we will engage in efforts to plan a comprehensive study of factors associated with cognition in children with T1D. At the completion of the proposed planning project, we will be prepared to conduct a longitudinal cohort study of children with newly diagnosed T1D. This study will determine how glycemic control and DKA exposure predict altered brain structure and cognition and establish whether markers of neuronal injury and inflammatory processes explain these longitudinal relations. Proposed assessments will include T1D-related factors (glycemic control, glycemic variability, hypoglycemia, DKA), brain structure and cognitive function (attention, memory and IQ). In addition, we will plan measurements of inflammatory mediators and markers of neuroinflammation using blood assays (cytokine measurements, exosome analyses, RNA microarrays), and evaluate factors that might modify inflammation such as diet (nutrient content), sleep quality and exercise. To optimize the study design, we will utilize the expertise of a multidisciplinary team to develop the study protocol, including experts in pediatric diabetes, cognitive development, neural and systemic inflammation, MR imaging, nutrition, sleep medicine, and data science. The team will work together to finalizing the protocol, work-flow and outcome measures, and identify the necessary computational infrastructure and data analysis strategies. The team will also assess study feasibility (factors affecting enrollment success and tolerance of the protocol) and determine necessary sample size by evaluating variability in biochemical and imaging measures. Alternative approaches to increase participant retention, such as remote (online) versus in person cognitive testing, will be explored. At the conclusion of this planning project, we will have developed and optimized a protocol to explore factors associated with cognitive decline in children with T1D, laying a foundation for future studies aimed at preserving cognitive function. Narrative. Individuals with type 1 diabetes often have declines in cognitive function over time, with a high risk of cognitive impairments and dementia as older adults. The physiological events responsible for cognitive damage in T1D are not understood, and it is unclear how cognitive decline might be prevented. In the proposed project, we will plan a comprehensive, multi-center study to investigate factors associated with declines in cognition in children with T1D at onset of the disease and over time.",Planning for a Cohort Study on Neurocognitive Complication of Type 1 Diabetes in Children,10020976,U34DK123894,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Aerobic Exercise ', ' Aerobic Activity ', ' Aerobic fitness ', ' Affect ', ' Age ', ' ages ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Antibodies ', ' Attention ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood - brain barrier anatomy ', ' Blood-Brain Barrier ', ' Hemato-Encephalic Barrier ', ' bloodbrain barrier ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Brain Chemistry ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Cognition ', ' Cohort Studies ', ' Concurrent Studies ', ' Complication ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Diabetic Ketoacidosis ', ' Diabetic Acidosis ', ' Diabetic Ketosis ', ' diabetic ketoacidotic ', ' Diet ', ' dietary ', ' Encephalitis ', ' Brain Inflammation ', ' Equilibrium ', ' balance ', ' balance function ', ' Exercise ', ' Family dynamics ', ' family structure/dynamics ', ' Feasibility Studies ', ' Foundations ', ' Future ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Inflammation ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Light ', ' Photoradiation ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Magnetic Resonance Spectroscopy ', ' MR Spectroscopy ', ' Medicine ', ' Memory ', ' Short-Term Memory ', ' Immediate Memory ', ' Shortterm Memory ', ' working memory ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Methods ', ' Persons ', ' nutrition ', ' Patients ', ' Play ', ' Quality of life ', ' QOL ', ' Research Design ', ' Study Type ', ' study design ', ' Risk ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Role ', ' social role ', ' Siblings ', ' Sleep ', ' Testing ', ' Time ', ' Work ', ' cytokine ', ' Measures ', ' Outcome Measure ', ' Procedures ', ' Site ', ' Chronic ', ' Phase ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Link ', ' Evaluation ', ' Individual ', ' Measurement ', ' Sample Size ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Acquired brain injury ', ' brain damage ', ' brain-injured ', ' Brain Injuries ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' disease onset ', ' disorder onset ', ' Onset of illness ', ' Multi-center studies ', ' Multicenter Studies ', ' Inflammatory ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' machine learned ', ' Machine Learning ', ' Life ', ' Disorder Management ', ' Disease Management ', ' cognitive function ', ' longterm memory ', ' long term memory ', ' Severities ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Amentia ', ' Dementia ', ' Neurocognitive ', ' success ', ' nerve cell death ', ' nerve cell loss ', ' neuron cell death ', ' neuron cell loss ', ' neuron death ', ' neuronal cell death ', ' neuronal cell loss ', ' neuronal death ', ' neuronal loss ', ' neuron loss ', ' cohort ', ' neural ', ' relating to nervous system ', ' Structure ', ' Nutrient ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' preventing ', ' prevent ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Data ', ' Cognitive ', ' enroll ', ' Enrollment ', ' Newly Diagnosed ', ' Rodent Model ', ' Process ', ' imaging ', ' Image ', ' cost ', ' neuron injury ', ' Neuronal Injury ', ' neuroinflammatory ', ' neuroinflammation ', ' diet and exercise ', ' glycemic control ', ' Outcome ', ' prospective ', ' 10 years of age ', ' age 10 years ', ' ten year old ', ' ten years of age ', ' 10 year old ', ' Impairment ', ' multidisciplinary ', ' nondiabetic ', ' non-diabetic ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' inflammation marker ', ' inflammatory marker ', ' type 1 diabetes onset ', ' insulin dependent diabetes mellitus onset ', ' computational infrastructure ', ' computer infrastructure ', ' BigData ', ' Big Data ', ' cognitive assessment ', ' cognitive testing ', ' cognitive development ', ' cognitive ability ', ' Data Science ', ' exosome ', ' Long-term cohort study ', ' Longterm cohort study ', ' Longitudinal cohort study ', ' participant retention ', ' preservation ', ' quality of sleep ', ' sleep quality ', ' risk factor for dementia ', ' risk for dementia ', ' dementia risk ', ' diabetes during childhood ', ' diabetes in childhood ', ' diabetes in children ', ' pediatric diabetes ', ' Childhood diabetes ', ' ']",NIDDK,UNIVERSITY OF CALIFORNIA AT DAVIS,U34,2020,352245,CA-03,-0.019643541039112342
"Clinical, Radiologic and Biochemical Factors Related to Diabetes Development after Acute Pancreatitis Abstract Nearly 40% of patients develop diabetes after an initial episode of acute pancreatitis (AP). Various studies have evaluated risk factors for the development of diabetes but they have shown inconsistent findings, suggesting methodologic shortcomings. The present proposal consists of three specific aims where we will attempt to determine the biochemical, radiologic and clinical factors related to the development of diabetes after AP. Aim 1: To identify autoantibodies associated with the progression of type 1 diabetes in patients after AP using a large human proteome array. Aim 2: To study the role of imaging, more specifically quantitative textural analysis to predict the development of type 1 diabetes after AP. Aim 3 is to build a machine learning model to predict type 1 diabetes after AP using patient-related risk factors, textural analysis on imaging and autoantibodies involved in disease progression. Our proposal will help us better understand diabetes after AP. Successful completion of this study has the potential to improve management for AP. Project Narrative Relevance to Public Health Statement Acute pancreatitis is increasing in incidence and can lead to diabetes in some patients. Diabetes is a morbid disease. We plan to study both established and novel risk factors for developing diabetes in patients with acute pancreatitis.","Clinical, Radiologic and Biochemical Factors Related to Diabetes Development after Acute Pancreatitis",10128083,U01DK127400,"['acute pancreatitis ', ' Antibodies ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' Autoantigens ', ' Autologous Antigens ', ' Self-Antigens ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmune Responses ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Communicable Diseases ', ' Infectious Disease Pathway ', ' Infectious Diseases ', ' Infectious Disorder ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Disease ', ' Disorder ', ' Fatty acid glycerol esters ', ' Fats ', ' Future ', ' Glucagon ', ' Antidiabetic Hormone ', ' Glukagon ', ' HG-Factor ', ' Hyperglycemic-Glycogenolytic Factor ', ' Goals ', ' Recording of previous events ', ' History ', ' Hospitals ', ' Human ', ' Modern Man ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Incidence ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Pancreas ', ' Pancreatic ', ' Pancreatic Diseases ', ' Pancreatic Disorder ', ' pancreas disorder ', ' Pathology ', ' Patients ', ' Public Health ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Recurrence ', ' Recurrent ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' Technology ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Total Pancreatectomy ', ' pancreas total excision ', ' Autologous Transplantation ', ' Autograft ', ' Autotransplant ', ' autologous graft ', ' autotransplantation ', ' Mediating ', ' base ', ' Organ ', ' improved ', ' Acute ', ' Clinical ', ' Serologic ', ' Serological ', ' Biochemical ', ' Autoimmune Diabetes ', ' Blood Serum ', ' Serum ', ' Individual ', ' Recovery ', ' Disease Progression ', ' pancreatitis necrotizing ', ' Acute Necrotizing Pancreatitis ', ' impaired glucose tolerance ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Inflammatory ', ' Prediabetes ', ' Prediabetic State ', ' pre-diabetes ', ' pre-diabetic ', ' prediabetic ', ' Prediabetes syndrome ', ' machine learned ', ' Machine Learning ', ' Life ', ' Visceral ', ' subcutaneous ', ' Texture ', ' Techniques ', ' experience ', ' Biopsy Sample ', ' Biopsy Specimen ', ' novel ', ' Proteome ', ' Modeling ', ' Proteomics ', ' Meta-Analysis ', ' model development ', ' Organ failure ', ' Insulin Cell ', ' Insulin Secreting Cell ', ' -cell ', ' -cells ', ' Cell ', ' Beta Cell ', ' Address ', ' Resolution ', ' Clinical Data ', ' Clinical/Radiologic ', ' Collection ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' systematic review ', ' macrovascular complication ', ' macrovascular disease ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' islet ', ' diabetic Autoantibodies ', ' Diabetes autoantibodies ', ' Impairment ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical risk ', ' nutrient absorption ', ' marker identification ', ' biomarker identification ', ' radiomics ', ' radiologic imaging ', ' radiological imaging ', ' Systemic Inflammatory Response Syndrome ', ' clinical center ', ' ']",NIDDK,JOHNS HOPKINS UNIVERSITY,U01,2020,286563,MD-07,0.14645880302430764
"Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer This is an application for renewal of Clinical Center designation of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). The Greater Los Angeles Clinical Center has provided considerable leadership in the organization and progress of the CPDPC. Dr. Pandol serves as co-chair of the Steering Committee and Dr. Goodarzi co-chairs the Type 3c Working Group. We have excelled in recruitment and retention of participants in the cohort studies implemented through the CPDPC designed to elucidate the natural history and develop means of diagnosis, treatment and clinical management of chronic pancreatitis (CP) and its complications in children and adults, and to determine the pathogenic interrelationships of diabetes and pancreatic cancer and develop the means of early diagnosis and management of pancreatic cancer. In addition, we have been performing a number ancillary and associated studies to support the overall goals of CPDPC, including: 1. Epidemiologic studies defining risk factors for pancreatic cancer and the natural history of CP; 2. Determining that genetic susceptibility for type 2 diabetes is a strong risk factor for diabetes associated with CP; 3. Developing liquid biopsy assays for aiding in the diagnosis of pancreatic cancer and CP; 4. Investigating mechanisms of pancreatitis and pancreatic cancer for rational pharmaceutical treatments; and 5. Conducting pilot clinical trials for treatment of recurrent acute and chronic pancreatitis. For the next phase of the CPDPC we are committed to the following Specific Aims: 1. Continue recruitment and retention of subjects in CPDPC cohort studies (PROCEED, INSPPIRE 2, NOD,  DETECT) in existing and additional study sites, as well as increase diversity in the study population. 2. Continue currently supported ancillary studies to further develop risk factor models combined with liquid  biopsy assays for early diagnosis of chronic pancreatitis and pancreatic cancer, and advance mechanism-  based treatments and clinical trials for recurrent acute and chronic pancreatitis and pancreatic cancer. 3. Build models that combine clinical features with genetic susceptibility to allow the prediction of future  development of diabetes in patients with chronic pancreatitis. 4. Determine the role of pancreatic enzyme replacement in regulating glucose homeostasis in patients with  chronic pancreatitis and diabetes, with or without pancreatic exocrine insufficiency. 5. Use existing and annotated pre-diagnostic CT scans to develop artificial intelligence-based techniques for  highly sensitive and specific methods for CT-based early pancreatic cancer detection. Our Center involves Cedars-Sinai Medical Center, UCLA Medical Center, the VA Greater Los Angeles Healthcare System and the University of Southern California/Los Angeles Public Health System with an organizational structure designed to expand recruitment into cohort studies of CPDPC with increased diversity and to facilitate our participation in ancillary studies. This is an application to renew the Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, which consists of an expert team well-qualified to carry out studies of the Consortium in Los Angeles County, the most populous and ethnically diverse county in the United States. We plan to adjust and expand our recruitment strategies for cohort studies of the Consortium to help meet national goals; we will also continue progress on a series of ancillary studies within the Consortium designed to detect and treat pancreatic diseases. In addition, we propose new studies to develop prediction models for diabetes in chronic pancreatitis, interrogate the role of digestive enzyme insufficiency in this form of diabetes, and develop novel imaging-based methods for early pancreatic cancer detection that will, in turn, decrease the morbidity of pancreatic cancer.","Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer",10263513,U01DK108314,"['acute pancreatitis ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' California ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Enzymes ', ' Enzyme Gene ', ' Future ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Human ', ' Modern Man ', ' Institutes ', ' Leadership ', ' Los Angeles ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Pancreatic Diseases ', ' Pancreatic Disorder ', ' pancreas disorder ', ' Pancreatitis ', ' Patients ', ' Public Health ', ' Recurrence ', ' Recurrent ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' Universities ', ' County ', ' recurrent pancreatitis ', ' chronic pancreatitis ', ' Natural History ', ' base ', ' Site ', ' Area ', ' Clinical ', ' Series ', ' pediatric ', ' Childhood ', ' Pancreatic Insufficiency ', ' Exocrine pancreatic insufficiency ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Malignant Pancreatic Neoplasm ', ' Pancreas Cancer ', ' Pancreatic Cancer ', ' pancreatic malignancy ', ' Malignant neoplasm of pancreas ', ' Diagnostic ', ' Complex ', ' Techniques ', ' Chronic Phase ', ' exocrine pancreatic ', ' Exocrine pancreas ', ' Medical center ', ' early detection ', ' Early Diagnosis ', ' novel ', ' disease risk ', ' disorder risk ', ' Organization Charts ', ' organizational structure ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Modeling ', ' response ', ' pancreas enzyme ', ' Pancreatic enzyme ', ' Data Monitoring Committees ', ' Data and Safety Monitoring Boards ', ' Safety Monitoring Boards ', ' Clinical Trials Data Monitoring Committees ', ' Pathogenicity ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Pancreas Ductal Adenocarcinoma ', ' Pancreatic Ductal Adenocarcinoma ', ' Health system ', ' NCI Organization ', ' National Cancer Institute ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' precancerous ', ' premalignant ', ' Ancillary Study ', ' Cancer Detection ', ' Clinical Management ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Principal Investigator ', ' developmental ', ' Development ', ' work group ', ' working group ', ' treatment trial ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' study population ', ' ethnically diverse ', ' ethnic diversity ', ' liquid biopsy ', ' recruit ', ' participant retention ', ' clinical center ', ' ']",NIDDK,CEDARS-SINAI MEDICAL CENTER,U01,2020,90342,CA-28,0.11819030120802701
"Machine learning approaches towards risk assessment and prediction of adverse pregnancy outcomes PROJECT SUMMARY The primary objectives of this project include understanding the interplay between molecular, genetic and clinical factors related to adverse pregnancy outcomes (APOs), method development for accurate risk assessment of APOs well before they occur, and method development for collecting additional clinical data in routine treatment of at-risk-subjects. Towards these goals we have assembled a team of investigators with clinical, translational, and computational expertise capable of identifying novel contributors to APOs as well as facilitating clinician-patient interactions using data-driven and theoretically sound machine learning approaches. Our strategies will rely on advanced machine learning as well as integration of clinical, genetic, and molecular data and hold promise to bring precision medicine to the treatment and experience of women during and post pregnancy. We will predominantly rely on the data collected during the national Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be; i.e., the nuMoM2b study. Using the cohort of 10,038 nulliparous women, we will efficiently accomplish 3 Aims: to integrate genetic, clinical, and molecular features towards a deep understanding of APOs; to develop machine learning models for advanced risk prediction; and to engage in active data collection towards risk assessment and model development. Using a close collaboration between computational and clinical scientists, we believe this proposal will result in important advances in understanding the molecular and clinical aspects of APOs as well as assessing the risk for APOs and thus providing tangible contributions to maternal health. PROJECT NARRATIVE Utilizing advanced machine learning as well as integration of clinical, genetic, and molecular data, this proposal seeks tangible advances in individualized risk prediction for adverse pregnancy outcomes. This research is relevant to public health in that it will provide mechanistic insights and opportunities for personalized prevention strategies for avoiding adverse pregnancy outcomes.",Machine learning approaches towards risk assessment and prediction of adverse pregnancy outcomes,10063323,R01HD101246,"['Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Data Collection ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Fetal Growth Retardation ', ' Fetal Growth Restriction ', ' IUGR ', ' Intrauterine Growth Retardation ', ' impaired fetal growth ', ' intra-uterine growth restriction ', ' intra-uterine growth retardation ', ' intrauterine growth restriction ', ' prenatal growth disorder ', ' Medical Genetics ', ' Clinical genetics ', ' Genome ', ' Genotype ', ' Goals ', ' Indiana ', ' Life Style ', ' Lifestyle ', ' Maternal Health ', ' Medical Informatics ', ' Mothers ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nulliparity ', ' Nulliparas ', ' Nulliparous ', ' Patients ', ' Perinatal mortality demographics ', ' Perinatal Mortalities ', ' Perinatal lethality ', ' perinatal deaths ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' First Pregnancy Trimester ', ' 1st trimester ', ' Early Placental Phase ', ' First Trimester ', ' Second Pregnancy Trimester ', ' 2nd trimester ', ' Midtrimester ', ' Second Trimester ', ' Public Health ', ' Records ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Social support ', ' social support network ', ' sound ', ' Stress ', ' Universities ', ' Woman ', ' Gestational Diabetes ', ' Gestational Diabetes Mellitus ', ' Pregnancy-Induced Diabetes ', ' pregnancy diabetes ', ' Molecular Genetics ', ' Risk Assessment ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' method development ', ' improved ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Medical ', ' insight ', ' Discipline ', ' Individual ', ' disease onset ', ' disorder onset ', ' Onset of illness ', ' Collaborations ', ' Genetic ', ' machine learned ', ' Machine Learning ', ' computer biology ', ' Computational Biology ', ' Knowledge ', ' Scientist ', ' Clinic ', ' Pattern ', ' Techniques ', ' at-risk fetus ', ' fetus at risk ', ' fetal ', ' Outcome Study ', ' experience ', ' Performance ', ' success ', ' cohort ', ' novel ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Modeling ', ' response ', ' Adverse Experience ', ' Adverse event ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' model development ', ' Ally ', ' Genetic Structures ', ' Pharmacogenomics ', ' Data ', ' NICHD ', "" National Institute of Children's Health and Human Development "", ' National Institute of Child Health and Human Development ', ' Resolution ', ' Clinical Data ', ' enroll ', ' Enrollment ', ' Monitor ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' pathway ', ' Pathway interactions ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Mind ', ' prospective ', ' demographics ', ' precision-based medicine ', ' precision medicine ', ' personalized prevention ', ' precision prevention ', ' individualized prevention ', ' perinatal morbidity ', ' phenotypic data ', ' adverse pregnancy outcome ', ' antepartum ', ' antenatal ', ' Individualized risk prediction ', ' personalized risk prediction ', ' Precision Health ', ' Data Scientist ', ' structured data ', ' ']",NICHD,INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,R01,2020,481588,IN-07,0.05737444878344082
"Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes PROJECT SUMMARY/ABSTRACT Dr. McCoy is an endocrinologist and primary care physician specializing in the care for patients with diabetes and other chronic health conditions. Her long-term goal is to become an independent researcher and leader in evaluating, improving, and individualizing diabetes care through effective use of big data completed by qualitative insights from patients and those involved in their care. The short-term training goals of this proposal are to acquire: 1) proficiency in statistics and data science; 2) experience in qualitative research; 3) skills in clinical trial design; and 4) communication and leadership skills to lead multi-disciplinary research. The proposal's research will be conducted at Mayo Clinic, which has a strong history of training physician scientists and a well-developed infrastructure for education and research. Dr. McCoy has access to an ideal set of data assets, the OptumLabs Data Warehouse and the Kaiser Permanente Northern California Diabetes Registry, and the support of an exceptional team of mentors and advisors who are national leaders in diabetes outcomes and health care delivery research, shared decision-making, qualitative research, and data science. Optimization of glycemic control, while avoiding severe hypoglycemia and hyperglycemia, is the cornerstone of diabetes management. Severe hypoglycemia and hyperglycemia are often preventable, yet continue to incur substantial morbidity, psychological distress, impaired quality of life, and economic burden. There are no validated tools to predict these events and as a result clinicians lack a practical and reliable means to identify high risk patients. The goal of Dr. McCoy's work is to address this critical gap in diabetes management. In Aim 1, she will use large database analysis and novel analytic methods to characterize the patterns of severe hypoglycemia and hyperglycemia among adults with diabetes in the U.S. In Aim 2, she will build on Aim 1 to develop and validate computationally efficient concurrent risk prediction models for severe hypoglycemia and hyperglycemia that could be used in clinical encounters. In Aim 3, she will directly engage patients and their clinicians in conversation about severe hypoglycemia /hyperglycemia risk in order to better understand how information about severe hypoglycemia/ hyperglycemia risk is perceived, interpreted, and used. These studies will serve as foundation for two R01 applications to be submitted during Years 4 and 5, and will advance the science and practice of personalized diabetes care through integration of data science and qualitative methods for the purpose of understanding, predicting, and ultimately preventing severe hypoglycemic/hyperglycemic events. Dr. McCoy has a proven track record of scientific productivity and innovation, and a strong foundation in using secondary data for health services and outcomes research in diabetes. In summary, the training, mentoring, and research proposed here are essential for Dr. McCoy's career development as she develops research independence and expertise in the crucial interface between patients and their clinical teams, evidence-based medicine, and big data. PROJECT NARRATIVE Severe hypoglycemic and hyperglycemic events in the management of diabetes mellitus continue to incur high morbidity, psychological distress, and economic costs; yet, these events may be prevented with individualization of treatment goals and regimens if high risk patients are identified prospectively. The proposed research will leverage big data analytics and qualitative research to 1) characterize the epidemiology of severe hypoglycemia and hyperglycemia in the U.S.; 2) develop and validate concurrent risk prediction models for severe hypoglycemia and hyperglycemia; and 3) enrich the understanding of severe hypoglycemia/ hyperglycemia risk and risk model utilization through qualitative patient and clinician engagement.",Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes,9983016,K23DK114497,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Calibration ', ' California ', ' Clinical Trials ', ' Communication ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Data Sources ', ' Decision Making ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Diabetes Mellitus ', ' diabetes ', ' Discrimination ', ' Cognitive Discrimination ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Face ', ' faces ', ' facial ', ' Foundations ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Hospitalization ', ' Hospital Admission ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Interview ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' Patients ', ' Physicians ', ' Primary Care Physician ', ' Productivity ', ' Quality of life ', ' QOL ', ' Registries ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Science ', ' Self Care ', ' personal care ', ' statistics ', ' Time ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' United States ', ' Work ', ' health care ', ' Healthcare ', ' Outcomes Research ', ' Dataset ', ' Data Set ', ' Caring ', ' Guidelines ', ' analytical method ', ' base ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' psychological ', ' psychologic ', ' Training ', ' insight ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Endocrinologist ', ' tool ', ' Evidence Based Medicine ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Event ', ' Clinic ', ' Pattern ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' experience ', ' skills ', ' novel ', ' member ', ' economic cost ', ' social ', ' psychological distress ', ' Modeling ', ' career development ', ' Qualitative Research ', ' preventing ', ' prevent ', ' Address ', ' qualitative reasoning ', ' Qualitative Methods ', ' Data ', ' Economic Burden ', ' K23 Award ', ' K23 Mechanism ', ' K23 Program ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' Mentored Patient-Oriented Research Career Development Award ', ' Research Training ', ' Clinical Trials Design ', ' Outcomes and Health Services Research ', ' Risk Estimate ', ' Validation ', ' developmental ', ' Development ', ' point of care ', ' disease phenotype ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' data integration ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' Outcome ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' Impairment ', ' multidisciplinary ', ' patient centered ', ' patient oriented ', ' high risk ', ' clinical care ', ' shared decision making ', ' Regimen ', ' data registry ', ' BigData ', ' Big Data ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' Patient risk ', ' health data ', ' support tools ', ' education research ', ' Data Science ', ' individual patient ', ' clinical decision support ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' Infrastructure ', ' machine learned algorithm ', ' machine learning algorithm ', ' Big Data Analytics ', ' Big Data Tools ', ' Big Data Methods ', ' risk prediction model ', ' large data sets ', ' large datasets ', ' clinical encounter ', ' ']",NIDDK,MAYO CLINIC ROCHESTER,K23,2020,169005,MN-01,0.08106836472278235
"Calcium oscillations and cell motility with corneal injury According to the World Health Organization, corneal blindness from disease and injury is one of the top causes of blindness. Diabetes increases the risk of improper wound repair after minor scratches, corneal transplantation, and removal of epithelium during vitrectomy or refractive surgery. Altered focal adhesion, hemidesmosome, and cell-cell junction dynamics are common hallmarks of poor wound healing. Our group has demonstrated increased expression of the ATP-binding purinoreceptor, P2X7 in human diabetic corneas and in a murine model of Type II diabetes (DIO) accompanied by impaired wound healing. Furthermore, changes in P2X7 alters focal adhesion turnover and actin bundling in vitro that may lead to impaired wound healing. We have preliminary data from both wounded corneal epithelial cultures and explants demonstrating that sustained calcium oscillations occur after stimulation and travel between cells for hours. We found that when calcium mobilizations were absent between cells at the leading edge, that lamellipodial protrusions were absent. It is not known which receptor is required for this activity; however, we predict that the oscillations are a result of a highly-orchestrated activation of purinoreceptors. Previously we demonstrated that knockdown of specific purinoreceptors altered downstream signaling pathways that involve cell motility and adhesion proteins.  Our goal in this innovative proposal is to use image processing and machine learning to understand the events that occur in cell-cell communication that induce cell migration in corneal epithelia and to examine how these events are mediated in corneas from a diabetic induced obesity murine model. The proposal challenges the accepted paradigm that the cell-cell communication wave in the wounded cornea is a short-lived on-and-off signal, but that it is a prolonged oscillating signal needed for healthy epithelial cell migration to effectively heal the wounded cornea. As the calcium and motility assays yield large data sets and complex patterns, we are collaborating with a neuroscientist and a computer scientist to utilize machine learning to determine when cells will interact if specific receptors or complexes of receptors are activated. To address these questions, we will simultaneously perform live cell imaging of calcium mobilization, actin and ATP release in epithelium of wounded corneas under normal and diabetic conditions. The aims are: 1. To determine if there are specific response signatures elicited by the sustained calcium mobilizations and signaling generated with injury in control corneas and corneas from diet induced obesity mice; and 2. To determine if the intercellular calcium mobilizations required for the initiation of lamellipodial ruffling are necessary for proper migration? Narrative Injury to the cornea can be both painful and compromise vision. We and others have shown that repair and innervation of the diabetic cornea is compromised. Our goal is to use a combination of live cell imaging, computational modeling and molecular tools to determine the changes in signals that tell corneal epithelial cells to heal under control conditions compared to those under pathologic conditions such as diabetes.",Calcium oscillations and cell motility with corneal injury,9853790,R21EY029097,"['Actins ', ' Affect ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Calcium ', ' Cell Adhesion Molecules ', ' Adhesion Molecule ', ' Cell Adhesion Molecule Gene ', ' cell adhesion protein ', ' Cell Communication ', ' Cell Interaction ', ' Cell-to-Cell Interaction ', ' cell motility ', ' Cell Locomotion ', ' Cell Migration ', ' Cell Movement ', ' Cellular Migration ', ' Cellular Motility ', ' Motility ', ' Cells ', ' Cell Body ', ' Communication ', ' Computers ', ' Cornea ', ' corneal ', ' Keratoplasty ', ' Cornea Transplantation ', ' Corneal Grafting ', ' Corneal Transplantation ', ' corneal keratoplasty ', ' corneal transplant ', ' Cytoskeleton ', ' Cellular Matrix ', ' Cytoskeletal System ', ' intracellular skeleton ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Epithelial Cells ', ' Epithelium ', ' Epithelium Part ', ' Exhibits ', ' Fingerprint ', ' Goals ', ' Human ', ' Modern Man ', ' In Vitro ', ' nerve supply ', ' innervation ', ' Intercellular Junctions ', ' Cell Junctions ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Obese Mice ', ' ob/ob mouse ', ' Minor ', ' Neurosciences ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Pain ', ' Painful ', ' Pathology ', ' Patients ', ' Quality of life ', ' QOL ', ' Risk ', ' Signal Pathway ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Travel ', ' Vision ', ' Sight ', ' visual function ', ' Vitrectomy ', ' World Health Organization ', ' wound healing ', ' Wound Repair ', ' wound resolution ', ' Mediating ', ' injuries ', ' Injury ', ' image processing ', ' repair ', ' repaired ', ' Epithelial ', ' Hemidesmosomes ', ' insight ', ' diabetic ', ' tool ', ' corneal wound ', ' Corneal Injury ', ' machine learned ', ' Machine Learning ', ' Scientist ', ' Hour ', ' Complex ', ' Event ', ' Pattern ', ' vision loss ', ' visual loss ', ' Blindness ', ' corneal epithelial ', ' corneal epithelium ', ' Co-ordination disorder ', ' Coordination Disorder ', ' Dyscoordination ', ' Incoordination ', ' Lack of Coordination ', ' Abnormal coordination ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' calcium flux ', ' calcium mobilization ', ' release of sequestered calcium ion into cytoplasm ', ' Receptor Protein ', ' receptor ', ' computer science ', ' Calcium Waves ', ' Calcium Oscillations ', ' Calcium Ion Signaling ', ' Calcium Signaling ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Regulation ', ' response ', ' Adhesion Plaques ', ' Cell-Matrix Adherens Junctions ', ' Focal Contacts ', ' Focal Adhesions ', ' Molecular Interaction ', ' Binding ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Resolution ', ' in vivo ', ' Pathologic ', ' Molecular ', ' Process ', ' healing ', ' knockdown ', ' knock-down ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' injury response ', ' response to injury ', ' tissue wound ', ' wounding ', ' wounds ', ' wound ', ' Impaired tissue repair ', ' abnormal tissue repair ', ' delayed wound healing ', ' Impaired wound healing ', ' Population ', ' migration ', ' Bundling ', ' innovate ', ' innovative ', ' innovation ', ' Impairment ', ' murine model ', ' mouse model ', ' therapeutic agent development ', ' therapeutic development ', ' new therapeutic approach ', ' new therapeutic intervention ', ' new therapeutic strategies ', ' new therapy approaches ', ' novel therapeutic approach ', ' novel therapy approach ', ' novel therapeutic intervention ', ' quantitative imaging ', ' live cell image ', ' live cellular image ', ' live cellular imaging ', ' live cell imaging ', ' corneal wound healing ', ' corneal epithelial wound healing ', ' wound closure ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' large data sets ', ' large datasets ', ' epithelial wound ', ' ']",NEI,BOSTON UNIVERSITY MEDICAL CAMPUS,R21,2020,206250,MA-07,0.04118587543606654
"Design and Evaluation of a Decision Support Engine for Advanced Treatment of Type 1 Diabetes Project Summary Type 1 diabetes (T1D) is a disease characterized by pancreatic beta destruction with subsequent insulin depletion. The alterations in glucose dynamics are incredibly difficult to manage and are confounded by meals, exercise, menstruation, and stress. Although automated insulin delivery systems are becoming commercially available, the large majority of people with T1D are treated with multiple daily injections of insulin (MDI). Dangerous complications of hypoglycemia and diabetic ketoacidosis can occur from failure to dose insulin correctly, however vigilant adherence to tedious insulin dosing strategies are difficult for MDI users maintain. This difficulty is magnified during exercise, which is critical to ameliorating long-term complications of diabetes; even when guidelines for insulin dosage adjustments are followed, acute hypoglycemia during exercise and night-time hypoglycemia can occur. In our recent survey of 1400 subjects living with T1D, the majority of subjects on MDI therapy were not confident in managing their glucose during exercise and felt they lacked tools to do so. In aggregate, difficult treatment schedules and bolus calculations, associated acute complications from daily activities, and the emotional and psychological toll of this chronic disease can result in treatment non-adherence and poor glycemic outcomes. Therefore, there is a critical need for decision support tools designed for MDI users to improve glycemic control surrounding meals, daily activities and exercise. The goal of this proposal to develop a decision support tool for patients with type 1 diabetes who utilize continuous glucose monitoring systems and multiple daily injection therapy. This tool will be called miTREAT, the multiple injection treatment recommender system for exercise-aware therapies. We hypothesize that use of a novel decision support tool equipped with content-based collaborative filtering methods and dynamic exercise hypoglycemia prediction algorithms will improve overall euglycemia and reduce time spent in hypoglycemia for patients on MDI therapy. In our first aim, we will leverage decades of research in computer science recommender systems and machine learning optimization strategies to develop a novel decision support system that identifies issues in glycemic control and recommends appropriate insulin dose and behavioral modifications. In our second aim, we will develop a new exercise model that reflects both the dynamics of rapid-uptake of glucose through GLUT-4 channels and the longitudinal biphasic insulin sensitivity profile. This new model structure will be used to predict hypoglycemia during and after the exercise period. In our third aim, we will explore the performance of our decision support engine in an in-vivo clinical trial. This clinical trial will assess the usability of a new smart-phone app designed to assist MDI users that we have developed at OHSU. In achieving these goals, we will develop the first decision support system that provides treatment and behavioral recommendations to patients on CGM-augmented MDI therapy. This system will improve overall time in euglycemia, and reduce the occurrence of acute complications surrounding exercise. Project Narrative Type 1 Diabetes is difficult to manage through multiple daily injections, and there is a paucity of tools available to assist patients with treatment decisions. In this proposal, the fields of computer science, machine learning, constrained optimization and clinical science are united to develop a novel decision support tool for multiple daily injection users. This is accomplished in three parts: 1) we will tune a decision support system to correctly identify issues in patient glycemic control and recommend appropriate treatment modifications; 2) we will develop a new hypoglycemia prediction tool that reflects the longitudinal dynamics of glucose uptake during and after exercise; and 3) we will explore the performance of this decision support system and hypoglycemia prediction tool in a clinical trial.",Design and Evaluation of a Decision Support Engine for Advanced Treatment of Type 1 Diabetes,9898150,F31DK121436,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Aerobic Exercise ', ' Aerobic Activity ', ' Aerobic fitness ', ' Awareness ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Clinical Trials ', ' Dangerousness ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Diabetic Ketoacidosis ', ' Diabetic Acidosis ', ' Diabetic Ketosis ', ' diabetic ketoacidotic ', ' Disease ', ' Disorder ', ' Exercise ', ' Fright ', ' Fear ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Recording of previous events ', ' History ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Injection of therapeutic agent ', ' injection therapy ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Menstruation ', ' Menses ', ' menstrual period ', ' monthly period ', ' Methods ', ' Structural Models ', ' Pancreas ', ' Pancreatic ', ' Patients ', ' Pilot Projects ', ' pilot study ', ' Recommendation ', ' Recurrence ', ' Recurrent ', ' Research ', ' Running ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Medical Technology ', ' Telephone ', ' Phone ', ' Time ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' Weight ', ' Assimilations ', ' Mediating ', ' Outcome Measure ', ' Guidelines ', ' base ', ' dosage ', ' human subject ', ' improved ', ' Site ', ' Acute ', ' Variation ', ' Variant ', ' psychological ', ' psychologic ', ' Evaluation ', ' Cutaneous ', ' Failure ', ' Trust ', ' Measurement ', ' root ', ' Plant Roots ', ' tool ', ' Diabetes Complications ', ' Diabetes-Related Complications ', ' Diabetic Complications ', ' Complications of Diabetes Mellitus ', ' machine learned ', ' Machine Learning ', ' Event ', ' Pattern ', ' System ', ' Clampings ', ' Closure by clamp ', ' Outcome Study ', ' Infusion ', ' Infusion procedures ', ' Performance ', ' heuristics ', ' computer science ', ' glucose uptake ', ' novel ', ' Study Subject ', ' Emotional ', ' Modeling ', ' Decision Support Systems ', ' response ', ' glucometer ', ' glucose meter ', ' glucose monitor ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' insulin sensitivity ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' preventing ', ' prevent ', ' Erythrocyte/Hepatoma Glucose Transporter ', ' GLUT ', ' GLUT1 ', ' Glucose Transporter 1 ', ' SLC2A1 ', ' Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1 ', ' SLC2A1 gene ', ' Dose ', ' Adherence ', ' Bolus ', ' Bolus Infusion ', ' Data ', ' in vivo ', ' Clinical Sciences ', ' Exercise Physiology ', ' Modification ', ' Tracer ', ' Behavioral ', ' Output ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' insulin stimulated glucose disposal ', ' glucose disposal ', ' Outcome ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' ecommerce ', ' internet commerce ', ' e-commerce ', ' usability ', ' primary outcome ', ' secondary outcome ', ' standard of care ', ' Regimen ', ' Crossover Trials ', ' Cross-Over Trials ', ' support tools ', ' exercise intensity ', ' resistance exercise ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' Android App ', ' Android Application ', ' Cell Phone Application ', ' Cell phone App ', ' Cellular Phone App ', ' Cellular Phone Application ', ' Smart Phone App ', ' Smart Phone Application ', ' Smartphone App ', ' iOS app ', ' iOS application ', ' iPhone App ', ' iPhone Application ', ' smartphone Application ', ' Injections ', ' euglycemia ', ' in silico ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,F31,2020,50520,OR-03,0.04619476568835987
"Chronic Inflammation and Type 2 Diabetes: A Multi-omics Approach ABSTRACT The etiology of type 2 diabetes (T2D) likely involves a complex interaction of polygenic, metabolic, and environmental factors including diet. Accumulating experimental, epidemiological, and clinical evidence supports a pathogenic role of chronic inflammation in T2D development. However, the precise mechanisms underlying these findings are largely unknown, and current evidence on the causal relationships between specific inflammatory pathways and T2D risk is inconclusive. Advances in omics technologies have led to the identification of genes and metabolites associated with T2D risk, but data on mechanisms and causality are still very limited. Multi-omics integration in the framework of systems epidemiology may provide new avenues to enhance our understanding of disease mechanisms. To systematically investigate the relation between chronic inflammation and T2D, I propose to examine 3 Specific Aims by leveraging the rich resources in the UK Biobank, Nurses Health Studies (NHS), Health Professional Follow-up Study (HPFS), Hispanic Community Health Study/Study of Latinos (SOL), and Genotype-Tissue Expression project (GTEx). In Aim 1 [K99], I will integrate existing genomic data from the UK Biobank, NHS/HPFS, SOL, and transcriptomic data in the GTEx to examine shared genetic architectures between systemic inflammatory markers and T2D and whether polygenic susceptibility to chronic inflammation confers T2D risk. Meanwhile, I will receive extensive training in T2D systems biology and cutting-edge high-dimensional data analytics and bioinformatics. In Aim 2 [R00], I will integrate dietary and metabolomic data to examine metabolomic profiles mediating the association between dietary inflammatory potentials and T2D risk in the prospective NHS/HPFS and the SOL. In Aim 3 [R00], I will conduct plasma proteomic profiling in a nested case-control study within the NHS to identify inflammatory protein networks in relation to T2D risk, and as a Secondary Aim, integrate findings from Aim 1-3 to explore T2D-related pathways co-regulating at multiple biological dimensions. Findings from this project may improve the understanding of inflammatory mechanisms underlying T2D and identify novel targets/pathways suitable for early detection and prevention. I will be mentored/advised by an interdisciplinary team that includes Dr. JoAnn Manson (diabetes epidemiologist), Dr. Liming Liang (expert in statistical omics methodologies), Dr. Frank Hu (nutritional epidemiologist), Dr. Peter Kraft, (statistical geneticist), Dr. Qibin Qi (genetic epidemiologist), Dr. Towia Libermann (expert in proteomics), and Dr. Clary Clish (expert in metabolomics). The outstanding training opportunities with key leaders in these areas will provide me advanced knowledge and skills, positioning me for a successful, independent career as a diabetes epidemiologist with expertise in systems biology and integrated-omics. This project aligns with the NIDDKs goal of integrating multi-omics technologies into diabetes research. PROJECT NARRATIVE This project seeks to systematically examine the relationship between chronic inflammation and type 2 diabetes (T2D) by incorporating multi-omics data from several large prospective cohort studies. The proposed research will yield novel evidence on the biological mechanisms underlying the relationship between chronic inflammation and T2D risk. Novel pathways, and specific genes, proteins, and metabolites identified in this research will serve as the critical first steps for future development of biomarkers and therapeutic targets for T2D prevention and treatment.",Chronic Inflammation and Type 2 Diabetes: A Multi-omics Approach,10003234,K99DK122128,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Follow-Up Studies ', ' Followup Studies ', ' Food ', ' Food or Food Product ', ' Future ', ' Genes ', ' Regulator Genes ', ' Transcriptional Regulatory Elements ', ' regulatory gene ', ' trans acting element ', ' Goals ', ' indexing ', ' Inflammation ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' White Blood Cell Count procedure ', ' Leukocyte Count ', ' Leukocyte Number ', ' White Blood Cell Count ', ' Mentors ', ' Methods ', ' Methodology ', ' mortality ', ' Nested Case-Control Study ', ' Phenotype ', ' Pilot Projects ', ' pilot study ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Proteins ', ' Public Health ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Retinal Diseases ', ' Retinal Disorder ', ' retina disease ', ' retina disorder ', ' retinopathy ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Technology ', ' Work ', ' cytokine ', ' Mediating ', ' base ', ' career ', ' improved ', ' Area ', ' Chronic ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Metabolic ', ' Genetic ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' Knowledge ', "" Ch'i "", ' Qi ', ' ACRP30 protein ', ' adipocyte complement-related protein 30-kDa ', ' adipocyte, C1q and collagen domain containing protein ', ' apM-1 protein ', ' apM1 (adipose-specific) protein ', ' adiponectin ', ' Dimensions ', ' Complex ', ' Pattern ', ' System ', ' early detection ', ' Early Diagnosis ', ' cohort ', ' skills ', ' novel ', ' disease prevention ', ' disorder prevention ', ' Self-Report ', ' Patient Self-Report ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Prevention ', ' Position ', ' Positioning Attribute ', ' Protein Gene Products ', ' Gene Proteins ', ' Proteome ', ' Dietary Assessment ', ' Modeling ', ' response ', ' case control ', ' Proteomics ', ' Genomics ', ' Limes ', ' Pathogenicity ', ' Bio-Informatics ', ' Bioinformatics ', ' diabetes risk ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' B-Cell Differentiation Factor Gene ', ' B-Cell Stimulatory Factor 2 Gene ', ' BSF-2 Gene ', ' BSF2 Gene ', ' Beta-2 Gene Interferon ', ' HSF Gene ', ' Hepatocyte Stimulatory Factor Gene ', ' Hybridoma Growth Factor Gene ', ' IFNB2 Gene ', ' IL-6 Gene ', ' IL6 ', ' Interleukin 6 (Interferon, Beta 2) Gene ', ' Interleukin-6 Gene ', ' IL6 gene ', ' CD 120a Antigen ', ' CD120a Antigens ', ' TNF Receptor p55 ', ' TNF-sR55 ', ' TNF- receptor ', ' TNFAR ', ' TNFR p60 ', ' TNFR, 55-kD ', ' TNFR, 60-kD ', ' TNFR-I ', ' TNFR1 ', ' TNFR55 ', ' TNFR60 ', ' TNFRSF1A ', ' TNFRSF1A Receptor ', ' TNFalpha receptor ', ' TNF receptor ', ' Tumor Necrosis Factor Receptor 1 ', ' Tumor Necrosis Factor Receptor 55 ', ' tumor necrosis factor alpha receptor ', ' tumor necrosis factor receptor 1A ', ' tumor necrosis factor  receptor ', ' TNFRSF1A gene ', ' Systems Biology ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Intake ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Regulatory Element ', ' i(19) ', ' Epidemiologist ', "" Nurses' Health Study "", ' nutritious ', ' Nutritional ', ' developmental ', ' Development ', ' Diabetes prevention ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' pathway ', ' Pathway interactions ', ' protein metabolite ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' transcriptomics ', ' therapeutic target ', ' inflammation marker ', ' inflammatory marker ', ' new marker ', ' novel biomarker ', ' novel marker ', ' biorepository ', ' biobank ', ' training opportunity ', ' Data Analytics ', ' biomarker development ', ' HCHS/SOL Study ', ' HCHS/SOL cohort ', ' Hispanic Community Health Study/Study of Latinos ', ' multiomics ', ' multiple omics ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' Study of Latinos ', ' metabonome ', ' metabolome ', ' GTEx ', ' Genotype-Tissue Expression Project ', ' entire genome ', ' full genome ', ' whole genome ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' Prospective cohort study ', ' high dimensionality ', ' cardiometabolic ', ' cardiometabolism ', ' genetic architecture ', ' high dimensional data ', ' multidimensional datasets ', ' multidimensional data ', ' multiple omic data ', ' Multiomic Data ', ' gene locus ', ' genetic locus ', ' genomic locus ', ' ']",NIDDK,HARVARD SCHOOL OF PUBLIC HEALTH,K99,2020,89999,MA-07,0.07074839585937691
"Informing national guidelines on diet patterns that promote healthy pregnancy outcomes SUMMARY The diet quality of U.S. childbearing aged women is worse now than any time in the last 50 years. Poor diet quality has been linked with adverse pregnancy outcomes that contribute to infant mortality and pose a tremendous societal burden. Nevertheless, formal recommendations on the diet patterns that promote healthy pregnancy outcomes are lacking. The US Congress recently mandated that dietary advice for pregnancy be included in the next edition of the Dietary Guidelines for Americansthe major nutrition policy document that provides dietary advice for health promotion. The USDA/HHS Pregnancy Work Group, which included PI Lisa Bodnar, was charged with summarizing existing knowledge on diet patterns that support healthy pregnancy outcomes to inform the pregnancy-specific guidelines. They identified an evidence base that was entirely insufficient for deriving empirical recommendations and called for research to fill this critical knowledge gap. Our objective is to generate empirical evidence that will inform national dietary guidance on the diet patterns that promote healthy pregnancy outcomes. We hypothesize that our results will suggest dietary recommendations for pregnant women that will diverge from prevailing nutrition advice. We expect this divergence because our innovative approaches will accommodate the complex synergy among foods in the diet. Using a large, prospective cohort of 7995 U.S. women enrolled at 8 U.S. academic centers, we will quantify the contribution of dietary patterns to variation in risk of adverse pregnancy outcomes (preterm birth <37 weeks, small-for-gestational-age birth, gestational diabetes, and preeclampsia). We will use machine learning techniques that allow for complex interactions among dietary components. Then, we will generalize recommended dietary patterns in our sample to the U.S. population of pregnant women using cutting edge transportability methods developed in the causal inference literature. Finally, we will develop machine learning algorithms that will identify subgroups who will benefit most from dietary pattern recommendations. The successful completion of this project will provide the Dietary Guidelines Scientific Advisory Committee with empirically-derived data on the ideal dietary patterns for promoting healthy pregnancy outcomes. Our innovative methodologies will serve as a template for nutritional epidemiologists in other areas of health to apply to their data, leading to a broad impact on the Dietary Guidelines. Developing practical data-driven dietary recommendations to optimize pregnancy outcomes will help to reduce the high economic and societal burden of adverse pregnancy outcomes and improve the health of mothers and their children. PROJECT NARRATIVE / RELEVANCE The Dietary Guidelines for Americans is the cornerstone of nutrition policy in the U.S., impacting WIC and other Federal nutrition assistance programs, health insurance incentives, weight and lifestyle interventions, policies to change the food environment, and nutrition education programs at the national, regional, state and local levels. This project will inform the next edition of the Dietary Guidelines by using cutting-edge analytic approaches to identify diet patterns that promote healthy outcomes of pregnancy. Although the causes of poor pregnancy outcomes are multifactorial, we focus on dietary intake because it is one of the few potentially modifiable risk factors, and has important implications for mother and child well beyond the childbearing years.",Informing national guidelines on diet patterns that promote healthy pregnancy outcomes,10026261,R01HD102313,"['Accounting ', ' Birth ', ' Parturition ', ' Charge ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Conceptions ', ' Congresses ', ' meeting reports ', ' Diet ', ' dietary ', ' Dietary Fiber ', ' whole grain ', ' Economics ', ' Fetal Growth Retardation ', ' Fetal Growth Restriction ', ' IUGR ', ' Intrauterine Growth Retardation ', ' impaired fetal growth ', ' intra-uterine growth restriction ', ' intra-uterine growth retardation ', ' intrauterine growth restriction ', ' prenatal growth disorder ', ' Food ', ' Food or Food Product ', ' Health ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Heterogeneity ', ' Incentives ', ' Infant Mortality ', ' Infant Mortality Total ', ' Small for Gestational Age Infant ', ' small for gestational age ', ' Health Insurance ', ' health insurance plan ', ' Literature ', ' Methods ', ' Methodology ', ' Mothers ', ' Nulliparity ', ' Nulliparas ', ' Nulliparous ', ' nutrition ', ' Nutritional Requirements ', ' nutrient requirement ', ' Oils ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' Planned Pregnancy ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Public Health ', ' Questionnaires ', ' Recommendation ', ' Research ', ' Risk ', ' Risk Factors ', ' Time ', ' Weight ', ' Woman ', ' Work ', ' Gestational Diabetes ', ' Gestational Diabetes Mellitus ', ' Pregnancy-Induced Diabetes ', ' pregnancy diabetes ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' Task Forces ', ' advisory team ', ' Advisory Committees ', ' Guidelines ', ' improved ', ' diet education ', ' nutrition education ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Medical ', ' Link ', ' Policies ', ' nutritional care ', ' nutritional therapy ', ' Nutritional Support ', ' Nutrition Policy ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Nutritional status ', ' Frequencies ', ' Complex ', ' Pattern ', ' Techniques ', ' Outcome Study ', ' death in first year of life ', ' infant demise ', ' infantile death ', ' infant death ', ' American ', ' synergism ', ' cohort ', ' disease risk ', ' disorder risk ', ' General Public ', ' General Population ', ' dietary control ', ' Modeling ', ' Sampling ', ' Dietary intake ', ' Data ', ' Dietary Component ', ' dietary pattern ', ' Dietary Practices ', ' Maternal and Child Health ', ' Subgroup ', ' enroll ', ' Enrollment ', ' Epidemiologist ', ' nutritious ', ' Nutritional ', ' Monitor ', ' Characteristics ', ' work group ', ' working group ', ' Female of childbearing age ', ' women of child bearing age ', ' women of childbearing age ', ' Female of child bearing age ', ' Outcome ', ' Population ', ' Consumption ', ' life style intervention ', ' lifestyle intervention ', ' innovate ', ' innovative ', ' innovation ', ' bear children ', ' bearing children ', ' childbearing ', ' child bearing ', ' modifiable risk ', ' fruits and vegetables ', ' pregnant ', ' evidence base ', ' flexible ', ' flexibility ', ' food environment ', ' adverse pregnancy outcome ', ' healthy pregnancy ', ' Prospective cohort ', ' Prospective cohort study ', ' health of the mother ', ' dietary guidelines ', ' machine learned algorithm ', ' machine learning algorithm ', ' WIC ', ' WIC program ', ' Women, Infants and Children (WIC) ', ' Special Supplemental Nutrition Program for Women, Infants, and Children ', ' machine learning method ', ' ']",NICHD,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2020,645069,PA-18,0.06408294841647234
"Indiana University clinical Center for acute pancreatitis and diabetes clinical research network PROJECT SUMMARY / ABSTRACT Pancreatogenic diabetes, or type 3c diabetes (T3cDM), is a known complication of acute pancreatitis (AP). Recent data suggest that T3cDM occurs more commonly than previously recognized and exhibits a spectrum of defects including features that overlap aspects of both type 1 and type 2 diabetes. At present, the extent to which immune activation,  cell dysfunction, and insulin resistance occur following AP and the genetic, metabolic and imaging correlates of these phenotypes have not been characterized. To address these knowledge gaps, we have assembled a multidisciplinary team with expertise in pancreatitis and exocrine pathophysiology, diabetes,  cell biology, diabetes genetics, and pancreatic imaging at the Indiana University School of Medicine. The IU Clinical Center will work with other members of the Type 1 Diabetes in Acute Pancreatitis Consortium to test the hypothesis that T3cDM encompasses a heterogeneous combination of metabolic and potentially immunologic phenotypes that are determined by distinct underlying pathophysiologies. We propose the following specific aims (SA) to meet the goals of this RFA. SA #1: To perform an observational study of robustly characterized adults with AP in order to address knowledge gaps in the natural history and incidence of autoantibody-positive diabetes (AAb+), impaired glucose tolerance (IGT)/impaired fasting glucose (IFG), and diabetes occurring subsequent to AP. Enrolled participants will be longitudinally characterized with emphasis on identifying genetic, immunological, metabolic, and clinical risk factors for the development of AAb+, IGT/IFG, or T3cDM. We will use state-of-the-art immunologic phenotyping and measurements of pancreatic  cell function to define the physiologic basis for metabolic dysregulation in T3cDM after AP. In tandem, a biorepository will be developed for undertaking translational, mechanistic and biomarker investigations and ancillary studies. SA#2: The Imaging Morphology of Pancreas in Diabetic Patients following Acute Pancreatitis (IMMINENT) study aims to utilize novel quantitative magnetic resonance imaging techniques as a non-invasive biomarker to identify patients at risk for the development of post-AP T3cDM. This longitudinal study will evaluate pancreatic parenchymal morphologic and pathophysiologic changes following AP in AAb+, euglycemic, IGT and DM individuals. Imaging phenotypes will be correlated with the metabolic, genetic and immunological phenotypes established in SA#1. SA#3: To perform a nested case control study using state-of-the-art techniques to define the underlying pathophysiology of endocrine and exocrine function in the subgroup of AAb+ individuals with AP-associated metabolic dysfunction relative to those who remain normoglycemic. We will undertake detailed metabolic phenotyping to evaluate islet cell responses (i.e.  and alpha cell function) in parallel with arginine-augmented hyperglycemic clamp methodology to measure functional  cell mass, and endoscopic assessment to define the relationship between impaired exocrine and endocrine function in AAb+ T3cDM. We will utilize 25 individuals with AAb+ and IGT or T3cDM and compare findings to results in 25 normoglycemic individuals with negative autoantibodies from SA#1. PROJECT NARRATIVE While diabetes is a known complication of acute pancreatitis (AP), a full understanding of the underlying etiology of this disorder is lacking. To address this gap in knowledge, we have assembled a multidisciplinary team at Indiana University, with expertise in exocrine pancreas pathophysiology, diabetes,  cell biology, genetics, and pancreatic imaging. As part of the newly formed Type 1 Diabetes in Acute Pancreatitis Consortium, members of the Indiana University Clinical Center will collaborate with other consortium members to undertake studies focused on the comprehensive clinical, epidemiological, biological and imaging characterization of diabetes occurring after AP.",Indiana University clinical Center for acute pancreatitis and diabetes clinical research network,10127104,U01DK127382,"['acute pancreatitis ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Arginine ', ' L-Arginine ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' Autoimmunity ', ' Autoimmune Status ', ' Cell Death ', ' necrocytosis ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Clinical Research ', ' Clinical Study ', ' Complication ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Disease ', ' Disorder ', ' Duodenum ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Evolution ', ' Exhibits ', ' Extracellular Matrix ', ' Cell-Extracellular Matrix ', ' ECM ', ' Fatty acid glycerol esters ', ' Fats ', ' Glucagon ', ' Antidiabetic Hormone ', ' Glukagon ', ' HG-Factor ', ' Hyperglycemic-Glycogenolytic Factor ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Glucose Intolerance ', ' Goals ', ' Health ', ' Hyperglycemia ', ' hyperglycemic ', ' Incidence ', ' Indiana ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Insulin Resistance ', ' insulin resistant ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methodology ', ' Motion ', ' Nested Case-Control Study ', ' OGTT ', ' Oral Glucose Tolerance Test ', ' Pancreas ', ' Pancreatic ', ' Structure of beta Cell of islet ', ' Pancreatic beta Cell ', ' Pancreatic -Cell ', ' pancreas beta cell ', ' pancreas  cell ', ' pancreatic b-cell ', ' Pancreatic Function Tests ', ' Pancreatitis ', ' Patients ', ' Perfusion ', ' Phenotype ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Relaxation ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' medical schools ', ' medical college ', ' school of medicine ', ' Secretin ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Measures ', ' Natural History ', ' glucose tolerance ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Individual ', ' Measurement ', ' Pancreatic Insufficiency ', ' Exocrine pancreatic insufficiency ', ' impaired glucose tolerance ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Genetic ', ' Morphology ', ' Infiltration ', ' Knowledge ', ' cell biology ', ' Cellular biology ', ' Investigation ', ' Immunes ', ' Immune ', ' Texture ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' extracellular ', ' Clampings ', ' Closure by clamp ', ' Endocrine ', ' exocrine pancreatic ', ' Exocrine pancreas ', ' diabetes genetics ', ' diabetes mellitus genetics ', ' novel ', ' Participant ', ' member ', ' Reporting ', ' Genetic analyses ', ' genetic analysis ', ' response ', ' depository ', ' repository ', ' Magnetic Resonance ', ' Meta-Analysis ', ' insulin sensitivity ', ' pancreas imaging ', ' DWI (diffusion weighted imaging) ', ' DWI-MRI ', ' Diffusion MRI ', ' Diffusion Weighted MRI ', ' Diffusion weighted imaging ', ' Diffusion-weighted Magnetic Resonance Imaging ', ' dMRI ', ' diffusion tensor imaging ', ' Diffusion Magnetic Resonance Imaging ', ' Glucagon Cell ', ' Glucagon Secreting Cell ', ' -cell ', ' Alpha Cell ', ' Insulin Cell ', ' Insulin Secreting Cell ', ' -cell ', ' -cells ', ' Cell ', ' Beta Cell ', ' insulin secretion ', ' impaired fasting glucose ', ' Impaired fasting glycaemia ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Address ', ' Defect ', ' Data ', ' Subgroup ', ' Ancillary Study ', ' cell stress ', ' Cellular Stress ', ' enroll ', ' Enrollment ', ' Magnetic Resonance Elastography ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Risk Marker ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Monitor ', ' Islet Cell ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' clinical phenotype ', ' islet ', ' Population ', ' diabetic Autoantibodies ', ' Diabetes autoantibodies ', ' prospective ', ' Impairment ', ' multidisciplinary ', ' nondiabetic ', ' non-diabetic ', ' beta cell development ', ' islet development ', ' endocrine pancreas development ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' diabetic patient ', ' biorepository ', ' biobank ', ' Immune Cell Activation ', ' immune activation ', ' clinical risk ', ' gDNA ', ' Genomic DNA ', ' contrast enhanced ', ' biomarker development ', ' metabotype ', ' metabolic phenotype ', ' radiomics ', ' metabolic imaging ', ' Insulin deficiency ', ' Metabolic dysfunction ', ' polygenic risk score ', ' clinical center ', ' ']",NIDDK,INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,U01,2020,278416,IN-07,0.12482688565214638
"Improving diabetes and depression self-management via adaptive mobile messaging Project Summary/Abstract Diabetes and depression are major public health problems that disproportionately affect racial/ethnic minorities and low-income individuals in the US. Efficacious interventions for depression and diabetes exist but are not often combined despite similar treatment recommendations (specifically physical activity) for both conditions. Especially in resource-constrained environments, mobile health (mHealth) technologies are cost effective and feasible methods for delivering self-management support given the more ubiquitous penetration across socioeconomic status. Existing mHealth interventions have shown preliminary success but have had difficulty sustaining engagement. When combined with machine learning algorithms, health messages can be adapted to specifically motivate individuals based on their unique profiles. In Aim 1, we will integrate content from interventions targeting diabetes, depression, and physical activity applying user design methods. We will utilize the existing HealthySMS platform as the basis for this intervention. This will be called the Diabetes and Mental Health Adaptive Notification Tracking and Evaluation (DIAMANTE) study. In Aim 2, we will test an mHealth intervention for diabetes and depression that will generate messages using an adaptive machine learning algorithm that learns from patient step count data (collected passively via a smartphone app) and patient entered blood glucose and mood ratings. We will compare this adaptive, personalized intervention with a static messaging intervention, typical of many existing text messaging interventions. In Aim 3, we will rerandomize non-responsive participants to receiving nurse outreach using a sequential, multiple assignment, randomized trial (SMART) design. We will leverage the SMART design to conserve more expensive one-on-one nurse outreach for the patients who are no longer engaged in the program and need the most support. We will test this intervention with 350 patients from a safety net setting in English and Spanish. The primary outcomes for this study are HbA1c levels and PHQ-9 scores. The results of this study will help us understand the impact of personalizing content utilizing machine learning algorithms as well as the impact of providing clinician support for those receiving mobile health interventions. Since we are testing this intervention in a resource-constrained environment, the results of this study will be relevant for a broader population. Project Narrative (Public Relevance Statement) Diabetes and depression are health problems that are often comorbid and are mutually detrimental when uncontrolled. This grant proposal seeks to develop and test a personalized motivational text messaging intervention to improve management of diabetes and depression with an emphasis on low-income populations. The findings from this study will aid in the development and dissemination of mobile health tools for chronic illness management in diverse patients.",Improving diabetes and depression self-management via adaptive mobile messaging,9968231,R01HS025429,[''],AHRQ,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2020,387831,CA-13,0.08739939243624692
"DFU Clinical Research Unit Abstract Diabetic foot ulcers (DFUs) are a prevalent diabetes complications affecting up to 25% of patients and leading to ~80,000 Americans having non-traumatic amputations each year, with five-year mortality rates of up to 40%. Recent evidence suggests that non-traumatic lower extremity amputations are on the rise, after decades of decline, in spite of advances in targeted wound care products, establishment of interdisciplinary clinical and surgical teams, and improving diabetes medical care. Given the worldwide epidemic of diabetes, the burden associated with DFU are high, including high costs of $9 billion-$13 billion per year and besides those associated with high morbidity and mortality. Thus, the establishment of a Diabetic Foot Consortium comprised of experienced DFU Clinical Research Units (CRU) for reliable DFU biomarker discovery cannot be understated. The main objective of this proposal is to integrate the robust infrastructure at Michigan Medicine with our highly skilled clinical and translational team to establish a DFU CRU as a strong contender and contributor within the DFC network that will be uniquely poised to participate in all DFU biomarker discovery and related wound healing projects undertaken by the Consortium. Additional aims are to The aims are to : identify, recruit, and phenotype a broad spectrum of DFU participants from the large base of patients with these conditions who are currently being followed at Michigan Medicine, according to the Consortium requirements; implement standardized mechanisms and protocols for effective longitudinal sample collection and retention; and actively participate in the DFC intellectually and provide all available resources to develop and support clinical study protocols to validate DFU biomarkers, including complex quantifications of wound image features; single cell, genetic, molecular, metabolomics, and microbiome analyses; and assessing additive predictors of DFU healing beyond clinical markers alone using multi-modal approaches. The expected outcome of this work is that the Michigan Medicine DFU Clinical Center will be an integral part of the Consortia collaborative network, with a highly positive impact for the entire spectrum of biomarker discovery and future novel therapies projects. Narrative This project has major public health relevance because diabetic foot ulcers (DFUs) remain one of the most common secondary complications of diabetes and are the leading cause of lower extremity amputation in the US. Current treatments are ineffective and given the recent surge in major lower extremity amputations in diabetic patients despite the previous decades of decline, identification of novel treatment avenues is of critical importance. The main objective of the Diabetic Foot Clinical Center at the University of Michigan is to use our robust infrastructure and highly skilled clinical and translational research team to generate a unique platform for investigating individual contributions to DFU wound healing from clinical samples, single cell genetic and molecular analyses from DFU samples, and image analyses.",DFU Clinical Research Unit,9948487,U01DK119083,"['Affect ', ' Age ', ' ages ', ' Amputation ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cells ', ' Cell Body ', ' Clinical Markers ', ' Clinical Research ', ' Clinical Study ', ' Cohort Studies ', ' Concurrent Studies ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Data Collection ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Mental Depression ', ' depression ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Sterile coverings ', ' Dressing ', ' Engineering ', ' Epidemic ', ' Future ', ' Heart failure ', ' cardiac failure ', ' Heterogeneity ', ' Infection ', ' Institutes ', ' Lower Extremity ', ' Lower Limb ', ' Membrum inferius ', ' male ', ' Marketing ', ' Medicine ', ' Methodology ', ' Michigan ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patient Outcomes Assessments ', ' Patient Reported Measures ', ' Patient Reported Outcomes ', ' Patients ', ' Peripheral Nervous System Diseases ', ' PNS Diseases ', ' Peripheral Nerve Diseases ', ' Peripheral Nervous System Disorders ', ' Peripheral Neuropathy ', ' Phenotype ', ' Psychosocial Factor ', ' psychosocial variables ', ' Publishing ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Schools ', ' Self Care ', ' personal care ', ' Standardization ', ' Technology ', ' Time ', ' Ulcer ', ' Ulceration ', ' Universities ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' wound healing ', ' Wound Repair ', ' wound resolution ', ' Gender ', ' Walking ', ' Foot Ulcer ', ' Caring ', ' base ', ' Label ', ' improved ', ' specimen collection ', ' sample collection ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Area ', ' Surface ', ' Clinical ', ' Biological ', ' Medical ', ' Charcot foot ', ' Diabetic Foot ', ' Individual ', ' European ', ' Data Bases ', ' data base ', ' Databases ', ' participant recruitment ', ' Patient Recruitments ', ' fluid ', ' liquid ', ' Liquid substance ', ' Genetic ', ' tool ', ' Diabetes Complications ', ' Diabetes-Related Complications ', ' Diabetic Complications ', ' Complications of Diabetes Mellitus ', ' machine learned ', ' Machine Learning ', ' cognitive function ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Location ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' interest ', ' American ', ' experience ', ' cohort ', ' novel ', ' Participant ', ' Devices ', ' Position ', ' Positioning Attribute ', ' Genetic analyses ', ' genetic analysis ', ' Sampling ', ' Bio-Informatics ', ' Bioinformatics ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Tissue Sample ', ' preventing ', ' prevent ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Address ', ' diabetic foot wound ', ' Diabetic Foot Ulcer ', ' Adherence ', ' Data ', ' Molecular Analysis ', ' Collection ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Molecular ', ' Behavioral ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' microbiome ', ' cost ', ' healing ', ' clinical site ', ' clinical research site ', ' Outcome ', ' tissue wound ', ' wounding ', ' wounds ', ' wound ', ' prospective ', ' transcriptomics ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' public health relevance ', ' multi-modality ', ' multimodality ', ' FDA approved ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' diabetic patient ', ' BigData ', ' Big Data ', ' precision-based medicine ', ' precision medicine ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' biomarker discovery ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' ineffective treatment ', ' ineffective therapies ', ' recruit ', ' practice setting ', ' analyze microbiome ', ' microbiome analysis ', ' Infrastructure ', ' wound assessment ', ' wound monitoring ', ' wound care ', ' clinical center ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2020,429000,MI-12,0.07566355151654874
"Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery System Project Summary Automated insulin delivery (AID) systems offer substantial opportunities for helping people with type 1 diabetes (T1D) to improve glucose control and lower HbA1c. However, the AID has only shown a benefit during the nighttime when meals, exercise, and stress do not significantly challenge the AID. Furthermore, hypoglycemia (<70 mg/dL) remains a common occurrence in people with type 1 diabetes and continues to occur even in the setting of AID, particularly with exercise. Integrating context awareness into an AID has the potential to improve glycemic time in range (70-180 mg/dL) during the daytime and reduce and possibly eliminate hypoglycemia. Contextual information can include inferred food intake, insulin dosing, inferred exercise type and duration, as well as movement patterns. An AID can be designed to recognize contextual patterns that relate to poor glycemic responses to meals and hypoglycemia and then adjust insulin dosing in response to these patterns in advance and help mitigate these problems. In this grant, we will explore how contextual information may be used within an AID to help (1) avoid hypoglycemia and (2) reduce postprandial dysglycemia. We will first conduct a data gathering study whereby we will collect a rich data set from people with T1D who will use sensor augmented pump therapy to manage their glucose. Data will be collected from these 30 patients over 28 days; data will include multivariable contextual information including continuous glucose monitoring (CGM) data, insulin data, food data, physical activity data (heart rate and accelerometry), as well as indoor/outdoor contextual movement patterns gathered using a novel beacon-based context-aware sensing system called MotioWear developed by our group in collaboration with our industry partner MotioSens. Next, we will utilize this contextual data set to construct a Bayesian glucose prediction algorithm. This will include a clustering algorithm that will group contextual sequences that are similar with each other and which lead to similar glycemic outcomes. This context-aware glucose prediction algorithm will be integrated into an adaptive, personalized, smartwatch-based context-aware AID (CA-AID) system. Contextual patterns that have a high likelihood of leading to hypoglycemia or postprandial dysglycemia will inform an insulin dosing aggressiveness factor to be adjusted for similar contextual sequences observed in the future (i.e. the CA-AID will reduce insulin for contextual sequences with high likelihood of hypoglycemia such as aerobic exercise). We expect that integrating context awareness into an AID will lead to significant improvements in time in target range during the day and will help reduce time in hypoglycemia. The CA-AID will be evaluated for safety in a small pilot study. We will then evaluate the CA-AID within a 6 week clinical study in 40 adults with type 1 diabetes on insulin pump therapy. Twenty will receive the CA-AID while the other 20 will receive a standard (non-context-aware) AID. The primary outcome measures of this study is the percent time in range. We hypothesize that the CA-AID will increase time in range by 10% as compared with a non-context aware AID. Project Narrative Diabetes is the leading cause of blindness, kidney failure, and non-traumatic amputations. While automated insulin delivery systems can help people with type 1 diabetes better manage their glucose levels during the night, improved glycemic control during the day has not been demonstrated and hypoglycemia continues to be a problem, especially during exercise. We propose to develop and evaluate in a clinical study a context-aware automated insulin delivery system that learns patterns of daily living, meal patterns, glucose patterns, insulin dosing patterns, and physical activity patterns that relate to dysglycemia and adapts the gains within the AID to improve postprandial time in target range (70-180 mg/dL) and reduce hypoglycemia.",Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery System,9977179,R01DK122583,"['Food Intake ', ' Engineering ', ' Exercise ', ' Fatty acid glycerol esters ', ' Fats ', ' Food ', ' Food or Food Product ', ' Future ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Grant ', ' Heart Rate ', ' Cardiac Chronotropism ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Insulin Infusion Systems ', ' insulin pump ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' Maps ', ' Movement ', ' body movement ', ' Outpatients ', ' Out-patients ', ' Patients ', ' Pilot Projects ', ' pilot study ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Restaurants ', ' Risk ', ' Running ', ' Safety ', ' Stress ', ' Testing ', ' Time ', ' Wrist ', ' Measures ', ' Outcome Measure ', ' Schedule ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' Pump ', ' sensor ', ' improved ', ' Physiologic ', ' Physiological ', ' Randomized Clinical Trials ', ' Physical activity ', ' Collaborations ', ' Knowledge ', ' Life ', ' Tactile ', ' Event ', ' Home ', ' Home environment ', ' Clinic ', ' Pattern ', ' System ', ' vision loss ', ' visual loss ', ' Blindness ', ' cohort ', ' expectation ', ' novel ', ' Participant ', ' response ', ' glucometer ', ' glucose meter ', ' glucose monitor ', ' glucose sensor ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Dose ', ' fitness ', ' Data ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' designing ', ' design ', ' glycemic control ', ' Outcome ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' usability ', ' high risk ', ' primary outcome ', ' industrial partnership ', ' industry partnership ', ' industry partner ', ' arm ', ' 2-arm study ', ' two-arm study ', ' accelerometry ', ' activity monitor ', ' activity tracker ', ' Accelerometer ', ' fitbit ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' recruit ', ' smartwatch ', ' smart watch ', ' body sensor ', ' body worn sensor ', ' wearable sensor ', ' wearable system ', ' wireless sensor technology ', ' wearable sensor technology ', ' machine learned algorithm ', ' machine learning algorithm ', ' evaluate effectiveness ', ' effectiveness evaluation ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Aerobic Exercise ', ' Aerobic Activity ', ' Aerobic fitness ', ' Algorithms ', ' Awareness ', ' Beds ', ' Behavior ', ' Calibration ', ' Clinical Research ', ' Clinical Study ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Eating ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,R01,2020,653880,OR-03,0.06659708097455712
"Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution PROJECT SUMMARY/ABSTRACT Many epidemiological investigations have associated exposure to traffic-derived air pollution from motor vehicles, air toxins from industry, and other environmental toxins with measures of poor birth outcomes consisting of preeclampsia (PE), preterm birth (PTB) and intra-uterine growth restriction (IUGR). These conditions, which collectively constitute ischemic placental disease, correlate strongly with infant morbidity and a host of adult diseases, ranging from coronary artery disease to cancer. Although it is widely believed that the pathophysiological mechanisms leading to complications of ischemic placental disease and placental insufficiency have similar biological origins, starting as early as defective placental implantation, to date there are no predictive studies that prospectively examine placental function. Thus, non-invasive assessment and prediction of normalcy versus aberrancy of placental function are lacking. Therefore, the overarching objective of this proposal is to develop and evaluate a suite of exosomal micro-transcriptomic and transcriptomic signatures (predictor) for predicting placental insufficiency. Moreover, we seek to use these novel signatures to assess the impact of environmental pollution exposure on placental aberrancy/insufficiency and related outcomes (PE, PTB and IUGR) (primary outcome). Our central hypothesis is that chronic exposure to environmental pollution, independent of socio-economic status (SES), increases the risk of placental insufficiency due to early gestational development of adverse placental function, and that these outcomes can be predicted non-invasively by developing maternal blood derived placental-enriched exosomal micro-transcriptomic and transcriptomic signatures. To test this hypothesis, our specific aims are to: AIM 1: Develop non-invasively in maternal blood, placenta-derived exosomal micro- transcriptomic and transcriptomic signatures that predict in-vivo placental function through all three trimesters. AIM 2: Use the micro-transcriptomic and transcriptomic data from Aim 1 to predict environmental pollution data collected during the course of this study. We will construct models to predict the environmental pollution state based on these signatures, so that they may be used as proxy of the pollution when this data is not available. AIM 3: Perform Epigenome Wide Association Studies using DNA methylation from placental tissues of the same cohort. We will use our Reduced Representation Bisulfite Sequencing to identify loci whose methylation is associated with placental insufficiency and environmental exposures. These studies will help identify genes confirmed by transcriptomic analysis that may be useful in future development of therapeutic interventions for women at high risk of placental insufficiency due to air pollution exposures. Identification of molecular signatures that predict the presence of environmental pollution and adverse pregnancy outcomes may become a game-changer. Obstetric practices may embrace these surveillance tactics in real-time to predict and perhaps reverse placental aberrancy/insufficiency. PROJECT NARRATIVE How environmental pollution contributes to poor pregnancy outcome is poorly understood, and the first trimester of pregnancy is a particularly vulnerable time period for the developing fetus, thus a mother's exposure to air pollution may alter the way that the placenta is established and how it functions throughout the rest of pregnancy. This project aims to identify new molecular markers reflecting normal and abnormal placental function that can be detected non-invasively in a pregnant woman's blood, towards assessing real- time placental function as pregnancy develops from the first to the third trimester. Thus, early detection, prevention strategies, and timely treatment of placental dysfunction as a result of environmental pollution exposures may be developed.",Biomarkers and Genes Associated with Placental Development and Function in Response to Environmental Pollution,9942495,R01HD089714,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Air ', ' Air Pollution ', ' Birth ', ' Parturition ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Coronary Arteriosclerosis ', ' Coronary Artery Disease ', ' Coronary Artery Disorder ', ' Coronary Atherosclerosis ', ' atherosclerotic coronary disease ', ' coronary arterial disease ', ' Disease ', ' Disorder ', ' Environmental Exposure ', ' Environmental Pollution ', ' environmental contaminant ', ' environmental contamination ', ' Fetal Development ', ' Developing fetus ', ' Fetal Growth Retardation ', ' Fetal Growth Restriction ', ' IUGR ', ' Intrauterine Growth Retardation ', ' impaired fetal growth ', ' intra-uterine growth restriction ', ' intra-uterine growth retardation ', ' intrauterine growth restriction ', ' prenatal growth disorder ', ' Future ', ' Genes ', ' Goals ', ' Gold ', ' Grant ', ' Histology ', ' Industry ', ' Maps ', ' Methylation ', ' Mothers ', ' Discipline of obstetrics ', ' Obstetrics ', ' Pathology ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Placenta Diseases ', ' Placenta Disorders ', ' Placental Diseases ', ' placental disorders ', ' Placental Insufficiency ', ' Placentation ', ' Placental Development ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' First Pregnancy Trimester ', ' 1st trimester ', ' Early Placental Phase ', ' First Trimester ', ' Second Pregnancy Trimester ', ' 2nd trimester ', ' Midtrimester ', ' Second Trimester ', ' Third Pregnancy Trimester ', ' 3rd trimester ', ' Last Trimester ', ' Third Trimester ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Prospective Studies ', ' Rest ', ' Risk ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Toxic Environmental Substances ', ' Environmental Toxin ', ' Toxic Environmental Agents ', ' environmental toxicant ', ' Toxin ', ' Measures ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' Motor Vehicles ', ' base ', ' Chronic ', ' Biological ', ' Histologically ', ' Histologic ', ' Training ', ' Individual ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' women at high risk ', ' High Risk Woman ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Ecological impact ', ' Environmental Impact ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Pollution ', ' early detection ', ' Early Diagnosis ', ' cohort ', ' Proxy ', ' novel ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' intervention therapy ', ' Therapeutic Intervention ', ' infant morbidity ', ' Modeling ', ' response ', ' Normalities ', ' Normalcy ', ' Data ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' in vivo ', ' Validation ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Outcome ', ' Population ', ' prospective ', ' transcriptomics ', ' implantation ', ' therapeutic agent development ', ' therapeutic development ', ' primary outcome ', ' molecular biomarker ', ' molecular marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' BS-seq ', ' Bisulfite-based sequencing ', ' bisulfite-seq ', ' bisulfite sequencing ', ' MicroRNA Expression Profiling ', ' global miRNA profiling ', ' miRNA sequencing ', ' miRNA-seq ', ' micro RNA expression profiling ', ' microRNA sequencing ', ' miRNA expression profiling ', ' EWAS ', ' epigenome wide association analysis ', ' epigenome-wide association studies ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' adverse pregnancy outcome ', ' exosome ', ' predictive signature ', ' imaging study ', ' recruit ', ' ']",NICHD,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2020,623441,CA-33,0.027065718717131884
"Modeling the Effect of Athletic Competition Anxiety on Blood Glucose Dynamics in Type 1 Diabetes Exercise is a challenge for people with type 1 diabetes (T1D) because different activity types and intensities have different impacts on glucose concentrations. This challenge is amplified on competition days, as the added stress and high-intensity activity causes drastically different glucose responses than during exercise on non- competition days. This can occur due to a combination of increased hepatic glycogenolysis anaerobic exercise and the counterregulatory hormone response associated with the stress of competition. Thus, many people with T1D limit their physical activity due to fear of hypoglycemia during or after the activity and the majority of people with T1D do not engage in enough physical activity with less than 20% performing aerobic exercise more than twice per week. Regardless of the desire to exercise, people with T1D may be caught in scenarios where they are doing physical activity such running to catch a bus to commute to work may cause a spike in blood glucose concentration due to the anaerobic nature of the sprint and the added stress of arriving late if he or she were to miss the bus. One would not have had time to consider the appropriate insulin dose to prevent hyperglycemia and would benefit greatly from a system that would monitor these states and make corrections without requiring user input. Artificial pancreas (AP) systems will simplify the treatment of T1D and more advanced research is needed to increase their efficacy during and after exercise. The AP automates the computation of the proper insulin dose by using a continuous subcutaneous glucose sensor (CGM), an automatic control system, and an insulin pump that continuously infuses insulin into the subcutaneous tissue. The limitation of this configuration is its reliance on a single measurement, the glucose concentration, which varies in response to changes in many factors such as meals and exercise. The Cinar group at Illinois Institute of Technology pioneered the multivariable AP development. Signals streamed in real time from wearable devices complement glucose data to build accurate models to predict future variations in glucose levels. These models are updated recursively with each new set of measurements and used in hypoglycemia prediction and adaptive control. A new generation multivariable AP system that will incorporate the presence of competition stress with knowledge of physical activity type and intensity with well-developed machine learning algorithms for data interpretation in real-time, hypoglycemia early-warning systems, and automatic control will be more effective in improving glucose control in physically-active people with T1D. Additionally, this technology will be safer by dramatically reducing the number and duration of hypoglycemic and hyperglycemic events, as compared to the current guidelines for maintaining euglycemia in exercise. Such AP systems can only be developed by using a sophisticated multivariable approach that includes glucose concentrations and a number of other physiological variables that impact glucose homeostasis during physical activity and under the presence of competition stress. PROJECT NARRATIVE The development of an exercise-smart artificial pancreas will improve the overall health and quality of life for people with type 1 diabetes through minimizing the number of treatment decisions required to maintain glucose homeostasis. This project will evaluate the glucose response during competitive and non-competitive exercise of various intensities, will build specific adaptive models that use data from glucose sensors and wearable devices to predict glucose trajectories for various exercise and stress conditions which will optimize insulin dosing with the exercise-smart artificial pancreas.",Modeling the Effect of Athletic Competition Anxiety on Blood Glucose Dynamics in Type 1 Diabetes,9994897,F31DK116524,"['Aerobic Exercise ', ' Aerobic Activity ', ' Aerobic fitness ', ' Algorithms ', ' Anxiety ', ' Anaerobic Bacteria ', ' anaerobe ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Glucose ', ' Blood Sugar ', ' Commuting ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Dehydration ', ' body water dehydration ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Environment ', ' Exercise ', ' Fright ', ' Fear ', ' Feedback ', ' Foundations ', ' Future ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Health ', ' Hormones ', ' Endocrine Gland Secretion ', ' Therapeutic Hormone ', ' Hydrocortisone ', ' Aeroseb-HC ', ' Cetacort ', ' Cort-Dome ', ' Cortef ', ' Cortenema ', ' Cortisol ', ' Cortispray ', ' Cortril ', ' Dermacort ', ' Eldecort ', ' Hydrocortone ', ' Hytone ', ' Nutracort ', ' Proctocort ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Illinois ', ' Institutes ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Insulin Infusion Systems ', ' insulin pump ', ' Ketosis ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Persons ', ' Physical Fitness ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Recommendation ', ' Research ', ' Running ', ' Safety ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Time ', ' Work ', ' Generations ', ' Measures ', ' Guidelines ', ' base ', ' improved ', ' Hepatic ', ' sedentary ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Training ', ' Physical activity ', ' Personality Traits ', ' Individual ', ' Measurement ', ' Hypodermis ', ' Subcutis ', ' Superficial Fascia ', ' Tela Subcutanea ', ' Subcutaneous Tissue ', ' Artificial Pancreas ', ' Nature ', ' Knowledge ', ' Event ', ' Stream ', ' Reaction ', ' subcutaneous ', ' Techniques ', ' System ', ' meter ', ' experience ', ' glycogenolysis ', ' Performance ', ' treatment planning ', ' member ', ' Reporting ', ' Modeling ', ' response ', ' glucose sensor ', ' preventing ', ' prevent ', ' Dose ', ' Athletic ', ' Data ', ' Detection ', ' Exercise Physiology ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Societal Factors ', ' Update ', ' Monitor ', ' pancreas development ', ' developmental ', ' Development ', ' physiologic model ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' Impairment ', ' nondiabetic ', ' non-diabetic ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' exercise intensity ', ' wearable electronics ', ' wearable technology ', ' wearable device ', ' machine learned algorithm ', ' machine learning algorithm ', ' euglycemia ', ' ']",NIDDK,ILLINOIS INSTITUTE OF TECHNOLOGY,F31,2020,41640,IL-01,0.04936497009329091
"DFU Clinical Research Unit Abstract Diabetic foot ulcers (DFUs) are a prevalent diabetes complications affecting up to 25% of patients and leading to ~80,000 Americans having non-traumatic amputations each year, with five-year mortality rates of up to 40%. Recent evidence suggests that non-traumatic lower extremity amputations are on the rise, after decades of decline, in spite of advances in targeted wound care products, establishment of interdisciplinary clinical and surgical teams, and improving diabetes medical care. Given the worldwide epidemic of diabetes, the burden associated with DFU are high, including high costs of $9 billion-$13 billion per year and besides those associated with high morbidity and mortality. Thus, the establishment of a Diabetic Foot Consortium comprised of experienced DFU Clinical Research Units (CRU) for reliable DFU biomarker discovery cannot be understated. The main objective of this proposal is to integrate the robust infrastructure at Michigan Medicine with our highly skilled clinical and translational team to establish a DFU CRU as a strong contender and contributor within the DFC network that will be uniquely poised to participate in all DFU biomarker discovery and related wound healing projects undertaken by the Consortium. Additional aims are to The aims are to : identify, recruit, and phenotype a broad spectrum of DFU participants from the large base of patients with these conditions who are currently being followed at Michigan Medicine, according to the Consortium requirements; implement standardized mechanisms and protocols for effective longitudinal sample collection and retention; and actively participate in the DFC intellectually and provide all available resources to develop and support clinical study protocols to validate DFU biomarkers, including complex quantifications of wound image features; single cell, genetic, molecular, metabolomics, and microbiome analyses; and assessing additive predictors of DFU healing beyond clinical markers alone using multi-modal approaches. The expected outcome of this work is that the Michigan Medicine DFU Clinical Center will be an integral part of the Consortia collaborative network, with a highly positive impact for the entire spectrum of biomarker discovery and future novel therapies projects. Narrative This project has major public health relevance because diabetic foot ulcers (DFUs) remain one of the most common secondary complications of diabetes and are the leading cause of lower extremity amputation in the US. Current treatments are ineffective and given the recent surge in major lower extremity amputations in diabetic patients despite the previous decades of decline, identification of novel treatment avenues is of critical importance. The main objective of the Diabetic Foot Clinical Center at the University of Michigan is to use our robust infrastructure and highly skilled clinical and translational research team to generate a unique platform for investigating individual contributions to DFU wound healing from clinical samples, single cell genetic and molecular analyses from DFU samples, and image analyses.",DFU Clinical Research Unit,10220471,U01DK119083,"['Affect ', ' Age ', ' ages ', ' Amputation ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cells ', ' Cell Body ', ' Clinical Markers ', ' Clinical Research ', ' Clinical Study ', ' Cohort Studies ', ' Concurrent Studies ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Data Collection ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Mental Depression ', ' depression ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Sterile coverings ', ' Dressing ', ' Engineering ', ' Epidemic ', ' Future ', ' Heart failure ', ' cardiac failure ', ' Heterogeneity ', ' Infection ', ' Institutes ', ' Lower Extremity ', ' Lower Limb ', ' Membrum inferius ', ' male ', ' Marketing ', ' Medicine ', ' Methodology ', ' Michigan ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patient Outcomes Assessments ', ' Patient Reported Measures ', ' Patient Reported Outcomes ', ' Patients ', ' Peripheral Nervous System Diseases ', ' PNS Diseases ', ' Peripheral Nerve Diseases ', ' Peripheral Nervous System Disorders ', ' Peripheral Neuropathy ', ' Phenotype ', ' Psychosocial Factor ', ' psychosocial variables ', ' Publishing ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Schools ', ' Self Care ', ' personal care ', ' Standardization ', ' Technology ', ' Time ', ' Ulcer ', ' Ulceration ', ' Universities ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' wound healing ', ' Wound Repair ', ' wound resolution ', ' Gender ', ' Walking ', ' Foot Ulcer ', ' Caring ', ' base ', ' Label ', ' improved ', ' specimen collection ', ' sample collection ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Area ', ' Surface ', ' Clinical ', ' Biological ', ' Medical ', ' Charcot foot ', ' Diabetic Foot ', ' Individual ', ' European ', ' Data Bases ', ' data base ', ' Databases ', ' participant recruitment ', ' Patient Recruitments ', ' fluid ', ' liquid ', ' Liquid substance ', ' Genetic ', ' tool ', ' Diabetes Complications ', ' Diabetes-Related Complications ', ' Diabetic Complications ', ' Complications of Diabetes Mellitus ', ' machine learned ', ' Machine Learning ', ' cognitive function ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Location ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' interest ', ' American ', ' experience ', ' cohort ', ' novel ', ' Participant ', ' Devices ', ' Position ', ' Positioning Attribute ', ' Genetic analyses ', ' genetic analysis ', ' Sampling ', ' Bio-Informatics ', ' Bioinformatics ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Tissue Sample ', ' preventing ', ' prevent ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Address ', ' diabetic foot wound ', ' Diabetic Foot Ulcer ', ' Adherence ', ' Data ', ' Molecular Analysis ', ' Collection ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Molecular ', ' Behavioral ', ' peripheral artery disease ', ' Peripheral arterial disease ', ' imaging ', ' Image ', ' microbiome ', ' cost ', ' healing ', ' clinical site ', ' clinical research site ', ' Outcome ', ' tissue wound ', ' wounding ', ' wounds ', ' wound ', ' prospective ', ' transcriptomics ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' public health relevance ', ' multi-modality ', ' multimodality ', ' FDA approved ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' diabetic patient ', ' BigData ', ' Big Data ', ' precision-based medicine ', ' precision medicine ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' biomarker discovery ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' ineffective treatment ', ' ineffective therapies ', ' recruit ', ' practice setting ', ' analyze microbiome ', ' microbiome analysis ', ' Infrastructure ', ' wound assessment ', ' wound monitoring ', ' wound care ', ' clinical center ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2020,49505,MI-12,0.07566355151654874
"The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center ABSTRACT The mechanistic underpinnings of diseases involving the exocrine pancreas are poorly understood. Chronic pancreatitis is often accompanied by inflammation of the pancreas, irreversible fibrosis, and destruction of the pancreatic parenchyma resulting in abdominal pain, malnutrition, exocrine pancreatic insufficiency, pancreatogenic diabetes, and, in some cases, pancreas cancer. We have developed a network of adult and pediatric investigators to form The Ohio State University Clinical Center (OSU CC). In a multidisciplinary collaboration with other clinical centers in the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer Clinical Centers (CPDPC-CCs) (U01), the OSU CC has helped develop four (4) major observational studies during the initial funding cycle to address research gaps in our understanding of diseases of the exocrine pancreas. Specifically, the OSU CC seeks to validate proposed diagnostic biomarkers in chronic pancreatitis, pancreatogenic diabetes, and pancreas cancer. Project Narrative We have developed a network of adult and pediatric medical research institutions to form The Ohio State University Clinical Center (OSU CC). In a multidisciplinary collaboration with other clinical centers in the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC- CCs) (U01), the OSU CC has helped developed 4 major observational studies during the initial funding cycle that address research gaps in our understanding of the exocrine pancreas. Specifically, the OSU CC seeks to confirm and validate proposed diagnostic biomarkers in chronic pancreatitis, pancreaticogenic diabetes and pancreas cancer.",The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center,10263457,U01DK108327,"['Abdominal Pain ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Clinical Trials ', ' Complement ', ' Complement Proteins ', ' Cross-Sectional Studies ', ' Cross Sectional Analysis ', ' Cross-Sectional Analyses ', ' Cross-Sectional Survey ', ' Disease Frequency Surveys ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Digestive System Disorders ', ' Digestive Diseases ', ' Digestive System Diseases ', ' GI tract disorder ', ' digestive disorder ', ' digestive tract disease ', ' gastrointestinal tract disease ', ' gastrointestinal tract disorder ', ' Disease ', ' Disorder ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Fibrosis ', ' Future ', ' Goals ', ' Grant ', ' Inflammation ', ' Institutes ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Ohio ', ' Pancreas ', ' Pancreatic ', ' Patients ', ' Publications ', ' Scientific Publication ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Ships ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Medical Research ', ' recurrent pancreatitis ', ' chronic pancreatitis ', ' chronic pain ', ' Nutritional Deficiency ', ' Undernutrition ', ' dietary deficiency ', ' malnourished ', ' nutrition deficiency ', ' nutrition deficiency disorder ', ' nutritional deficiency disorder ', ' Malnutrition ', ' Natural History ', ' Biological ', ' Evaluation ', ' pediatric ', ' Childhood ', ' insight ', ' Fostering ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' Progress Reports ', ' Funding ', ' Pancreatic Insufficiency ', ' Exocrine pancreatic insufficiency ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Malignant Pancreatic Neoplasm ', ' Pancreas Cancer ', ' Pancreatic Cancer ', ' pancreatic malignancy ', ' Malignant neoplasm of pancreas ', ' Protocol ', ' Protocols documentation ', ' exocrine pancreatic ', ' Exocrine pancreas ', ' Services ', ' Manuscripts ', ' novel ', ' Participant ', ' Basic Research ', ' Basic Science ', ' Organization Charts ', ' organizational structure ', ' Position ', ' Positioning Attribute ', ' response ', ' depository ', ' repository ', ' Institution ', ' Address ', ' Aliquot ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' NCI Organization ', ' National Cancer Institute ', ' Research Infrastructure ', ' Ancillary Study ', ' Cancer Research Infrastructure ', ' Clinical Cancer Center ', ' Clinical Sciences ', ' Collection ', ' enroll ', ' Enrollment ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' work group ', ' working group ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' diagnostic marker ', ' diagnostic biomarker ', ' Infrastructure ', ' Big Data Analytics ', ' Big Data Tools ', ' Big Data Methods ', ' clinical center ', ' ']",NIDDK,OHIO STATE UNIVERSITY,U01,2020,120000,OH-03,0.09548857767348978
"Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer This is an application for renewal of Clinical Center designation of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). The Greater Los Angeles Clinical Center has provided considerable leadership in the organization and progress of the CPDPC. Dr. Pandol serves as co-chair of the Steering Committee and Dr. Goodarzi co-chairs the Type 3c Working Group. We have excelled in recruitment and retention of participants in the cohort studies implemented through the CPDPC designed to elucidate the natural history and develop means of diagnosis, treatment and clinical management of chronic pancreatitis (CP) and its complications in children and adults, and to determine the pathogenic interrelationships of diabetes and pancreatic cancer and develop the means of early diagnosis and management of pancreatic cancer. In addition, we have been performing a number ancillary and associated studies to support the overall goals of CPDPC, including: 1. Epidemiologic studies defining risk factors for pancreatic cancer and the natural history of CP; 2. Determining that genetic susceptibility for type 2 diabetes is a strong risk factor for diabetes associated with CP; 3. Developing liquid biopsy assays for aiding in the diagnosis of pancreatic cancer and CP; 4. Investigating mechanisms of pancreatitis and pancreatic cancer for rational pharmaceutical treatments; and 5. Conducting pilot clinical trials for treatment of recurrent acute and chronic pancreatitis. For the next phase of the CPDPC we are committed to the following Specific Aims: 1. Continue recruitment and retention of subjects in CPDPC cohort studies (PROCEED, INSPPIRE 2, NOD,  DETECT) in existing and additional study sites, as well as increase diversity in the study population. 2. Continue currently supported ancillary studies to further develop risk factor models combined with liquid  biopsy assays for early diagnosis of chronic pancreatitis and pancreatic cancer, and advance mechanism-  based treatments and clinical trials for recurrent acute and chronic pancreatitis and pancreatic cancer. 3. Build models that combine clinical features with genetic susceptibility to allow the prediction of future  development of diabetes in patients with chronic pancreatitis. 4. Determine the role of pancreatic enzyme replacement in regulating glucose homeostasis in patients with  chronic pancreatitis and diabetes, with or without pancreatic exocrine insufficiency. 5. Use existing and annotated pre-diagnostic CT scans to develop artificial intelligence-based techniques for  highly sensitive and specific methods for CT-based early pancreatic cancer detection. Our Center involves Cedars-Sinai Medical Center, UCLA Medical Center, the VA Greater Los Angeles Healthcare System and the University of Southern California/Los Angeles Public Health System with an organizational structure designed to expand recruitment into cohort studies of CPDPC with increased diversity and to facilitate our participation in ancillary studies. This is an application to renew the Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, which consists of an expert team well-qualified to carry out studies of the Consortium in Los Angeles County, the most populous and ethnically diverse county in the United States. We plan to adjust and expand our recruitment strategies for cohort studies of the Consortium to help meet national goals; we will also continue progress on a series of ancillary studies within the Consortium designed to detect and treat pancreatic diseases. In addition, we propose new studies to develop prediction models for diabetes in chronic pancreatitis, interrogate the role of digestive enzyme insufficiency in this form of diabetes, and develop novel imaging-based methods for early pancreatic cancer detection that will, in turn, decrease the morbidity of pancreatic cancer.","Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer",10074162,U01DK108314,"['acute pancreatitis ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' California ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Enzymes ', ' Enzyme Gene ', ' Future ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Human ', ' Modern Man ', ' Institutes ', ' Leadership ', ' Los Angeles ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Pancreatic Diseases ', ' Pancreatic Disorder ', ' pancreas disorder ', ' Pancreatitis ', ' Patients ', ' Public Health ', ' Recurrence ', ' Recurrent ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' Universities ', ' County ', ' recurrent pancreatitis ', ' chronic pancreatitis ', ' Natural History ', ' base ', ' Site ', ' Area ', ' Clinical ', ' Series ', ' pediatric ', ' Childhood ', ' Pancreatic Insufficiency ', ' Exocrine pancreatic insufficiency ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Malignant Pancreatic Neoplasm ', ' Pancreas Cancer ', ' Pancreatic Cancer ', ' pancreatic malignancy ', ' Malignant neoplasm of pancreas ', ' Diagnostic ', ' Complex ', ' Techniques ', ' Chronic Phase ', ' exocrine pancreatic ', ' Exocrine pancreas ', ' Medical center ', ' early detection ', ' Early Diagnosis ', ' novel ', ' disease risk ', ' disorder risk ', ' Organization Charts ', ' organizational structure ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Modeling ', ' response ', ' pancreas enzyme ', ' Pancreatic enzyme ', ' Data Monitoring Committees ', ' Data and Safety Monitoring Boards ', ' Safety Monitoring Boards ', ' Clinical Trials Data Monitoring Committees ', ' Pathogenicity ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Pancreas Ductal Adenocarcinoma ', ' Pancreatic Ductal Adenocarcinoma ', ' Health system ', ' NCI Organization ', ' National Cancer Institute ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' precancerous ', ' premalignant ', ' Ancillary Study ', ' Cancer Detection ', ' Clinical Management ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Principal Investigator ', ' developmental ', ' Development ', ' work group ', ' working group ', ' treatment trial ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' study population ', ' ethnically diverse ', ' ethnic diversity ', ' liquid biopsy ', ' recruit ', ' participant retention ', ' clinical center ', ' ']",NIDDK,CEDARS-SINAI MEDICAL CENTER,U01,2020,523936,CA-28,0.11819030120802701
"Effectiveness of Digital Versus In-Person Diabetes Prevention Programs 1 PROJECT SUMMARY  Millions of U.S. adults living with prediabetes, a high risk state for future type 2 diabetes, do not receive appropriate lifestyle counseling to lower their risk of type 2 diabetes. Mobile health (mHealth) technologies represent a potential scalable solution to address this far-reaching problem. The objective of this project is to compare the real-world effectiveness of a digital diabetes prevention program (dDPP) to standard of care in- person diabetes prevention programs (ipDPPs). This study will test a novel, fully-automated digital health platform (Sweetch Health, Ltd.) that uses artificial intelligence technology to provide just-in-time and adaptive lifestyle change coaching for prediabetic adults. Preliminary evidence from feasibility or observational studies suggests that JITAIs, which are often delivered via smartphone apps by virtue of their ability to provide continuous self-monitoring and feedback, can be effective. However, it is currently not known whether dDPPs that deliver a JITAI are as effective as ipDPPs in improving health outcomes in patients with prediabetes, a susceptible patient population that is positioned to benefit from such an intervention.  The overarching goal of this project, therefore, is to compare the effectiveness of the Sweetch digital diabetes prevention program (dDPP) to real-world in-person diabetes prevention programs (ipDPPs) for promoting weight loss, increasing physical activity, and reducing hemoglobin A1C in prediabetic adults. The proposed study addresses an evidence gap in the science of chronic disease prevention and health behavior change and is supported by promising short-term results from a previous pilot trial conducted by our team. Building on our previous study and leveraging the collective expertise of our multidisciplinary study team, we will conduct a randomized controlled trial of 382 overweight/obese, prediabetic adults ages 18-75 with 6 and 12 month follow-up visits: Arm 1 (N=191) will receive the fully automated Sweetch digital health kit (dDPP arm) and Arm 2 (N=191) will be referred to a local CDC-recognized ipDPP. Both arms will have physical activity measured serially during the trial using actimetry at baseline and 2 month intervals. We hypothesize that the dDPP will be more effective than the ipDPP for the outcomes of weight loss, physical activity, and lowering of hemoglobin A1C at 6 months, with sustained effects at 12 months. We further hypothesize that the overall engagement and acceptability will be greater in the dDPP, and that the superiority of the dDPP on clinical outcomes will be mediated by higher engagement in this arm.  This project will advance chronic disease prevention and behavioral science research by elucidating the extent to which fully-automated digital interventions using artificial intelligence technology can deliver effective, scalable, sustainable, and cost-effective health-promoting behavioral change interventions in high-risk populations. The implications of this fully-automated approach for scalability in diabetes prevention are profound. 2 PROJECT NARRATIVE  Prediabetes, a high risk state for future type 2 diabetes, currently affects nearly 1 in 3 Americans, the vast majority of whom do not receive appropriate lifestyle counseling to lower their risk for type 2 diabetes. In this project, we propose to evaluate the real-world effectiveness of a fully-automated digital diabetes prevention program for weight reduction, promotion of physical activity, and lowering of hemoglobin A1C (a measure of average blood glucose control) compared to standard of care in-person diabetes prevention programs. Since this digital diabetes prevention program uses artificial technology and requires no human component, it would potentially offer a breakthrough in improving population health in a scalable and cost- effective way, helping the tens of millions of affected U.S. patients and hundreds of millions of patients globally living with prediabetes.",Effectiveness of Digital Versus In-Person Diabetes Prevention Programs,10034797,R01DK125780,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Age ', ' ages ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Behavioral Sciences ', ' Blood Glucose ', ' Blood Sugar ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Counseling ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Fatty acid glycerol esters ', ' Fats ', ' Feasibility Studies ', ' Feedback ', ' Future ', ' Goals ', ' Health ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Human ', ' Modern Man ', ' Hybrids ', ' Life Style ', ' Lifestyle ', ' Maintenance ', ' Methods ', ' Motivation ', ' Persons ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Questionnaires ', ' Research ', ' Risk ', ' Science ', ' Technology ', ' Testing ', ' Time ', ' Weight Gain ', ' Weight Increase ', ' body weight gain ', ' body weight increase ', ' wt gain ', ' Body Weight decreased ', ' Weight Loss ', ' Weight Reduction ', ' body weight loss ', ' wt-loss ', ' Weight ', ' Generations ', ' Measures ', ' Mediating ', ' Outcome Measure ', ' base ', ' improved ', ' Clinical ', ' Physical activity ', ' Randomized Controlled Trials ', ' tool ', ' Prediabetes ', ' Prediabetic State ', ' pre-diabetes ', ' pre-diabetic ', ' prediabetic ', ' Prediabetes syndrome ', ' Knowledge ', ' programs ', ' Hour ', ' Over weight ', ' Overweight ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' Visit ', ' American ', ' novel ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' Prevention ', ' Modality ', ' Manpower ', ' personnel ', ' Human Resources ', ' Position ', ' Positioning Attribute ', ' Health Care Technology ', ' Healthcare Technology ', ' Health Technology ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' caloric restricted ', ' calorically restricted ', ' calorie restricted ', ' calorie restriction ', ' Caloric Restriction ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Effectiveness ', ' Favorable Clinical Outcome ', ' Address ', ' Adherence ', ' Data ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Monitor ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Behavioral ', ' Diabetes prevention ', ' diabetes prevention program ', ' pilot trial ', ' cost ', ' digital ', ' Outcome ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' dietary monitoring ', ' Diet Monitoring ', ' cost effective ', ' life style intervention ', ' lifestyle intervention ', ' Health behavior change ', ' multidisciplinary ', ' compare effectiveness ', ' high risk ', ' patient population ', ' standard of care ', ' population health ', ' arm ', ' m-Health ', ' mobile health ', ' mHealth ', ' high risk group ', ' high risk population ', ' Android App ', ' Android Application ', ' Cell Phone Application ', ' Cell phone App ', ' Cellular Phone App ', ' Cellular Phone Application ', ' Smart Phone App ', ' Smart Phone Application ', ' Smartphone App ', ' iOS app ', ' iOS application ', ' iPhone App ', ' iPhone Application ', ' smartphone Application ', ' program costs ', ' adult adiposity ', ' adults with obesity ', ' adult obesity ', ' comparative effectiveness study ', ' ']",NIDDK,JOHNS HOPKINS UNIVERSITY,R01,2020,733116,MD-07,0.12509423782011958
"Improving glucose control with advanced technology designed for high risk patients with type 1 diabetes Summary The objective of this proposal is to optimize the design and evaluate a robust artificial pancreas (R-AP) system for use in patients with uncontrolled type 1 diabetes (T1D) with HbA1C greater than 8% and compare HbA1C outcomes in these patients relative to a decision support system that utilizes continuous glucose monitoring (CGM) and multiple daily injection (MDI) therapy. Although high risk patients have possibly the most to gain from usage of AP technology, they are oftentimes under-represented or excluded from clinical trials. This has been because of the increased risk of failure of these AP systems that were not designed to handle inconsistent reporting of meals, variable activity level, and infusion set failures. An AP system for high risk patients needs to be designed to achieve maximal benefit, including reducing the risk of acute and chronic complications. A major obstacle for enabling the AP for usage by high-risk patients is that these patients may be less compliant with use guidelines for the system including missed meal announcements, infrequent sensor calibrations, and prolonged infusion set wear leading to infusion set failures. In this grant, we will integrate new risk-mitigation features into the OHSU single-hormone AP to enable usage by high-risk patients that fall into the categories described above. We present new algorithms for automating the detection of missed meal announcements, missed calibrations, and robust handling of hybrid usage mode. While AP systems may be an optimal choice for improving glycemic control, many people with T1D prefer MDI therapy. Decision support systems such as the DailyDose decision support system developed at OHSU can be used to improve glycemic control for patients who prefer MDI therapy. The DailyDose decision support system is designed for CGM augmented MDI therapy. It enables on-demand calculation of insulin doses, automates insulin dose adjustments based on pattern recognition, and uses machine learning approaches to alert the patients to events such as predicted hypoglycemia and missed meal doses.The benefit of the DailyDose system is that it is a simple system and does not require use of an insulin pump, which may be a challenge for some patients with uncontrolled type 1 diabetes as pump therapy is more intensive and requires infusion set changes. It is unknown in this high risk group of people whether patient needs, quality of life, and glycemic control are best addressed with an AP system or decision support tool or if both treatments are appropriate. We have designed a 3-month clinical study to compare glycemic outcomes during AP vs. decision support interventions in a high- risk T1D cohort (HbA1C 8-10.5%), with the aim of demonstrating a significant clinically relevant reduction in HbA1C. Our hypothesis is that both AP and decision support therapies will decrease HbA1C relative to baseline but that the AP will provide further benefit over DailyDose. Project Narrative Diabetes is the leading cause of blindness, kidney failure, and non-traumatic amputations. We propose to integrate features into the OHSU artificial pancreas to optimize it for high risk patients with type 1 diabetes (HbA1c>8-10.5%) and compare it to DailyDose, a decision support system that uses multiple daily injections.",Improving glucose control with advanced technology designed for high risk patients with type 1 diabetes,9969424,R01DK120367,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Algorithms ', ' Awareness ', ' Calibration ', ' Carbohydrates ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Diabetic Ketoacidosis ', ' Diabetic Acidosis ', ' Diabetic Ketosis ', ' diabetic ketoacidotic ', ' Exercise ', ' Fright ', ' Fear ', ' Grant ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Hormones ', ' Endocrine Gland Secretion ', ' Therapeutic Hormone ', ' Human ', ' Modern Man ', ' Hybrids ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Injection of therapeutic agent ', ' injection therapy ', ' Inpatients ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Insulin Infusion Systems ', ' insulin pump ', ' Manuals ', ' Outpatients ', ' Out-patients ', ' Patients ', ' Personality ', ' Quality of life ', ' QOL ', ' Questionnaires ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Risk ', ' Running ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Testing ', ' Time ', ' falls ', ' Outcome Measure ', ' Guidelines ', ' base ', ' Pump ', ' sensor ', ' improved ', ' Acute ', ' Chronic ', ' Multi-center trial ', ' Multicenter Trials ', ' Randomized Clinical Trials ', ' Failure ', ' Artificial Pancreas ', ' machine learned ', ' Machine Learning ', ' Event ', ' System ', ' vision loss ', ' visual loss ', ' Blindness ', ' Outcome Study ', ' Infusion ', ' Infusion procedures ', ' Performance ', ' cohort ', ' expectation ', ' Categories ', ' Reporting ', ' Emotional ', ' Decision Support Systems ', ' response ', ' glucometer ', ' glucose meter ', ' glucose monitor ', ' Adverse Experience ', ' Adverse event ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Address ', ' Dose ', ' Detection ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' Cognitive ', ' Pattern Recognition ', ' Update ', ' Characteristics ', ' Modification ', ' Behavioral ', ' designing ', ' design ', ' glycemic control ', ' Outcome ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' clinical relevance ', ' clinically relevant ', ' clinical significance ', ' clinically significant ', ' engineering design ', ' high risk ', ' patient population ', ' primary outcome ', ' secondary outcome ', ' risk minimization ', ' risk mitigation ', ' arm ', ' support tools ', ' high risk group ', ' high risk population ', ' Bluetooth ', ' smartwatch ', ' smart watch ', ' Injections ', ' in silico ', ' automatic algorithm ', ' automated algorithm ', ' diabetes distress ', ' ']",NIDDK,OREGON HEALTH & SCIENCE UNIVERSITY,R01,2020,599203,OR-03,0.05961180450961011
"Conception Failure and Pregnancy Loss in the U.S. NEW EVIDENCE ON CONCEPTION AND PREGNANCY LOSS IN THE U.S. ABSTRACT Conception failure and pregnancy loss impede the pathway to parenthood for millions of US couples each year. Despite being modifiable and commonpregnancy loss occurs fifty times as often as infant mortality miscarriage is among the least well-studied aspects of population health or population dynamics. We know little about what causes these losses, the generalizability of estimates generated from the study of small recruited samples, including how the risk of miscarriage differs across time, place, or subpopulation.  These enormous gaps are driven by how difficult it is to study the pathway to live birth in humans, requiring a sufficiently large and diverse preconception cohort. To date small, nonrepresentative cohorts contribute most of what we know about early pregnancy. But limited sample size, variation, and coverage preclude the study of social and ecological factorspoverty, partner health, environmental exposuresthat are now widely understood to shape mortality at later ages: e.g., stillbirth, infant, and child mortality. Such omissions are consequential. Conception failures and pregnancy loss have significant emotional and economic costs. Though pregnancy failures are likely distributed unevenly across populations, the size of this disparate burden is unknown. We do not have evidence about the potential impact of policies on the prevention of these outcomes.  Our research combines the tools of data science and social science to scale the preconception design to a large, diverse cohort in the US. Period and pregnancy tracking on digital devices is now common among reproductive-age women. We use data on 4 million womens day-to-day recording of menstrual cycles, ovulation, and pregnancy, as well as reported social and economic characteristics. The data allow us to measure both reported and detected conception and pregnancy loss. We combine the data with georeferenced information about the physical, social, economic, and policy environments in which women and their partners live. The sample is diverse: users come from over 99% of U.S. counties; over 1 million users are on Medicaid. We use these extraordinary data to provide the first estimates of large-scale population variability in the pathway to live birth and to document factors that affect this pathway. Aim 1 develops new estimates of conception and pregnancy loss, including disparities associated with education, income, racial identification, and neighborhood poverty. Aim 2 estimates the contribution of male partner characteristics to conception and pregnancy loss, drawing on detailed data reported about partners. Aim 3 uses quasi-experimental designs to provide the first estimates of understudied exposures from multiple environmental, social, economic domains on conception and pregnancy loss. The research sheds new light on a pervasive and massively understudied public health concern, with direct implications for the improvement of early pregnancy outcomes. In so doing, the research also generates estimates that are much-needed inputs to support advancement in multiple, connected fields of study in the social, health, and biomedical sciences. NARRATIVE Conception failure and miscarriage affect millions of U.S. couples each year. This research uses new georeferenced data on pre-pregnancy and early pregnancy for 4 million U.S. women to provide the first evidence on individual, family, ecological, and policy factors that reduce the risk of early pregnancy failure.",Conception Failure and Pregnancy Loss in the U.S.,9998409,R01HD102207,"['Spontaneous abortion ', ' Miscarriage ', ' Affect ', ' Age ', ' ages ', ' Behavior ', ' Child Mortality ', ' Communities ', ' Conceptions ', ' Couples ', ' Data Reporting ', ' data representation ', ' Economic Conditions ', ' Economical Conditions ', ' Economics ', ' Education ', ' Educational aspects ', ' Environment ', ' Environmental Exposure ', ' Experimental Designs ', ' Family ', ' Fertility ', ' Fecundability ', ' Fecundity ', ' Health ', ' Health behavior ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Health Status ', ' Level of Health ', ' Human ', ' Modern Man ', ' Income ', ' Economic Income ', ' Economical Income ', ' Infant Mortality ', ' Infant Mortality Total ', ' Inflammation ', ' Statutes and Laws ', ' Legislation ', ' Light ', ' Photoradiation ', ' male ', ' Maternal Health ', ' Medicaid ', ' men ', "" men's "", ' Menstrual cycle ', ' mortality ', ' Neighborhoods ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Ovulation ', ' Population Dynamics ', ' Population Sizes ', ' Poverty ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' Probability ', ' Public Health ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Risk ', ' Science ', ' Smoking ', ' Social Conditions ', ' Societal Conditions ', ' Social Sciences ', ' Time ', ' Translations ', ' Weight ', ' Woman ', ' County ', ' Measures ', "" Women's Health "", ' Female Health ', ' Rural Community ', ' Variation ', ' Variant ', ' Evaluation ', ' Failure ', ' Individual ', ' Policies ', ' Sample Size ', ' Economic Policy ', ' Shapes ', ' programs ', ' Event ', ' Clinic ', ' Live Birth ', ' stillborn ', ' stillbirth ', ' experience ', ' field based data ', ' field learning ', ' field test ', ' field study ', ' success ', ' cohort ', ' economic cost ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Pregnancy loss ', ' Prevention ', ' Devices ', ' Reporting ', ' social ', ' reproductive ', ' Emotional ', ' Sampling ', ' Consequentialism ', ' disparity in health ', ' health disparity ', ' Address ', ' Data ', ' Stratification ', ' Validation ', ' Characteristics ', ' Process ', ' pathway ', ' Pathway interactions ', ' digital ', ' designing ', ' design ', ' Outcome ', ' Population ', ' Fertility Study ', ' Implant ', ' spatiotemporal ', ' pregnant ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical practice ', ' population health ', ' stress reactivity ', ' Data Science ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' tribal lands ', ' recruit ', ' early pregnancy ', ' prepregnancy ', ' machine learned algorithm ', ' machine learning algorithm ', ' failed pregnancy ', ' pregnancy failure ', ' trying to conceive ', ' social factors ', ' data tools ', ' ']",NICHD,UNIVERSITY OF WISCONSIN-MADISON,R01,2020,315760,WI-02,0.05300985769966315
"Modeling and Assessment of Maternal Uteroplacental Circulation During Pregnancy ABSTRACT In this proposal I am interested in developing a computational fluid dynamic (CFD) modeling approach for volumetric assessment of human uteroplacental blood flow in vivo. The placenta is an organ that exchanges nutrients and oxygen between the maternal circulation and the growing fetus. In the United States, about 3.4% of pregnancies per year are affected by hypertensive pregnancy disorders (HPD) such as preeclampsia (PE), which have been found to carry both fetal and maternal risk. Associated placental pathologies are believed to be linked to alterations in maternal arterial remodeling. Currently, Doppler ultrasound (US) is the primary method of assessing flow to the placenta from the uterine artery (UtA). Clinical studies have shown a relationship between high UtA flow resistance and risk of adverse pregnancy outcome late in gestation, but it has not been reliable as an early gestation screening tool. In order to improve predictive technologies for reliable risk assessment assessment of HPD, more research into the relationship between vessel structure and function in the UtA is needed. I hypothesize that CFD modeling can be a useful tool for investigating possible pathophysiological mechanisms of HPD by simulating complex hemodynamics of the maternal vascular system including pressure, wall shear stress, and pulse wave velocity. I plan to set up various 1D CFD simulations to understand the hemodynamic parameters of normal versus abnormal pregnancies. Then, I will validate the simulations with 4D flow MRI acquired from an in vitro flow phantom and a cohort of normal and hypertensive pregnant women. I anticipate that the results of this investigation can advance scientific knowledge regarding the progression of early HPD phenotypes to adverse pregnancy outcomes. This CFD study can also demonstrate the extent to which patient-specific hemodynamic simulations can be reliable for future improvement of clinical management. This training experience will provide opportunities to build my expertise in cardiovascular physiology, fluid mechanics, medical imaging, data analysis, and clinical care. I will be publishing articles on my CFD/4D flow MRI findings and communicating the impact of this work in medicine at various internal and external symposia. This research will be conducted under the mentorship of award-winning experts and the University of Pennsylvania in cardiovascular MRI (Walter Witschey), fluid mechanics and computational modeling (Paris Perdikaris), maternal fetal medicine (Nadav Schwartz) and cardiovascular physiology (Victor Ferrari). PROJECT NARRATIVE The human placenta is an understudied organ believed to play a critical role in pregnancy health and the pathophysiology of hypertensive pregnancy disorders. Current technologies like ultrasound are limited in its ability to assess complex hemodynamics, and clinical studies have not yet found reliable biomarkers of adverse pregnancy outcomes. We will develop a computational fluid dynamic model of the maternal vessels delivering blood to the placenta and validate it with magnetic resonance imaging to characterize uteroplacental structure and function, providing future avenues for new predictive biomarkers of pregnancy health.",Modeling and Assessment of Maternal Uteroplacental Circulation During Pregnancy,9991192,F31HD100171,"['Abdomen ', ' Abdominal ', ' Affect ', ' Angiography ', ' Angiogram ', ' angiographic imaging ', ' Arteries ', ' Award ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Blood Vessels ', ' vascular ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cardiovascular Physiology ', ' cardiovascular function ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Disease ', ' Disorder ', ' Engineering ', ' Environment ', ' Fetus ', ' Future ', ' Goals ', ' Health ', ' hemodynamics ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' In Vitro ', ' Joints ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Medical Imaging ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Oxygen ', ' O element ', ' O2 element ', ' Paris, France ', ' Paris ', ' Pathology ', ' Patients ', ' Pennsylvania ', ' Phenotype ', ' Physics ', ' Physiology ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Placenta Diseases ', ' Placenta Disorders ', ' Placental Diseases ', ' placental disorders ', ' Placentation ', ' Placental Development ', ' Play ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' Third Pregnancy Trimester ', ' 3rd trimester ', ' Last Trimester ', ' Third Trimester ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' pressure ', ' Publishing ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Technology ', ' Testing ', ' Ultrasonography ', ' Echography ', ' Echotomography ', ' Medical Ultrasound ', ' Ultrasonic Imaging ', ' Ultrasonogram ', ' Ultrasound Diagnosis ', ' Ultrasound Medical Imaging ', ' Ultrasound Test ', ' diagnostic ultrasound ', ' sonogram ', ' sonography ', ' sound measurement ', ' ultrasound ', ' ultrasound imaging ', ' ultrasound scanning ', ' United States ', ' Universities ', ' Uterus ', ' womb ', ' Woman ', ' Work ', ' Measures ', ' falls ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Risk Assessment ', ' doubt ', ' Uncertainty ', ' pregnancy disorder ', ' Velocimetries ', ' Doppler Ultrasound ', ' Tube ', ' base ', ' Organ ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Link ', ' screening tools ', ' Screening procedure ', ' Training ', ' Blood flow ', ' insight ', ' Bayesian computation ', ' Bayesian inference ', ' Bayesian network analysis ', ' Bayesian spatial analysis ', ' Bayesian statistical analysis ', ' Bayesian statistical inference ', ' Bayesian statistics ', ' Bayesian Analysis ', ' Electrical Capacitance ', ' capacitance ', ' Electric Capacitance ', ' Measurement ', ' Uteroplacental Circulation ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' fluid ', ' liquid ', ' Liquid substance ', ' Morphology ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' mechanical ', ' Mechanics ', ' Pulse ', ' Physiologic pulse ', ' Scientist ', ' Investigation ', ' Complex ', ' Texture ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Vascular System ', ' fetal ', ' interest ', ' early detection ', ' Early Diagnosis ', ' experience ', ' phantom model ', ' cohort ', ' Structure ', ' Nutrient ', ' simulation ', ' Agreement ', ' disease risk ', ' disorder risk ', ' Reporting ', ' Modeling ', ' Property ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' cardiovascular imaging ', ' shear stress ', ' Data ', ' Predictive Value ', ' Reproducibility ', ' Resolution ', ' in vivo ', ' ACOG ', ' American College of Obstetricians and Gynecologists ', ' Clinical Management ', ' scientific accomplishments ', ' scientific advances ', ' Scientific Advances and Accomplishments ', ' Pathologic ', ' Monitor ', ' developmental ', ' Development ', ' arterial remodeling ', ' Outcome ', ' resistant ', ' Resistance ', ' spatiotemporal ', ' high risk ', ' clinical care ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' screening ', ' Geometry ', ' noninvasive imaging ', ' non-invasive imaging ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' 4-D MR imaging ', ' 4-D MRI ', ' 4-D flow MR imaging ', ' 4-D flow MRI ', ' 4-D flow imaging ', ' 4-D flow magnetic resonance imaging ', ' 4-D magnetic resonance imaging ', ' 4D MR imaging ', ' 4D flow MR imaging ', ' 4D flow MRI ', ' 4D flow imaging ', ' 4D flow magnetic resonance imaging ', ' 4D magnetic resonance imaging ', ' four dimensional MR imaging ', ' four dimensional MRI ', ' four dimensional flow ', ' four dimensional magnetic resonance imaging ', ' 4D MRI ', ' NavierStokes equations ', ' adverse pregnancy outcome ', ' imaging based approach ', ' imaging approach ', ' Maternal-fetal medicine ', ' neural network ', ' maternal risk ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' ']",NICHD,UNIVERSITY OF PENNSYLVANIA,F31,2020,45520,PA-03,0.049780125780407594
"Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetes PROJECT SUMMARY/ABSTRACT Hospital readmission is an undesirable, costly outcome that may be preventable. Hospitalized patients with diabetes are at higher risk of readmission within 30 days (30-d readmission) than patients without diabetes, and >1 million readmissions occur among diabetes patients in the US annually. Certain interventions can reduce readmission risk, but applying these interventions widely is cost prohibitive. One approach for improving the efficiency of interventions that reduce readmission risk is to target high-risk patients. We previously published a model, the Diabetes Early Readmission Risk Indicator (DERRITM), that predicts the risk of all-cause 30-d readmission of patients with diabetes. The DERRI, however, has modest predictive accuracy (C-statistic 0.63- 0.69), and requires manual data input. Recently, we demonstrated that adding variables to the DERRI substantially improves predictive accuracy (DERRIplus, C-statistic 0.82). However, using this larger model to predict readmission risk based on manual input of data would be too labor intensive for clinical settings. Indeed, most readmission risk prediction models are limited by the trade-off between accuracy and ease of use; lack of translation to a tool that integrates with clinical workflow; modest accuracy; lack of validation; and dependence on data only available after hospital discharge.  The objectives of the current proposal are: 1) To develop more accurate all-cause unplanned 30-d readmission risk prediction models using electronic health record (EHR) data of patients with diabetes (eDERRI); 2) To translate the models to an automated, EHR-based tool that predicts % readmission risk of hospitalized patients; and 3) To prospectively validate the eDERRI models and tool. The new eDERRI models will expand upon the variables in the DERRIplus based on availability in EHR data (e.g., sociodemographics, encounter history, medication use, laboratory results, comorbidities, and length of stay). To develop the models, we will leverage data from the PaTH Clinical Data Research Network (CDRN), a multi-center, 40-plus hospital member of the National Patient-Centered Clinical Research Network (PCORnet). We will apply state-of-the-art deep-learning methods to develop optimal predictive models. This project will analyze a large, multi-center cohort of nearly 340,000 discharges with cutting-edge techniques to develop better models and translate them to an automated tool that predicts readmission risk for individual patients with diabetes. The proposed tool would identify higher risk patients more likely to benefit from intervention, thus improving care and reducing costs. PROJECT NARRATIVE This project seeks to develop more accurate models that predict the risk of repeat hospitalizations among patients with diabetes. The models will be programmed into a tool that will be integrated with an electronic health record system and automatically predict the re-hospitalization risk of patients. Such a tool could be used to identify higher risk diabetes patients more likely to benefit from intervention, thus improving care and reducing costs.",Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetes,9971861,R01DK122073,"['Clinical Research ', ' Clinical Study ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Complement ', ' Complement Proteins ', ' Diabetes Mellitus ', ' diabetes ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Goals ', ' Recording of previous events ', ' History ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Laboratories ', ' Length of Stay ', ' Number of Days in Hospital ', ' hospital days ', ' hospital length of stay ', ' hospital stay ', ' Manuals ', ' Patient Readmission ', ' patient re-admission ', ' Patients ', ' Publishing ', ' Research ', ' Risk ', ' Risk Factors ', ' statistics ', ' Testing ', ' Translating ', ' Translations ', ' Work ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' improved ', ' Clinical ', ' Clinical Paths ', ' tool ', ' machine learned ', ' Machine Learning ', ' Dependence ', ' Techniques ', ' System ', ' experience ', ' cohort ', ' hospital re-admission ', ' re-admission ', ' re-hospitalization ', ' readmission ', ' rehospitalization ', ' hospital readmission ', ' Participant ', ' member ', ' Admission ', ' Admission activity ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' model development ', ' diabetes risk ', ' Institution ', ' Data ', ' Clinical Data ', ' Collection ', ' co-morbidity index ', ' comorbidity Index ', ' Validation ', ' point of care ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' cost ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' prospective ', ' patient centered ', ' patient oriented ', ' demographics ', ' high risk ', ' clinical practice ', ' learning activity ', ' learning method ', ' learning strategy ', ' individual patient ', ' predictive tools ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' re-admission risk ', ' readmission risk ', ' cost outcomes ', ' deep learning ', ' risk prediction model ', ' socio-demographics ', ' sociodemographics ', ' ']",NIDDK,TEMPLE UNIV OF THE COMMONWEALTH,R01,2020,658109,PA-02,0.09030102862910495
"Cardiovascular Health After Placental Abruption (CHAP) Abstract Placental abruption is an obstetrical complication defined as premature placental separation. Despite its elusive etiology, it is believed to be the consequence of acute stimuli  ischemia, inflammation, and oxidative stress at the maternalfetal interface  associated with rupture of the decidual artery, resulting in (premature) placental separation. The study of abruption and maternal and newborn longterm cardiovascular and hemorrhagic/thrombotic cerebrovascular events is the central focus of the proposed project. We will examine the longterm impact of abruption on rates of cardiovascular and cerebrovascular morbidity and mortality in women and in their children. We will also investigate the relationship of clinical classification (mild and severe forms) of abruption, risks based on abruption across successive pregnancies, and abruption in twin pregnancies, on rates of cardiovascular and cerebrovascular events. We will undertake a causal mediation analysis to evaluate the extent to which these associations may be mediated through (i) preterm delivery and (ii) small for gestational age births. We will perform this analysis by clinical classification of abruption and estimate the extent of mediation following corrections for both measured (sociodemographic characteristics, including maternal smoking, comorbid medical conditions, and obstetrical events), and unmeasured confounding. A unique aspect of this project will be to identify, through applications of Support Vector Machines and Deep Learning algorithms, subsets of women at high risk for abruption and cardiovascular and cerebrovascular mortality and morbidity. Finally, we will examine whether maternal race/ethnicity and socioeconomic status are effect measure modifiers of the association between abruption and risks of cardiovascular and cerebrovascular events. We propose to address these aims through a large populationbased epidemiologic study, utilizing data from the Myocardial Infarction Data Acquisition System (MIDAS), a New Jersey statewide database of all patients admitted to all nonfederal acute care hospitals in NJ with a CVD diagnosis, with longitudinal followup of up to 30 years. The MIDAS data will be linked to the NJ fetal death and linked live birth infant death data with associated maternal and newborn hospitalization data between 19802017 to create one of the largest and most comprehensive databases in the US to evaluate the extent to which sentinel events in pregnancy impart lasting risk for women's and children's health later in life. This project will provide unprecedented opportunities to address public health, policy implications and clinical screening recommendations of women during the period following delivery regarding risk susceptibility to cardiovascular and cerebrovascular disease. PROJECT NARRATIVE (PUBLIC HEALTH SIGNIFICANCE) The overarching goal of this project is to examine the associations between placental abruption and risks of cardiovascular and cerebrovascular morbidity and mortality later in life. The project will focus on overall associations, as well as identifying subsets of women at high risk based on abruption severity, recurrent abruptions, gestational age at delivery, and fetal growth restriction. This project will provide unprecedented opportunities to address public health, and policy implications regarding women's health, and clinical screening recommendations of women during the period following delivery regarding risk susceptibility to cardiovascular and cerebrovascular diseases.",Cardiovascular Health After Placental Abruption (CHAP),10051711,R01HL150065,"['Abruptio Placentae ', ' Premature Separation of Placenta ', ' placental abruption ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Arteries ', ' Attention ', ' Birth ', ' Parturition ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cerebrovascular Disorders ', ' Brain Vascular Disorders ', ' Cerebrovascular Disease ', ' Intracranial Vascular Diseases ', ' Intracranial Vascular Disorders ', ' brain vascular disease ', ' brain vascular dysfunction ', ' cerebral vascular disease ', ' cerebral vascular dysfunction ', ' cerebrovascular dysfunction ', ' intracranial vascular dysfunction ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Classification ', ' Systematics ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Cessation of life ', ' Death ', ' Cardiovascular Diagnostic Techniques ', ' Cardiovascular Diagnostic Technics ', ' cardiovascular disease diagnosis ', ' cardiovascular disorder diagnosis ', ' Disease ', ' Disorder ', ' Fetal Death ', ' fetus death ', ' Fetal Growth Retardation ', ' Fetal Growth Restriction ', ' IUGR ', ' Intrauterine Growth Retardation ', ' impaired fetal growth ', ' intra-uterine growth restriction ', ' intra-uterine growth retardation ', ' intrauterine growth restriction ', ' prenatal growth disorder ', ' Future ', ' Gestational Age ', ' Chronologic Fetal Maturity ', ' Fetal Age ', ' Goals ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Congestive Heart Failure ', ' Cardiac Failure Congestive ', ' Heart Decompensation ', ' chronic heart failure ', ' Hemorrhage ', ' Bleeding ', ' blood loss ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Infant Mortality ', ' Infant Mortality Total ', ' Newborn Infant ', ' 0-4 weeks old ', ' Newborns ', ' newborn child ', ' newborn children ', ' Small for Gestational Age Infant ', ' small for gestational age ', ' Inflammation ', ' Ischemia ', ' Maternal-Fetal Exchange ', ' Transplacental Exposure ', ' maternal-fetal interface ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Myocardial Infarction ', ' Cardiac infarction ', ' Myocardial Infarct ', ' cardiac infarct ', ' coronary attack ', ' coronary infarct ', ' coronary infarction ', ' heart attack ', ' heart infarct ', ' heart infarction ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' New Jersey ', ' Discipline of obstetrics ', ' Obstetrics ', ' Patients ', ' Perinatal mortality demographics ', ' Perinatal Mortalities ', ' Perinatal lethality ', ' perinatal deaths ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Public Health ', ' Pulmonary Embolism ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Recommendation ', ' Recurrence ', ' Recurrent ', ' Risk ', ' Risk Factors ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Twin Multiple Birth ', ' Twins ', ' Uterus ', ' womb ', ' Vision ', ' Sight ', ' visual function ', ' Woman ', ' Measures ', "" Women's Health "", ' Female Health ', ' Gestational Diabetes ', ' Gestational Diabetes Mellitus ', ' Pregnancy-Induced Diabetes ', ' pregnancy diabetes ', ' Mediating ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' Ischemic Heart ', ' Ischemic Heart Disease ', ' Ischemic myocardium ', ' cardiac ischemia ', ' coronary ischemia ', ' heart ischemia ', ' myocardial ischemia/hypoxia ', ' myocardium ischemia ', ' Myocardial Ischemia ', ' hypertensive cardiomyopathy ', ' hypertensive heart disorder ', ' hypertensive heart disease ', ' Acute myocardial infarct ', ' Acute myocardial infarction ', ' base ', ' improved ', ' Acute ', ' Clinical ', ' prematurity ', ' premature ', ' Medical ', ' Infant Health ', ' Link ', ' Susceptibility ', ' Predisposition ', ' insight ', ' Stimulus ', ' Workshop ', ' Educational workshop ', ' Data Bases ', ' data base ', ' Databases ', ' women at high risk ', ' High Risk Woman ', ' Oxidative Stress ', ' Ethnicity ', ' Ethnic Origin ', ' machine learned ', ' Machine Learning ', ' Life ', ' Frequencies ', ' Severities ', ' Event ', ' System ', ' Live Birth ', ' interest ', ' death in first year of life ', ' infant demise ', ' infantile death ', ' infant death ', ' stillborn ', ' stillbirth ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Reporting ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Sentinel ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Address ', ' Data ', ' NICHD ', "" National Institute of Children's Health and Human Development "", ' National Institute of Child Health and Human Development ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' cerebral vascular ', ' cerebro-vascular ', ' cerebrovascular ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' maternal smoking ', ' maternal cigarette smoking ', ' Rupture ', ' Outcome ', ' data acquisition ', ' high risk ', ' population based ', ' policy implication ', ' cardiovascular health ', ' health of the mother ', ' Child Health ', ' deep learning algorithm ', ' socio-demographics ', ' sociodemographics ', ' recommended screening ', ' screening recommendations ', ' screening guidelines ', ' obstetrical complication ', ' maternal risk ', ' acute care ', ' support vector machine ', ' ']",NHLBI,RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,R01,2020,707286,NJ-06,0.008347459077655646
"Associating retinal nerve fiber layer thickness with glucose metabolism and diabetic retinopathy Project Summary/Abstract Type 2 diabetes mellitus (T2DM), a metabolic disease that affects over 300 million people worldwide and that can be accompanied by serious health complications such as heart disease, kidney failure, stroke, and damage to the eyes, in particular diabetic retinopathy (DR), which is diagnosed in a third of people with diabetes and which is the leading cause of blindness within the age group between 20 and 64 years. T2DM is clinically diagnosed by parameters related to glucose metabolism obtained by blood tests. Due to its long pre- symptomatic phase, an estimate of 25% of diabetics in the US are undiagnosed. In this project, the relationship between spatial patterns of retinal nerve fiber layer (RNFL) thickness (RNFLT), measured by spectral-domain optical coherence tomography (OCT), and blood test levels as well as levels of DR severity is investigated in 9,261 participants of a population based study.  In a first step, OCT RNFLT measurements of the macular and the circumpapillary area around optic nerve head are segmented into spatial sectors, and representative spatial patterns of RNFLT are calculated by an unsupervised machine learning method. Afterwards, a multivariate linear model comparison is performed with the coefficients of the spatial RNFLT patterns as regressors and diagnostic blood test results as dependent variable. The optimal combination of the RNFLT patterns, determined by an established model selection criterion (Bayes Factor), is expected to reveal insight into the association between the specific retinal locations of RNFL thinning accompanying the change in parameters related glucose metabolism during the development and progression of T2DM. Furthermore, fundus images are graded by DR severity following a nine-step scale derived from the Early Treatment Diabetic Retinopathy Study from no DR to severe proliferative DR. The spatial RNFLT patterns and metabolic blood test scores are then compared with respect to modeling DR severity by linear regression. An optimal model of DR severity combining glucose metabolism parameters and RNFLT patterns is developed. Finally, in an analogous procedure, DR severity of the follow-up measurement, five years after baseline, is statistically predicted from RNFLT and metabolic blood parameters and from their change over time.  To summarize, the proposed research identifies spatial patterns of RNFLT associated with parameters of glucose metabolism and their development over DR severity. Once accomplished, the proposed project would provide the details to establish RNFLT as an alternative manifestation of T2DM that complements diagnostic blood tests and thereby, for instance, lay the foundations for the development of novel and more accurate T2DM progression monitoring or the prediction of the onset of DR. Project Narrative Parameters related to glucose metabolism obtained by blood tests are clinically used to diagnose diabetes, a metabolic disease that affects over 300 million people worldwide and that can be accompanied by serious health complications, such as diabetic retinopathy (DR), the leading cause of blindness within the age group between 20 and 64 years. Decreased levels of blood glucose tolerance have been associated with retinal nerve fiber layer (RNFL) thinning, but these results were based on comparisons between small populations of diagnosed diabetics and healthy controls, and RNFL was typically represented by coarse summary parameters which neglect retinal anatomy. This project contributes directly and immediately to public health by exploring the relationship between spatial patterns of RNFL thickness, present and future DR severity, and diagnostic blood test results in 9,261 participants of a population based study, with the final goal to establish and quantify RNFL thickness as an alternative manifestation of diabetes that complements diagnostic blood tests and lays the foundations for the development of novel and more accurate disease progression monitoring or the prediction of DR onset.",Associating retinal nerve fiber layer thickness with glucose metabolism and diabetic retinopathy,10002287,R21EY030631,"['Affect ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Glucose ', ' Blood Sugar ', ' Complement ', ' Complement Proteins ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diabetic Retinopathy ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Eye ', ' Eyeball ', ' Foundations ', ' Future ', ' Goals ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Blood Tests ', ' Hematologic Tests ', ' Hematological Tests ', ' Hematology Testing ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Linear Models ', ' Linear Regressions ', ' Maps ', ' Metabolic Diseases ', ' Metabolic Disorder ', ' Thesaurismosis ', ' metabolism disorder ', ' Optic Disk ', ' Optic Nerve Head ', ' Optic Papilla ', ' OGTT ', ' Oral Glucose Tolerance Test ', ' Patients ', ' Public Health ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Research ', ' Retina ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Testing ', ' Thinness ', ' Leanness ', ' Time ', ' Measures ', ' proliferative diabetic retinopathy ', ' base ', ' glucose tolerance ', ' Procedures ', ' Area ', ' Clinical ', ' Phase ', ' insight ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' Selection Criteria ', ' Metabolic ', ' clinical Diagnosis ', ' Diagnostic ', ' Dimensions ', ' Severities ', ' Scanning ', ' Pattern ', ' Techniques ', ' Location ', ' vision loss ', ' visual loss ', ' Blindness ', ' Test Result ', ' disease severity ', ' Severity of illness ', ' age group ', ' glucose metabolism ', ' novel ', ' Participant ', ' population-based study ', ' population-level study ', ' studies of populations ', ' study of the population ', ' Population Study ', ' Modeling ', ' Doppler OCT ', ' OCT Tomography ', ' optical Doppler tomography ', ' optical coherence Doppler tomography ', ' Optical Coherence Tomography ', ' Thickness ', ' Thick ', ' Data ', ' Sum ', ' Validation ', ' Monitor ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' fasting plasma glucose ', ' neglect ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' macular ', ' macula ', ' Population ', ' early therapy ', ' Early treatment ', ' RNFL ', ' retinal nerve fiber layer ', ' public health relevance ', ' Bayesian adaptive designs ', ' Bayesian adaptive models ', ' Bayesian belief network ', ' Bayesian belief updating model ', ' Bayesian framework ', ' Bayesian hierarchical model ', ' Bayesian network model ', ' Bayesian nonparametric models ', ' Bayesian spatial data model ', ' Bayesian spatial image models ', ' Bayesian spatial models ', ' Bayesian statistical models ', ' Bayesian tracking algorithms ', ' Bayesian Modeling ', ' fundus imaging ', ' unsupervised machine learning ', ' unsupervised learning ', ' archetypal analysis ', ' machine learning method ', ' ']",NEI,SCHEPENS EYE RESEARCH INSTITUTE,R21,2020,240285,MA-08,-0.04240159114915743
"The initial care of younger adults with newly diagnosed type 2 diabetes PROJECT SUMMARY Dr. Anjali Gopalan, MD, MSHP is a board-certified Internist at the Kaiser Permanente Northern California (KPNC) Oakland Medical Center and a Research Scientist I (equivalent to Assistant Professor) at the KPNC Division of Research (DOR). With the proposed K23 mentored career development award, Dr. Gopalan will gain the advanced training and expertise necessary to become an independent investigator who can develop and implement tailored interventions for patients with early-onset type 2 diabetes (EOT2D). By focusing on adults with EOT2D, she seeks to address the comparatively poor micro- and macrovascular outcomes in this population that may result partly from inadequate management of hyperglycemia and other cardiovascular disease risk factors. Dr. Gopalans research premise posits that it is particularly critical for newly diagnosed patients with EOT2D to achieve early disease control, since tighter glycemic control during the year following diagnosis confers long-lasting micro- and macrovascular benefits. In support of the premise, the Research Aims of this K23 are to: 1) use electronic health record [EHR] data to identify EOT2D patient subgroups at highest risk of inadequate early disease control, 2) identify barriers to and facilitators of initial EOT2D management, and 3) examine prospective associations between patient-reported factors (e.g., disease-related distress, health literacy) and inadequate early disease control. The proposed research will be supported by experienced mentors and advisors, as well as advanced training in the following areas: 1) the use of advanced statistical modeling, 2) qualitative data analysis to inform intervention development, 3) the role of social determinants in health, and 4) implementation science. KPNC and DOR are ideal environments for the proposed work. KPNC is an integrated learning healthcare delivery system with a diverse membership of 4.2 million people (>350,000 with diabetes). DOR has a long track record of effectively training early stage investigators and has well-established internal research programs and collaborative relationships with nearby institutions that provide the infrastructure needed for career development. This environment, along with the proposed Research and Training Plans and an outstanding mentorship team, will enable Dr. Gopalan to continue to build the skills and generate the foundational data needed to submit an R01-level proposal during the final years of the proposed award period. In this planned R01, Dr. Gopalan will refine and implement an intervention (with a design based on the results of the three K23 Research Aims) to improve early care for newly diagnosed EOT2D patients and evaluate its impact on early outcomes in this growing, high-risk population. In summary, the proposed K23 award will support the career development of Dr. Gopalan and is vital to her acquiring the skill set and expertise required to become a successful, independent investigator. PROJECT NARRATIVE Adults diagnosed with type 2 diabetes at a younger age have higher rates of complications than those diagnosed later in life. Given the lasting benefit conferred by early disease control, the initial care provided to this growing, high-risk population is particularly crucial. With this proposed career development award, Dr. Gopalan will acquire the research skills necessary to identify patients at highest risk for inadequate early disease control, define barriers to initial disease management, and develop an intervention designed to improve the care of adults (ages 21-44) with newly diagnosed type 2 diabetes.",The initial care of younger adults with newly diagnosed type 2 diabetes,10001486,K23DK116968,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Age ', ' ages ', ' Award ', ' California ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Reporting ', ' data representation ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Environment ', ' Face ', ' faces ', ' facial ', ' Foundations ', ' Future ', ' Goals ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Hyperglycemia ', ' hyperglycemic ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Interview ', ' Learning ', ' literacy ', ' Mentors ', ' Mentorship ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Myocardial Infarction ', ' Cardiac infarction ', ' Myocardial Infarct ', ' cardiac infarct ', ' coronary attack ', ' coronary infarct ', ' coronary infarction ', ' heart attack ', ' heart infarct ', ' heart infarction ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Population Characteristics ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Risk Management ', ' Role ', ' social role ', ' Smoke ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Trees ', ' United Kingdom ', ' Work ', ' Latino ', ' Research Methods ', ' Research Methodology ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Training ', ' Distress ', ' insight ', ' adult youth ', ' young adulthood ', ' young adult ', ' Internist ', ' integrated health system ', ' integrated healthcare systems ', ' Integrated Health Care Systems ', ' Diabetes Complications ', ' Diabetes-Related Complications ', ' Diabetic Complications ', ' Complications of Diabetes Mellitus ', ' machine learned ', ' Machine Learning ', ' Life ', ' Disorder Management ', ' Disease Management ', ' programs ', ' Scientist ', ' System ', ' Medical center ', ' diabetes education ', ' experience ', ' professor ', ' cohort ', ' Familiarity ', ' skills ', ' member ', ' Self-Report ', ' Patient Self-Report ', ' Reporting ', ' Modeling ', ' Sampling ', ' career development ', ' stigma ', ' social stigma ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disease control ', ' disorder control ', ' Qualitative Research ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Risk Reduction ', ' Provider ', ' Institution ', ' Address ', ' Data ', ' Health Sciences ', ' K23 Award ', ' K23 Mechanism ', ' K23 Program ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' Mentored Patient-Oriented Research Career Development Award ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Research Training ', ' Clinical Data ', ' Newly Diagnosed ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' early onset ', ' health literacy ', ' macrovascular complication ', ' macrovascular disease ', ' burden of disease ', ' disease burden ', ' years of life lost to disability ', ' years of life lost to disease ', ' burden of illness ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' prospective ', ' protective effect ', ' racial and ethnic ', ' comparative ', ' implementation science ', ' intervention design ', ' treatment design ', ' therapy design ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' high risk ', ' patient population ', ' e-Health ', ' eHealth ', ' individual patient ', ' improved outcome ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' ethnically diverse ', ' ethnic diversity ', ' high risk group ', ' high risk population ', ' Retrospective cohort ', ' barrier to health care ', ' barrier to healthcare ', ' barrier to treatment ', ' obstacle to care ', ' obstacle to healthcare ', ' barrier to care ', ' Infrastructure ', ' sociodeterminant ', ' social determinants ', ' ']",NIDDK,KAISER FOUNDATION RESEARCH INSTITUTE,K23,2020,192914,CA-13,0.06730211780386315
"Diabetic Retinopathy: genetics and neurodegeneration PROJECT SUMMARY/ABSTRACT Diabetes mellitus (DM) is the leading cause of vision loss among working aged adults. Its prevalence is increasing and despite the strides in knowledge and treatments, our understanding of the pathways leading to vision loss in DM remains limited. Hyperglycemia and duration of DM contribute to but do not fully explain the predisposition to develop diabetic retinal diseases. Given the predisposition for diabetic retinal diseases to cluster in families, genetic risk factors are thought to be important but none has so far been definitively implicated. Furthermore, data from small studies suggest that there are more phenotypes of diabetic retinal disease than are currently recognized in clinical practice. Diabetic retinal disease has traditionally been considered primarily a vascular process: diabetic retinopathy (DR) and diabetic macular edema (DME) are the main clinical manifestations. With improved imaging modalities and image analysis algorithms, there has been increasing recognition of a new clinical manifestation of diabetic retinal disease, diabetic retinal neurodegeneration (DRN). This is visible as alterations in thickness of retinal nerve fiber (RNFL) and/or ganglion cell layer (GCL) on optical coherence tomography (OCT) images. To date, DRN is poorly understood, and its role in clinical management of patients with DM has not been established. However, if retinal neurodegeneration occurs and is progressive, it can lead to profound visual difficulties for patients with DM. DRN may account for previously unexplained poor visual outcomes among patients with diabetic retinal disease despite standard of care treatment. Dr. Channa is a retina specialist, with prior research experience in retinal imaging and clinical trials of novel treatments for DME. In this K23 career development award she proposes to use a nationally representative dataset, the UK Biobank cohort to: 1) improve our understanding of DRN by determining RNFL and GCL thickness, using OCT imaging, in participants with DM (who have no DR or DME) compared to those who do not have DM 2) determine genetic factors associated with DR, DME and DRN. Dr. Channa proposes a career development plan, which includes mentorship, coursework, publications and clinical time. This will situate her as an independent clinician-scientist with expertise in translational research employing bioinformatics and computational skills in genomics and retinal image analysis to elucidate pathways of vision loss among patients with DM, ultimately leading to development of novel therapies. Her research work and career development will take place in the academic and collaborative environment of the largest medical center in the world, where she has institutional support and mentorship to develop as an independent clinician-scientist. PROJECT NARRATIVE In this career development award we aim to use genetic and retinal imaging data to enhance our understanding of the pathways that can lead to vision loss among people with diabetic retinal diseases. Improved understanding will translate into interventions aimed at preventing blindness from diabetes.",Diabetic Retinopathy: genetics and neurodegeneration,9868630,K23EY030911,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Blood Vessels ', ' vascular ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Diabetic Retinopathy ', ' Disease ', ' Disorder ', ' Environment ', ' Family ', ' Future ', ' Genes ', ' Goals ', ' Hyperglycemia ', ' hyperglycemic ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Mentors ', ' Mentorship ', ' Methods ', ' Nerve ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Nerve Fibers ', ' Patients ', ' Phenotype ', ' Publications ', ' Scientific Publication ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Regression Analysis ', ' Regression Analyses ', ' Regression Diagnostics ', ' Statistical Regression ', ' Research ', ' Retina ', ' Retinal Diseases ', ' Retinal Disorder ', ' retina disease ', ' retina disorder ', ' retinopathy ', ' Retinal Ganglion Cells ', ' retinal ganglion ', ' Risk Factors ', ' Role ', ' social role ', ' Testing ', ' Time ', ' Translating ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' Specialist ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Clinical ', ' Susceptibility ', ' Predisposition ', ' Training ', ' disability ', ' Visual ', ' diabetic ', ' Measurement ', ' Development Plans ', ' Sample Size ', ' macular edema ', ' Genetic ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Knowledge ', ' Scientist ', ' Scanning ', ' Techniques ', ' vision loss ', ' visual loss ', ' Blindness ', ' Medical center ', ' American ', ' experience ', ' fiber cell ', ' cohort ', ' family genetics ', ' skills ', ' novel ', ' Participant ', ' Prevention ', ' Reporting ', ' Appearance ', ' Fundus ', ' inherited factor ', ' genetic risk factor ', ' career development ', ' disease duration ', ' disease length ', ' illness length ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Genomics ', ' Doppler OCT ', ' OCT Tomography ', ' optical Doppler tomography ', ' optical coherence Doppler tomography ', ' Optical Coherence Tomography ', ' Bio-Informatics ', ' Bioinformatics ', ' VEGF ', ' VEGFs ', ' Vascular Endothelial Growth Factors ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Thickness ', ' Thick ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Disease Pathway ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Clinical Management ', ' Ganglion Cell Layer ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' diabetic management ', ' diabetes management ', ' Outcome ', ' Prevalence ', ' aged ', ' computer algorithm ', ' Computational algorithm ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' population based ', ' standard of care ', ' clinical practice ', ' biorepository ', ' biobank ', ' screening ', ' Algorithmic Analyses ', ' Analyses of Algorithms ', ' Analysis of Algorithms ', ' Algorithmic Analysis ', ' Business-Friendly Atmosphere ', ' business-friendly environment ', ' collaborative atmosphere ', ' interactive atmosphere ', ' interactive environment ', ' interdisciplinary atmosphere ', ' interdisciplinary environment ', ' peer-group atmosphere ', ' peer-group environment ', ' collaborative environment ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' retina imaging ', ' retinal imaging ', ' large data sets ', ' large datasets ', ' ']",NEI,BAYLOR COLLEGE OF MEDICINE,K23,2020,290835,TX-09,0.009786438813581976
"Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium This application describes a robust Southern California-based Clinical Center for participation in the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC). Proposed protocols address the metabolic mechanisms and the genetic, protein, and imaging signature of patients with acute pancreatitis (AP) and recurrent acute pancreatitis (RAP) who are at high risk for future development of diabetes. AP is the most common cause of pancreatogenic diabetes. While meta-analyses have revealed an incidence rate of 23% for diabetes arising after AP, they have not shed light on the type of diabetes that develops, which may comprise autoimmune or idiopathic type 1 diabetes (T1DM), type 2 diabetes (T2DM), or a unique diabetes pathobiology. A detailed understanding of diabetes developing after AP will yield great benefit by facilitating novel approaches to predict, prevent, and treat this form of diabetes. The following aims are proposed to address these goals:  Specific Aim 1. Recruit a cohort of non-diabetic patients with a recent episode of AP or RAP and prospectively characterize their islet autoimmunity and glucose/insulin homeostasis using the frequently sampled intravenous glucose tolerance test and mixed meal tolerance tests performed 1 month after hospital discharge, and at 3, 6, 12, 18, and 24 months, and yearly thereafter. The goals of this aim are to (a) determine the incidence of diabetes after AP, (b) identify the types of diabetes that develop after AP, (c) identify early metabolic trajectories associated with post-AP diabetes, (d) assemble the cohort that will be the platform for Aims 2-4.  Specific Aim 2. Evaluate genetic and protein risk factors for diabetes in patients with AP or RAP. This Aim will evaluate association of genetic risk scores for T1DM and T2DM with post AP diabetes. Thirteen candidate proteins, associated with post AP diabetes in preliminary studies, will be assessed for association with incident diabetes after AP, yielding a key set of proteins with utility not only in diabetes prediction but also targets for future preventive or therapeutic measures.  Specific Aim 3. Characterize the imaging phenotype that predicts development of diabetes after AP or RAP. Retrospective CT scans obtained during hospitalization for AP as well as CT and novel multiparametric MRI scans obtained 1 and 12 months afterward will undergo artificial intelligence analysis to identify the imaging biomarkers that signal diabetes risk.  Specific Aim 4. Develop a multi-factorial model to predict development of diabetes after AP or RAP. A wealth of data will be collected from Aims 1-3, which will be combined with clinical factors to build and validate (in independent datasets) an integrative predictive model of post AP diabetes. The goal is to create a model that can be used in clinical settings to identify those at highest risk, facilitating targeted measures to prevent diabetes.  This innovative research will be conducted by an experienced team of investigators in endocrinology, gastroenterology, imaging, physiology, and epidemiology to solve a problem of great public health significance. This is an application for the establishment of a Southern California Clinical Center to participate in the Type 1 Diabetes in Acute Pancreatitis Consortium, comprised of an expert team to carry out studies of the Consortium in Los Angeles County, the most populous and ethnically diverse county in the United States. Acute pancreatitis, one of the most frequent causes of hospitalization in the USA, greatly increases the risk of future development of diabetes, yet the type of diabetes is unclear. We propose studies to determine the metabolic mechanisms and the genetic, protein, and imaging signature of diabetes occurring after pancreatitis, which will provide the means to understand, prevent, and treat this form of diabetes.",Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium,10128180,U01DK127403,"['acute pancreatitis ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' Autoimmunity ', ' Autoimmune Status ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Blood ', ' Blood Reticuloendothelial System ', ' California ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Fasting ', ' fasted ', ' fasts ', ' Future ', ' Gastroenterology ', ' Genotype ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Health ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Incidence ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Insulin Resistance ', ' insulin resistant ', ' intravenous glucose tolerance test ', ' IVGTT ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Light ', ' Photoradiation ', ' Los Angeles ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methods ', ' Necrosis ', ' Necrotic ', ' Pancreas ', ' Pancreatic ', ' Pancreatitis ', ' Patients ', ' Phenotype ', ' Physiology ', ' Proteins ', ' Public Health ', ' Recurrence ', ' Recurrent ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Swelling ', ' Testing ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' County ', ' Measures ', ' recurrent pancreatitis ', ' chronic pancreatitis ', ' Dataset ', ' Data Set ', ' HLA-DR Associated Protein II ', ' IGAAD ', ' Inhibitor of GZMA-Activated DNase ', ' Phosphatase 2A Inhibitor I2PP2A ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Template Activating Factor I Beta ', ' Set protein ', ' base ', ' improved ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Individual ', ' Therapeutic ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Genetic ', ' Frequencies ', ' Severities ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Autoimmune ', ' Autoimmune Process ', ' Hormonal ', ' experience ', ' cohort ', ' novel ', ' Participant ', ' Modeling ', ' Sampling ', ' response ', ' Proteomics ', ' Magnetic Resonance Imaging Scan ', ' MRI Scans ', ' Meta-Analysis ', ' pancreas imaging ', ' diabetes risk ', ' insulin secretion ', ' preventing ', ' prevent ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genetic association ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Address ', ' Preventive ', ' Defect ', ' Data ', ' Intake ', ' Collection ', ' enroll ', ' Enrollment ', ' Genetic Risk ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' genetic profiling ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' islet ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' nondiabetic ', ' non-diabetic ', ' type 1 and type 2 diabetes ', ' type I and type II diabetes ', ' high risk ', ' genome scale ', ' genomewide ', ' genome-wide ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' ethnically diverse ', ' ethnic diversity ', ' recruit ', ' clinical center ', ' ']",NIDDK,CEDARS-SINAI MEDICAL CENTER,U01,2020,324613,CA-28,0.16964474836831364
"Effects of Chronic Kidney Disease on Cardiovascular Disease and Dementia Among People with Diabetes: Causal Modeling with Machine Learning Approach PROJECT SUMMARY/ABSTRACT Diabetes has been the major public health issues imposing substantial health and economic burden on individuals and society. Given the Sustainable Development Goals (SDGs) in which United Nations has resolved to reduce morbidity and mortality from non-communicable diseases by one-third by year 2030, understanding the major risk factors of long-term adverse health outcomes such as cardiovascular disease (CVD) among patients with diabetes are imperative. While chronic kidney disease (CKD) and depression are closely interrelated with both diabetes and CVD, the causal link between these non-communicable diseases have not been sufficiently established. This is possibly due to (1) ill-defined temporality (i.e. unclear time- ordering of disease occurrence) and (2) their complex multifactorial and high-dimensional interaction with potential confounders such as demographic characteristics, socio-economic status, and comorbidities. The overall objective of this application is to investigate the causal relationship between diabetes and its complications including CKD. My specific aims are as follows: Aim 1 (F99 phase) assesses the causal relationship between depression and CVD among people with diabetes. After summarizing the previous literature, I will utilize longitudinal data to examine the joint effect of diabetes and depression on CVD sufficiently considering time-dependent exposure and confounders. Aim 2 (K00 phase) examines the causal pathway from diabetes to CKD, and to CVD mortality. I will develop the machine learning-based prediction model of CKD among people with diabetes, and then estimate the effect of CKD on CVD mortality using the obtained prediction model within causal inference structure. I will also investigate the extent to which CKD mediates the pathway from diabetes to CVD mortality. This study presents a timely opportunity to contribute to growing literature on how these non-communicable diseases (i.e. diabetes, depression, CKD, and CVD) interact with each other. Moreover, applications of machine learning in causal inference structure will contribute to the precision health concept by targeting high-risk populations and design effective interventions to prevent future non-communicable diseases and their complications. PROJECT NARRATIVE Diabetes, depression, chronic kidney disease (CKD), and Cardiovascular disease (CVD) are major health concerns imposing substantial health and economic burden on individuals and society. This study proposes to estimate the effects of depression on CVD events among people with diabetes (F99 phase) and investigate the causal relationship between diabetes, CKD, and CVD mortality using machine learning within the causal inference structure (K00 phase). This project will provide research and training, contributing a much-needed analysis of diabetes and CKD on long-term adverse health outcomes as well as helping me develop into an independent researcher with expertise in diabetic kidney disease epidemiology.",Effects of Chronic Kidney Disease on Cardiovascular Disease and Dementia Among People with Diabetes: Causal Modeling with Machine Learning Approach,10059131,F99DK126119,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Aging ', ' Award ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Cessation of life ', ' Death ', ' Mental Depression ', ' depression ', ' Diabetes Mellitus ', ' diabetes ', ' Diabetic Nephropathy ', ' Diabetic Kidney Disease ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiologic Methods ', ' Epidemiological Methods ', ' Epidemiological Techniques ', ' Methods Epidemiology ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Future ', ' Goals ', ' Health ', ' Incidence ', ' Joints ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Laboratories ', ' Literature ', ' Mentors ', ' Metabolic Diseases ', ' Metabolic Disorder ', ' Thesaurismosis ', ' metabolism disorder ', ' Methodology ', ' Mexican Americans ', ' Chicanas ', ' Chicanos ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Probability ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk Factors ', ' Scoring Method ', ' Societies ', ' Testing ', ' Time ', ' United Nations ', ' United States ', ' Weight ', ' Emotional Depression ', ' depression symptom ', ' depressive ', ' depressive symptoms ', ' Latino ', ' Mediating ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' base ', ' improved ', ' Area ', ' Phase ', ' Link ', ' Individual ', ' Fostering ', ' Sustainable Development ', ' Genetic ', ' machine learned ', ' Machine Learning ', ' NHANES ', ' National Health and Nutrition Examination Survey ', ' Dimensions ', ' Complex ', ' Event ', ' Amentia ', ' Dementia ', ' cohort ', ' Structure ', ' Disease Outcome ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' General Public ', ' General Population ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Statistical Methods ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' preventing ', ' prevent ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Address ', ' Data ', ' Economic Burden ', ' Research Training ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Update ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' pathway ', ' Pathway interactions ', ' health economics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' diet and exercise ', ' Outcome ', ' Prevalence ', ' life style intervention ', ' lifestyle intervention ', ' innovate ', ' innovative ', ' innovation ', ' demographics ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' high risk ', ' effective intervention ', ' successful intervention ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' diabetic patient ', ' clinical practice ', ' BigData ', ' Big Data ', ' causal diagram ', ' causal model ', ' individual patient ', ' high risk group ', ' high risk population ', ' Long-term cohort ', ' Longterm cohort ', ' Longitudinal cohort ', ' high dimensionality ', ' Precision Health ', ' ']",NIDDK,UNIVERSITY OF CALIFORNIA LOS ANGELES,F99,2020,34360,CA-33,0.06897513318091779
"The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center ABSTRACT The mechanistic underpinnings of diseases involving the exocrine pancreas are poorly understood. Chronic pancreatitis is often accompanied by inflammation of the pancreas, irreversible fibrosis, and destruction of the pancreatic parenchyma resulting in abdominal pain, malnutrition, exocrine pancreatic insufficiency, pancreatogenic diabetes, and, in some cases, pancreas cancer. We have developed a network of adult and pediatric investigators to form The Ohio State University Clinical Center (OSU CC). In a multidisciplinary collaboration with other clinical centers in the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer Clinical Centers (CPDPC-CCs) (U01), the OSU CC has helped develop four (4) major observational studies during the initial funding cycle to address research gaps in our understanding of diseases of the exocrine pancreas. Specifically, the OSU CC seeks to validate proposed diagnostic biomarkers in chronic pancreatitis, pancreatogenic diabetes, and pancreas cancer. Project Narrative We have developed a network of adult and pediatric medical research institutions to form The Ohio State University Clinical Center (OSU CC). In a multidisciplinary collaboration with other clinical centers in the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC- CCs) (U01), the OSU CC has helped developed 4 major observational studies during the initial funding cycle that address research gaps in our understanding of the exocrine pancreas. Specifically, the OSU CC seeks to confirm and validate proposed diagnostic biomarkers in chronic pancreatitis, pancreaticogenic diabetes and pancreas cancer.",The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center,10072698,U01DK108327,"['Abdominal Pain ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Clinical Trials ', ' Complement ', ' Complement Proteins ', ' Cross-Sectional Studies ', ' Cross Sectional Analysis ', ' Cross-Sectional Analyses ', ' Cross-Sectional Survey ', ' Disease Frequency Surveys ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Digestive System Disorders ', ' Digestive Diseases ', ' Digestive System Diseases ', ' GI tract disorder ', ' digestive disorder ', ' digestive tract disease ', ' gastrointestinal tract disease ', ' gastrointestinal tract disorder ', ' Disease ', ' Disorder ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Fibrosis ', ' Future ', ' Goals ', ' Grant ', ' Inflammation ', ' Institutes ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Ohio ', ' Pancreas ', ' Pancreatic ', ' Patients ', ' Publications ', ' Scientific Publication ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Ships ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Medical Research ', ' recurrent pancreatitis ', ' chronic pancreatitis ', ' chronic pain ', ' Nutritional Deficiency ', ' Undernutrition ', ' dietary deficiency ', ' malnourished ', ' nutrition deficiency ', ' nutrition deficiency disorder ', ' nutritional deficiency disorder ', ' Malnutrition ', ' Natural History ', ' Biological ', ' Evaluation ', ' pediatric ', ' Childhood ', ' insight ', ' Fostering ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' Progress Reports ', ' Funding ', ' Pancreatic Insufficiency ', ' Exocrine pancreatic insufficiency ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Malignant Pancreatic Neoplasm ', ' Pancreas Cancer ', ' Pancreatic Cancer ', ' pancreatic malignancy ', ' Malignant neoplasm of pancreas ', ' Protocol ', ' Protocols documentation ', ' exocrine pancreatic ', ' Exocrine pancreas ', ' Services ', ' Manuscripts ', ' novel ', ' Participant ', ' Basic Research ', ' Basic Science ', ' Organization Charts ', ' organizational structure ', ' Position ', ' Positioning Attribute ', ' response ', ' depository ', ' repository ', ' Institution ', ' Address ', ' Aliquot ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' NCI Organization ', ' National Cancer Institute ', ' Research Infrastructure ', ' Ancillary Study ', ' Cancer Research Infrastructure ', ' Clinical Cancer Center ', ' Clinical Sciences ', ' Collection ', ' enroll ', ' Enrollment ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' work group ', ' working group ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' diagnostic marker ', ' diagnostic biomarker ', ' Infrastructure ', ' Big Data Analytics ', ' Big Data Tools ', ' Big Data Methods ', ' clinical center ', ' ']",NIDDK,OHIO STATE UNIVERSITY,U01,2020,468000,OH-03,0.09548857767348978
"Diabetes Treatments and Hypoglycemic-Related Adverse Events in Nursing Home Residents PROJECT SUMMARY/ABSTRACT The National Institute of Health report Diabetes in America (2018) noted that 39.5% of adults with diabetes are aged  65 years, and the prevalence of diabetes in older adults is dramatically increasing. Management of diabetes in older adults in nursing homes is challenging due to this population having heterogeneous comorbid medical conditions, and associated medications, many of which are contraindicated for common antidiabetic drugs. Intensive diabetes management in older adults is associated with an increased risk of hypoglycemia. Drug induced hypoglycemia is the 3rd most common adverse drug event among hospitalized Medicare beneficiaries. Hypoglycemia is experienced by 18% to 40% of nursing home residents. There is a lack of observational or clinical evidence pertaining to antidiabetic treatments in long-term care nursing home residents, despite this population being at high risk for diabetes, diabetes-related complications, and adverse effects of antidiabetic drugs. The American Diabetes Associations consensus report on diabetes in older adults noted that There are essentially no directly applicable clinical trial data on glucose control for large segments of the older diabetic patient population. Furthermore, there are few real-world studies of antidiabetic treatments in nursing home residents. In recognition of this knowledge gap in this high-risk population, the Diabetes Mellitus Interagency Coordinating Committee, as reported in the NIDDK Recent Advances & Emerging Opportunities (2019), issued a call for studies that increase our understanding of diabetes treatments in long-term care settings, with a particular emphasis on the need to understand the impact of cognitive and functional impairments, multimorbidity, polypharmacy, and risk of hypoglycemia. These priorities are central to our proposed scope of research. Using the Federally-mandated Minimum Data Set 3.0, linked to Medicare Part A and D claims, the aims are to: 1) characterize antidiabetic treatment practices among nursing home residents; 2) identify and describe clinically relevant phenotypes of diabetic nursing home residents based on patterns of cognitive/functional impairments, comorbidities, and treatment procedures/medications, and 3) estimate the occurrence of hospitalizations (overall, hypoglycemia-related, and hypoglycemia-specific) by propensity- matched patterns of antidiabetic treatments, across resident phenotypes. We hypothesize that risks associated with antidiabetic treatments will be heterogeneous across resident phenotypes. We anticipate that the phenotypic approach we propose will serve as a foundation for future work to conduct phenotypic-specific comparative effectiveness research in support of evidence-based personalized antidiabetic treatment recommendations. PROJECT NARRATIVE Nursing home residents have a high prevalence of diabetes and high risks of diabetes complications. There is limited observational or clinical evidence supporting antidiabetic treatment decisions in long-term care nursing home residents. This study will examine the use and safety of antidiabetic treatments across subgroups (phenotypes) of older nursing home residents with diabetes.",Diabetes Treatments and Hypoglycemic-Related Adverse Events in Nursing Home Residents,9957331,R21NR019160,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age Distribution ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Americas ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Data Sources ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Eligibility Determination ', ' Eligibility ', ' Protocol Screening ', ' Feedback ', ' Foundations ', ' Future ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Health ', ' Medicare ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Title 18 ', ' health insurance for disabled ', ' Home Nursing Care ', ' Non-Professional Home Care ', ' Non-Professional Homecare ', ' Nonprofessional Home Care ', ' Nonprofessional Homecare ', ' Nursing Homecare ', ' Hospitalization ', ' Hospital Admission ', ' Hypoglycemia ', ' hypoglycemic ', ' hypoglycemic episodes ', ' Long-Term Care ', ' extended care ', ' longterm care ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Persons ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nurses ', ' nurse ', ' Nursing Homes ', ' nursing home ', ' Paper ', ' Patients ', ' Phenotype ', ' Public Health ', ' Recommendation ', ' Research ', ' Risk ', ' Safety ', ' Work ', ' Generations ', ' Medicare Part A ', ' Medicare Hospital Insurance Program ', ' Price ', ' pricing ', ' Dataset ', ' Data Set ', ' Analgesic Management ', ' Pharmacologic Management ', ' medication therapy management ', ' Medication Management ', ' Guidelines ', ' analytical method ', ' base ', ' cross-link ', ' crosslink ', ' Polypharmacy ', ' Procedures ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Evaluation ', ' Individual ', ' diabetic ', ' Fostering ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' Diabetes Complications ', ' Diabetes-Related Complications ', ' Diabetic Complications ', ' Complications of Diabetes Mellitus ', ' instrument ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' Knowledge ', ' Pattern ', ' Techniques ', ' Coin ', ' American ', ' experience ', ' 65+ years old ', ' Aged 65 and Over ', ' age 65 and greater ', ' age 65 and older ', ' aged 65 and greater ', ' aged 65 ', ' human old age (65+) ', ' Medicare/Medicaid ', ' novel ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Functional impairment ', ' functional disability ', ' Adverse Experience ', ' Adverse event ', ' Adverse effects ', ' Anti-diabetic Agents ', ' Antidiabetic Agents ', ' anti-diabetic ', ' anti-diabetic drugs ', ' antidiabetic ', ' Antidiabetic Drugs ', ' diabetes risk ', ' Age-Years ', ' Data ', ' High Prevalence ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Subgroup ', ' Cognitive ', ' Nursing Home Nursing ', ' longterm care nursing ', ' Long-Term Care Nursing ', ' trend ', ' Modification ', ' beneficiary ', ' cost ', ' virtual ', ' diabetic management ', ' diabetes management ', ' Outcome ', ' glucose control ', ' glucose homeostasis ', ' glucose regulation ', ' blood glucose regulation ', ' Population ', ' Prevalence ', ' clinical relevance ', ' clinically relevant ', ' clinical applicability ', ' clinical application ', ' person centered ', ' high risk ', ' evidence base ', ' patient population ', ' diabetic patient ', ' multimorbidity ', ' multiple chronic conditions ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' Adverse drug event ', ' high risk group ', ' high risk population ', ' adverse event risk ', ' advanced analytics ', ' Comparative Effectiveness Research ', ' ']",NINR,UNIV OF MASSACHUSETTS MED SCH WORCESTER,R21,2020,251250,MA-02,0.062256513294334244
"Adverse pregnancy outcomes in women with systemic lupus erythematosus: improving and validating risk prediction ABSTRACT: Systemic lupus erythematosus (SLE) predominantly affects women during reproductive years, raising concerns regarding maternal and fetal health during pregnancy. Although physicians no longer uniformly discourage women with SLE from childbearing, patients face 20% likelihood of adverse pregnancy outcomes (APO), including preeclampsia, fetal and neonatal death, growth restriction, and preterm delivery, even during clinical disease quiescence. Because there are no established instruments to predict APO in individual patients, SLE pregnancies are intensely monitored at an emotional cost to patients and financial burden to society. The ability to identify, early in pregnancy, patients at high risk of APO would significantly enhance our capacity to clinically manage patients. Furthermore, validated risk stratification models are needed to design and execute trials to prevent APOs. In PROMISSE, the largest multi-center, multi-ethnic and multi-racial study of pregnant SLE patients to date, several risk factors were identified as significant predictors of APO. Although a major advance, these results have neither been externally validated nor shown to generalize to independent study populations. Moreover, risk factors were identified using standard statistical models that did not fully account for complex effects of multiple predictor variables. In this project, an international team of SLE, obstetric and biostatistics researchers, led by PROMISSE investigators, will rigorously develop and externally validate an APO prediction model by leveraging data from PROMISSE (N=447), as well as five independent cohorts of lupus patients from different countries (total N = 979). In Aim 1, powerful machine learning algorithms will be applied to PROMISSE data to create an accurate and clinically useful model to predict APOs in SLE patients. To maximize utility of this model in the real world, only clinical and laboratory features that are routinely and accurately assessed on SLE patients during clinical care will be considered as potential predictors. In Aim 2, the APO model will be externally validated in prospective cohorts of pregnant lupus patients from Europe (France: N=246; Germany: N=180; Norway: N=349) and regions in the US, not included in PROMISSE (South Carolina: N=82; Bronx, NY: N=122). These cohorts are heterogeneous with respect to race, ethnicity, socioeconomic strata, and SLE disease activity, allowing for a thorough investigation into generalizability and transportability of the APO model to diverse lupus patient populations. In each cohort, detailed baseline and longitudinal clinical, laboratory and pregnancy outcome data have been obtained using procedures similar to those in PROMISSE. The overarching goal is development of an online risk calculator that will significantly improve real world clinical decision making and enable risk stratification for future APO prevention trials. Impact: An accurate, validated, and user-friendly prediction model for APO is necessary for effective clinical care of pregnant lupus patients, optimal allocation of healthcare resources, and the design of and recruitment to future clinical trials of experimental interventions to prevent APO. Project Narrative Pregnancies in patients with systemic lupus erythematosus (SLE) are at increased risk for poor outcomes, such as very premature delivery, fetal death or growth restriction, yet there are no validated instruments to predict pregnancy outcomes in individual patients and focus care on those most likely to have serious complications. Our proposal is to develop and validate a prediction model that can be used to identify, early in pregnancy, SLE patients at high risk for adverse outcomes. This tool will significantly enhance the capacity to manage these patients, optimize allocation of healthcare resources, and design and conduct trials of new treatments to prevent the placental insufficiency that can result in poor outcomes.",Adverse pregnancy outcomes in women with systemic lupus erythematosus: improving and validating risk prediction,9873121,R21AR076612,"['Affect ', ' Angiogenic Factor ', ' Angiogenesis Factor ', ' Antihypertensive Agents ', ' Anti-Hypertensive Agents ', ' Anti-Hypertensive Drugs ', ' Anti-Hypertensives ', ' Antihypertensive Drugs ', ' Antihypertensives ', ' Hypotensive Agent ', ' Hypotensive Drugs ', ' Hypotensives ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Blood Platelets ', ' Marrow platelet ', ' Platelets ', ' Thrombocytes ', ' Clinical Trials ', ' Complement Activation ', ' complement pathway regulation ', ' Conceptions ', ' Financial cost ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Europe ', ' Face ', ' faces ', ' facial ', ' Fetal Death ', ' fetus death ', ' Fetal Growth Retardation ', ' Fetal Growth Restriction ', ' IUGR ', ' Intrauterine Growth Retardation ', ' impaired fetal growth ', ' intra-uterine growth restriction ', ' intra-uterine growth retardation ', ' intrauterine growth restriction ', ' prenatal growth disorder ', ' Fetus ', ' France ', ' Future ', ' Germany ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Laboratories ', ' Systemic Lupus Erythematosus ', ' Lupus Erythematosus Disseminatus ', ' SLE ', ' Systemic Lupus Erythematous ', ' Systemic Lupus Erythmatosus ', ' disseminated lupus erythematosus ', ' systemic lupus erythematosis ', ' Maternal Health ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mothers ', ' Norway ', ' Discipline of obstetrics ', ' Obstetrics ', ' Patients ', ' Physicians ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Placental Insufficiency ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' First Pregnancy Trimester ', ' 1st trimester ', ' Early Placental Phase ', ' First Trimester ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Salmon ', ' Societies ', ' South Carolina ', ' Testing ', ' Vascularization ', ' Woman ', ' Lupus Coagulation Inhibitor ', ' Lupus Anticoagulant ', ' Antiphospholipid Syndrome ', ' Anti-Phospholipid Antibody Syndrome ', ' Anti-Phospholipid Syndrome ', ' Antiphospholipid Antibody Syndrome ', ' Familial antiphospholipid syndrome ', ' health care ', ' Healthcare ', ' Schedule ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Dataset ', ' Data Set ', ' Caring ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' Anti-Phospholipid Antibodies ', ' Antiphospholipid Antibodies ', ' improved ', ' Procedures ', ' Clinical ', ' Failure ', ' Patient Focused Care ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' instrument ', ' neonatal demise ', ' neonatal death ', ' Adopted ', ' Investigation ', ' Complex ', ' Country ', ' fetal ', ' cohort ', ' novel ', ' reproductive ', ' Emotional ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' model development ', ' preventing ', ' prevent ', ' Data ', ' International ', ' Clinical Management ', ' Monitor ', ' Characteristics ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' developmental ', ' Development ', ' cost ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Lupus ', ' Outcome ', ' prospective ', ' bear children ', ' bearing children ', ' childbearing ', ' child bearing ', ' multidisciplinary ', ' user-friendly ', ' high risk ', ' pregnant ', ' clinical care ', ' patient population ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical practice ', ' clinical decision-making ', ' adverse consequence ', ' adverse outcome ', ' hypoperfusion ', ' Prevention trial ', ' individual patient ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' study population ', ' adverse pregnancy outcome ', ' Prospective cohort ', ' Risk stratification ', ' recruit ', ' Fetal health ', ' random forest ', ' machine learned algorithm ', ' machine learning algorithm ', ' financial burden ', ' financial distress ', ' financial strain ', ' financial stress ', ' Financial Hardship ', ' maternal risk ', ' machine learning method ', ' ']",NIAMS,HOSPITAL FOR SPECIAL SURGERY,R21,2020,249418,NY-12,0.06148113689870701
"Mentoring and research in applying digital technologies to prevent chronic Illnesses     DESCRIPTION (provided by applicant): For this K24 midcareer investigator award in patient-oriented research (POR) award, my goals are: 1) to become an international leader in the primary prevention of type 2 diabetes and cardiovascular diseases by applying emerging digital technologies and social media; 2) to conduct high-impact research in testing innovative, cost-effective lifestyle interventions (physical activity) using machine leaning; and 3) to provide a hih quality mentorship and training environment that supports the conduct of high POR impact research in cardiovascular and diabetes prevention. This K24 award will allow me to take on a broader and more formal mentorship role not only in the School of Nursing but also throughout the University of California, San Francisco campus. The overall goals of the new research in this application are to develop decision rule algorithms and quantitative models to optimize real-time predictions of future physical activity intervention adherences and to pilot test these algorithms and models in an intervention trial. The specific aims are: 1) to determine the extent to which baseline factors can predict adherence in self-monitoring (using mobile apps and wearing advanced accelerometers); 2) to determine the extent to which early app-based self-monitoring and evaluation (e.g., advanced accelerometers and diary use, and step counts in the first few weeks) can be optimized to make real-time predictions of future treatment failures; 3) to assess the feasibility of the ""Physical Activity Plus"" intervention using developed real-time prediction models (developed in Aim 2), compared to a ""regular physical activity"" intervention, for changes in total daily steps and duration of moderate and intensive physical activity over a three-month period. To tailor intervention intensity, we will evaluate the frequency of study visits and real-time feedback to minimize treatment failures and maximize adherence. Junior investigators in the POR have adapted digital mobile technologies as part of their research tools and have generated large volumes of continuous data. However, only a few training opportunities are available in this research area; in particular, for methods to rigorously and fully utilize the richness of the data collected. Therefore, the proposed K24 application will also meet these mentees' urgent needs across disciplines. PUBLIC HEALTH RELEVANCE: This K24 application will allow Dr. Fukuoka to use her cardiovascular and diabetes research program as a platform to mentor and guide the careers of junior investigators in patient-oriented research (POR) and to further develop her leadership and mentoring skills.",Mentoring and research in applying digital technologies to prevent chronic Illnesses,9732635,K24NR015812,"['Role ', ' social role ', ' Running ', ' San Francisco ', ' School Nursing ', ' School Health Nursing ', ' Technology ', ' Testing ', ' Thinness ', ' Leanness ', ' Time ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' United States ', ' Universities ', ' Measures ', ' therapy failure ', ' Treatment Failure ', ' Guidelines ', ' Clip ', ' base ', ' career ', ' improved ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Randomized Controlled Clinical Trials ', ' Link ', ' Evaluation ', ' Training ', ' Physical activity ', ' Failure ', ' Discipline ', ' Individual ', ' Sample Size ', ' Funding ', ' tool ', ' machine learned ', ' Machine Learning ', ' diaries ', ' programs ', ' Frequencies ', ' Complex ', ' Visit ', ' physical model ', ' skills ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' Interventional trial ', ' Intervention Trial ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' patient oriented study ', ' patient oriented research ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Mobile Phones ', ' Car Phone ', ' preventing ', ' prevent ', ' Address ', ' Adherence ', ' Data ', ' International ', ' K24 Award ', ' Mid-Career Clinical Scientist Award (K24) ', ' K24 Mechanism ', ' K24 Program ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Emergent Technologies ', ' Emerging Technologies ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Principal Investigator ', ' To specify ', ' developmental ', ' Development ', ' Behavioral ', ' Diabetes prevention ', ' cost ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' cost effective ', ' life style intervention ', ' lifestyle intervention ', ' innovate ', ' innovative ', ' innovation ', ' public health relevance ', ' Secure ', ' mobile app ', ' mobile application ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' social media ', ' training opportunity ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' accelerometry ', ' activity monitor ', ' activity tracker ', ' Accelerometer ', ' physical activity intervention ', ' exercise intervention ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' short message service ', ' texting ', ' Text Messaging ', ' pedometer ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Algorithms ', ' Award ', ' Back ', ' Dorsum ', ' Behavior ', ' California ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Electronic Mail ', ' E-Mail ', ' Email ', ' electronic communication ', ' Environment ', ' Epidemic ', ' Feedback ', ' Future ', ' Goals ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Methods ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Primary Prevention ', ' Recommendation ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' ']",NINR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",K24,2020,183406,CA-12,0.021391706915573305
"ChartGlucose4Moms: Characterizing, by Trimester, Continuous Glucose Monitoring Measurements for determining effects on Maternal & Offspring Metabolic Sequelae PROJECT SUMMARY/ABSTRACT: Gestational diabetes (GDM) rates are on the rise in the US, particularly among racial and ethnic minorities. GDM is associated with higher rates of large for gestational age (LGA) infants, C-section, and serious perinatal complications, and increased long-term risks of Type 2 diabetes and morbidity in both mothers and infants. Women who get treatment for GDM are less likely to experience perinatal complications and give birth to LGA infants than those who do not; therefore, rapid detection of GDM may be critical to reducing perinatal complications and disparities in birth outcomes. GDM is normally diagnosed by oral glucose tolerance testing (OGTT) at 24-28 weeks gestation, but clinically important insulin resistance and metabolic dysfunction may be missed by not testing earlier. A metabolically unhealthy uterine environment in early pregnancy may lead to long-term negative impacts on mother and child, but how and when to test for insulin resistance and associated metabolic dysfunction in pregnancy is poorly defined. More data are needed on how glucose levels and other metabolic measures change across pregnancy to better evaluate women's metabolic risks and how those risks relate to perinatal and long-term outcomes. Using continuous glucose monitoring (CGM) and metabolic biomarker assays, we will describe detailed metabolic phenotype profiles over the course of pregnancy and examine how they are associated with perinatal and postpartum outcomes. We propose to recruit a diverse sample of 400 women in their first trimester from Kaiser Permanente Northwest and Kaiser Permanente Hawaii and to perform CGM, OGTT, and obtain biomarkers at 12 weeks, 20 weeks, and 28 weeks of gestation to examine how these measures relate to each other and to perinatal outcomes. Aim 1 and Aim 3 will assess the effects of CGM variables (Aim 1) and OGTT and other biomarkers (Aim 3) at each time point on the risk of LGA, other perinatal outcomes, and postpartum diabetes. Aim 2 will assess the relationship between CGM variables and diagnosis of GDM by OGTT, as well as the relationship between CGM variables and other metabolic biomarkers. We hypothesize that dysglycemia is just one marker of a much larger metabolic dysregulation that can be characterized through the work of this consortium. Characterizing a broader spectrum of metabolic dysregulation and its association with adverse perinatal outcomes will lead to improved screening regimens and treatments for pregnant women and better outcomes for both mothers and babies. PROJECT NARRATIVE Gestational diabetes (GDM) is a type of diabetes that develops during pregnancy that increases the risk of pregnancy and birth complications. New tests may allow doctors to identify women with GDM earlier and more accurately than the tests currently being used, but we need to understand them better. We will recruit 400 pregnant women and screen them using both traditional and new GDM screening tools at 12, 20, and 28 weeks of pregnancy to determine how well these tools identify women who are at risk of complications and need treatment.","ChartGlucose4Moms: Characterizing, by Trimester, Continuous Glucose Monitoring Measurements for determining effects on Maternal & Offspring Metabolic Sequelae",10021656,U01DK123791,"['Adipose tissue ', ' Fatty Tissue ', ' adipose ', ' white adipose tissue ', ' yellow adipose tissue ', ' Affect ', ' Age ', ' ages ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Birth ', ' Parturition ', ' Brachial plexus structure ', ' Brachial Plexus ', ' C-Peptide ', ' connecting peptide ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cesarean section ', ' Abdominal Delivery ', ' C section ', ' Cesarean ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Oral Diagnosis ', ' Dystocia ', ' Environment ', ' Fasting ', ' fasted ', ' fasts ', ' Nonesterified Fatty Acids ', ' Free Fatty Acids ', ' Fracture ', ' bone fracture ', ' Future ', ' Gestational Age ', ' Chronologic Fetal Maturity ', ' Fetal Age ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Hawaii ', ' Health ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Hyperglycemia ', ' hyperglycemic ', ' Hypertriglyceridemia ', ' Hyperglyceridemia ', ' Raised TG ', ' Raised triglycerides ', ' elevated tg ', ' elevated triglyceride ', ' high triglycerides ', ' increased triglycerides ', ' Infant ', ' Inflammation ', ' Insulin Resistance ', ' insulin resistant ', ' Laboratories ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Life Style ', ' Lifestyle ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mothers ', ' OGTT ', ' Oral Glucose Tolerance Test ', ' Outpatients ', ' Out-patients ', ' Phenotype ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Complications ', ' complications during pregnancy ', ' pregnancy-related complications ', ' First Pregnancy Trimester ', ' 1st trimester ', ' Early Placental Phase ', ' First Trimester ', ' Third Pregnancy Trimester ', ' 3rd trimester ', ' Last Trimester ', ' Third Trimester ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Risk ', ' Shoulder ', ' Technology ', ' Testing ', ' Time ', ' Triglycerides ', ' Triacylglycerol ', ' Uterus ', ' womb ', ' Woman ', ' Work ', ' Measures ', ' Gestational Diabetes ', ' Gestational Diabetes Mellitus ', ' Pregnancy-Induced Diabetes ', ' pregnancy diabetes ', ' Postpartum ', ' post-partum ', ' Postpartum Period ', ' injuries ', ' Injury ', ' Peripartum ', ' Perinatal ', ' improved ', ' Clinical ', ' Ensure ', ' screening tools ', ' Screening procedure ', ' Organogenesis ', ' Measurement ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Metabolic ', ' Deposit ', ' Deposition ', ' tool ', ' machine learned ', ' Machine Learning ', ' neonatal demise ', ' neonatal death ', ' fetal ', ' Gestational Hypertension ', ' Hypertension induced by pregnancy ', ' Hypertension-Associated Pregnancy Disorder ', ' Pregnancy Associated Hypertension ', ' hypertensive disease of pregnancy ', ' pregnancy hypertension ', ' stillborn ', ' stillbirth ', ' experience ', ' Participant ', ' offspring ', ' reproductive ', ' Modeling ', ' Sampling ', ' glucometer ', ' glucose meter ', ' glucose monitor ', ' Symptoms ', ' Data ', ' Detection ', ' developmental ', ' Development ', ' rapid detection ', ' Outcome ', ' ethnic minority ', ' ethnic minority population ', ' high risk ', ' primary outcome ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' obesigenic ', ' obesogenic ', ' Regimen ', ' screening ', ' birth complications ', ' delivery complications ', ' perinatal outcomes ', ' metabotype ', ' metabolic phenotype ', ' metabolic profile ', ' perinatal complications ', ' marker identification ', ' biomarker identification ', ' racial minority ', ' recruit ', ' Metabolic dysfunction ', ' early pregnancy ', ' post-partum outcome ', ' postpartum outcome ', ' ']",NIDDK,KAISER FOUNDATION RESEARCH INSTITUTE,U01,2020,662614,CA-13,0.06928491964330337
"Physical Activity, Sedentary Behavior, and Cancer Incidence in Women Abstract In the United States in 2016, an estimated 600,000 people will die from cancer and 1.7 million new cases of cancer will be diagnosed. Considering the life span, almost 40% of women and men will be diagnosed with cancer at some point in their lifetime. Understanding amenable risk factors that contribute to this large public health burden is essential. Observational studies consistently indicate associations between self-reported physical activity and increased risk of many types of cancer, especially breast cancer. However, there is insufficient evidence regarding the amount, intensity, duration, and types of physical activity required to reduce cancer risk, especially for older women. Sedentary behavior may provide a more feasible intervention target, especially for older adults. However, even less is known about sedentary behavior and cancer risk. To date, no prospective studies have examined accelerometry-derived physical activity and sedentary behavior to risk of incident cancer outcomes. Advances have been made in new measurement methods by our team, but have not been applied to health outcomes to assess their value. In this application, we propose to assemble accelerometry-assessed physical activity and sedentary behavior and cancer incident events and deaths from two cohort studies of women: the Women's Health Study (WHS) and the Women's Health Initiative (WHI) Study. We will apply sophisticated, yet directly interpretable, methods to determine which physical activity and sedentary behavior features are most important for reducing cancer risk among more than 22,000 women 63 to 101 years of age. For both cohorts, one-week of accelerometry data were collected in a similar manner during 2011-2014. Follow-up of both cohorts for adjudicated cancer outcomes is planned through 2020 and likely beyond. We propose three aims. Aim 1 will apply novel and translational measures of accelerometry- assessed physical activity and sedentary behavior using latent class analysis, an activity index, and machine learning algorithms of raw accelerometry data for use in Aims 2 and 3. We will then investigate the association of accelerometry-assessed physical activity (Aim 2) and sedentary behavior (Aim 3) to overall and site-specific (e.g., breast, uterine, ovarian) incident and fatal cancer. This cost-efficient study will investigate in detail whether and how patterns of frequency, duration, intensity, bouts, and type of physical activity and sedentary behavior predict cancer outcomes. Identification of new cancer-protective patterns of physical activity and sedentary behavior will provide much-needed evidence to inform physical activity and sedentary behavior guidelines for disease prevention, can be used in interventions to reduce risk, and could revolutionize the monitoring of human responses in physical activity and sedentary behavior interventions. Project Narrative We will develop novel exposure metrics to determine the association of accelerometry-assessed physical activity and sedentary behavior to overall and site-specific incident and fatal cancer. This cost efficient project will provide much-needed evidence to inform physical activity and sedentary behavior guidelines for disease prevention in older women. Our findings can be applied to intervention studies to reduce risk. The exposure developments made from this project could revolutionize the monitoring of human responses to physical activity and sedentary behavior.","Physical Activity, Sedentary Behavior, and Cancer Incidence in Women",10019477,R01CA227122,"['Age ', ' ages ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Breast ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cause of Death ', ' Cohort Studies ', ' Concurrent Studies ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Human ', ' Modern Man ', ' Incidence ', ' indexing ', ' Intervention Studies ', ' intervention research ', ' interventional research ', ' interventional study ', ' interventions research ', ' Light ', ' Photoradiation ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Prospective Studies ', ' Public Health ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Science ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Time ', ' Translating ', ' United States ', ' Uterus ', ' womb ', ' Woman ', ' Measures ', ' Walking ', "" Women's Health "", ' Female Health ', ' Leisures ', ' Guidelines ', ' analytical method ', ' base ', ' improved ', ' Cervical ', ' Ovarian ', ' Site ', ' Chronic ', ' sedentary ', ' Physical activity ', ' insight ', ' adult youth ', ' young adulthood ', ' young adult ', ' Measurement ', ' machine learned ', ' Machine Learning ', ' Frequencies ', ' Event ', ' Pattern ', ' age group ', ' cancer risk ', ' cohort ', ' novel ', ' disease prevention ', ' disorder prevention ', ' Program Announcement ', ' NIH Program Announcements ', ' Laboratory Study ', ' Self-Report ', ' Patient Self-Report ', ' Reporting ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' data processing ', ' computerized data processing ', ' Address ', ' Dose ', ' Age-Years ', ' Data ', ' Interruption ', ' Resolution ', ' Collection ', ' Light Activity ', ' Light Exercise ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Monitor ', ' sex ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' cost ', ' adjudicate ', ' Outcome ', ' cost efficient ', ' cancer type ', ' older women ', ' Sedentary behavior ', ' Sedentary life-style ', ' sedentary lifestyle ', ' accelerometry ', ' activity monitor ', ' activity tracker ', ' Accelerometer ', ' vigorous intensity ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NCI,UNIV OF NORTH CAROLINA CHAPEL HILL,R01,2020,643923,NC-04,-0.002291334903876643
"The initial care of younger adults with newly diagnosed type 2 diabetes PROJECT SUMMARY Dr. Anjali Gopalan, MD, MSHP is a board-certified Internist at the Kaiser Permanente Northern California (KPNC) Oakland Medical Center and a Research Scientist I (equivalent to Assistant Professor) at the KPNC Division of Research (DOR). With the proposed K23 mentored career development award, Dr. Gopalan will gain the advanced training and expertise necessary to become an independent investigator who can develop and implement tailored interventions for patients with early-onset type 2 diabetes (EOT2D). By focusing on adults with EOT2D, she seeks to address the comparatively poor micro- and macrovascular outcomes in this population that may result partly from inadequate management of hyperglycemia and other cardiovascular disease risk factors. Dr. Gopalans research premise posits that it is particularly critical for newly diagnosed patients with EOT2D to achieve early disease control, since tighter glycemic control during the year following diagnosis confers long-lasting micro- and macrovascular benefits. In support of the premise, the Research Aims of this K23 are to: 1) use electronic health record [EHR] data to identify EOT2D patient subgroups at highest risk of inadequate early disease control, 2) identify barriers to and facilitators of initial EOT2D management, and 3) examine prospective associations between patient-reported factors (e.g., disease-related distress, health literacy) and inadequate early disease control. The proposed research will be supported by experienced mentors and advisors, as well as advanced training in the following areas: 1) the use of advanced statistical modeling, 2) qualitative data analysis to inform intervention development, 3) the role of social determinants in health, and 4) implementation science. KPNC and DOR are ideal environments for the proposed work. KPNC is an integrated learning healthcare delivery system with a diverse membership of 4.2 million people (>350,000 with diabetes). DOR has a long track record of effectively training early stage investigators and has well-established internal research programs and collaborative relationships with nearby institutions that provide the infrastructure needed for career development. This environment, along with the proposed Research and Training Plans and an outstanding mentorship team, will enable Dr. Gopalan to continue to build the skills and generate the foundational data needed to submit an R01-level proposal during the final years of the proposed award period. In this planned R01, Dr. Gopalan will refine and implement an intervention (with a design based on the results of the three K23 Research Aims) to improve early care for newly diagnosed EOT2D patients and evaluate its impact on early outcomes in this growing, high-risk population. In summary, the proposed K23 award will support the career development of Dr. Gopalan and is vital to her acquiring the skill set and expertise required to become a successful, independent investigator. PROJECT NARRATIVE Adults diagnosed with type 2 diabetes at a younger age have higher rates of complications than those diagnosed later in life. Given the lasting benefit conferred by early disease control, the initial care provided to this growing, high-risk population is particularly crucial. With this proposed career development award, Dr. Gopalan will acquire the research skills necessary to identify patients at highest risk for inadequate early disease control, define barriers to initial disease management, and develop an intervention designed to improve the care of adults (ages 21-44) with newly diagnosed type 2 diabetes.",The initial care of younger adults with newly diagnosed type 2 diabetes,10226398,K23DK116968,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Age ', ' ages ', ' Award ', ' California ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Reporting ', ' data representation ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Environment ', ' Face ', ' faces ', ' facial ', ' Foundations ', ' Future ', ' Goals ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Hyperglycemia ', ' hyperglycemic ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Interview ', ' Learning ', ' literacy ', ' Mentors ', ' Mentorship ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Myocardial Infarction ', ' Cardiac infarction ', ' Myocardial Infarct ', ' cardiac infarct ', ' coronary attack ', ' coronary infarct ', ' coronary infarction ', ' heart attack ', ' heart infarct ', ' heart infarction ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Population Characteristics ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Risk Management ', ' Role ', ' social role ', ' Smoke ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Trees ', ' United Kingdom ', ' Work ', ' Latino ', ' Research Methods ', ' Research Methodology ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Training ', ' Distress ', ' insight ', ' adult youth ', ' young adulthood ', ' young adult ', ' Internist ', ' integrated health system ', ' integrated healthcare systems ', ' Integrated Health Care Systems ', ' Diabetes Complications ', ' Diabetes-Related Complications ', ' Diabetic Complications ', ' Complications of Diabetes Mellitus ', ' machine learned ', ' Machine Learning ', ' Life ', ' Disorder Management ', ' Disease Management ', ' programs ', ' Scientist ', ' System ', ' Medical center ', ' diabetes education ', ' experience ', ' professor ', ' cohort ', ' Familiarity ', ' skills ', ' member ', ' Self-Report ', ' Patient Self-Report ', ' Reporting ', ' Modeling ', ' Sampling ', ' career development ', ' stigma ', ' social stigma ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disease control ', ' disorder control ', ' Qualitative Research ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Risk Reduction ', ' Provider ', ' Institution ', ' Address ', ' Data ', ' Health Sciences ', ' K23 Award ', ' K23 Mechanism ', ' K23 Program ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' Mentored Patient-Oriented Research Career Development Award ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Research Training ', ' Clinical Data ', ' Newly Diagnosed ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' early onset ', ' health literacy ', ' macrovascular complication ', ' macrovascular disease ', ' burden of disease ', ' disease burden ', ' years of life lost to disability ', ' years of life lost to disease ', ' burden of illness ', ' designing ', ' design ', ' diabetic management ', ' diabetes management ', ' glycemic control ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' prospective ', ' protective effect ', ' racial and ethnic ', ' comparative ', ' implementation science ', ' intervention design ', ' treatment design ', ' therapy design ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' high risk ', ' patient population ', ' e-Health ', ' eHealth ', ' individual patient ', ' improved outcome ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' ethnically diverse ', ' ethnic diversity ', ' high risk group ', ' high risk population ', ' Retrospective cohort ', ' barrier to health care ', ' barrier to healthcare ', ' barrier to treatment ', ' obstacle to care ', ' obstacle to healthcare ', ' barrier to care ', ' Infrastructure ', ' sociodeterminant ', ' social determinants ', ' ']",NIDDK,KAISER FOUNDATION RESEARCH INSTITUTE,K23,2020,54000,CA-13,0.06730211780386315
"A Health Equity Paradigm Shift:   Predictors of Healthy Pregnancy in African American Women ABSTRACT African-American women bear a disproportionate burden of maternal morbidity and mortality in the United States, regardless of socio-economic, educational, or marital status. Fortunately, maternal death rarely occurs without warning. Pregnancy complications, such as those that increase the risk of future cardiovascular disease (preterm birth, growth restriction, preeclampsia, and gestational diabetes), or severe maternal morbidity (SMM) can serve as sentinel events that herald the impending possibility of a mother's increased risk for maternal mortality (MM). Most health disparities studies to date have used a deficit-based model and have included white women as the reference group to identify detrimental factors. In this supplement, I propose to instead use a strength-based model that utilizes African-American women with healthy pregnancy outcomes as the reference group. I will compare them to African American women with pregnancy complications to identify protective factors because African American women with healthy pregnancies may provide key insight to inform future prevention strategies. The objective of this supplement is to identify environmental, systems, behavioral, medical, and biological constructs that predict a healthy, uncomplicated pregnancy in African- American women. The proposed supplemental study leverages a rich repository of clinical, survey and biospecimen data from a contemporary cohort of 852 African American women enrolled in an observational preterm birth study from 2017-2020, 549 (64%) of whom went on to have a healthy pregnancy, free from complications that predict future cardiovascular disease. I will use two complementary approaches, multi-level modeling and machine learning, to quantify the relative contributions of modifiable protective factors to a healthy pregnancy across multiple levels and domains of influence. Using an adaptation of the National Institute on Minority Health Disparities Research Framework, I will identify factors that protect African-American women from pregnancy complications that predict future cardiovascular disease (Aim 1.1), SMM (Aim 1.2), and a composite morbidity index combining the two (Aim 1.3). Finally, the work of interpreting the empirical findings from Aim 1, to develop potential interventions and policy changes, will begin in Aim 2. This aim is aspirational in nature, but included in this brief supplement to stress the importance of identifying actionable items from study findings of protective factors that are most amenable to targeting through interventions and/or health policy. A team of diverse stakeholders, including a Maternal Advisory Panel of African American Mothers, Clinicians, and Perinatal Researchers will use intervention mapping (a rigorous method that has been used to create behavioral health interventions) to review study findings, methodically think through ways to translate study findings into action, and make recommendations for future directions that are most likely to promote health equity for African American mothers. 1 NARRATIVE Most health disparities studies that have attempted to identify factors that explain the higher rates of severe maternal morbidity and mortality among African-American women have used a deficit-based model and included white women as the reference group to identify detrimental factors. In this supplement, I propose to instead use a strength-based model that utilizes African American women with healthy pregnancies as the reference group to identify protective factors that can be targeted through the design of future interventions to promote health equity. 1",A Health Equity Paradigm Shift:   Predictors of Healthy Pregnancy in African American Women,10200462,K23HD095075,"['Ursidae Family ', ' Bears ', ' Ursidae ', ' bear ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Educational Status ', ' Educational Achievement ', ' educational level ', ' training achievement ', ' training level ', ' training status ', ' Fetal Growth Retardation ', ' Fetal Growth Restriction ', ' IUGR ', ' Intrauterine Growth Retardation ', ' impaired fetal growth ', ' intra-uterine growth restriction ', ' intra-uterine growth retardation ', ' intrauterine growth restriction ', ' prenatal growth disorder ', ' Future ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Hematology ', ' indexing ', ' Institutes ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Life Experience ', ' Marital Status ', ' Maternal Mortality ', ' maternal death ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mothers ', ' Discipline of obstetrics ', ' Obstetrics ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Pregnancy Complications ', ' complications during pregnancy ', ' pregnancy-related complications ', ' Pregnancy Outcome ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Translating ', ' United States ', ' Woman ', ' Work ', ' Measures ', ' Gestational Diabetes ', ' Gestational Diabetes Mellitus ', ' Pregnancy-Induced Diabetes ', ' pregnancy diabetes ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Dataset ', ' Data Set ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' pregnancy disorder ', ' base ', ' Organ ', ' Peripartum ', ' Perinatal ', ' Area ', ' Acute ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Medical ', ' racism ', ' Ensure ', ' insight ', ' Policies ', ' Funding ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Event ', ' System ', ' Live Birth ', ' respiratory ', ' Consult ', ' cohort ', ' Proxy ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Predictive Factor ', ' reproductive ', ' methods to study multiple-level influences ', ' multi-level analysis ', ' multi-level model ', ' multilevel model ', ' multilevel modeling ', ' multilevel analysis ', ' Modeling ', ' career development ', ' theories ', ' depository ', ' repository ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Sentinel ', ' disparity in health ', ' health disparity ', ' Data ', ' enroll ', ' Enrollment ', ' Modification ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' Behavioral ', ' work group ', ' working group ', ' minority health ', ' designing ', ' design ', ' Outcome ', ' Trauma ', ' multidisciplinary ', ' pregnant ', ' health equity ', ' Secure ', ' behavioral health intervention ', ' maternal morbidity ', ' adverse pregnancy outcome ', ' healthy pregnancy ', ' protective factors ', ' early pregnancy ', ' health goals ', ' maternal risk ', ' severe maternal morbidity ', ' ']",NICHD,WASHINGTON UNIVERSITY,K23,2020,162000,MO-01,0.054306125568550294
"A Smartphone Intervention for Pregnancy Smoking Cessation with Peer Support PROJECT SUMMARY/ABSTRACT  Tobacco smoking among women in Romania increased dramatically, by close to 30%, between 2011-2018 and the share of smokers with quit attempts decreased by 37%. Tobacco kills more than 8 million people a year around the world. The burden of tobacco-related illness and death is heaviest in low- and middle-income countries (LMICs) like Romania, where 80% of the worldwide 1.1 billion smokers live. Our work showed that 30% of women smoke pre-pregnancy in Romania and half of the smokers continue during pregnancy. It is critically important to address tobacco smoking during pregnancy, an extraordinary window of opportunity for sustained cessation. The objectives of this application are to develop, implement, and test the feasibility and effectiveness of an adaptive mobile pregnancy tobacco cessation app-based intervention using deep tailoring and a self-nominated support person, and to build mHealth research capacity in Romania. We build on our pregnancy smoking cessation trials with spousal support in Romania, including the ongoing Smoke Free Together (SFT1.0) mHealth pilot trial and the Quit Together telephone counseling trial that shows preliminary evidence of efficacy, and on our partnerships in Romania. The central hypothesis is that the intervention will show evidence of feasibility and effectiveness in increasing positive support, pregnancy cessation, and postnatal abstinence. The app will be novel in its use of the unique functionality of smartphones, use of reinforcement learning (RL) and deep tailoring to continuously adapt the intervention, the emphasis on increasing positive support, and the use of the app by both smoker and quit-partner. The aims are: 1. (R21 phase). Develop and test the feasibility and acceptability of the SFT2.0 app-based mobile smoking cessation intervention with quit-partner support during pregnancy and postpartum in Romania; 2. (R33 phase). Test the SFT2.0 app-based smoking cessation intervention in a hybrid effectiveness and implementation randomized controlled trial; 3. (R21 and R33 phases). Develop mHealth research capacity by enhancing individual and institutional research capabilities in Romania and expanding the existing international research network. With respect to expected outcomes, the proposed application is anticipated to advance understanding of the effectiveness and implementation of a smartphone-based app for pregnancy smoking cessation with quit- partner support. Such results are anticipated to have a system wide sustainable positive impact on the prevention of prenatal and postnatal smoking as the intervention has a high potential to be adopted in the universal health system in Romania, with applications to the US and other populations. The development of the international research network and the individual and institutional mHealth research capacity building is expected to positively impact mHealth research in CEE and the neighboring region. The proposed research is relevant to public health because the findings will have a system wide sustainable impact on the prevention of prenatal and postnatal tobacco smoking in Romania and in Central and Eastern Europe, with applications to the US and other populations. The research is also expected to have an important impact on the methodology and design of mobile technology clinical and public health interventions during the reproductive years with lifelong potential implications. Thus, the proposed research is relevant to the part of NIH's mission that pertains to developing fundamental knowledge that will help enhance health and reduce the burdens of human illness.",A Smartphone Intervention for Pregnancy Smoking Cessation with Peer Support,10057086,R21HD103039,"['Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Birth ', ' Parturition ', ' Control Groups ', ' Counseling ', ' Professional counselor ', ' Counselor ', ' Couples ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Eastern Europe ', ' Goals ', ' Health ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Human ', ' Modern Man ', ' Hybrids ', ' Learning ', ' Methodology ', ' Mission ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Persons ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Ownership ', ' Pregnancy ', ' Gestation ', ' Pregnancy Tests ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Public Health ', ' Psychological reinforcement ', ' Reinforcement ', ' Research ', ' Romania ', ' Self Determination ', ' Smoke ', ' Smoking ', ' Stress ', ' Telephone ', ' Phone ', ' Testing ', ' Tobacco ', ' Woman ', ' Work ', ' Friends ', ' smoking cessation ', ' cease smoking ', ' quit smoking ', ' stop smoking ', ' health care ', ' Healthcare ', ' Postpartum ', ' post-partum ', ' Postpartum Period ', ' Married Persons ', ' Spouses ', ' base ', ' Clinical ', ' Phase ', ' Series ', ' Individual ', ' Randomized Controlled Trials ', ' Smoker ', ' Knowledge ', ' programs ', ' Adopted ', ' postnatal ', ' System ', ' Tobacco smoking ', ' Tobacco smoking behavior ', ' behavior change ', ' Tobacco Cessation ', ' Tobacco Use Cessation ', ' unborn ', ' prenatal ', ' novel ', ' offspring ', ' motivational interview ', ' motivational enhancement therapy ', ' General Public ', ' General Population ', ' Prevention ', ' reproductive ', ' craving ', ' theories ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Mobile Phones ', ' Car Phone ', ' smoking cessation treatment ', ' Smoking Cessation Intervention ', ' Effectiveness ', ' Address ', ' Health system ', ' International ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' developmental ', ' Development ', ' tobacco control ', ' pilot trial ', ' designing ', ' design ', ' Outcome ', ' Population ', ' Abstinence ', ' user centered design ', ' usability ', ' iterative design ', ' arm ', ' m-Health ', ' mobile health ', ' mHealth ', ' public health intervention ', ' peer support ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' adaptive learning ', ' LMIC ', ' low and middle-income countries ', ' prenatal smoking ', ' smoking during pregnancy ', ' smoking abstinence ', ' prepregnancy ', ' pregnant cigarette smoker ', ' pregnant smoker ', ' prenatal cigarette smoking ', ' ']",NICHD,MICHIGAN STATE UNIVERSITY,R21,2020,210787,MI-08,0.028402589176197885
"Obesity Prevention in Postpartum Women at High-Risk of Cardiovascular Disease PROJECT SUMMARY  Obesity is a significant risk factor for cardiovascular (CV) disease that affects 39% of adults in the U.S. Obesity rates are disproportionately rising among women and contribute to increasing rates of diabetes and CV mortality among women younger than 55 years. Pregnancy represents a life transition when many women gain excess weight. The effect of obesity is further magnified in women with preeclampsia, an independent and underappreciated risk factor for future CV disease. There is a pressing need to better understand predictors of excessive postpartum weight retention in order to deliver effective and scalable weight loss interventions during a period when women at highest risk may be particularly receptive to lifestyle change.  Social incentives, or the influences that impact behavior change based on relationships, are strong motivators of healthy behavior. The use of game design elements, such as goal-setting, has been successfully combined with social incentives to enhance healthy behavior in other disease settings. The central hypothesis of this proposal is that a behavioral intervention using these novel approaches, combined with an established behavioral weight loss program, will provide an effective, and scalable solution to reduce the incidence of postpartum obesity. This proposal will leverage mentorship of senior investigators (Drs. Michal Elovitz and Peter Groeneveld) and Penns mature research programs in cardiovascular medicine, maternal fetal medicine, and behavioral economics. Research will be conducted in an urban and racially diverse population since these women are most likely to benefit from interventions to reduce CV risk. Aim 1 will use robust statistical methods and machine learning to create a clinical prediction tool for postpartum weight retention in an existing electronic health record database enriched with neighborhood-level data. Aim 2 will use qualitative and mixed methods to identify strategies to enhance the design of a pilot intervention using patient feedback. Aim 3 will implement a 2-arm single site randomized clinical trial to achieve weight loss in women with preeclampsia or gestational hypertension participating in an online behavioral weight loss program using remote technology and social feedback from other postpartum women.  This proposal will identify women at an early stage in life who will benefit the most from intensive lifestyle changes and will test and refine interventions that are able to be disseminated to postpartum women remotely. Dr. Lewey is a general cardiologist trained in womens health and population science with established expertise in pregnancy associated cardiovascular disorders. The training she proposes in advanced statistical methods, qualitative analysis, and behavioral clinical trial design will position her to become a leader in womens cardiovascular health. By the conclusion of this program, she will be able to independently design, target, and evaluate behavioral interventions to prevent heart disease in women. The results of the proposed K23 will be invaluable pilot work for a planned R01-level application. PROJECT NARRATIVE The postpartum period represents a unique time in a womens life when many women gain excess weight and make the transition to becoming overweight or obese. We propose to rigorously study predictors of postpartum obesity and evaluate an innovative approach to improve weight loss in the postpartum period using an online behavioral weight loss program and social feedback from a team of other postpartum women. By identifying women at an early stage in life who will benefit the most from intensive lifestyle changes and testing interventions that are low cost, sustainable, and remotely delivered, we hope to significantly improve cardiovascular health and reduce the burden of cardiovascular disease in women, which is a central mission of the National Heart, Lung, and Blood Institute (NHLBI).",Obesity Prevention in Postpartum Women at High-Risk of Cardiovascular Disease,10040416,K23HL153667,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Award ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Censuses ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Elements ', ' Face ', ' faces ', ' facial ', ' Feedback ', ' Future ', ' Goals ', ' Health behavior ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Incentives ', ' Incidence ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Life Style ', ' Lifestyle ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Mission ', ' mortality ', ' Mothers ', ' Persons ', ' Neighborhoods ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Pennsylvania ', ' Postpartum Women ', ' Post-partum Women ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Rewards ', ' Risk Factors ', ' Social Characteristics ', ' Social Environment ', ' social climate ', ' social context ', ' socioenvironment ', ' socioenvironmental ', ' Technology ', ' Testing ', ' Time ', ' Universities ', ' Weight Gain ', ' Weight Increase ', ' body weight gain ', ' body weight increase ', ' wt gain ', ' Body Weight decreased ', ' Weight Loss ', ' Weight Reduction ', ' body weight loss ', ' wt-loss ', ' Weight ', ' Woman ', ' Work ', ' Accountability ', "" Women's Health "", ' Female Health ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' Postpartum ', ' post-partum ', ' Postpartum Period ', ' pregnancy disorder ', ' base ', ' career ', ' Peripartum ', ' Perinatal ', ' improved ', ' Site ', ' Clinical ', ' Randomized Clinical Trials ', ' Link ', ' Training ', ' Physical activity ', ' Individual ', ' Health Care Utilization ', ' health care service use ', ' healthcare service use ', ' healthcare service utilization ', ' healthcare utilization ', ' health care service utilization ', ' Data Bases ', ' data base ', ' Databases ', ' women at high risk ', ' High Risk Woman ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Life ', ' programs ', ' Techniques ', ' Over weight ', ' Overweight ', ' behavior change ', ' Physical environment ', ' Gestational Hypertension ', ' Hypertension induced by pregnancy ', ' Hypertension-Associated Pregnancy Disorder ', ' Pregnancy Associated Hypertension ', ' hypertensive disease of pregnancy ', ' pregnancy hypertension ', ' cohort ', ' skills ', ' social ', ' Position ', ' Positioning Attribute ', ' Statistical Methods ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Modeling ', ' career development ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Institution ', ' preventing ', ' prevent ', ' Address ', ' qualitative reasoning ', ' Qualitative Methods ', ' Data ', ' Health Sciences ', ' Population Sciences ', ' Clinical Trials Design ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' Behavioral ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' obesity prevention ', ' cost ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' weight loss intervention ', ' behavioral clinical trial ', ' patient centered ', ' patient oriented ', ' high risk ', ' secondary outcome ', ' arm ', ' healthy life-style ', ' healthy lifestyle ', ' gestational weight gain ', ' behavioral economics ', ' cardiovascular health ', ' peer support ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' predictive tools ', ' racially diverse ', ' racial diversity ', ' neighborhood disadvantage ', ' post-partum weight ', ' postpartum weight ', ' recruit ', ' weight loss programming ', ' weight loss program ', ' Maternal-fetal medicine ', ' Infrastructure ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,K23,2020,175248,PA-03,-0.0035569296359027444
